User:Daniel Mietchen/Wikidata lists/Items with MeSH Codes

This page mirrors information available on Wikidata. See also Autolist and wiga for other ways to browse this information.


This list is automatically generated from data in Wikidata and is periodically updated by Listeriabot.
Edits made within the list area will be removed on the next update!

Act of Congress edit

Article instance of subclass of description MeSH Code Commons category image
American Recovery and Reinvestment Act of 2009 Act of Congress N03.706.615.049 American Recovery and Reinvestment Act of 2009
Employee Retirement Income Security Act of 1974 Act of Congress N01.824.417.510.300
N01.824.417.700.325.300
N03.219.521.576.343.290.300
N03.706.615.215
N04.452.677.800.325.300
Health Insurance Portability and Accountability Act Act of Congress N03.219.521.576.343.349
N03.706.615.273
Medicare Access and CHIP Reauthorization Act of 2015 Act of Congress N03.219.521.346.506.564.663.250
N03.219.521.576.343.840.254
N03.706.615.696.500
Tax Equity and Fiscal Responsibility Act of 1982 Act of Congress N03.219.900.880
N03.706.615.889


ChEBI Ontology term edit

Article instance of subclass of description MeSH Code Commons category image
adrenergic agonist ChEBI Ontology term drug
agonist
Adrenergic Agents
drug that stimulates a response from the adrenergic receptors D27.505.696.577.050.100
D27.505.519.625.050.100
analgesic ChEBI Ontology term drug
Central Nervous System Agents
Sensory System Agents
pharmaceutical drug D27.505.696.663.850.014
D27.505.954.427.040
Analgesics
anesthetic ChEBI Ontology term drug
Central Nervous System Depressants
drug that causes anesthesia D27.505.954.427.210.100
D27.505.696.277.100
Anesthetics
angiogenesis inhibitor ChEBI Ontology term drug
antineoplastic
Growth Inhibitors
Angiogenesis Modulating Agents
agent and endogenous substance that antagonizes or inhibits the development of new blood vessels D27.505.696.377.450.100
D27.505.954.248.025
D27.505.696.377.077.099
Angiogenesis inhibitors
anthelmintic ChEBI Ontology term antiparasitic Substance intended to kill parasitic worms (helminths) D27.505.954.122.250.075 Antihelmintics
anti-diabetic medication ChEBI Ontology term Physiological Effects of Drugs Substances which lower blood glucose levels D27.505.696.422 Anti-diabetic drugs
anti-ulcer drug ChEBI Ontology term drug
Gastrointestinal Agents
One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. D27.505.954.483.203
antiarrhythmic agent ChEBI Ontology term drug
Cardiovascular Agents
group of pharmaceuticals that are used to suppress abnormal rhythms of the heart (cardiac arrhythmias), such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. D27.505.954.411.097 Antiarrhythmic agents
anticholinergic ChEBI Ontology term drug
Cholinergic Agents
chemical substance that blocks the neurotransmitter acetylcholine in the central and the peripheral nervous system D27.505.519.625.120.200
D27.505.696.577.120.200
Anticholinergics
anticonvulsant ChEBI Ontology term drug
Central Nervous System Agents
Class of medications D27.505.954.427.080 Anticonvulsants
antiemetic ChEBI Ontology term drug
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
drug used to prevent nausea or vomiting D27.505.696.663.050.030
D27.505.954.483.200
D27.505.954.427.095
Antiemetics
antifungal medication ChEBI Ontology term drug
Anti-Infective Agents
Category of pharmaceutical drugs D27.505.954.122.136 Antifungals
antihypertensive drug ChEBI Ontology term drug
Cardiovascular Agents
all drugs for hypertension's treatment D27.505.954.411.162 Antihypertensive agents
antineoplastic ChEBI Ontology term drug
Therapeutic Uses
group of chemical compounds D27.505.954.248 Antineoplastic agents
antiparasitic ChEBI Ontology term drug
Anti-Infective Agents
A substance used to treat or prevent parasitic infections D27.505.954.122.250 Antiparasitic agents
antiprotozoal ChEBI Ontology term antiparasitic class of pharmaceuticals used in treatment of protozoan infection D27.505.954.122.250.100 Antiprotozoal agents
antipruritic ChEBI Ontology term dermatologic drug drug, usually applied topically, that relieves pruritus (itching) D27.505.954.444.075
antipsychotic ChEBI Ontology term tranquilizer class of medications D27.505.696.277.950.040
D27.505.954.427.700.872.331
D27.505.954.427.210.950.040
Antipsychotic drugs
antipyretic ChEBI Ontology term drug
Physiological Effects of Drugs
drug that prevents or reduces fever by lowering the body temperature from a raised state D27.505.696.068 Antipyretics
antitussive ChEBI Ontology term drug
Central Nervous System Agents
Respiratory System Agents
Agents that suppress cough. They act centrally on the medullary cough center. Expectorants, also used in the treatment of cough, act locally D27.505.954.427.153
D27.505.954.796.090
Antitussives
 
antiviral agent ChEBI Ontology term antibiotic
Anti-Infective Agents
substance that destroys or inhibits replication of viruses D27.505.954.122.388
anxiolytic ChEBI Ontology term tranquilizer medication or other intervention that inhibits anxiety D27.505.954.427.210.950.015
D27.505.954.427.700.872.015
D27.505.696.277.950.015
Anxiolytics
bronchodilator ChEBI Ontology term drug
Autonomic Agents
Anti-Asthmatic Agents
substance that dilates the bronchi and bronchioles, decreasing resistance in the respiratory airway and increasing airflow to the lungs D27.505.696.663.050.110
D27.505.954.796.050.100
Bronchodilators
dermatologic drug ChEBI Ontology term drug
Therapeutic Uses
drug used to treat or prevent skin disorders or for the routine care of skin D27.505.954.444
diuretic ChEBI Ontology term chemical substance
Natriuretic Agents
substance that promotes the production of urine D27.505.696.560.500 Diuretics
histaminergic ChEBI Ontology term neurotransmitter Class of medications D27.505.519.625.375
D27.505.696.577.375
hypolipidemic ChEBI Ontology term drug
Antimetabolites
Lipid Regulating Agents
substance used to treat hyperlipidemia (an excess of lipids in the blood) D27.505.954.557.500
D27.505.519.186.071
Hypolipidemic agents
keratolytic ChEBI Ontology term dermatologic drug drug that softens, separates, and causes desquamation of the cornified epithelium or horny layer of skin D27.505.954.444.400
local anesthetic ChEBI Ontology term anesthetic
Sensory System Agents
medication that causes reversible absence of pain sensation D27.505.954.427.210.100.200
D27.505.696.277.100.200
D27.505.696.663.850.025
Local anesthetics
non-steroidal anti-inflammatory drug ChEBI Ontology term non-opioid analgesic
anti-inflammatory agent
disease-modifying antirheumatic drug
class of drug D27.505.696.663.850.014.040.500
D27.505.954.329.030
D27.505.954.158.030
Non-steroidal anti-inflammatory drugs
nootropic ChEBI Ontology term chemical substance
Central Nervous System Agents
drug, supplement, or other substance that improves cognitive function D27.505.954.427.637 Nootropics
opioid ChEBI Ontology term psychoactive drug
analgesic
narcotic
psychoactive chemical D27.505.696.277.600.500
D27.505.954.427.210.600.500
D27.505.954.427.040.550.500
D27.505.696.663.850.014.760.500
Opioids
Prostaglandin antagonist ChEBI Ontology term Hormone antagonist
Hormone Antagonists
compound that inhibits the action of prostaglandins D27.505.696.399.450.710
Proteasome inhibitor ChEBI Ontology term drug
Protease inhibitor
drug that blocks the action of proteasomes, cellular complexes that break down proteins D27.505.519.389.745.705
tranquilizer ChEBI Ontology term drug
Central Nervous System Depressants
Psychotropic Drugs
drug that induces tranquility in an individual D27.505.954.427.700.872
D27.505.696.277.950
D27.505.954.427.210.950
vasodilator agent ChEBI Ontology term Cardiovascular Agents drug used to cause dilation of the blood vessels D27.505.954.411.918 Vasodilators


academic discipline edit

Article instance of subclass of description MeSH Code Commons category image
anthropology academic discipline
academic major
social science science of humanity I01.076 Anthropology
computational biology academic discipline biology
computational science
information science
data-analytical and theoretical methods, mathematical modeling and computational simulation techniques to the study of biological, behavioral, and social systems H01.158.273.180
L01.313.124
Bioinformatics
humanities academic discipline
non-science
academic major
knowledge academic disciplines that study human culture K Humanities
 
sociology academic discipline
academic major
social science scientific study of human society and its origins, development, organizations, and institutions I Sociology


anatomical region edit

Article instance of subclass of description MeSH Code Commons category image
armpit anatomical region anatomical region area of human body beneath joint between arm and torso A01.378.800.090 Armpits
 
upper arm anatomical region
anatomical structure
anatomical structure proximal part of the free upper limb between the shoulder and the elbow A01.378.800.075 Arms


anatomical structure edit

Article instance of subclass of description MeSH Code Commons category image
abdominal cavity anatomical structure abdominopelvic cavity A01.047.025
 
acetabulum anatomical structure A02.835.232.611.108 Acetabulum
adenoid anatomical structure A10.549.100 Adenoids
adrenal gland anatomical structure endocrine gland endocrine gland that produces a variety of hormones A06.407.071 Adrenal glands
 
anal canal anatomical structure part of large intestine A03.556.124.526.070
 
ankle anatomical structure region where the foot and the leg meet A02.835.583.378.062 Ankles
anterior hypothalamic nucleus anatomical structure A08.186.211.730.385.357.342.063
anterior pituitary anatomical structure glandular, anterior lobe that, together with the posterior lobe, makes up the pituitary gland A06.407.747.608
appendix anatomical structure
animal organ
animal organ blind-ended tube connected to the cecum, from which it develops embryologically A03.556.124.526.209.290 Vermiform appendix
Bowman's membrane anatomical structure A09.371.060.217.113
bronchus anatomical structure airway in the respiratory tracti A04.411.125 Bronchi
 
carpal bone anatomical structure bone of hand bone A02.835.232.087.144 Carpus
cecum anatomical structure pouch that is considered to be the beginning of the large intestine A03.556.124.526.209 Cecum
 
central nervous system anatomical structure part of the nervous system consisting of the brain and spinal cord A08.186 Central nervous system
cerebral aqueduct anatomical structure A08.186.211.132.659.822.187 Cerebral aqueduct
Chordae tendineae anatomical structure cord-like tendons that connect the papillary muscles to the tricuspid valve and the mitral valve in the heart A07.541.510.240
choroid anatomical structure vascular layer of the eye, containing connective tissue, and lying between the retina and the sclera A09.371.894.223 Choroid
ciliary body anatomical structure A09.371.894.280
cochlea anatomical structure organ of the inner ear A09.246.631.246 Cochlea
cochlear duct anatomical structure A09.246.631.246.292
conjunctiva anatomical structure Outer covering of sclera A09.371.192 Sight
corpus callosum anatomical structure axon brain part A08.186.211.730.885.362 Corpus callosum
dental alveolus anatomical structure A02.835.232.781.324.502.125.800
descending colon anatomical structure the part of the colon from the splenic flexure to the beginning of the sigmoid colon A03.556.124.526.356.500
 
diencephalon anatomical structure brain region consists of structures that are lateral to the third ventricle, and includes the thalamus, the hypothalamus, the epithalamus and the subthalamus; one of the main vesicles of the brain formed during embryogenesis A08.186.211.730.385 Diencephalon
 
duodenum anatomical structure first section of the small intestine A03.556.124.684.124 Duodenum
 
eardrum anatomical structure membrane organ membrane that separates the external ear from the middle ear A09.246.272.702 Eardrum
elbow anatomical structure synovial hinge joint between the humerus in the upper arm and the radius and ulna in the forearm A02.835.583.290 Elbow
 
endolymphatic sac anatomical structure A09.246.631.909.957.360.701
ependyma anatomical structure epithelial lining of the ventricular system of the brain and the central canal of the spinal cord, made up of ependymal cells A08.186.211.276.460
epidermis anatomical structure outermost layers of the skin A10.272.497
A17.815.250
Epidermis (skin)
epithalamus anatomical structure part of diencephalon A08.186.211.577.200
esophagus anatomical structure organ in vertebrates A03.556.875.500 Esophagus
ethmoid sinus anatomical structure paranasal sinus A04.531.621.267
Eustachian tube anatomical structure A09.246.397.369 Eustachian tube
eye anatomical structure animal organ
facial feature
organ that detects light and converts it into electro-chemical impulses in neurons A01.456.505.420 Eyes
 
eyelid anatomical structure thin fold of skin that covers and protects the human eye A01.456.505.420.504 Eyelids
 
face anatomical structure part of the body at the front of the head A01.456.505 Faces
Fallopian tube anatomical structure A05.360.319.114.373 Fallopian tube
foramen magnum anatomical structure opening in the occipital bone of the cranium A02.835.232.781.572.434 Foramen magnum
forearm anatomical structure anatomical structure part of the body A01.378.800.585 Forearms
 
fourth ventricle anatomical structure ventricular system A08.186.211.276.500 Fourth ventricle
frontal sinus anatomical structure paranasal sinus A04.531.621.387 Frontal sinuses
glomerular basement membrane anatomical structure basement membrane A11.284.295.310.279
glomerulus anatomical structure A05.810.453.324.359 Renal corpuscle
hard palate anatomical structure thin horizontal bony plate of the skull, located in the roof of the mouth A02.835.232.781.324.502.660
heart anatomical structure animal organ
muscle
organ for the circulation of blood in animal circulatory systems A07.541 Heart (organ)
 
hip anatomical structure anatomical region anatomical region A01.378.610.400 Hip
 
humerus anatomical structure
bone
arm bone long bone of the upper arm A02.835.232.087.090.400 Humerus
 
hypothalamus anatomical structure part of diencephalon A08.186.211.730.385.357 Hypothalamus
 
ileocecal valve anatomical structure valve A03.556.124.684.249.400 Ileocecal valve
inferior olivary nucleus anatomical structure A08.186.211.132.810.406.574
inner ear anatomical structure innermost part of the vertebrate ear A09.246.631 Inner ear
interatrial septum anatomical structure cardiac septum The interatrial septum is the wall of tissue that separates the right and left atria of the heart. A07.541.459
interventricular septum anatomical structure cardiac septum A07.541.459 ECHOpedia case 'Ventricular septum defect with right to left shunt'
iris anatomical structure part of an eye A09.371.894.513 Iris (eye)
jejunum anatomical structure part of small intestine A03.556.124.684.500
 
kidney anatomical structure animal organ internal organ in most animals, including vertebrates and some invertebrates A05.810.453 Kidneys
 
lateral ventricle anatomical structure brain region
ventricular system
A08.186.211.276.650 Lateral ventricles
loop of Henle anatomical structure kidney tubule A05.810.453.736.560.610
mammillary body anatomical structure pair of small round bodies, located on the undersurface of the brain that, as part of the diencephalon, form part of the limbic system A08.186.211.730.385.357.362.500 Mammillary bodies
maxillary sinus anatomical structure paranasal sinus A04.531.621.578 Maxillary sinuses
 
metacarpal bone anatomical structure bone of hand bone of hand A01.378.800.667.572 Metacarpus
metacarpophalangeal joint anatomical structure hand joint anatomical structure A02.835.583.345.512
metatarsal bone anatomical structure bone bones in the foot A01.378.610.250.300.480 Metatarsus
middle ear anatomical structure A09.246.397 Middle ear
mitral valve anatomical structure heart valve
atrioventricular valve
A07.541.510.507 Mitral valves
 
nasal concha anatomical structure turbinate A02.835.232.781.324.948
nasal septum anatomical structure separator of the left and right airways in the nose A02.165.407.600
optic chiasm anatomical structure Optical part of brain A08.800.800.120.680.600 Optic chiasm
optic disc anatomical structure A08.800.800.120.680.660
organ of Corti anatomical structure type of mechanoreceptor A09.246.631.246.577 Organ of Corti
otolith anatomical structure calcium carbonate structure in the inner ear of vertebrates A09.246.631.909.625.125.680 Otoliths
outer ear anatomical structure outer part of ear A09.246.272 Outer ear
ovarian follicle anatomical structure A05.360.319.114.630.535 Ovarian follicles
ovary anatomical structure
female organ
gonad ovum-producing reproductive organ, often found in pairs as part of the vertebrate female reproductive system A05.360.319.114.630 Ovary
 
palate anatomical structure A14.521.658 Palate
 
parotid gland anatomical structure major salivary gland A03.556.500.760.464 Parotid glands
 
pelvis anatomical structure anatomical region lower part of the trunk of the human body between the abdomen and the thighs (sometimes also called pelvic region of the trunk A01.673 Pelvis
perineum anatomical structure region of the body including the perineal body and surrounding structures A01.719 Human anogenital area
Peyer's patch anatomical structure lymphatic tissue A10.549.600 Peyer's patches
pharynx anatomical structure part of the throat that is behind the mouth and nasal cavity A03.556.750 Pharynx
posterior cranial fossa anatomical structure A01.456.830.200 Posterior cranial fossa
posterior pituitary anatomical structure posterior lobe of the pituitary gland A06.407.747.734
pulmonary valve anatomical structure heart valve
semi-lunar valve
semilunar valve of the heart A07.541.510.738 Pulmonary valve
rectum anatomical structure animal organ final section of intestine A03.556.124.526.767 Rectum
 
renal calyx anatomical structure A05.810.453.537.503
renal cortex anatomical structure A05.810.453.324
renal medulla anatomical structure A05.810.453.466
renal pelvis anatomical structure basin-like or funnel-like dilated proximal part of the ureter in the kidney A05.810.453.537 Renal pelvis
retina anatomical structure light-sensitive organ in the eye A09.371.729 Retina
 
saccule anatomical structure otolith organ membranous labyrinth in the vestibule of ear A09.246.631.909.625
salivary gland anatomical structure exocrine gland exocrine gland that produces saliva A03.556.500.760 Salivary glands
scala tympani anatomical structure A09.246.631.246.848
scalp anatomical structure anatomical area bordered by the face anteriorly and the neck to the sides and posteriorly A01.456.810 Scalps
sclera anatomical structure A09.371.784
scrotum anatomical structure anatomical male reproductive structure that consists of a suspended sack of skin A05.360.444.661 Scrotum
File:HQ SAM ST2.jpg
semicircular canal anatomical structure tube located inside the ear A09.246.631.663 Semicircular canals
sinoatrial node anatomical structure group of cells located in the wall of the right atrium of the heart A07.541.409.819 Sinoatrial node
small intestine anatomical structure part of the digestive tract, following the stomach and followed by the large intestine A03.556.124.684 Small intestine
soft palate anatomical structure tissue constituting the back of the roof of the mouth A14.549.617.780
spermatic cord anatomical structure cord-like structure in males A05.360.444.777 Human spermatic cord
sphenoidal sinus anatomical structure paranasal sinus A04.531.621.827
spinal canal anatomical structure dorsal body cavity the space in the vertebral column formed by the vertebrae through which the spinal cord passes; it is a process of the dorsal body cavity; this canal is enclosed within the vertebral foramen of the vertebrae A02.835.232.834.803
 
spleen anatomical structure animal organ
lymphatic tissue
internal organ in most vertebrate animals A10.549.700 Spleen
 
stomach anatomical structure animal organ digestive organ A03.556.875.875 Stomachs
stria vascularis anatomical structure capillary or blood vessel in the wall of cochlear duct A09.246.631.246.292.876
subarachnoid space anatomical structure A08.186.566.166.686
sublingual gland anatomical structure major salivary gland A03.556.500.760.687
 
submandibular gland anatomical structure major salivary gland A03.556.500.760.812 Submandibular glands
subthalamic nucleus anatomical structure nucleus A08.186.211.730.385.800.800 Subthalamic nucleus
taste buds anatomical structure specialized receptor organ located in the epithelium of the papillae of the tongue and in the soft palate, epiglottis, and pharynx A03.556.500.885.779 Taste buds
 
tectorial membrane anatomical structure membrane in the cochlea of the inner ear A09.246.631.246.292.906 Tectorial membrane
thoracic diaphragm anatomical structure sheet of internal skeletal muscle A02.633.567.900.300 Thoracic diaphragm
 
thorax anatomical structure anatomical region frontal part of an animal's body, between its head and abdomen A01.911 Thorax
thymus anatomical structure lymphatic tissue organ of the immune system A10.549.750 Thymus (organ)
 
tongue anatomical structure mouth organ that tastes and facilitates speech A03.556.500.885 Tongue
 
tonsil anatomical structure lymphatic tissue A04.623.603.925 Tonsils
trabecular meshwork anatomical structure A09.371.060.932 Trabecular meshwork
trachea anatomical structure cartilaginous tube that connects the pharynx and larynx to the lungs A04.889 Trachea (anatomy)
tricuspid valve anatomical structure heart valve
mitral valve
one-way valve present between right auricle and right ventricle A07.541.510.893 Tricuspid valve
 
tuber cinereum anatomical structure A08.186.211.730.385.357.352.870
tunica intima anatomical structure inner layer of blood vessel A07.231.330.800 Tunica intima
tunica media anatomical structure middle layer of blood vessel A02.633.570.491.800
ulna anatomical structure
bone
arm bone long bone of the forearm A02.835.232.087.090.850 Ulna
ureter anatomical structure tubes used in the urinary system in most animals A05.810.776 Ureter
urethra anatomical structure tube that connects the urinary bladder to the genitals A05.360.444.492.726 Urethra
urinary bladder anatomical structure animal organ
urinary system
internal organ in most animals A05.810.161 Urinary bladder
uvea anatomical structure pigmented middle of the three concentric layers that make up an eye A09.371.894
uvula anatomical structure fleshy appendage that hangs from the back of the palate A14.549.617.780.729 Palatine uvula
vagina anatomical structure feminine reproductive organ A05.360.319.779 Vaginas
 
vena cava anatomical structure
umbrella term
vein
large veins (venous trunks) that return deoxygenated blood from the body into the heart A07.231.908.949
ventricular system anatomical structure set of structures containing cerebrospinal fluid in the brain A08.186.211.276
vestibular aqueduct anatomical structure A09.246.631.909.957


artery edit

Article instance of subclass of description MeSH Code Commons category image
abdominal aorta artery A07.231.114.056.205
anterior cerebral artery artery A07.231.114.228.100 Arteria cerebri anterior
aorta artery
umbrella term
Q15057490
artery largest artery in the body A07.231.114.056 Aorta
 
axillary artery artery A07.231.114.085 Axillary arteries
basilar artery artery artery that supplies the brain with oxygen-rich blood A07.231.114.106 Arteria basilaris
brachial artery artery A07.231.114.139 Brachial arteries
brachiocephalic artery artery aorta descendens A07.231.908.130
carotid sinus artery the carotid sinus is a dilated area at the base of the internal carotid artery just superior to the bifurcation of the internal carotid and external carotid A07.231.114.186.456
celiac artery artery A07.231.114.207 Human anatomy, celiac artery
central retinal artery artery A07.231.114.765
common carotid artery artery carotid artery A07.231.114.186.200 Arteria carotis communis
coronary artery artery artery
vas privatum
A07.231.114.269 Coronary vessels
ductus arteriosus artery
embryonic structure
blood vessel connecting the pulmonary artery to the proximal descending aorta A07.541.278.395 Ductus arteriosus
external carotid artery artery carotid artery major artery of the head and neck A07.231.114.186.200.210 Arteria carotis externa
femoral artery artery A07.231.114.351 Femoral artery
inferior mesenteric artery artery A07.231.114.565.510
internal carotid artery artery carotid artery A07.231.114.186.200.230 Arteria carotis interna
internal iliac artery artery A07.231.114.444
internal thoracic artery artery artery A07.231.114.891.525
Lateral thoracic artery artery Lateralis+thoracic+artery
 
ophthalmic artery artery A07.231.114.622 Arteria ophthalmica
popliteal artery artery A07.231.114.681
posterior cerebral artery artery A07.231.114.228.700 Arteria cerebri posterior
pulmonary artery artery
umbrella term
artery in the pulmonary circulation that carries deoxygenated blood from the heart to the lungs A07.231.114.715 Pulmonary artery
radial artery artery A07.231.114.740
renal artery artery A07.231.114.745
splenic artery artery A07.231.114.814
subclavian artery artery major arteries of the upper thorax, below the clavicle A07.231.114.839 Subclavian arteries
Superficial epigastric artery artery A07.231.114.330
superior mesenteric artery artery A07.231.114.565.755 Superior mesenteric artery
thoracic aorta artery part of the aorta located in the thorax A07.231.114.056.372
ulnar artery artery A07.231.114.920
Umbilical artery artery A07.231.114.929
vertebral artery artery A07.231.114.839 Arteria vertebralis


bone edit

Article instance of subclass of description MeSH Code Commons category image
auditory ossicle bone bone A09.246.397.247 Ossicles
cervical vertebra bone vertebra A02.835.232.834.151 Cervical vertebrae
 
clavicle bone plain bone of short length that serves as a strut between the scapula and the sternum A02.835.232.087.227 Clavicula
 
ethmoid bone bone bone bone in the skull that separates the nasal cavity from the brain A02.835.232.781.292 Ethmoid bones
femur bone bone
long bone
most proximal bone of the leg for tetrapode vertebrates, longest bone for humans A02.835.232.043.650.247 Femur
 
hip bone bone
flat bone
flat bone bone of the pelvis A02.835.232.043.825.434 Hip bone
ilium bone A02.835.232.611.434 Ilium
incus bone auditory ossicle bone in the middle ear A09.246.397.247.362 Incus
ischium bone lower and back part of the hip bone A02.835.232.611.548 Ischium
malleus bone auditory ossicle bone of the middle ear- handle of malleus 5 mm, head of malleus -2 mm A09.246.397.247.524 Malleus
occipital bone bone
flat bone
bone saucer-shaped membrane bone situated at the back and lower part of the cranium A02.835.232.781.572 Occipital bones
parietal bone bone
flat bone
bone bones in the human skull which, when joined together, form the sides and roof of the cranium A02.835.232.781.651 Parietal bones
pubic bone bone the ventral and anterior of the three principal bones composing either half of the pelvis A02.835.232.611.781 Pubis
radius bone arm bone one of the two long bones of the forearm A02.835.232.087.090.700 Radius (bone)
sacrum bone bone bone of the pelvis A02.835.232.834.717 Sacrum
scapula bone
flat bone
bone bone that connects the humerus (upper arm bone) with the clavicle (collar bone) A02.835.232.087.783 Scapula
stapes bone auditory ossicle bone of the middle ear A09.246.397.247.806 Stapes
thoracic vertebra bone vertebra vertebrae between the cervical vertebrae and the lumbar vertebrae A02.835.232.834.892 Thoracic vertebrae
vomer bone
flat bone
bone facial bone A02.835.232.781.324.971 Vomer
 


bovine disease edit

Article instance of subclass of description MeSH Code Commons category image
bovine malignant catarrhal fever bovine disease
infectious disease
bovine disease cattle disease C02.256.466.606
C22.196.540
Bovine malignant catarrhal fever
foot rot bovine disease
sheep disease
goat disease
animal disease C22.394
infectious bovine rhinotracheitis bovine disease
infectious disease
bovine disease Human disease C02.256.466.488
C22.196.429
mastitis in dairy cattle bovine disease bovine disease inflammation of the udder in cows C22.196.581 Mastitis in animals
milk fever bovine disease animal disease A disease of pregnant and lactating cows and ewes leading to generalized paresis and death. The disease, which is characterized by hypocalcemia, occurs at or shortly after parturition in cows and within weeks before or after parturition in ewes. C22.695 Hypocalcemia in ruminants
rinderpest bovine disease Morbillivirus infectious disease
animal disease
disease (caused by the virus in Q2153407) C02.782.580.600.500.700
C22.780
Rinderpest
 


brain region edit

Article instance of subclass of description MeSH Code Commons category image
caudate nucleus brain region A08.186.211.730.885.105.487.550.184 Caudate nucleus
cerebellum brain region anatomical structure a region of the brain that coordinates motor functions and muscle tone A08.186.211.132.810.428.200 Cerebellum
 
cerebrum brain region large part of the brain containing the cerebral cortex (of the two cerebral hemispheres), as well as several subcortical structures, including the hippocampus, basal ganglia, and olfactory bulb A08.186.21.730.885 Cerebrum
 
frontal lobe brain region cerebral lobe part of the brain A08.186.211.730.885.213.270 Frontal lobe
globus pallidus brain region sub-cortical structure of the brain A08.186.211.730.885.105.487.397 Globus pallidus
mesencephalon brain region A08.186.211.132.659 Mesencephalon
parietal lobe brain region cerebral lobe part of the brain A08.186.211.730.885.213.670 Parietal lobe
prefrontal cortex brain region part of brain A08.186.211.730.885.213.270.700 Prefrontal cortex
subthalamus brain region part of diencephalon A08.186.211.730.385.800 Subthalamus
temporal lobe brain region cerebral lobe part of the brain A08.186.211.730.885.213.863 Temporal lobe
thalamus brain region part of diencephalon, which is in turn part of prosencephalon (forebrain) A08.186.211.730.385.826 Thalamus
 


branch of science edit

Article instance of subclass of description MeSH Code Commons category image
biology branch of science
academic discipline
natural science study of life G Biology
 
education branch of science service learning in which knowledge and skills is transferred through teaching I Education


cat disease edit

Article instance of subclass of description MeSH Code Commons category image
feline leukemia cat disease
cancer in cats
cat disease
leukemia
cat disease C02.782.815.622
C04.557.337.385
C22.180.500
Feline leukaemia
sparganosis cat disease
disease
infectious disease
parasitic helminthiasis infectious disease
zoonosis
Q4505372
lung disease
urinary system disease
orbital disease
brain disease
breast disease
inner ear disease
Helminthiasis C03.335.190.304.780


chemical compound edit

Article instance of subclass of description MeSH Code Commons category image
Agglutinin chemical compound Immunologic Factors chemical compound D27.505.696.477.136
alkylating agent chemical compound Noxae
mechanism of action
Highly reactive chemical that introduces alkyl radicals into biologically active molecules and thereby prevents their proper functioning. D27.505.519.124
D27.888.569.035
Chemosterilant chemical compound pesticide chemical compound D27.888.723.141
D27.720.031.700.141
crystal violet chemical compound
drug
chemical compound for for microbiological staining D02.092.146.400 Methyl violet
omeprazole chemical compound
drug
heterocyclic compound
essential medicine
Proton-pump inhibitor medication used in the treatment of gastroesophageal reflux disease, peptic ulcer disease, and Zollinger–Ellison syndrome.[ D02.886.640.074.500
D03.383.725.024.500
D03.633.100.103.034.500
Omeprazole
phencyclidine chemical compound
heterocyclic compound
chemical compound D03.383.621.699 Phencyclidine
skatole chemical compound chemical compound D03.633.100.473.808
warfarin chemical compound
drug
flammable solid
essential medicine
anticoagulant medication that is used as an anticoagulant D03.438.150.446.520.914
D03.830.219.446.520.914
Warfarin
 


clinical sign edit

Article instance of subclass of description MeSH Code Commons category image
Hyperesthesia clinical sign Sensory processing disorder
somatosensory disorder
C10.597.751.791.450
C23.888.592.763.770.450
photophobia clinical sign vision disorder
photosensitivity
medical condition C10.597.751.941.661
C11.966.741
C23.888.592.763.941.661
Sister Mary Joseph nodule clinical sign metastasis
abdominal cancer
C04.588.033.740


cranial nerve edit

Article instance of subclass of description MeSH Code Commons category image
abducens nerve cranial nerve A08.800.800.120.030 Nervus abducens
 
accessory nerve cranial nerve cranial nerve A08.800.800.120.060 Nervus accessorius
 
facial nerve cranial nerve
mixed nerve
A08.800.800.120.250 Nervus facialis
 
glossopharyngeal nerve cranial nerve
mixed nerve
A08.800.800.120.290 Nervus glossopharyngeus
 
hypoglossal nerve cranial nerve cranial nerve A08.800.800.120.330 Nervus hypoglossus
 
oculomotor nerve cranial nerve A08.800.800.120.600 Nervus oculomotorius
 
olfactory nerve cranial nerve A08.800.800.120.640 Nervus olfactorius
 
optic nerve cranial nerve
sensory nerve
paired nerve that transmits visual information from the retina to the brain A08.800.800.120.680 Nervus opticus
 
trigeminal nerve cranial nerve nerve in human face A08.800.800.120.760 Nervus trigeminus
 
trochlear nerve cranial nerve cranial nerve A08.800.800.120.800 Nervus trochlearis
 
vagus nerve cranial nerve tenth cranial nerve A08.800.800.122.901 Nervus vagus
 
vestibulocochlear nerve cranial nerve A08.800.800.120.910 Nervus vestibulocochlearis
 


developmental defect during embryogenesis edit

Article instance of subclass of description MeSH Code Commons category image
coarctation of the aorta developmental defect during embryogenesis aortic disease
genetic disease
rare genetic cardiac disease
aortic malformation
genetic vascular anomaly
congenital condition whereby the aorta is narrow, usually in the area where the ductus arteriosus (ligamentum arteriosum after regression) inserts. C14.240.400.090
C14.280.400.090
C16.131.240.400.090
Coarctation of the aorta
congenital rubella syndrome developmental defect during embryogenesis
infectious disease
vertically transmitted infection
infectious embryofetopathy
infectious disease with epilepsy
human disease C02.782.930.700.700.700
C16.131.077.790
Congenital rubella syndrome
 
triploidy developmental defect during embryogenesis polyploidy
genetic disease
chromosomal anomaly with cataract
syndromic obesity
extremely rare chromosomal disorder C23.550.210.702.500
Watson syndrome developmental defect during embryogenesis pulmonary valve stenosis C04.557.580.600.580.590.650
C04.700.645.650
C10.562.600.500
C10.574.500.549.400
C10.668.829.675
C16.320.400.560.400
C16.320.700.645.650


disease edit

Article instance of subclass of description MeSH Code Commons category image
abducens nerve palsy disease cranial nerve palsy
paralytic squint
non-neoplastic or neoplastic disorder affecting the abducens nerve (sixth cranial nerve) C10.292.150 Sixth nerve palsy
abetalipoproteinemia disease
developmental defect during embryogenesis
hypolipoproteinemia
autosomal recessive metabolic cerebellar ataxia
metabolic disease with dementia
metabolic disease with intestinal involvement
hypobetalipoproteinemia
neurometabolic disease
developmental anomaly of metabolic origin
syndromic dyslipidemia
constitutional hemolytic anemia due to acanthocytosis
rare hereditary metabolic disease with peripheral neuropathy
metabolic disease with pigmentary retinitis
intestinal disease due to fat malabsorption
Human disease C16.320.565.398.500.440.500
C18.452.584.500.875.440.500
C18.452.648.398.500.440.500
Abetalipoproteinemia
abrasion disease tooth wear C07.793.818.124 Dental abrasion
abscess disease
infectious disease
suppuration localized collection of pus that has built up within the tissue of the body C01.539.830.025
C23.550.470.756.100
Abscesses
 
Absent radius-anogenital anomalies syndrome disease
developmental defect during embryogenesis
Radial aplasia
dysostosis of genetic origin with limb anomaly as a major feature
syndrome with limb reduction defects
human disease C535281
Acanthamoeba keratitis disease keratitis Human disease C03.300.125
C03.752.049.203
C11.204.564.112
C11.294.725.125
 
acanthosis nigricans disease pigmentation disease Human disease C17.800.621.430.530.100 Acanthosis nigricans
acariasis disease
infectious disease
parasitic ectoparasitic infectious disease parasitic ectoparasitic infectious disease that involves infestation of mites belonging to the family Sarcoptidae, Trombiculidae and Demodicidae C03.858.211.480
Accelerated phase chronic myelogenous leukemia disease disease C04.557.337.539.250.300
C15.378.190.636.370.300
achalasia disease esophageal disease esophageal disease characterized by an inability of the esophagus to move food toward the stomach resulting from the lower esophogeal sphincter not fully relaxing during swallowing C06.405.117.119.500.432 Achalasia
achondroplasia disease
dwarfism
osteochondrodysplasia an osteochondrodysplasia that results in dwarfism which has material basis in abnormal ossification of cartilage in located in long bone. C05.116.099.343.110
C05.116.099.708.017
C16.320.240.500
Achondroplasia
 
achromatopsia disease monochromacy
color blindness
color blindness that is characterized by a congenital cone color vision disorder, the inability to perceive color and to achieve satisfactory visual acuity at high light levels has material basis in autosomal recessive inheritance C10.597.751.941.256
C11.966.256
C23.888.592.763.941.256
Achromatopsia
acid erosion disease teeth hard tissue disease
tooth wear
loss of tooth structure due to chemical dissolution by acids not of bacterial origin C07.793.818.500 Acid erosion
acne disease sebaceous gland disease sebaceous gland's disease characterized by areas of blackheads, whiteheads, pimples, greasy skin, and possibly scarring. C17.800.030.150
C17.800.794.111
Acne
 
acoustic neuroma disease neurilemmoma Human disease C04.557.465.625.650.595.610
C04.557.580.600.610.595.610
C04.557.580.625.650.595.610
C04.588.614.300.015
C04.588.614.596.240.015
C09.218.807.800.675
C09.647.675
C10.292.225.750
C10.292.910.600
Vestibular schwannoma
 
acrocephalosyndactylia disease synostosis
craniosynostosis
syndactyly
group of diseases C05.116.099.370.894.232.015
C05.116.099.370.894.819.100
C05.660.207.240.100
C05.660.585.800.100
C05.660.906.364.100
C05.660.906.819.100
C16.131.621.207.240.100
C16.131.621.585.800.100
C16.131.621.906.364.100
C16.131.621.906.819.100
Acrodynia disease occupational disease
rare intoxication
C10.668.829.025
C10.720.475.600.150
C25.723.647.500.100
acromegaly disease hyperpituitarism Human disease / micro cephaly opposite C05.116.132.082
C10.228.140.617.738.250.100
C19.700.355.179
Acromegaly
 
actinic keratosis disease pre-malignant neoplasm Human disease C04.834.450
C17.800.428.570
Actinic keratosis
 
actinomycosis disease
infectious disease
commensal bacterial infectious disease
respiratory system disease
bacterial infectious disease
Human disease C01.252.410.040.137 Actinomycosis
acute abdomen disease abdominal pain medical term for sudden, severe abdominal pain of unclear origin C10.597.617.044.200
C23.888.592.612.054.200
C23.888.821.030.249
Acute abdomen
acute cystitis disease cystitis human and animal infection C01.539.895
C12.777.892
C13.351.968.892
Infectious diseases and disorders of the urinary system
 
acute disseminated encephalomyelitis disease encephalomyelitis An encephalomyelitis characterized by inflammation located in brain and located in spinal cord that damages myelin. It usually occurs after viral infection, but also following vaccination, bacterial or parasitic infection. C10.114.375.225
C10.228.140.695.562.225
C10.314.350.225
C20.111.258.250.350
acute intermittent porphyria disease acute porphyria
porphyria
human disease C06.552.830.150
C16.320.850.742.150
C17.800.827.742.150
C18.452.811.400.150
Acute interstitial pneumonitis disease adult respiratory distress syndrome
interstitial lung disease
idiopathic interstitial pneumonia
Human disease C08.381.765 Acute interstitial pneumonia
acute kidney injury disease kidney failure abrupt loss of kidney function that develops within 48 hours C12.777.419.780.050
C13.351.968.419.780.050
Acute kidney injury
acute myeloid leukemia disease myeloid leukemia myeloid leukemia that is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells C04.557.337.539.275 Acute myeloid leukemia
 
acute porphyria disease Hepatic porphyria
porphyria
porphyria that has symptom abdominal pain, has symptom neuropathy, has symptom autonomic instability and has symptom psychosis C06.552.830
C16.320.850.742
C17.800.827.742
C18.452.811.400
acute promyelocytic leukemia disease acute myeloid leukemia
bilineal acute myeloid leukemia
acute myeloid leukemia characterized by accumulation of promyelocytes in the bone marrow and by a translocation between chromosomes 15 and 17 C04.557.337.539.275.700
 
acute stress disorder disease anxiety disorder human disease C23.550.470.099
adenocarcinoma disease carcinoma carcinoma that has material basis in abnormally proliferating cells, derives from epithelial cells, which originate in glandular tissue C04.557.470.200.025 Adenocarcinomas
 
Adenoid cystic carcinoma disease cancer
Cylindroma
adenocarcinoma
adenoid cystic carcinoma C04.557.470.200.025.220 Adenoid cystic carcinoma
adenoma disease cell type benign neoplasm cell type benign neoplasm that is composed of epithelial tissue in which tumor cells form glands or glandlike structures C04.557.470.035 Adenomas
 
Adenovirus infection disease Human disease C02.256.076
C02.256.076.045
Adie syndrome disease syndrome Human disease C10.177.045
C10.292.562.700.250
C11.590.436.200
C11.710.800.180
Adie syndrome
adiposis dolorosa disease lipomatosis
subcutaneous tissue disease
Human disease C17.800.463.249
C18.452.584.718.500
adrenal adenoma disease endocrine organ benign neoplasm
adrenal gland disease
benign epithelial neoplasm
benign neoplasm of adrenal gland
endocrine organ benign neoplasm, a benign tumor of the glandular type (adenoma) in the adrenal gland C04.588.322.078.265.500
adrenocortical carcinoma disease adrenal cortex cancer adrenal cortex cancer that forms in the outer layer of tissue of the adrenal gland and that has material basis in abnormally proliferating cells derives from epithelial cells C04.557.470.200.025.152
C04.588.322.078.265.750
C19.053.098.265.750
C19.053.347.500.750
C19.344.078.265.750
Adrenocortical carcinoma
adult Refsum disease disease lipid metabolism disorder
autosomal recessive metabolic cerebellar ataxia
Human disease C10.228.140.163.100.813
C10.500.300.780
C10.574.500.495.780
C10.668.829.800.300.780
C16.131.666.300.780
C16.320.400.375.780
C16.320.565.189.813
C16.320.565.663.760
C18.452.132.100.813
C18.452.648.189.813
C18.452.648.663.760
Refsum disease
adult respiratory distress syndrome disease respiratory failure
pulmonary injury
acute respiratory insufficiency
Human disease C08.381.840
C08.618.840
Acute respiratory distress syndrome
 
adult-onset Still's disease disease
Designated intractable/rare diseases
Still's disease
arthritis
collagen disease
arthritis that is a rare from of inflammatory arthritis characterized by fevers, rash, and joint pain C05.550.114.154.870
C05.799.114.870
C17.300.775.099.870
C20.111.199.870
advanced sleep phase syndrome disease sleep disorder
obsolete chronobiology disease
sleep disorder that involves an altered circadian rhythm resulting in falling asleep in early evening and awaking very early in the morning C10.281.800
C10.886.425.200
C24.900
African horse sickness disease
infectious disease
horse disease insect-borne reovirus infection of horses, mules and donkeys in Africa and the Middle East; characterized by pulmonary edema, cardiac involvement, and edema of the head and neck C02.081.030
C02.782.791.142
C22.488.088
agammaglobulinemia disease B cell deficiency B cell deficiency that is caused by a reduction in all types of gamma globulins C15.378.147.142
C15.604.515.032
C20.673.088
age related macular degeneration disease
Maculopathy
degeneration of macula and posterior pole
visual impairment
degeneration of macula and posterior pole that is characterized by a loss of vision in the center of the visual field (the macula) resulting from damage to the retina and resulting in blurring of the sharp central vision C11.768.585.439 Macular degeneration
agenesis of the corpus callosum disease genetic nervous system disorder
genetic disease
disease C10.500.034
C16.131.666.034
C23.300.008
Agenesis of the corpus callosum
Aggressive fibromatosis disease C04.557.450.565.590.340.410 Desmoid tumor
agnosia disease
symptom
communication disorder
perceptual disorder
communication disorder that is a loss of ability to recognize objects, persons, sounds, shapes, or smells while the specific sense is not defective nor is there any significant memory loss. C10.597.606.762.100
C23.888.592.604.764.100
C10.597.606.881.350
C23.888.592.604.882.350
Agnosia
agranulocytosis disease leukopenia Human disease C15.378.553.546.184
Aicardi syndrome disease
developmental defect during embryogenesis
syndrome
genetic syndrome with corpus callosum agenesis/dysgenesis as a major feature
X-linked mental retardation
nervous system anomaly with eye involvement
syndromic developmental defect of the eye
cerebral malformation with epilepsy
polymalformative genetic syndrome with increased risk of developing cancer
syndrome that is characterized by absence or underdeveloped tissue connecting the left and right halves of the brain, infantile spasms and chorioretinal lacunae, which are defects in the light-sensitive tissue at the back of the eye C10.500.034.687
C11.270.019
C16.131.162
C16.131.666.034.687
C16.320.290.019
C16.320.322.030
ainhum disease connective tissue disease
foot disease
genetic disease
Human disease C05.116.264.143 Ainhum
air embolism disease embolism
barotrauma
vascular blockage by air bubbles C14.907.355.350.254
akinetic mutism disease brain disease brain disease characterized by marked reduction of nearly all motor functions including facial expressions, gestures and speech output, but with some degree of alertness C10.228.140.042
Alagille syndrome disease liver disease congenital disorder of digestive system C06.130.120.135.250.125
C06.552.150.125
C14.240.400.044
C16.131.077.065
C16.131.240.400.044
C16.320.051
alex cannon disease
developmental defect during embryogenesis
autosomal recessive disease
genetic photodermatosis
polymalformative genetic syndrome with increased risk of developing cancer
inherited skin tumor
tumor of hematopoietic and lymphoid tissues
Photodermatosis
rare genetic developmental defect during embryogenesis
malformation syndrome with short stature
developmental anomaly of metabolic origin
rare genetic hematologic disease
DNA repair defect other than combined T-cell and B-cell immunodeficiencies
Don't sub at YT cannon C16.131.077.137
C18.452.284.100
Bloom's syndrome
 
Alexander disease disease
Designated intractable/rare diseases
leukodystrophy
genetic neurodegenerative disease
eye degenerative disease
congenital disorder of nervous system C10.228.140.163.100.362.312
C10.228.140.695.625.312
C10.314.400.312
C10.574.500.024
C16.320.400.024
C16.320.565.189.362.312
C18.452.132.100.362.312
C18.452.648.189.362.312
Alexander disease
Alice in Wonderland syndrome disease Dysmetropsia disorienting neurological condition C10.228.140.546.399.750.124
C10.597.606.762.150
C10.597.751.941.036
C23.888.592.604.764.150
C23.888.592.763.941.036
F01.700.750.150
 
Alien hand syndrome disease Eetu on homo neuropsychiatric disorder C10.597.606.881.350.099
C23.888.592.604.882.350.099
alkaptonuria disease amino acid metabolic disorder
tyrosinemia
other metabolic disease with skin involvement
pigmented conjunctival lesion
amino acid metabolic disorder that involves phenylalanine and tyrosine metabolism with the accumulation of homogentisic acid, a toxic tyrosine byproduct C16.320.565.100.187
C18.452.648.100.187
Alkaptonuria
allergic bronchopulmonary aspergillosis disease
infectious disease
aspergillosis
respiratory allergy
rare allergic respiratory disease
lung disease
An aspergillosis that involves an allergic reaction due to the spores of Aspergillus moulds (A. fumigatus), which colonizes the mucus in the airways causing inflammation. The disease has symptom cough, has symptom wheezing and has symptom fever. C01.703.080.074
C01.703.080.768.500
C01.703.295.328.249.074
C01.703.534.045.074
C08.381.472.850.500
C08.674.060
C08.730.435.090
C17.800.838.208.416.249.074
C20.543.480.680.085
Allergic bronchopulmonary aspergillosis
allergic conjunctivitis disease chronic conjunctivitis chronic conjunctivitis that is an inflammation of the conjunctiva involing red, itchy, and watery eyes a resulting from an exposure to an allergen or an irritant C11.187.183.200
C20.543.480.200
Allergic conjunctivitis
allergic rhinitis disease rhinitis Human disease C08.460.799.315
C08.674.453
C09.603.799.315
C20.543.480.680.443
Allergic rhinitis
 
Alpers' disease disease cerebellar degeneration
mitochondrial DNA depletion syndrome
cerebral degeneration that results in progressive degeneration of grey matter in the cerebrum and has symptom convulsions C10.114.375.112
C10.228.140.400
C10.228.140.695.562.112
C10.314.350.112
C20.111.258.250.175
alpha 1-antitrypsin deficiency disease plasma protein metabolism disease
rare metabolic liver disease
lung disease
rare genetic respiratory disease
nephropathy secondary to a storage or other metabolic disease
other inborn metabolic disease
Human disease C06.552.074
C08.381.112
C16.320.060
C23.550.325.500.500
Alpha 1-antitrypsin deficiency
alpha thalassemia disease thalassemia
hematological disorder with renal involvement
alpha-thalassemia and related diseases
Alpha thalassemia is a thalassemia involving the genes HBA1and HBA2 hemoglobin genes C15.378.071.141.150.875.100
C15.378.420.826.100
C16.320.070.875.100
C16.320.365.826.100
alpha-mannosidosis disease
developmental defect during embryogenesis
lysosomal storage disease
Mannosidosis
neurometabolic disease
oligosaccharidosis
rare genetic developmental defect during embryogenesis
lysosomal storage disease with skeletal involvement
metabolic disease with cataract
metabolic disease with corneal opacity
cataract associated with a metabolic disease
lysosomal storage disease that has material basis in deficiency of the alpha-D-manosidase enzyme resulting in the impairment of cell function from a build up of complex sugars derived from glycoproteins in the lysosome C16.320.565.202.607.500
C16.320.565.595.577.500
C18.452.648.202.607.500
C18.452.648.595.577.500
Alpha-mannosidosis
Alport syndrome disease monogenic disease
genetic disease
monogenic disease characterized by glomerulonephritis, endstage kidney disease, and hearing loss C12.706.742
C12.777.419.570.620
C13.351.875.742
C13.351.968.419.570.620
C16.131.939.742
C17.300.200.517
Alport syndrome
alveolar osteitis disease periostitis human disease C07.465.227
amblyopia disease eye disease
visual impairment
Human disease C10.228.140.055
C10.597.751.941.073
C11.966.073
C23.888.592.763.941.073
Amblyopia
 
amebiasis disease
infectious disease
parasitic protozoa infectious disease
protozoal dysentery
Amoebozoa infectious disease
human protozoa disease C03.752.049
C03.752.049.407
Amoebiasis
 
ameloblastoma disease
head and neck disease
cell type benign neoplasm
odontogenic tumor
benign epithelial neoplasm
cell type benign neoplasm that has material basis in odontogenic epithelium C04.557.695.065 Ameloblastoma
amelogenesis imperfecta disease dental enamel hypoplasia dental enamel hypoplasia characterized by abnormal enamel formation C07.650.800.255.500
C07.793.700.255.500
C16.131.850.800.255.500
Amelogenesis imperfecta
amenorrhea disease female reproductive system disease
menstrual disorder
absence of a menstrual period in a woman of reproductive age C23.550.568.500
Amino acid transport disorder disease Congenital disorders of amino acid metabolism Human disease C16.320.565.151
C18.452.648.151
amyloidosis disease acquired metabolic disease
systemic disease
proteostasis deficiency
acquired metabolic disease that involves abnormal deposited of amyloid proteins in organs and/or tissues C18.452.845.500 Amyloidosis
 
amyotrophic lateral sclerosis disease
Designated intractable/rare diseases
motor neuron disease
TDP-43 Proteinopathies
neurodegeneration
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscular paralysis reflecting degeneration of motor neurons in the primary motor cortex, corticospinal tracts, brainstem and spinal cord C10.228.854.139
C10.574.562.250
C10.574.950.050
C10.668.467.250
C18.452.845.800.050
Amyotrophic lateral sclerosis
 
anal fistula disease rectal disease anus disease characterized by is an abnormal connection between the epithelialised surface of the anal canal and the perianal skin C06.267.550.600
C06.405.469.471.600
C06.405.469.860.752
C23.300.575.185.550.600
Anal fistula
Anaplastic astrocytoma disease astrocytoma astrocytoma that is characterized by cells with regular, round to oval nuclei C04.557.465.625.600.380.080
C04.557.470.670.380.080
C04.557.580.625.600.380.080
Anaplastic large-cell lymphoma disease T-cell lymphoma
non-Hodgkin lymphoma
non-Hodgkin lymphoma involving aberrant T-cells C04.557.386.480.750.399
C15.604.515.569.480.750.600
C20.683.515.761.480.750.399
anasarca disease medical condition characterized by widespread swelling C23.888.277
Andersen-Tawil syndrome disease long QT syndrome
muscular channelopathy
genetic peripheral neuropathy
periodic paralysis
genetic cardiac rhythm disease
Human disease C14.280.067.565.070
C16.131.240.400.715.070
C23.550.073.547.070
androgen insensitivity syndrome disease pseudohermaphroditism
sex differentiation disease
sex differentiation disease that is characterized by the partial or complete inability of the cell to respond to androgens in individuals with a karyotype of 46,XY resulting in female physical traits but male genetic makeup C12.706.316.096.500
C13.351.875.253.096.500
C16.131.939.316.096.500
C16.320.322.061
C19.391.119.096.500
Androgen insensitivity syndrome
anencephaly disease cephalic disorder absence of a major portion of the brain, skull, and scalp that occurs during embryonic development C10.500.680.196
C16.131.085.197
C16.131.666.680.196
Anencephaly
aneurysm disease vascular disease bulge in the wall of a blood vessel C14.907.055 Aneurysms
 
Angelman syndrome disease
Designated intractable/rare diseases
developmental defect during embryogenesis
chromosomal disease
rare genetic syndromic intellectual disability
organic brain syndrome
chromosomal anomaly with epilepsy as a major feature
Human disease C10.228.662.075
C16.131.077.095
C16.131.260.040
C16.320.180.040
Angelman syndrome
angiodysplasia disease vascular disease vascular disease that is characterized as a small vascular malformation of the gut C14.907.075
 
angioedema disease skin disease
vascular skin disease
urticaria
skin disease characterized by the rapid swelling of the dermis, subcutaneous tissue, mucosa and submucosal tissues C14.907.079
C17.800.862.945.066
C20.543.480.904.066
Angioedema
 
angiokeratoma disease skin hemangioma Human disease C04.557.645.115 Angiokeratoma
 
Angiomatosis disease capillary disease
angioma
a benign vascular malformation involving skin, subcutaneous tissue, skeletal muscle and occasionally bone. C14.907.077
angiomyolipoma disease cell type benign neoplasm cell type benign neoplasm that from perivascular epithelioid cells C04.557.450.550.125
C04.557.450.692.249
Renal angiomyolipoma
angular cheilitis disease cheilitis cheilitis characterized by inflammation of one or both of the corners of the mouth C07.465.409.215 Angular cheilitis
anhidrosis disease sweat gland disease
hypohidrosis
Human disease C17.800.946.370
aniridia disease iris disease Human disease C11.250.060
C11.270.060
C11.941.375.060
C16.131.384.079
C16.320.290.078
Aniridia
aniseikonia disease refractive error
Dysmetropsia
Human disease C11.744.116
anisometropia disease refractive error Human disease C11.744.126
ankyloglossia disease tongue disease
genetic nervous system disorder
genetic disease
congenital disorder of digestive system C07.160 Ankyloglossia
ankylosis disease arthropathy
joint stiffness
Human disease C05.550.069 Ankylosis
anodontia disease tooth disease
agenesis
tooth agenesis
Human disease C07.650.800.100
C07.793.700.100
C16.131.850.800.100
anogenital venereal wart disease
infectious disease
vaginal disease
anus disease
herpangina
penile disease
cervix disease
Sexually Transmitted Diseases, Viral
sexually transmitted disease C02.256.650.810.217 Genital warts
anomalous left coronary artery from the pulmonary artery disease
thoracic disease
coronary artery anomaly
arterio-arterial fistula
coronary artery anomaly in which the left coronary artery (LCA) branches off the pulmonary artery instead of the aortic sinus C14.240.400.210.249
C14.240.850.984.500.500
C14.280.400.210.249
C14.907.933.110.500
C16.131.240.400.210.249
C16.131.240.850.500.500
C23.300.575.950.150.500
Anomalous left coronary artery from the pulmonary artery
anterior compartment syndrome of the lower leg disease compartment syndrome disease C05.651.180.063
C14.907.303.063
anterior ischemic optic neuropathy disease optic nerve disease
ischemic neuropathy
ischemic optic neuropathy
Human disease C10.292.700.600
C11.640.643
C14.907.601
anterior spinal artery syndrome disease syndrome
cerebrovascular disease
vascular myelopathy
Human disease C10.228.854.785.650.100
C14.907.790.550.100
anterograde amnesia disease amnesia loss of the ability to create new memories after the onset of amnesia C10.597.606.525.100.075
C23.888.592.604.529.100.075
anthracosilicosis disease pneumoconiosis Human disease C08.381.483.581.062.500
C08.381.483.581.760.125
C08.381.520.702.062.500
C08.381.520.702.760.125
C24.800.834.201
anthracosis disease occupational disease
pneumoconiosis
Human disease C08.381.483.581.062
C08.381.520.702.062
antiphospholipid syndrome disease autoimmune disease Human disease C20.111.197
Antley-Bixler syndrome disease
developmental defect during embryogenesis
autosomal recessive disease
multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome
syndromic craniosynostosis
autosomal recessive disease that is characterized at birth or prenatally by malformations and deformities affecting the majority of the skeleton and other areas of the body with autosomal recessive inheritance of the FGFR2 gene C05.116.099.370.894.115
C05.660.906.181
C16.131.621.906.181
C16.320.565.925.324
C18.452.648.925.324
anuria disease kidney disease Human disease C12.777.419.078
C12.777.934.141
C13.351.968.419.078
C13.351.968.934.070
anus cancer disease large intestine cancer
anus disease
anal canal cancer
large intestine cancer that is located in the anus C04.588.274.476.411.307.790.040
C06.301.371.411.307.790.040
C06.405.249.411.307.790.040
C06.405.469.491.307.790.040
C06.405.469.860.101.163
C06.405.469.860.180.500.040
Anal cancer
anus disease disease rectal disease Human disease C06.405.469.860.101
C06.405.469.860.101.430
Anal fissure
 
aortic aneurysm disease aortic disease
aneurysm
orta to greater than 1.5 times normal size. C14.907.055.239
C14.907.109.139
C14.907.055.185.125
C14.907.055.239.175
C14.907.109.139.175
C26.761.125
Aortic aneurysms
aortic valve insufficiency disease aortic valve disease aortic valve disease that is characterized by leaking of the aortic valve of the heart causes blood to flow in the reverse direction during ventricular diastole, from the aorta into the left ventricle C14.280.484.095 Aortic valve insufficiency
 
aortic valve stenosis disease
developmental defect during embryogenesis
aortic valve disease
aortic disease
aortic valve disease that has physical basis in incomplete opening of the aortic valve C14.280.484.150
C14.280.955.249
Aortic valve stenosis
aortitis disease aortic disease inflammation of the aortic wall C14.907.109.320
C14.907.940.080
Aortoiliac occlusive disease disease peripheral artery disease C14.907.109.661
C14.907.137.427
Aortoiliac occlusive disease (Leriche syndrome)
Apert syndrome disease acrocephalosyndactylia congenital disorder of digestive system C05.116.099.370.894.232.015
C05.116.099.370.894.819.100
C05.660.207.240.100
C05.660.585.800.100
C05.660.906.364.100
C05.660.906.819.100
C16.131.621.207.240.100
C16.131.621.585.800.100
C16.131.621.906.364.100
C16.131.621.906.819.100
Apert syndrome
aphthous stomatitis disease stomatitis stomatitis characterized by the repeated formation of benign and non-contagious mouth ulcers C07.465.864.750 Aphthous ulcer
 
aplastic anemia disease
Designated intractable/rare diseases
anemia
bone marrow failure
rare constitutional anemia
anemia that is characterized by a deficiency of red blood cells, white blood cells and platelets produced by bone marrow C15.378.071.085
C15.378.190.196
Aplastic anemias
apparent life-threatening event syndrome disease cyanosis C08.618.846.600
C23.888.248.500
C23.888.852.700
appendicitis disease
colonic disease
cecal disease
intraabdominal infection
inflammation of the appendix C01.539.463.099
C06.405.205.099
C06.405.469.110.207
Appendicitis
 
apraxia disease
symptom
agnosia agnosia that is a loss of the ability to map out physical actions in order to repeat them in functional activities C10.597.606.881.350
C23.888.592.604.882.350
Arachnoid cyst disease
developmental defect during embryogenesis
Central nervous system cyst
central nervous system cystic malformation
Human disease C04.182.044
C04.588.614.250.387.100
C10.500.142.100
C10.551.240.375.100
C16.131.666.142.100
Arachnoid cyst
arcus senilis disease corneal degeneration
rare genetic eye disease
genetic disease
Human disease C11.204.299.070 Arcus senilis
 
argininosuccinic aciduria disease amino acid metabolic disorder amino acid metabolic disorder that involves the accumulation of argininosuccinic acid (ASA) in the blood and urine C10.228.140.163.100.937.124
C16.320.565.100.940.124
C16.320.565.189.937.124
C18.452.132.100.937.124
C18.452.648.100.940.124
C18.452.648.189.937.124
argyria disease abnormal skin coloration
rare intoxication
medical condition C17.800.621.166
C25.723.068
Argyria (illness)
 
arteriosclerosis disease artery disease thickening, hardening and loss of elasticity of the walls of arteries C14.907.137.126 Atherosclerosis
 
arteriovenous fistula disease fistula
simple vascular malformation
abnormal, epithelial-lined connection between an artery and vein that is present at the time of birth C14.240.850.750.147
C14.240.850.984.750
C14.907.150.125
C14.907.933.555
C16.131.240.850.750.125
C23.300.575.950.250
C14.240.850.984
C14.907.933
C23.300.575.950
Arteriovenous fistula
arteriovenous malformation disease hemangioma
vascular malformation
vascular anomaly C14.240.850.750
C14.907.150
C16.131.240.850.750
Arteriovenous malformation
arthritis disease
arthropathy
bone inflammation disease
inflammatory disease
arthropathy
form of joint disorder that involves inflammation of one or more joints C05.550.114 Arthritis
arthropathy disease joint disorder
bone disease
bone inflammation disease that is located in a joint C05.550 Arthropathies
arthus reaction disease type III hypersensitivity Human disease C20.543.520.100
asbestosis disease pneumoconiosis
asbestos-related disease
pneumoconiosis caused by inhalation and retention of asbestos fibers C08.381.483.581.125
C08.381.520.702.125
C24.800.127
Asbestosis
 
ascariasis disease
infectious disease
nematode infection
anthroponotic disease
soil-transmitted helminthiasis
parasitic helminthiasis infectious disease
Human disease C03.335.508.700.100.070 Ascaris
aspergilloma disease aspergillosis C01.703.080.768
C08.381.472.850
Aspergilloma
 
aspergillosis disease opportunistic mycosis
type I hypersensitivity
infectious disease of humans, birds and other animals C01.703.080
C01.703.295.328.249
C01.703.534.045
C17.800.838.208.416.249
Aspergillosis
 
Aspermia disease C12.294.365.700.126
aspiration pneumonia disease bacterial pneumonia bronchopneumonia that develops due to the entrance of foreign materials into the lungs usually oral or gastric contents C08.381.677.529
C08.730.610.529
Aspiration pneumonia
asthenopia disease eye disease Human disease C11.093
astigmatism disease refractive error refractive error characterized by the optics of the eye to focus a point object into a sharp focused image on the retina, has_symptom blurred vision. C11.744.212 Astigmatism (eye)
astrocytoma disease glioma
cerebrum cancer
brain astrocytoma
malignant glioma that is has_material_basis_in astocyte cells, a type of star-shaped glial cell, located_in the cerebrum. C04.557.465.625.600.380.080
C04.557.470.670.380.080
C04.557.580.625.600.380.080
Astrocytic tumors
 
ataxia telangiectasia disease autosomal recessive cerebellar ataxia
autosomal recessive cerebellar ataxia due to a DNA repair defect
A disease a rare, neurodegenerative, autosomal recessive human disease causing severe disability. C10.228.140.252.190.530.060
C10.562.100
C10.597.350.090.500.530.060
C14.907.823.213
C16.320.080
C18.452.284.060
C20.673.290
Ataxia telangiectasia
atopic dermatitis disease dermatitis A dermatitis that is a chronically relapsing inflammatory allergic response located in the skin that causes itching and flaking. C16.320.850.210
C17.800.174.193
C17.800.815.193
C17.800.827.210
C20.543.480.343
Atopic dermatitis
 
atrial fibrillation disease heart conduction disease abnormal heart rhythm characterized by rapid and irregular beating C14.280.067.198
C23.550.073.198
Atrial fibrillation
atrial heart septal defect disease
birth defect
heart septal defect A heart septal defect located in in the septum that separates the two atria of the heart. C14.240.400.560.375
C14.280.400.560.375
C16.131.240.400.560.375
Atrial septal defect
 
atrioventricular block disease
thoracic disease
heart conduction disease heart conduction disease that is characterized by the impairment of the conduction between the atria and ventricles of the heart C14.280.067.558.230
C23.550.073.425.062
Atrioventricular block
atrioventricular septal defect disease heart septal defect Human disease C14.240.400.560.350
C14.280.400.560.350
C16.131.240.400.560.350
Atrioventricular septal defect
atrophic gastritis disease gastritis Human disease C06.405.205.697.394
C06.405.748.398.394
atrophy disease partial or complete wasting away of a part of the body C23.300.070 Atrophy
atypical teratoid rhabdoid tumor disease brain cancer brain cancer that is usually located in the brain, but can occur anywhere in the central nervous system C04.588.614.250
C10.551.240
autoimmune hepatitis disease
Designated intractable/rare diseases
autoimmune disease of gastrointestinal tract
hepatitis
immune system disease
rare parenchymal liver disease
autoimmune disease of gastrointestinal tract that results in inflammation located in liver caused by the body's immune system attacking the liver cells C06.552.380.350.050
C20.111.567
Autoimmune hepatitis
 
autoimmune lymphoproliferative syndrome disease Lymphoproliferative disorders
type IV hypersensitivity
Human disease C15.604.515.138
C16.320.089
C20.111.288
C20.683.515.124
autoimmune polyendocrine syndrome disease autoimmune disease of endocrine system autoimmune disease of endocrine system characterized by abnormal functioning of the immune system that causes auto-reactivity against endocrine organs C19.787
C20.111.750
autoimmune thrombocytopenic purpura disease
Designated intractable/rare diseases
primary thrombocytopenia
thrombocytopenic purpura
primary thrombocytopenia that involves relatively few platelets in blood as a result of autoantibodies C15.378.100.802.687.600
C15.378.140.855.925.750.600
C15.378.463.740
C20.111.759
C20.841.600
C23.550.414.950.687.600
C23.888.885.687.687.600
autoimmune thyroiditis disease autoimmune disease of endocrine system
thyroiditis
autoimmune disease of endocrine system that involves inflammation located in thyroid gland caused by the immune system reacting against its own tissues C19.874.871.102
C20.111.809
autosomal dominant cerebellar ataxia disease hereditary ataxia
late-onset ataxia with dementia
nervous system heredodegenerative disease
eye degenerative disease
cerebellar degeneration
hereditary ataxia that has material basis in autosomal dominant inheritance C10.228.140.252.190.530
C10.228.140.252.700.700
C10.228.854.787.875
C10.574.500.825.700
C10.597.350.090.500.530
C16.320.400.780.875
autosomal recessive congenital ichthyosis disease autosomal recessive congenital ichthyosis congenital skin disease C16.131.831.512.400.410
C16.320.850.400.410
C16.614.492.400.410
C17.800.428.333.250.410
C17.800.804.512.400.410
C17.800.827.400.410
 
azoospermia disease male infertility
oligospermia
male infertility disease characterized by the absence of any measurable level of sperm in semen C12.294.365.700.380 Azoospermia
azotemia disease hematopoietic system diseases abnormally high levels of nitrogen in the blood C12.777.419.936.231
C13.351.968.419.936.231
C23.550.145
babesiosis disease
infectious disease
parasitic protozoa infectious disease Human disease C03.701.688.122
C03.752.625.122
C03.752.875.175
C22.674.710.122
Babesiosis
 
bacillary angiomatosis disease bartonellosis
Angiomatosis
Human disease C01.252.400.126.100.050
C01.252.825.150
C01.539.800.720.150
C14.907.077.060
C17.800.838.765.150
C17.800.862.060
bacillus anthracis disease
infectious disease
primary bacterial infectious disease
zoonosis
acute disease caused by the bacterium Bacillus anthracis. C01.252.410.090.072 Anthrax (disease)
 
bacterial infectious disease disease
infectious disease
infectious disease
Bacterial Infections and Mycoses
rare infectious disease
disease caused by bacteria C01.252.400
C01.252
C01.252.410
Diseases and disorders due to bacteria
bacterial vaginosis disease
infectious disease
vaginitis Smelly vaginal bacteria C01.252.954
C13.351.500.894.906.800
Bacterial vaginosis
 
bacteriuria disease urinary system disease medical term denoting the presence of bacteria in urine C01.539.895.219
C12.777.892.219
C13.351.968.892.219
 
balanitis disease penile disease
inflammatory disease
An infectious or non-infectious inflammatory process that affects the glans penis. Symptoms include redness and pain of the glans penis and foreskin and discharge. C12.294.494.136 Balanitis
File:Inflammation of the glans penis and the preputial mucosa.jpg
baldness disease
hairstyle
hair disease
hypotrichosis
alopecia
hairstyle
hair anomaly
state where most of hair from the head has been lost C17.800.329.937.122
C23.300.035
Baldness
 
Balkan nephropathy disease interstitial nephritis
Alport syndrome
interstitial nephritis endemic to the regions along the Danube river, in the modern countries of Croatia, Bosnia and Herzegovina, Serbia, Romania and Bulgaria C12.777.419.570.643.150
C13.351.968.419.570.643.150
Balo concentric sclerosis disease demyelinating disease
neurodegeneration
demyelinating disease characterized by the fact that the demyelinated tissues form concentric layers C10.114.375.112
C10.228.140.400
C10.228.140.695.562.112
C10.314.350.112
C20.111.258.250.175
Bannayan-Riley-Ruvalcaba syndrome disease
developmental defect during embryogenesis
autosomal dominant disease
multiple hamartoma syndrome
inherited digestive tract tumor
rare genetic vascular tumor
brain cancer
complex vascular malformation with associated anomalies
rare nervous system tumor
multiple congenital anomalies/dysmorphic syndrome-intellectual disability
rare genetic syndromic intellectual disability
rare genetic skin vascular disorder
overgrowth syndrome
a rare overgrowth syndrome and hamartomatous disorder with occurrence of multiple subcutaneous lipomas, macrocephaly and hemangiomas. C04.445.435
C04.651.435
C04.700.435
C16.320.700.435
Bardet-Biedl syndrome disease autosomal recessive disease Human disease C10.228.140.617.200
C16.131.077.245.125
C16.320.184.125
Bardet–Biedl syndrome
Barre-Lieou syndrome disease syndrome
neurological disorder
syndrome that involves occipital head aches, nystagmus on head movement, tinnitus, spasms, blurred vision, corneal hyperaesthesia, and corneal ulcers C05.116.900.596
Barrett's esophagus disease esophageal disease Human disease C06.198.102
C06.405.117.102
Barrett's esophagus
 
Barth syndrome disease
developmental defect during embryogenesis
lipid metabolism disorder
3-methylglutaconic aciduria
syndromic dyslipidemia
mitochondrial myopathy
constitutional neutropenia with extra-hematopoietic manifestations
disorder of phospholipids, sphingolipids and fatty acids biosynthesis with skeletal muscle predominant involvement
mitochondrial disease with dilated cardiomyopathy
lipid metabolism disorder that has material basis in X-linked inheritance of the tafazzin gene and is characterized by decreased production of an enzyme required to produce cardiolipin C14.240.400.172
C14.280.400.172
C16.131.077.121
C16.131.240.400.172
C16.320.322.068
C16.320.565.398.224
C18.452.648.398.224
Barth syndrome
bartonellosis disease
infectious disease
primary bacterial infectious disease primary bacterial infectious disease that is caused by the bacteria of the genus Bartonella C01.252.400.126.100
Bartter disease disease renal tubular transport disease Human disease C12.777.419.815.279
C13.351.968.419.815.279
C19.053.800.604.249
basal-cell carcinoma disease skin cancer
skin carcinoma
A subtype of basal-cell carcinoma most commonly occurring on the sun-exposed areas of the head and neck C04.557.470.200.165
C04.557.470.565.165
C04.557.470.565
Basal-cell carcinoma
 
Beckwith-Wiedemann syndrome disease syndrome
overgrowth syndrome
syndrome characterized by overgrowth (macrosomia), an increased risk of childhood cancer and congenital malformations C16.131.077.133
C16.131.260.080
C16.320.180.080
Behcet's disease disease
Designated intractable/rare diseases
vasculitis
secondary glomerular disease
rare skin disease
systemic diseases with anterior uveitis
systemic diseases with posterior uveitis
systemic diseases with panuveitis
autoinflammatory syndrome with skin involvement
vascular skin disease
unclassified autoinflammatory syndrome
predominantly large-vessel vasculitis
inflammatory and autoimmune disease with epilepsy
rare immune-mediated small-vessel systemic vasculitis in humans C07.465.075
C11.941.879.780.880.200
C14.907.940.100
C16.320.382.250
C17.800.827.368.250
C17.800.862.150
Behçet's disease
bejel disease treponematosis
mouth disease
bone disease
cellulitis
primary bacterial infectious disease
Human disease C01.252.400.840
C01.252.847.840
Nonvenereal endemic syphilis
Bell's palsy disease facial paralysis facial paralysis resulting from dysfunction in the cranial nerve VII (facial nerve) C02.256.466.087
C07.465.094
C07.465.299.250
C10.292.319.250
Bell's palsy
 
benign epilepsy with centrotemporal spikes disease childhood electroclinical syndrome Human disease C10.228.140.490.360.280
benign paroxysmal positional nystagmus disease peripheral vertigo disorder arising from a problem in the inner ear C09.218.568.900.883.500
C10.597.951.500
C23.888.592.958.500
 
beriberi disease nutritional deficiency disease
vitamin B1 deficiency
Human disease C18.654.521.500.133.699.827.223 Beriberi
Bernard-Soulier syndrome disease Giant platelet disorder
inherited blood coagulation disease
Human disease C15.378.100.100.080
C15.378.140.120
C15.378.463.080
C16.320.099.080
berylliosis disease pneumoconiosis
occupational lung disease
pneumoconiosis that involves allergic response located in lungs caused by inhalation of beryllium compounds C08.381.483.581.225
C08.381.520.702.225
C24.800.225
Berylliosis
beta-mannosidosis. disease
developmental defect during embryogenesis
lysosomal storage disease
Mannosidosis
hypertrophic cardiomyopathy
lysosomal storage disease with skeletal involvement
rare hereditary metabolic disease with peripheral neuropathy
lysosomal disease with hypertrophic cardiomyopathy
rare genetic developmental defect during embryogenesis
oligosaccharidosis
lysosomal storage disease that has material basis in deficiency of the beta-A-manosidase enzyme resulting in the disruption of N-linked glycoprotein oligosaccharide catabolism. C16.320.565.202.607.750
C16.320.565.595.577.750
C18.452.648.202.607.750
C18.452.648.595.577.750
biliary atresia disease
developmental defect during embryogenesis
cholestasis
non-neoplastic bile duct disorder
non-syndromic visceral malformation
genetic biliary tract disease
congenital disorder of digestive system investigation of choice of the disease is MRCP C06.130.120.123
C06.198.125
C16.131.314.125
Biliary atresia
biliary dyskinesia disease gallbladder disease
common bile duct disease
gallbladder disease characterized by altered tonus of the sphincter of Oddi, disturbance in the coordination of contraction of the biliary ducts, and/or reduction in the speed of emptying of the biliary tree C06.130.120.250.098
bilirubin metabolic disorder disease inherited metabolic disorder
hyperbilirubinemia
inherited metabolic disorder that involves elevated levels of bilirubin resulting from disruption of bilirubin metabolism C16.320.565.300
C18.452.648.300
C23.550.429
binasal hemianopsia disease hemianopia
heteronymous hemianopsia
C10.597.751.941.512
C11.966.075.500
C23.888.592.763.941.512
Binasal hemianopsia
biotinidase deficiency disease multiple carboxylase deficiency
disorder of other vitamins and cofactors metabolism and transport
rare genetic epilepsy
rare hereditary metabolic disease with peripheral neuropathy
multiple carboxylase deficiency that involves a deficiency in biotinidase C16.320.565.100.620.100
C16.320.565.202.720.100
C18.452.648.100.620.100
C18.452.648.202.720.100
 
Bisphosphonate-associated osteonecrosis of the jaw disease Osteonecrosis of the jaw disease C05.116.852.087
C05.500.086
C07.320.086
C23.550.717.732.183
blackwater fever disease
infectious disease
malaria Human disease C03.752.530.650.228
bladder cancer disease urinary system cancer
bladder disease
urinary system cancer that results in malignant growth located in the urinary bladder C04.588.945.947.960
C12.758.820.968
C12.777.829.813
C13.351.937.820.945
C13.351.968.829.707
Bladder urothelial carcinoma
 
Bladder exstrophy disease bladder disease
bladder exstrophy-epispadias-cloacal exstrophy complex
congenital disorder of urinary system C12.706.132
C12.777.829.132
C13.351.875.132
C13.351.968.829.132
C16.131.939.132
Bladder exstrophy
blastomycosis disease
infectious disease
primary systemic mycosis primary systemic mycosis that results in a systemic fungal infection, has material basis in Blastomyces dermatitidis, transmitted by airborne spores and has symptom skin lesions, has symptom lung lesions and has symptom pleural thickening C01.539.800.200.055
C01.703.295.055
C01.703.534.395
C08.381.472.350
C08.730.435.395
C17.800.838.208.055
Blastomycosis
 
blepharitis disease eyelid disease
eye inflammation
inflammatory disease
eyelid disease that is characterized by often chronic inflammation of the eyelid, generally the part where eyelashes grow C11.338.133 Blepharitis
 
blepharophimosis disease eyelid disease
congenital physical abnormalitie
Human disease C11.250.090
C11.338.190
C16.131.384.190
blepharospasm disease focal dystonia
cranio-facial dystonia
focal dystonia that is characterized by the involuntary, forcible contraction of the muscles controlling eye blinks C11.338.250
 
blindness disease visual impairment
eye disease
complete or nearly complete vision loss C10.597.751.941.162
C11.966.075
C23.888.592.763.941.162
Visual impairment
 
Bloch-Sulzberger syndrome disease pigmentation disease a genetic disorder that affects the skin, hair, teeth, nails, and central nervous system. C16.131.077.445
C16.131.831.580
C16.320.850.420
C17.800.621.497
C17.800.804.580
C17.800.827.420
Incontinentia pigmenti
blood coagulation disease disease hematopoietic system diseases condition in which the blood’s ability to coagulate (form clots) is impaired C15.378.100
bone cyst disease C04.182.089
C05.116.070
Bone cyst
bone inflammation disease disease bone disease
inflammation
inflammation of bone C05.116.680
bone marrow cancer disease bone marrow disease
hematologic cancer
connective tissue neoplasm
hematopoietic cancer that derives from the blood-forming stem cells of the bone marrow C04.588.448.200
C15.378.190.250
C15.378.400.200
C15.378.190.636
botulism disease
infectious disease
primary bacterial infectious disease
bacterial infectious disease
acquired neuromuscular junction disease
infectious disease of the nervous system
human and animal disease C01.252.410.222.151
C10.668.758.200
C10.720.150
C25.723.415.151
Botulism
 
boutonneuse fever disease spotted fever Human disease C01.252.400.780.790.125
C01.252.400.825.125
bovine sponginess encephalitic disease transmissible spongiform encephalopathy
bovine disease
bovine counterpart to variant Creutzfeldt-Jakob disease C10.228.228.800.260
C10.574.843.300
C22.196.250
Bovine spongiform encephalopathy
brachydactyly disease dysostosis A bone development disease characterized by short fingers and toes. C05.660.585.262
C16.131.621.585.262
brain disease disease central nervous system disease central nervous system disease that is located in the brain C10.228.140 Encephalopathy
brain edema disease brain disease human disease C10.228.140.187 Cerebral edema
breast cancer disease thoracic cancer
breast disease
cancer that originates in the mammary gland C04.588.180
C17.800.090.500
Breast cancer
 
breast cyst disease
thoracic disease
breast benign neoplasm
benign mammary dysplasia
Human disease C04.182.156
C17.800.090.249
breast fibroadenoma disease breast benign neoplasm breast benign neoplasm comprised of fibrous and glandoular tissues located in breast C04.557.450.565.590.595.350
C04.557.470.625.350
Breast fibroadenomas
breast fibrocystic disease disease breast benign neoplasm
benign mammary dysplasia
Human disease C17.800.090.750 Mastitis in animals
Brill-Zinsser disease disease epidemic typhus epidemic typhus that is a mild form of the disease, which recurs in someone after a long period of latency due to immunosuppression, malnutrition or other illnesses C01.252.400.780.790.805
bronchiolitis disease lung disease
bronchospasm
human disease C08.127.446.135
C08.381.495.146.135
C08.730.099.135
C02.109
C08.127.446.135.321
C08.381.495.146.135.321
C08.730.099.135.321
Bronchiolitis
 
bronchiolitis obliterans disease interstitial lung disease
bronchospasm
lung disease involving obstruction of the bronchioles C08.127.446.135.140
C08.381.495.146.135.140
Bronchiolitis obliterans
bronchitis disease bronchospasm
chronic obstructive pulmonary disease
type of lower respiratory disease C08.127.446
C08.381.495.146
C08.730.099
C08.127.446.567
C08.381.495.146.567
C08.381.495.389.500
C08.730.099.567
Bronchitis
bronchopneumonia disease
infectious disease
pneumonia pneumonia involving inflammation of lungs C08.127.509
C08.381.677.127
C08.730.610.127
bronchopulmonary dysplasia disease
developmental defect during embryogenesis
perinatal respiratory disorder
non-syndromic respiratory or mediastinal malformation
respiratory malformation
rare genetic respiratory disease
Human disease C08.381.520.750.500
C16.614.521.125
Bronchopulmonary dysplasia
bronchospasm disease lower respiratory tract disease lower respiratory tract disease that affects the airways leading into the lungs C08.127
C08.127.321
Brown-Séquard syndrome disease paraplegia Human disease C10.597.622.669.300
C23.888.592.636.637.300
Brown-Séquard syndrome
Brown's tendon sheath syndrome disease mechanical strabismus
genetic disease
Human disease C10.228.758
C10.292.562
C11.590
brucellosis disease
infectious disease
primary bacterial infectious disease
bacterial infectious disease
Human disease C01.252.400.167 Brucellosis
 
Brugada syndrome disease heart conduction disease
Sudden unexpected death syndrome
heart conduction disease that is characterized by abnormal electrocardiogram (ECG) findings and an increased risk of sudden cardiac death C14.280.067.322
C16.320.100
Brugada syndrome
bruxism disease sleep disorder
parafunctional habit
sleep disorder that involves involuntarily grinding or clenching of the teeth while sleeping C07.793.099
C07.793.099.500
C10.886.659.637
Bruxism
 
bubonic plague disease plague
lymph node disease
human and animal disease C01.252.400.310.980.745 Black Death
 
bulimia disease eating disorder eating disorder characterized by binge eating followed by purging. Binge eating refers to eating a large amount of food in a short amount of time C23.888.821.645.500 Bulimia nervosa
bullous pemphigoid disease autoimmune disease of skin and connective tissue
pemphigoid
bullous skin disease
autoimmune disease of skin and connective tissue characterized by large blisters C17.800.865.690
C20.111.730
Bullous pemphigoid
Burkitt lymphoma disease mature B-cell neoplasm mature B-cell neoplasm of B-cells found in the germinal center C02.256.466.313.165
C02.928.313.165
C04.557.386.480.150.165
C15.604.515.569.480.150.165
C20.683.515.761.480.150.165
Burkitt's lymphoma
 
burning mouth syndrome disease mouth disease
dysesthesia
glossalgia
rare headache disorder
Human disease C07.465.114
bursitis disease arthropathy
synovial, tendon or bursa disorder
inflammation
human disease C05.550.251 Bursitis
 
Buruli ulcer disease disease primary bacterial infectious disease
mycobacterium infectious disease
tropical disease C01.252.410.040.552.475.247
C17.800.893.295
Buruli ulcer
byssinosis disease pneumoconiosis Human disease C08.381.483.581.275
C08.381.520.702.275
C24.800.323
CADASIL disease leukodystrophy
genetic neurodegenerative disease
eye degenerative disease
autosomal dominant cerebrovascular disorder characterized by recurrent subcortical ischemic stroke and cognitive impairment C10.228.140.300.275.249
C10.228.140.300.400.203
C10.228.140.300.510.200.175
C10.228.140.380.230.124
C14.907.253.329.249
C14.907.253.560.200.175
C16.320.129
CADASIL syndrome
 
calcinosis disease calcium metabolism disease calcium metabolism disease that is the result of the formation of calcium deposits in any soft tissue C18.452.174.130 Calcinosis
calciphylaxis disease calcinosis
systemic disease
vascular disease
Human disease C18.452.174.130.186 Calciphylaxis
calculus disease C23.550.537 Lithiasis
campomelic dysplasia disease osteochondrodysplasia osteochondrodysplasia that has material basis in a mutation in chromosome 17 which results in bowing in the located in tibia or located in femur C05.660.142
C16.131.621.142
campylobacteriosis disease
infectious disease
gastroenteritis Human disease C01.252.400.177
Camurati-Engelmann disease disease
developmental defect during embryogenesis
osteosclerosis
primary bone dysplasia with increased bone density
rare disease C05.116.099.708.180
C16.320.144
Cancer of unknown primary origin disease metastasis disease C04.697.650.895
C23.550.727.650.895
candidiasis disease opportunistic mycosis fungal infection due to any type of Candida C01.703.160 Candidiasis
 
capillary leak syndrome disease capillary disease
Urticarial syndromes
Human disease C14.907.218
Caplan's syndrome disease pneumoconiosis pneumoconiosis that results in humans that also have rheumatoid arthritis C05.550.114.154.219
C05.799.114.219
C08.381.483.581.300
C08.381.520.702.300
C17.300.775.099.219
C24.800.340
carbuncle disease pyoderma Human disease C01.252.410.868.820.270.200
C01.252.825.770.270.200
C01.539.800.720.770.270.200
C17.800.838.765.770.270.200
Carbuncles
 
carcinoid disease C04.557.465.625.650.200
C04.557.470.200.025.200
C04.557.580.625.650.200
Carcinoid tumors
cardiac arrest disease
thoracic disease
congestive heart failure sudden stop in effective blood flow due to the failure of the heart to contract effectively C14.280.383 Cardiac arrest
 
cardiac tamponade disease
thoracic disease
pericardial effusion pericardial effusion in which fluid accumulates in the pericardium (the sac in which the heart is enclosed) and the pericardial spaces fills up faster than the pericardial sac can stretch C14.280.155 Cardiac tamponade
cardiomyopathy disease heart disease
myopathy
A heart disease and a myopathy that is characterised by deterioration of the function of the heart muscle C14.280.238 Cardiomyopathies
Carney complex disease autosomal dominant disease
primary pigmented nodular adrenocortical disease
Cutaneous myxoma
autosomal dominant disease characterized by myxomas, spotty pigmentation of the skin and endocrine overactivity C04.557.450.565.550.312
C04.588.894.309.500
C14.280.459.500
C16.131.077.229
C16.131.831.108
Caroli disease disease bile duct disease bile duct disease that is characterized by abnormal dilatation of the intrahepatic bile ducts C06.130.120.127.500
C06.198.184.500
C16.131.077.245.250
C16.131.314.184.500
C16.320.184.250
carotid artery stenosis disease carotid artery disease
peripheral artery disease
narrowing or constriction of the inner surface (lumen) of the carotid artery, usually caused by atherosclerosis C10.228.140.300.200.360
C14.907.137.230
C14.907.253.123.360
Carotid artery stenosis
 
carpal tunnel syndrome disease nerve compression syndrome Human Syndrome C10.668.829.500.500.200
C10.668.829.550.200
C26.844.150.206
Carpal tunnel syndrome
cat-scratch disease disease
infectious disease
bartonellosis
lymph node disease
bacterial infectious disease
immune system disease
Human disease C01.252.400.126.100.150
C01.252.400.200
C15.604.315.249
Cat-scratch disease
cataract disease lens disease clouding of the lens inside the eye, which leads to low vision C11.510.245 Cataracts
 
Cauda equina syndrome disease peripheral nervous system disease
syndrome
nerve damage at the end of the spinal cord C10.668.829.800.750.700 Cauda equina syndrome
cavernous hemangioma disease vascular hemostatic disease type of blood vessel malformation C04.557.645.375.385
C14.907.454.385
C15.378.463.515.385
Cavernous hemangiomas
cellulitis disease
infectious disease
skin disease
connective tissue disease
bacterial skin disease
Human disease C01.539.800.130
C01.539.830.200
C17.300.185
C23.550.470.756.200
Cellulite
 
central core myopathy disease congenital structural myopathy Human disease C05.651.575.300
C10.668.491.550.300
central nervous system vasculitis disease vasculitis Human disease C10.114.875
C10.228.140.300.850
C14.907.253.946
C14.907.940.907
C20.111.258.962
central pontine myelinolysis disease demyelinating disease
demyelinating disease of central nervous system
demyelination disease that is characterized by severe damage to the myelin sheath of the pons' nerve cells and has symptom acute paralysis, has symptom dysphagia, and has symptom dysarthria C10.228.140.163.560
C10.314.500
C18.452.132.560
Central pontine myelinolysis
 
centronuclear myopathy disease myopathy myopathy characterized by abnormally located nuclei in skeletal muscle cells C05.651.575
C10.668.491.550
cephalic disorder disease birth defect
central nervous system disease
congenital conditions that stem from damage to, or abnormal development of, the budding nervous system C10.500
C16.131.666
Congenital diseases and disorders of the nervous system
cerebellar ataxia disease cerebellar disease cerebellar disease characterized by ataxia originating in the cerebellum. C10.228.140.252.190
C10.597.350.090.500
C23.888.592.350.090.200
cerebral amyloid angiopathy disease amyloidosis amyloidosis where amyloid protein progressively deposits in cerebral blood vessel walls with subsequent degenerative vascular changes that usually result in spontaneous cerebral hemorrhage, ischemic lesions and progressive dementia C10.228.140.163.100.168
C10.228.140.300.275.311
C10.228.140.300.510.200.200.160
C14.907.253.329.311
C14.907.253.560.200.200.160
C16.320.565.176.160
C16.320.565.189.168
C18.452.132.100.168
C18.452.648.176.160
C18.452.648.189.168
C18.452.845.500.075.160
C18.452.845.500.100.160
Cerebral amyloid angiopathy
 
Cerebral arteriovenous malformation disease arteriovenous malformation
brain disease
rare genetic vascular tumor
rare nervous system tumor
neurovascular malformation
rare genetic epilepsy
genetic central nervous system and retinal vascular disease
arteriovenous malformation that is located in the brain C10.228.140.300.520
C10.500.190.500
C14.240.850.750.295
C14.240.850.875.500
C14.907.150.295
C14.907.253.560.400
C16.131.240.850.750.295
C16.131.240.850.875.500
C16.131.666.190.500
Cerebral arteriovenous malformation
cerebral hemorrhage disease intracranial hemorrhage
stroke
type of intracranial hemorrhage that occurs within the brain tissue itself C10.228.140.300.535.200
C14.907.253.573.200
C23.550.414.913.100
C10.228.140.199.275
C10.228.140.300.535.450.200
C10.900.300.087.187
C10.900.300.837.150
C14.907.253.573.400.150
C26.915.300.200.175
C26.915.300.490.150
C10.228.140.199.275.300
C10.228.140.300.535.200.200
C10.228.140.300.535.450.200.750
C10.900.300.087.187.300
C10.900.300.837.150.650
C14.907.253.573.200.200
C14.907.253.573.400.150.300
C26.915.300.200.175.300
C26.915.300.490.150.300
Cerebral hemorrhage
cerebral infarction disease brain infarction type of ischemic stroke resulting from a blockage in the blood vessels supplying blood to the brain C10.228.140.300.150.477.200
C10.228.140.300.775.200.200
C14.907.253.092.477.200
C14.907.253.855.200.200
 
cerebral palsy disease brain disease
cerebral degeneration
A group of disorders affecting the development of movement and posture, often accompanied by disturbances of sensation, perception, cognition, and behavior. It results from damage to the fetal or infant brain. C10.228.140.140.254 Cerebral palsy
 
cervical cancer disease uterine cancer
cervix disease
cancer arising from the cervix, caused by a sexually transmitted virus C04.588.945.418.948.850
C13.351.500.852.593.131
C13.351.500.852.762.850
C13.351.937.418.875.850
Cervical cancer
 
Cervical intraepithelial neoplasia disease Intraepithelial neoplasia C04.557.470.200.240.250
cervix erosion disease cervix disease ectropion C13.351.500.852.593.112 Cervical ectropion
Chagas disease disease trypanosomiasis human disease C03.752.300.900.200 Chagas disease
 
Charcot–Marie–Tooth disease disease
Designated intractable/rare diseases
hereditary motor and sensory neuropathy
neuromuscular disease
neuromuscular disease that is characterized by a slowly progressive degeneration of the muscles of the foot, lower leg, hand and forearm C10.500.300.200
C10.574.500.495.200
C10.668.829.800.300.200
C16.131.666.300.200
C16.320.400.375.200
Charcot-Marie-Tooth disease
CHARGE syndrome disease
head and neck disease
developmental defect during embryogenesis
syndrome
immunodeficiency due to absence of thymus
syndromic genetic deafness
rare disorder with female infertility due to a congenital hypogonadotropic hypogonadism
syndromic renal or urinary tract malformation
lens shape anomaly
multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome
syndromic developmental defect of the eye
syndrome or malformation associated with head and neck malformations
rare syndrome with cardiac malformations
syndromic urogenital tract malformation
rare abdominal surgical disease
rare genetic bone disease
syndrome that is acterized by a pattern of congenital anomalies including choanal atresia and malformations of the heart, inner ear, and retina C16.131.077.239
C16.320.165
CHARGE syndrome
Chediak-Higashi syndrome disease autosomal recessive disease
nervous system heredodegenerative disease
eye degenerative disease
autosomal recessive disease characterized by oculocutaneous albinism, immune deficiency, coagulation deficiency and neuropathy; it is that has material basis in mutations in the CHS1 gene C15.378.553.774.257
C20.673.774.257
cheilitis disease lip disease
inflammation
inflammation of the lips C07.465.409.215 Cheilitis
cherubism disease
developmental defect during embryogenesis
autosomal dominant disease
jaw disease
primary bone dysplasia with disorganized development of skeletal components
hereditary cancers
genetic systemic or rheumatologic disease
autoinflammatory syndrome with immune deficiency
rare disease with odontological manifestation
multiple congenital anomalies/dysmorphic syndrome without intellectual disability
Human disease C05.116.099.708.375.199
C05.500.174
C07.320.173
C16.131.621.207.540.170
C16.320.170
Cherubism
chikungunya disease
infectious disease
viral infectious disease
Alphavirus infection
arboviral diseases
arbovirosis
infection caused by the chikungunya virus, sintomas: dolor de cabeza, fiebre, y comezón C02.782.930.100.184 Chikungunya
 
chilblains disease trauma
cold injury
chillblains C26.212.500.217
C26.417.217
Chilblains
 
chlamydia infection disease
sexually transmitted infection
commensal bacterial infectious disease
primary Chlamydiaceae infectious disease
sexually transmitted infection caused by the bacterium Chlamydia trachomatis. C01.252.400.210.210
C01.252.810.301
C01.539.778.281.301
C12.294.668.281.301
C13.351.500.711.281.301
Chlamydia
 
choanal atresia disease
head and neck disease
developmental defect during embryogenesis
nasal cavity disease
genetic otorhinolaryngologic disease
rare genetic respiratory disease
rare genetic developmental defect during embryogenesis
nose and cavum anomaly
genetic nervous system disorder
genetic disease
congenital disorder of respiratory system C08.460.171
C08.695.271
C09.603.171
C16.131.740.271
Choanal atresia
cholangiocarcinoma disease bile duct adenocarcinoma bile duct adenocarcinoma that has_material_basis_in bile duct epithelial cells. C04.557.470.200.025.450 Cholangiocarcinoma
 
cholangitis disease bile duct disease
non-neoplastic bile duct disorder
inflammatory disease
bile duct disease that is an inflammation of the bile duct C06.130.120.200 Ascending cholangitis
 
cholecystitis disease cholangitis cholangitis that is characterized by an inflammation that is located in the gallbladder C06.130.564.263
C06.130.564.263.500
Cholecystitis
choledochal cyst disease bile duct disease congenital disorder of digestive system C04.182.198
C06.130.120.127
C06.198.184
C16.131.314.184
Choledochal cysts
cholestasis disease bile duct disease Human disease C06.130.120.135 Cholestasis
cholesteatoma disease keratosis keratosis characterized by keratinizing squamous epithelium located in middle ear and/or mastoid, subepithelial connective tissue and by the progressive accumulation of keratin debris with or without surrounding inflammatory reaction C17.800.428.260 Cholesteatoma
 
cholesterol embolism disease vascular disease vascular disease that is characterized by blood vessel obstruction resulting from the release of cholesterol from the inside of blood vessels along the bloodstream C14.907.355.350.454.500
chondroblastoma disease connective tissue neoplasm Human disease C04.557.450.565.250 Chondroblastoma
chondrocalcinosis disease arthritis arthritis that has material basis in the accumulation of salt crystals located in joint C05.550.114.264
C05.550.354.125
Chondrocalcinosis
chondrodysplasia punctata disease
developmental defect during embryogenesis
genetic disease
primary bone dysplasia
Human disease C05.116.099.708.195
chondroma disease cell type benign neoplasm
Cartilage tumor
cell type benign neoplasm that is a cartilaginous tumor encapsulated with a lobular growing pattern C04.557.450.565.265 Chondroma
chondromalacia patellae disease
arthropathy
developmental defect during embryogenesis
chondromalacia
knee disorder
bone disease
patellar dysostosis
Human disease C05.182.100
C17.300.182.100
Chondromalacia patellae
chondropathy disease osteochondropathy
connective tissue disease
human disease C05.182
C17.300.182
Chondropathies
chondrosarcoma disease connective tissue neoplasm
Cartilage tumor
connective tissue cancer that has material basis in cells derived from transformed cells that produce cartilage C04.557.450.565.280
C04.557.450.795.300
Chondrosarcoma
chordoma disease notochordal cancer notochordal cancer that derives from cellular remnants of the notochord C04.557.465.220 Chordoma
choreatic disease disease movement disorder
Huntington disease-like syndrome
movement disease characterized by brief, semi-directed, irregular movements that not repetitive or rhythmic, but appear to flow from one muscle to the next C10.228.662.262.249
C10.597.350.250
C23.888.592.350.250
Chorea
choriocarcinoma disease placenta cancer
Gestational trophoblastic disease
trophoblastic neoplasm
Human disease C04.557.465.955.207
C04.557.470.200.025.455
C04.850.908.208
C13.703.720.949.208
Choriocarcinoma
chorioretinitis disease eye disease
uveitis
Human disease C11.768.773.348
C11.941.160.478.400
C11.941.879.780.900.300.318
Chorioretinitis
choroid plexus papilloma disease papilloma
choroid plexus cancer
Human disease C04.588.614.250.195.205.200.500
C10.228.140.211.280.300.500
C10.551.240.250.200.200.500
Choroid plexus papilloma
chronic fatigue syndrome disease syndrome
primary immunodeficiency disease
medical condition involving tiredness C02.330
C05.651.310
C10.228.440.600
C10.668.364
chronic granulomatous disease disease Phagocyte bactericidal dysfunction
lung disease
bone disease
cellulitis
Human disease C15.378.553.774.535
C16.320.322.233
C20.673.774.535
chronic inflammatory demyelinating polyradiculoneuropathy disease autoimmune disease
acquired disorder
polyradiculoneuropathy
demyelinating polyneuropathy
acquired immune-mediated inflammatory disorder of the peripheral nervous system C10.114.750.175
C10.314.750.700
C10.668.829.800.750.600
C20.111.258.750.800
chronic kidney disease disease kidney failure progressive loss in kidney function over a period of months or years C12.777.419.780.750.500
C13.351.968.419.780.750.500
C12.777.419.780.750
C13.351.968.419.780.750
chronic lymphocytic leukemia disease lymphoblastic leukemia
chronic leukemia
small lymphocytic lymphoma
lymphoblastic leukemia characterized by over production of B-cells and their accumulation in bone marrow and blood C04.557.337.428.080.125
C15.604.515.560.080.125
C20.683.515.528.080.125
Chronic lymphocytic leukemia
 
chronic myeloid leukemia disease myeloid leukemia
chronic leukemia
myeloid leukemia that is characterized by over production of white blood cells C04.557.337.539.250
C15.378.190.636.370
Chronic myeloid leukemia
 
Chronic myelomonocytic leukemia disease leukemia
chronic myeloid leukemia
chronic leukemia
chronic leukemia characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood C04.557.337.539.522
C15.378.190.615.510
Chronic myelomonocytic leukemia
Chronic neutrophilic leukemia disease bone marrow cancer
chronic leukemia
chronic leukemia characterized by neutrophilic leukocytosis with no detectable Philadelphia chromosome or BCR/ABL fusion gene C15.378.190.636.380
chronic obstructive pulmonary disease disease obstructive lung disease type of obstructive lung disease characterized by long-term poor airflow C08.381.495.389 Chronic obstructive pulmonary disease
 
chronic progressive external ophthalmoplegia disease mitochondrial myopathy human disease C05.651.460.700
C10.292.562.750.250
C10.597.622.447.511
C10.668.491.500.700
C11.590.472.250
C18.452.660.560.700
C23.888.592.636.447.511
chronic wasting disease disease animal disease
transmissible spongiform encephalopathy
animal disease C10.228.228.800.858
C10.574.843.925
C22.955
Chronic wasting disease
chylothorax disease pleural effusion C08.528.142 Chylothorax
cicatricial pemphigoid disease bullous skin disease
pemphigoid
bullous skin disease characterized by skin lesions and scaring and located in mucous membranes and located in skin C11.187.482
C17.800.865.670
CINCA syndrome disease Cryopyrin-associated periodic syndrome
autoimmune disease
rare genetic eye disease
systemic diseases with anterior uveitis
Chronic Infantile Neurological, Cutaneous, and Articular (CINCA) syndrome is characterised by skin rash, joint involvement, chronic meningitis with granulocytes and, in some cases, sensorineural hearing loss and ocular signs C16.320.382.500
C17.800.827.368.500
citrullinemia disease urea cycle disorder urea cycle disorder that involves the accumulation of ammonia in the blood. C10.228.140.163.100.937.374
C16.320.565.100.940.374
C16.320.565.189.937.374
C18.452.132.100.937.374
C18.452.648.100.940.374
C18.452.648.189.937.374
cleidocranial dysplasia disease osteochondrodysplasia osteochondrodysplasia that has material basis in mutations in the RUNX2 gene which results in undeveloped or absent located in clavicle along with delayed closing of fontanels in the located in skull C05.116.099.708.207
C05.660.207.207
C16.131.621.207.207
Cleidocranial dysostosis
clonorchiasis disease
infectious disease
parasitic helminthiasis infectious disease
liver disease
human disease C03.335.865.148 Clonorchiasis
Clostridium difficile colitis disease colitis
commensal Clostridium infectious disease
colitis characterized by an overgrowth of Clostridium difficile bacteria C01.252.410.222.310
C06.405.205.596.800
C06.405.469.363.800
Pseudomembranous colitis
 
clubfoot disease dysmelia
bone development disease
foot deformity
bone development disease where one or both are inclined inwards, axially rotated outwards, and pointing downwards with concomitant soft tissue abnormalities C05.330.488.655.063
C05.330.495.681.063
C05.660.585.512.380.813.063
C16.131.621.585.512.500.681.063
Club foot
cluster headache disease headache
facial neuralgia
trigeminal autonomic cephalalgia
C10.228.140.546.399.937.500 Cluster headache
 
Coats disease disease retinal telangiectasia
congenital vitreoretinal dysplasia
secondary glaucoma due to a proliferation and differentiation anomaly
rare genetic vascular disease
genetic central nervous system and retinal vascular disease
rare central nervous system and retinal vascular disease
Human disease C11.768.748
C14.907.823.502
Coats' disease
 
coccidioidomycosis disease primary systemic mycosis Human disease C01.703.203 Coccidioidomycosis
 
coccidiosis disease
infectious disease
parasitic protozoa infectious disease A parasitic protozoa infectious disease that occurs in the intestinal tract of animals and humans caused by Coccidia protozoa. Immunocompromised persons are at greater risk of developing the infection. C03.752.250 Coccidiosis
Cockayne syndrome disease
Designated intractable/rare diseases
autosomal recessive disease
eye degenerative disease
nervous system heredodegenerative disease
Cockayne syndrome (CS) is a multisystem condition characterized by short stature, a characteristic facial appearance, premature aging, photosensitivity, progressive neurological dysfunction, and intellectual deficit C05.116.099.343.250
C10.574.500.362
C16.131.077.250
C16.320.240.562
C16.320.400.200
C18.452.284.250
Coffin-Lowry syndrome disease
developmental defect during embryogenesis
X-linked disease
X-linked mental retardation
syndromic obesity
rare genetic epilepsy
rare genetic bone disease
scoliosis
Human disease C10.597.606.643.455.249
C16.320.322.500.249
C16.320.400.525.249
Cogan syndrome disease
head and neck disease
eye disease
rare otorhinolaryngologic disease
rare eye disease
predominantly large-vessel vasculitis
a rare vasculitis of children and young adults characterized by nonsyphilitic interstitial keratitis of cornea, fever and fatigue. C10.292.910.299
C11.180
C14.907.940.320
collagen disease disease connective tissue disease Human disease C17.300.200 Collagen diseases
collagenous colitis disease microscopic colitis colitis characterized by a distinctive thickening of the subepithelial collagen table C06.405.205.265.173.500
C06.405.469.158.188.173.500
coloboma disease eye disease eye disease characterized by missing pieces of tissue in structures that form the eye, such as the iris, retina, choroid or optic disc C11.250.110
C16.131.384.282
Coloboma
color blindness disease vision disorder
Q471812
blindness
inability or decreased ability to see colour, or perceive colour differences, under normal lighting conditions C10.597.751.941.256
C11.966.256
C23.888.592.763.941.256
Color blindness
Colorado tick fever disease
infectious disease
viral infectious disease
tick-borne disease
infectious disease with epilepsy
Human disease C02.081.885.200
C02.782.791.482
colorectal cancer disease large intestine cancer
colonic tumor
cancer of the colon or rectum C04.588.274.476.411.307
C06.301.371.411.307
C06.405.249.411.307
C06.405.469.158.356
C06.405.469.491.307
C06.405.469.860.180
Colorectal cancer
 
colorectal polyp disease intestinal polyp
colonic tumor
C23.300.825.411.235 Colorectal polyp
common variable immunodeficiency disease agammaglobulinemia Human disease C20.673.330
communication disorder disease specific developmental disorder specific developmental disorder that involves specific developmental disorders of speech and language C10.597.606.150
C23.888.592.604.150
compartment syndrome disease ischemia Human disease C05.651.180
C14.907.303
Compartment syndrome
 
Complete androgen insensitivity syndrome disease androgen insensitivity syndrome C12.706.316.096.500
C13.351.875.253.096.500
C16.131.939.316.096.500
C16.320.322.061
C19.391.119.096.500
complex regional pain syndrome disease
health problem
neurological disorder
autonomic nervous system disease Human disease C10.177.195
C10.668.829.250
Complex regional pain syndrome
 
conductive hearing loss disease deafness C09.218.458.341.562
C10.597.751.418.341.562
C23.888.592.763.393.341.562
congenital central hypoventilation syndrome disease autonomic nervous system disease Human disease C08.618.085.852.800
C10.886.425.800.750.800
Central hypoventilation syndrome
congenital cystic adenomatoid malformation disease
developmental defect during embryogenesis
lung disease
respiratory malformation
rare genetic respiratory disease
non-syndromic respiratory or mediastinal malformation
congenital disorder of respiratory system C08.381.150
C08.695.290
C16.131.740.290
Congenital cystic adenomatoid malformation
congenital diaphragmatic hernia disease
Designated intractable/rare diseases
developmental defect during embryogenesis
diaphragm disease
diaphragmatic hernia
birth defect
rare genetic developmental defect during embryogenesis
rare genetic respiratory disease
diaphragm disease characterized by the lack of development of all or part of the diaphragm, which results in an abnormal opening that allows the stomach and intestines to move into the chest cavity and crowd the heart and lungs C23.300.707.500 Congenital diaphragmatic hernia
congenital disorder of glycosylation disease carbohydrate metabolic disorder carbohydrate metabolic disorder that involves deficient or defective glycosylation of a variety of tissue proteins and/or lipids C16.320.565.202.125
C18.452.648.202.125
congenital erythropoietic porphyria disease porphyria
Erythropoietic porphyria
skin disease
rare constitutional hemolytic anemia due to an enzyme disorder
congenital human disease C16.320.850.738
C17.800.827.738
C18.452.811.250
congenital heart disease disease
developmental defect during embryogenesis
heart disease
birth defect
cardiovascular abnormality
rare genetic cardiac disease
genetic disease
rare genetic developmental defect during embryogenesis
cardiovascular disease C14.240.400
C14.280.400
C16.131.240.400
Congenital diseases and disorders of the heart
congenital hypothyroidism disease hypothyroidism hypothyroidism that is present at birth C05.116.099.343.347
C05.116.132.256
C16.320.240.625
C19.297.155
C19.874.482.281
Congenital hypothyroidism
conjoined twins disease identical twins
Diseases in Twins
identical twins joined in utero C16.131.085.806 Conjoined twins
 
Conn's syndrome disease hyperaldosteronism
adrenal adenoma
adrenal gland disease
adrenal adenoma characterized by over production of aldosterone C19.053.800.604 Primary aldosteronism
 
connective tissue disease disease musculoskeletal disorder
skin and connective tissue diseases
musculoskeletal system disease that affects tissues such as skin, tendons, and cartilage C17.300 Connective tissue diseases
constipation disease bowel dysfunction bowel dysfunction that is characterized by infrequent or difficult evacuation of feces. C23.888.821.150 Constipation
contact dermatitis disease dermatitis
eczema
Human disease C17.800.174.255
C17.800.815.255
Contact dermatitis
contagious pustular dermatitis disease
infectious disease
viral infectious disease
skin disease
Human disease C02.256.743.193
C22.836.259
Orf (animal disease)
 
cor pulmonale disease congestive heart failure congestive heart failure that involves a failure of the right side of the heart and is characterized by an enlargement of the right ventricle of the heart as a response to increased resistance or high blood pressure in the lungs C14.280.832 Pulmonary heart disease
corneal neovascularization disease keratitis
Neovascularization
Human disease C11.204.290 Corneal neovascularization
corneal ulcer disease keratitis
corneal disease
Area of epithelial tissue loss from corneal surface; associated with inflammatory cells in the cornea and anterior chamber C01.539.375.177
C11.204.564.225
C11.294.177
Corneal ulcer
Cornelia de Lange syndrome disease genetic disease genetic disease that is characterized by slow growth before and after birth, intellectual disability that is usually severe to profound, skeletal abnormalities involving the arms and hands, and distinctive facial features C10.597.606.643.210
C16.131.077.272
C16.131.260.210
C16.320.180.210
Cornelia de Lange syndrome
 
coronary artery disease disease artery disease
cardiovascular disease
artery disease characterized by plaque building up along the inner walls of the arteries of the heart resulting in a narrowing of the arteries and a reduced blood supply to the cardiac muscles C14.280.647.250.260
C14.907.137.126.339
C14.907.585.250.260
C14.280.647.250
C14.907.585.250
C14.280.647
C14.907.585
Coronary artery disease
 
coronary thrombosis disease coronary artery disease
thrombosis
arterial thrombosis
Human disease C14.280.647.250.290
C14.907.355.830.220
C14.907.585.250.290
cortical blindness disease visual cortex disease
cerebral visual impairment
Human disease C10.597.751.941.162.250
C11.966.075.250
C23.888.592.763.941.162.250
Costello syndrome disease
Designated intractable/rare diseases
developmental defect during embryogenesis
autosomal dominant disease
rare genetic syndromic intellectual disability
polymalformative genetic syndrome with increased risk of developing cancer
dermis elastic tissue disorder
hypertrophic cardiomyopathy
Moyamoya syndrome
Noonan syndrome and Noonan-related syndrome
multiple congenital anomalies/dysmorphic syndrome-intellectual disability
malformation syndrome with skin/mucosae involvement
syndrome characterized by craniofacial dysmorphology, cardiac defects, mild mental retardation, and high birth weight followed by a failure to thrive and developmental delays C05.660.207.219
C16.131.077.256
C16.320.185
Costello syndrome
Cowden disease disease autosomal dominant disease
multiple hamartoma syndrome
inherited disorder causing tumor-like growth and increased cancer risk C04.445.435
C04.651.435
C04.700.435
C16.320.700.435
Cowden syndrome
cowpox disease
infectious disease
viral infectious disease Human disease C02.256.743.175 Cowpox
 
Coxa valga disease hip dysplasia C05.116.214.750.500
C05.116.327
C23.300.970.374.500
Coxa valga
Coxa vara disease hip dysplasia
bone anteversion
genetic disease
Hip deformity in which the femoral neck leans forward resulting in a decrease in the angle between femoral neck and its shaft. It may be congenital often syndromic, acquired, or developmental. C05.116.214.500.500
C23.300.970.249.500
Coxa vara
craniopharyngioma disease central nervous system organ benign neoplasm Human disease C04.557.465.625.200
C04.557.580.625.200
Craniopharyngiomas
 
craniosynostosis disease synostosis
rare disease
craniofacial disease
synostosis that results in premature fusion located in skull C05.116.099.370.894.232
C05.660.207.240
C05.660.906.364
C16.131.621.207.240
C16.131.621.906.364
Craniosynostosis
 
CREST syndrome disease syndrome
limited scleroderma
syndrome characterized by calcinosis, Raynaud's phenomeno, esophageal dysmotility, sclerodactyly and telangiectasia C06.405.117.119.500.204
C14.907.617.812.500
C14.907.823.225
C17.300.799.801.500
C17.800.784.801.500
C18.452.174.130.204
CREST syndrome
Cri-Du-Chat syndrome disease chromosomal deletion syndrome
autosomal deletion syndrome
Human disease C10.597.606.643.180
C16.131.077.262
C16.131.260.190
C16.320.180.190
Cri du chat syndrome
Crigler-Najjar syndrome disease bilirubin metabolic disorder bilirubin metabolic disorder that involves a build up of bilirubin as bilirubin is not being broken down as a result of a lack or deficiency of the enzyme uridine diphosphate glycosyltransferase (UGT) C16.320.565.300.281
C18.452.648.300.281
 
Crimean-Congo hemorrhagic fever disease
infectious disease
viral infectious disease
rare skin disease
Skin infection
viral disease C02.081.885.430
C02.782.147.444
C02.782.417.412
 
critical illness polyneuropathy disease inflammatory and toxic neuropathy
polyneuropathy
Human disease C10.668.829.800
Cronkhite-Canada syndrome disease
Designated intractable/rare diseases
developmental defect during embryogenesis
stomach disease
polyposis
gastric hamartomatous polyp
inherited digestive tract tumor
hamartoma of skin appendage
inherited skin tumor
Human disease C06.405.469.578
croup disease
infectious disease
respiratory system disease
acute laryngitis
respiratory condition that is usually triggered by an acute viral infection of the upper airway C08.360.535.365
C09.400.535.365
Croup
 
Crouzon syndrome disease
developmental defect during embryogenesis
craniosynostosis
craniostenosis associated with a strabismus
syndromic craniosynostosis
congenital disorder of digestive system C05.116.099.370.231
C05.660.207.231
C16.131.621.207.231
Crouzon syndrome
cryoglobulinemia disease type IV hypersensitivity hypersensitivity reaction type IV disease that involves large amounts of cryoglobulins in the blood which become thick or gel-like in cold temperatures C14.907.454.140
C15.378.147.780.243
C15.378.463.515.140
C20.683.780.250
Cryoglobulinemia
Cryopyrin-associated periodic syndrome disease
Designated intractable/rare diseases
Periodic fever syndrome syndrome C16.320.382.500
C17.800.827.368.500
cryptococcosis disease
infectious disease
opportunistic mycosis
fungal infectious disease
immune system disease
opportunistic mycosis that results in fungal infection and has material basis in Cryptococcus neoformans or Cryptococcus gattii. C01.703.248 Cryptococcosis
cryptogenic organizing pneumonia disease
infectious disease
idiopathic interstitial pneumonia Human disease C08.127.446.135.140.200
C08.381.483.487.249
C08.381.495.146.135.140.200
Cryptogenic organizing pneumonia
cryptorchidism disease birth defect
testicular disease
male reproductive system disease
genetic disease
Human disease C12.294.829.258
C12.706.258
C16.131.939.258
C19.391.829.258
Cryptorchidism
cryptosporidiosis disease
infectious disease
coccidiosis
intestinal disease
Intestinal parasite
Human disease C03.432.269
C03.701.688.235
C03.752.250.269
C03.752.625.235
C06.405.469.452.269
C22.674.710.235
Cryptosporidiosis
 
Cushing's syndrome disease adrenal gland hyperfunction that is caused by overactivity of the adrenal cortex caused by a tumor of the pituitary gland C19.053.800.367 Cushing's syndrome
Cutaneous larva migrans disease
infectious disease
parasitic helminthiasis infectious disease
parasitic skin disease
C03.335.508.523
C03.858.424
C17.800.838.775.424
Cutaneous larva migrans
cyst disease lesion closed sac growth on the body C04.182
C23.300.306
Cysts
cystadenoma disease adenoma adenoma that is a cystic C04.557.470.035.320
C04.557.470.590.485
Mucinous cystoadenoma of the ovary
cystic fibrosis disease autosomal recessive disease
lung disease
genetic biliary tract disease
genetic pancreatic disease
rare genetic respiratory disease
rare male fertility disorder with obstructive azoospermia
rare genetic disorder with obstructive azoospermia
autosomal recessive disease that is characterized by the buildup of thick, sticky mucus that can damage many organs. C06.689.202
C08.381.187
C16.320.190
C16.614.213
Cystic fibrosis
 
cystic lymphangioma disease lymphangioma
Cystic lymphatic malformation
Human disease C04.557.375.450.450 Cystic hygroma
cysticercosis disease
infectious disease
taeniasis
eye disease
muscle tissue disease
heart disease
skin disease
intestinal disease
Human helminthiasis C03.335.190.902.185 Cysticercosis
 
cystinosis disease lysosomal storage disease
inborn disorder of lysosomal amino acid transport
A lysosomal storage disease characterized by the abnormal accumulation of cystine in the lysosomes. It follows an autosomal recessive inheritance pattern and has material basis in mutations in the CTNS gene, located on chromosome 17. C16.320.565.595.377
C18.452.648.595.377
Cystinosis
 
cystinuria disease amino acid metabolic disorder amino acid metabolic disorder that involves the formation of cystine stones in the kidneys, ureter, and bladder C12.777.419.815.885.250
C13.351.968.419.815.885.250
C16.320.565.861.885.250
C18.452.648.861.885.250
cystitis disease bladder disease
inflammation
inflammatory disease
human Disease C12.777.829.495
C13.351.968.829.495
Cystitis
 
cystoisosporiasis disease
infectious disease
coccidiosis coccidiosis that involves infection of the epithelial cells of the small intestine with Cystoisospora belli, which results in nonbloody diarrhea with crampy abdominal pain, malabsorption and weight loss C03.752.250.410 Isosporiasis
dacryoadenitis disease lacrimal apparatus disease Human disease C11.496.221
dacryocystitis disease acute inflammation of lacrimal passage Human disease C11.496.221 Dacryocystitis
Dandy-Walker syndrome disease
developmental defect during embryogenesis
cerebellar disease
rare genetic developmental defect during embryogenesis
cystic malformation of the posterior fossa
genetic nervous system disorder
malformation of the cerebellar vermis
congenital disorder of nervous system C10.228.140.252.300
C10.228.140.602.500
C10.500.205
C16.131.666.205
Dandy–Walker syndrome
De Quervain disease disease
arthropathy
occupational disease
arthropathy
stenosing tenosynovitis
human disease C05.651.869.816.200 De Quervain syndrome
 
decubitus ulcer disease chronic ulcer of skin Decubitus ulcer is a chronic ulcer of skin where the ulcer is an ulceration of tissue deprived of adequate blood supply by prolonged pressure C17.800.893.665 Pressure ulcers
 
delayed sleep phase disorder disease sleep disorder
obsolete chronobiology disease
circadian rhythm sleep disorder
chronic mismatch between a person's normal daily rhythm, compared to other people and societal norms C10.281
delirium tremens disease alcohol withdrawal syndrome human disease C10.720.112.200
C25.723.705.150.200
C25.775.100.087.193.200
C25.775.835.250
Delirium tremens
dementia disease cognitive disorder long-term brain disorders causing personality changes and impaired memory, reasoning, and normal function C10.228.140.380 Dementia
demyelinating disease disease neurological disorder
neurodegeneration
type of neurological disease where the myelin sheath of neurons is damaged C10.314 Demyelinating diseases
dengue fever disease viral infectious disease tropical disease caused by the dengue virus, transmitted by mosquito C02.081.270
C02.782.350.250.214
C02.782.417.214
Dengue
 
dental caries disease teeth hard tissue disease disease involving breakdown of teeth C07.793.720.210 Dental caries
 
dental fluorosis disease tooth disease Human disease C07.793.330 Dental fluorosis
 
dentatorubral-pallidoluysian atrophy disease autosomal dominant cerebellar ataxia
autosomal dominant cerebellar ataxia type IV
Huntington disease-like syndrome
congenital disorder of nervous system C10.228.140.490.250.650
Dentine hypersensitivity disease tooth disease
teeth hard tissue disease
Human disease C07.793.266 Dentistry
dentinogenesis imperfecta disease tooth disease Human disease C07.650.800.270
C07.793.700.270
C16.131.850.800.270
Dentinogenesis imperfecta
Denys-Drash syndrome disease
developmental defect during embryogenesis
autosomal dominant disease
nephroblastoma
pseudohermaphroditism
primary glomerular disease
syndrome with disorder of sex development of gynecological interest
polymalformative genetic syndrome with increased risk of developing cancer
syndrome with 46,XY disorder of sex development
Human disease C04.557.435.595.220
C04.588.945.947.535.585.220
C04.700.635.220
C12.706.316.096.562
C12.758.820.750.585.220
C12.777.419.473.585.220
C13.351.875.253.096.562
C13.351.937.820.535.585.220
C13.351.968.419.473.585.220
C16.131.939.316.096.562
C16.320.700.642.220
C19.391.119.096.562
dermatitis disease skin disease skin disease C17.800.174 Dermatitis
dermatitis herpetiformis disease autoimmune disease of skin and connective tissue
bullous skin disease
pemphigoid
Human disease C17.800.174.360
C17.800.865.360
C20.111.318
Dermatitis herpetiformis
dermatofibrosarcoma protuberans disease fibrosarcoma
inherited soft tissue tumor
rare skin tumor or hamartoma
rare genetic dermis disorder
skin sarcoma
A fibrosarcoma that is located in the dermis laryer of the skin and that begins as a hard nodule and grows slowly. C04.557.450.565.590.350.320
C04.557.450.795.350.320
Dermatofibrosarcoma protuberans
dermatomyositis disease polymyositis
myositis
skin disease
myositis that results in inflammation located in muscle or located in skin where a skin rash is often seen prior to the onset of muscle weakness C05.651.594.819.500
C10.668.491.562.575.500
C17.300.250
C17.800.185
Dermatomyositis
 
dermoid cyst disease cystic teratoma Elf disease C04.182.201
C04.557.465.910.250
Dermoid cyst
 
deuteranopia disease congenital color blindness
color blindness
red–green color blindness
Human disease C10.597.751.941.256
C11.966.256
C23.888.592.763.941.256
dextrocardia disease congenital heart disease rare congenital defect in which the apex of the heart is located on the right side of the body C14.240.400.280
C14.280.400.280
C16.131.240.400.280
C16.131.810.250
Dextrocardia
 
diabetes insipidus disease kidney disease
polyuric-polydipsic syndrome
Human disease C12.777.419.135
C13.351.968.419.135
C19.700.159
Diabetes insipidus
diabetic angiopathy disease arterial occlusive disease
complications of diabetes mellitus
Human disease C14.907.320
C19.246.099.500
Diabetic angiopathy
diabetic ketoacidosis disease complications of diabetes mellitus
type 2 diabetes mellitus
potentially life-threatening complication in people with diabetes mellitus C18.452.076.176.652.500
C18.452.394.750.535
C19.246.099.812
diabetic retinopathy disease retinal vascular disease
complications of diabetes mellitus
diabetic angiopathy
Human disease C11.768.257
C14.907.320.382
C19.246.099.500.382
Diabetic retinopathy
Diamond-Blackfan anemia disease erythroblastopenia
congenital hypoplastic anemia
rare disease C15.378.071.085.080.090
C15.378.071.750.500
C15.378.190.196.080.090
C16.320.077.090
dicrocoeliasis disease
infectious disease
parasitic helminthiasis infectious disease
distomatosis
A parasitic helminthiasis infectious disease that involves parasitic infection of the bile ducts of the liver by Dicrocoelium dendriticum. C03.335.865.224
Diffuse esophageal spasm disease esophageal disease
Esophageal spasm
C06.405.117.119.500.450 Diffuse esophageal spasm
diffuse idiopathic skeletal hyperostosis disease
developmental defect during embryogenesis
calcinosis
spinal disease
developmental anomaly of metabolic origin
dysostosis with predominant vertebral and costal involvement
calcinosis that is the calcification or a bony hardening of ligaments in areas where they attach to your spine C05.116.540.410
C05.116.900.815.651
Diffuse idiopathic skeletal hyperostosis
 
DiGeorge syndrome disease chromosomal deletion syndrome T cell deficiency disease that is the result of a large deletion of chromosome 22 which includes the DGS gene needed for development of the thymus and related glands with subsequent lack of T-cell production C05.660.207.103.500
C14.240.400.021.500
C14.280.400.044.500
C15.604.451.249.500
C16.131.077.019.500
C16.131.240.400.021.500
C16.131.260.019.500
C16.131.482.249.500
C16.131.621.207.103.500
C16.320.180.019.500
C19.642.482.500.500
DiGeorge Syndrome
dilated cardiomyopathy disease intrinsic cardiomyopathy intrinsic cardiomyopathy that is characterized by an an enlarged heart and damage to the myocardium causing the heart to pump blood inefficiently C14.280.195.160
C14.280.238.070
Dilated cardiomyopathy
diphtheria disease
infectious disease
primary bacterial infectious disease
bacterial infectious disease
Infectious disease C01.252.410.040.246
C01.252.410.040.246.388
Diphtheria
 
dirofilariasis disease
infectious disease
filariasis
parasitic helminthiasis infectious disease
nematode infection
zoonosis
lung disease
skin disease
parasitic skin disease
rare skin disease
Human disease C03.335.349.320
C03.335.508.700.750.361.290
C03.701.377.320
C22.674.377.320
 
disseminated intravascular coagulation disease thrombophilia pathological process characterized by the widespread activation of the clotting cascade that results in the formation of blood clots in the small blood vessels throughout the body C15.378.100.220
C15.378.463.250
C15.378.925.220
Disseminated intravascular coagulation
diverticulitis disease intestinal disease
diverticular disease
inflammatory disease
digestive disease caused by an inflammation of a herniating pouch (diverticulum) within the wall of the intestine, most often colon C01.539.463.298
C06.405.205.298
Diverticulitis
double outlet right ventricle disease ventricular septal defect
congenital heart disease
cyanotic heart defect
Human disease, Congenital Heart Disease C14.240.400.915.300
C14.280.400.915.300
C16.131.240.400.915.300
dracunculiasis disease
infectious disease
nematode infection
parasitic helminthiasis infectious disease
filariasis
Human helminthiasis C03.335.508.700.750.299 Dracunculus medinensis
 
Drusen disease degeneration of macula and posterior pole Human disease C11.768.585.585 Drusen
Duane retraction syndrome disease strabismus Human disease C10.292.562.250
C11.270.235
C11.590.224
C16.320.290.235
Duane syndrome
Dubin-Johnson syndrome disease bilirubin metabolic disorder
rare metabolic liver disease
Human disease C16.320.565.300.764
C16.614.451.500.250
C18.452.648.300.764
Duchenne muscular dystrophy disease muscular dystrophy
myopathy with eye involvement
qualitative or quantitative defects of dystrophin
Duchenne and Becker muscular dystrophy
Duchenne muscular dystrophy (DMD) is a neuromuscular disease characterized by rapidly progressive muscle weakness and wasting due to degeneration of skeletal, smooth and cardiac muscle C05.651.534.500.300
C10.668.491.175.500.300
C16.320.322.562
C16.320.577.300
Duchenne muscular dystrophy
 
dumping syndrome disease postgastrectomy syndrome Human disease C06.405.748.630.310
C23.550.767.812.500
duodenitis disease intestinal disease Human disease C06.405.205.462.249
C06.405.469.275.600
C06.405.469.326.750
Dupuytren's contracture disease fibromatosis
contracture
superficial fibromatosis
A superficial fibromatosis arising from the soft tissue of the palm. It is characterized by the presence of spindle-shaped fibroblasts, and an infiltrative growth pattern. It predominantly affects adult males. C04.557.450.565.590.340.173
C05.651.197.270
C17.300.270
Dupuytren's contracture
 
dysarthria disease motor speech disorder disglosia C10.597.606.150.500.800.150.200
C23.888.592.604.150.500.800.150.200
dyscalculia disease learning disability
Mathematical anxiety
difficulty in learning or comprehending arithmetic C10.597.606.150.550.099
C23.888.592.604.150.550.099
Dyscalculia
 
dysentery disease gastroenteritis
intestinal infectious disease
waterborne disease
inflammation of the intestine causing diarrhea with blood C06.405.205.331
C06.405.469.300
 
dysgerminoma disease germ cell cancer
malignant germ cell tumor
germ cell cancer that derives from cells that give rise to egg cells C04.557.465.330.300
dysgraphia disease writing disorder
learning disability
writing disorder that involves a deficiency in the ability to write where the writing is distorted or incorrect, spelling difficulty, poor handwriting or trouble putting thoughts on paper C10.597.606.150.500.050
C23.888.592.604.150.500.050
Dysgraphia
dyskinesia of esophagus disease esophageal disease
Esophageal motility disorder
human disease C06.405.117.119.500
dyslexia disease
learning disability
reading disorder
language disorder
learning disability
reading/writing disorder C10.597.606.150.500.300
C10.597.606.150.550.200
C23.888.592.604.150.500.300
C23.888.592.604.150.550.200
Dyslexia
 
dysmenorrhea disease menstrual disorder
pelvic pain
C23.550.568.750
C23.888.592.612.944.500
Dysmenorrhea
dysostosis disease
developmental defect during embryogenesis
bone development disease bone development disease that results in defective ossification of located in bone C05.116.099.370
dyspepsia disease functional gastric disease Human disease C23.888.821.236
dysplasia disease congenital abnormality abnormal development, at macroscopic or microscopical level C04.697.098.500
C23.550.727.098.500
dystonia disease movement disorder
rare genetic dystonia
neurological movement disorder C10.228.662.300
C10.597.350.300
C23.888.592.350.300
Dystonia
Ebstein anomaly disease
developmental defect during embryogenesis
tricuspid valve disease
congenital heart disease
cyanotic heart defect
rare genetic developmental defect during embryogenesis
aortic disease
genetic cardiac malformation
congenital tricuspid malformation
rare genetic vascular disease
tricuspid valve disease that is a congenital heart defect in which the septal leaflet of the tricuspid valve is displaced towards the apex of the right ventricle of the heart C14.240.400.395
C14.280.400.395
C16.131.240.400.395
Ebstein's anomaly
 
echinococcosis disease
infectious disease
tapeworm infection
zoonosis
parasitic helminthiasis infectious disease
parasitic disease of tapeworms of the Echinococcus type C03.335.190.396 Echinococcosis
 
Echolalia disease speech disorder speech disorder that involves the automatic repetition of vocalizations made by another person C10.597.606.150.500.800.300
C23.888.592.604.150.500.800.300
eclampsia disease pre-eclampsia pre-eclampsia characterized by the presence of seizures C13.703.395.124 Eclampsia
ecthyma disease impetigo Human disease C01.252.410.890.210
C01.252.825.210
C01.539.800.720.210
C17.800.695.210
C17.800.838.765.210
Ecthyma
Ectopia cordis disease
developmental defect during embryogenesis
congenital malformation in which the heart is abnormally located either partially or totally outside of the thorax C14.240.400.422
C16.131.240.400.422
Ectopia lentis disease disorder of lens C11.250.300
C11.510.598.373
C16.131.384.405
Ectopia lentis
ectopic pregnancy disease female reproductive system disease
Human Pregnancy
female reproductive system disease characterized by the implantation of the embryo outside the uterine cavity C13.703.733 Ectopic pregnancy
ectropion disease eyelid disease Human disease C11.338.362 Ectropion
 
egg allergy disease food allergy
health effects of eggs
food allergy that is an allergy or hypersensitivity to dietary substances from the yolk or whites of eggs, causing an overreaction of the immune system which may lead to severe physical symptoms C20.543.480.370.150
Ehlers-Danlos syndrome disease
Designated intractable/rare diseases
collagen disease rare disease C14.907.454.240
C15.378.463.515.240
C16.131.831.428
C16.320.850.260
C17.300.200.310
C17.800.804.428
C17.800.827.260
Ehlers-Danlos syndrome
Eisenmenger's syndrome disease congenital heart disease
cyanotic heart defect
pulmonary arterial hypertension associated with congenital heart disease
fetal heart defect C14.240.400.450
C14.280.400.450
C16.131.240.400.450
Eisenmenger's syndrome
Ellis-Van Creveld syndrome disease
developmental defect during embryogenesis
autosomal recessive disease
rare syndrome with cardiac malformations
rare abdominal surgical disease
syndromic renal or urinary tract malformation
Human disease C05.116.099.708.327
C16.131.077.350.398
C16.131.831.350.398
C16.320.850.250.398
C17.800.804.350.398
C17.800.827.250.398
Ellis–van Creveld syndrome
 
embryonal carcinoma disease embryonal cancer
extragonadal germ cell cancer
extragonadal non-dysgerminomatous germ cell tumor
embryonal cancer that is a type of germ cell tumour that is located in the ovaries or located in the testes C04.557.465.200 Embryonal carcinoma
Emery-Dreifuss muscular dystrophy disease muscular dystrophy muscular dystrophy that chiefly affects muscles used for movement (skeletal) and heart (cardiac) muscle C05.651.534.500.350
C10.668.491.175.500.350
C16.320.322.625
C16.320.577.350
empty sella syndrome disease pituitary gland disease endocrine disease C10.228.140.617.738.200
C19.700.320
Empty sella syndrome
empyema disease
infectious disease
gathering of pus within a naturally existing anatomical cavity C01.539.830.305
C23.550.470.756.305
Empyemas
encephalitis disease brain disease
brain inflammatory disease
brain disease that is characterized as an acute inflammation of the brain with flu-like symptoms C10.228.140.430 Encephalitis
 
encephalitozoonosis disease
infectious disease
microsporidiosis Human disease C01.703.617.300
encephalomalacia disease brain disease Human disease C10.228.140.461
encephalomyelitis disease central nervous system disease
inflammatory disease
Human disease C10.228.228.291
C10.228.440
endemic goiter disease goiter
nutritional deficiency disease
Human disease C19.874.283.300
endocarditis disease endocardium disease
inflammation of heart layer
endocardium disease characterized by inflammation of the endocardium of the heart chambers and valves C14.280.282 Endocarditis
 
endolymphatic hydrops disease
head and neck disease
oedema
peripheral vertigo
human disease C09.218.568.217
endometrial cancer disease uterine cancer
uterine corpus cancer
endometriosis
uterine cancer that is located in tissues lining the uterus C04.588.945.418.948.585
C13.351.500.852.762.200
C13.351.937.418.875.200
Endometrial cancer
 
Endometrial hyperplasia disease C13.351.500.852.228
endometriosis disease female reproductive system disease female reproductive system disease characterized by the growth of endometrial tissue outside the uterine body C13.351.500.163 Endometriosis
 
endometriosis of uterus disease endometriosis
uterine disease
medical condition characterized by the presence of glandular tissue in muscle C13.351.500.852.113 Adenomyosis of the uterus
endometritis disease endometrial disease inflammation of inner lining of uterus C13.351.500.056.750.249
C13.351.500.852.299
Endometritis
endophthalmitis disease globe disease
eye inflammation
globe disease that is characterized by inflammation of the inside of the eye C01.539.375.265
C11.294.265
enophthalmos disease orbital disease Human disease C11.675.319
enterobiasis disease
infectious disease
nematode infection
anthroponotic disease
parasitic helminthiasis infectious disease
Human worm infection C03.335.508.700.550.550
C03.335.508.700.550.550.375
Enterobius vermicularis
 
entropion disease eyelid disease Human disease C11.338.443 Entropion
 
eosinophilia disease leukocyte disease Human disease C15.378.553.231
C15.378.553.231.549
eosinophilic granuloma disease Langerhans cell histiocytosis in childhood and adulthood C05.116.391
C08.381.483.375.500
C15.378.553.231.348
C15.604.250.400.360
C23.550.382.250
Eosinophilic granuloma
ependymoma disease tumor that arises from the ependyma, a tissue of the central nervous system C04.557.465.625.600.380.290
C04.557.470.670.380.290
C04.557.580.625.600.380.290
Ependymal tumors
epidemic pleurodynia disease
infectious disease
viral infectious disease
muscle tissue disease
Human disease C02.782.687.359.213.737
epidemic typhus disease typhus Human disease C01.252.400.780.790.805 Epidemic Typhus
 
epidermodysplasia verruciformis disease autosomal recessive disease
viral infectious disease
skin disease
immune deficiency with skin involvement
other immunodeficiency syndromes due to defects in innate immunity
Human disease C02.256.650.810.345
C02.825.810.260
C02.928.914.345
C17.800.838.790.810.260
Epidermodysplasia verruciformis
 
epidermolysis bullosa disease
Designated intractable/rare diseases
vesiculobullous skin disease Human disease C16.131.831.493
C16.320.850.275
C17.800.804.493
C17.800.827.275
C17.800.865.410
Epidermolysis bullosa
epididymitis disease
infectious disease
male reproductive system disease
infectious disease
inflammatory disease
Human disease C12.294.199 Epididymitis
epiglottitis disease
infectious disease
upper respiratory tract disease
supraglottitis
inflammatory disease
Human disease C08.730.798.200 Epiglottitis
epispadias disease
developmental defect during embryogenesis
penile disease
bladder exstrophy-epispadias-cloacal exstrophy complex
congenital disorder of urinary system C12.706.374
C12.777.767.374
C13.351.875.374
C13.351.968.767.374
C16.131.939.374
Epispadias
epulis disease gingival overgrowth Human disease C07.465.714.258 Epulis
Erdheim-Chester disease disease non-Langerhans-cell histiocytosis
granulomatous autoinflammatory syndrome
histiocytic and dendritic cell cancer
connective tissue neoplasm
immune system disease
rare disease C15.604.250.410.224 Erdheim–Chester disease
 
erethism disease C10.720.475.600
C25.723.647.500
erysipelas disease dermatitis
streptococcal infection
human disease C01.252.410.890.328
C01.252.825.260
C01.539.800.720.260
C17.800.838.765.260
Erysipelas
 
erysipeloid disease primary bacterial infectious disease
Erysipelothrix infectious disease
Human disease C01.252.410.334.329
erythema infectiosum disease
infectious disease
viral exanthem
parvovirus infectious disease
viral infectious disease
Skin infection
Human disease C02.256.700.300
C02.825.260
C17.800.229.335
C17.800.838.790.260
Parvovirus
 
erythema multiforme disease skin disease
erythema
skin disease that is a type of allergic reaction located in skin, which occurs in response to medications, infections, or illness C17.800.229.400
C17.800.865.475
Erythema multiforme
erythema nodosum disease Reactive neutrophilic dermatoses skin disease C17.800.174.600.375
C17.800.229.413
C20.543.206.380.375
C25.100.468.380.375
Erythema nodosum
erythrasma disease pyoderma Human disease C01.252.410.040.246.430
C01.252.825.320
C01.539.800.720.320
C17.800.838.765.320
Erythrasma
erythroderma disease
symptom
skin disease C17.800.174.318
C17.800.815.318
erythromelalgia disease arterial occlusive disease
vascular skin disease
autosomal dominant hereditary sensory and autonomic neuropathy
rare genetic skin vascular disorder
unclassified genetic skin disorder
Human disease C14.907.617.500 Erythromelalgia
erythropoietic protoporphyria disease acute porphyria
Erythropoietic porphyria
porphyria
acute porphyria characterized by a deficiency in the enzyme ferrochelatase, leading to abnormally high levels of protoporphyrin in the tissue C06.552.830.812
C16.320.850.742.812
C17.800.827.742.812
C18.452.811.400.812
Erythropoietic protoporphyria
 
esophageal atresia disease
thoracic disease
esophageal disease
atresia
birth defect
congenital disorder of digestive system C06.198.330
C06.405.117.260
C16.131.314.330
Oesophageal atresia
esophageal cancer disease gastrointestinal system cancer
esophageal disease
gastrointestinal system cancer that is located in the esophagus C04.588.274.476.205
C04.588.443.353
C06.301.371.205
C06.405.117.430
C06.405.249.205
Esophageal cancer
 
esophagitis disease
thoracic disease
esophageal disease inflammation of the esophagus C06.405.117.620
C06.405.205.663
esotropia disease strabismus Esotropia is a strabismus in which the eye turns inward toward the nose C10.292.562.887.300
C11.590.810.400
Esotropia
Essential thrombocytosis disease myeloproliferative neoplasm Human disease C15.378.100.832
C15.378.140.860.800
C15.378.190.636.860.800
C15.378.463.825
essential tremor disease movement disorder
tremor
A movement disorder that causes involuntary tremors, especially in the hands. It occurs alone without other neurological signs and symptoms. C10.228.662.350
esthesioneuroblastoma disease blastoma
head and neck cancer
olfactory nerve neoplasm
Human disease C04.557.465.625.600.590.650.550.150
C04.557.470.670.590.650.550.150
C04.557.580.625.600.590.650.550.150
C10.292.650.200
eumycotic mycetoma disease dermatomycosis Human disease C01.252.410.040.692.606
C01.252.825.557
C01.539.800.200.500
C01.539.800.720.557
C01.703.295.522
C17.800.838.208.557
C17.800.838.765.557
euthyroid sick syndrome disease thyroid gland disease Secondary allostasis of thyroid function in fetal life, starving and in critical illness C19.874.255
Ewing's sarcoma disease sarcoma
bone cancer
Ewing family of tumor
bone cancer that has material basis in neural crest cells derives from undeveloped, undifferentiated neuroectoderm C04.557.450.565.575.650.800
C04.557.450.795.620.800
C04.557.465.625.600.590.650
C04.557.470.670.590.650
C04.557.580.625.600.590.650
Ewing's sarcoma
exanthema subitum disease viral infectious disease
Roseolovirus infectious disease
Human disease C02.256.466.850.290
C02.825.290
C17.800.257.335
C17.800.838.790.290
Roseola
excessive tearing disease lacrimal apparatus disease Human disease C11.496
exocrine pancreatic insufficiency disease pancreas disease Human disease C06.689.276
exophthalmos disease
clinical sign
eye disease eye disease that is characterized by a bulging of the eye anteriorly out of the orbit C11.675.349 Exophthalmos
 
exostosis disease hyperostosis hyperostosis that involves formation of new bone on the surface of preexisting bone C05.116.540.310 Exostoses
exotropia disease strabismus Human disease C10.292.562.887.650
C11.590.810.440
Exotropia
experimental autoimmune encephalomyelitis disease encephalomyelitis C10.114.703.300
C10.228.140.695.562.250
C10.314.350.250
C20.111.258.625.300
Experimental autoimmune encephalomyelitis
expressive aphasia disease acute aphasia C10.597.606.150.500.800.100.100
C23.888.592.604.150.500.800.100.100
 
Fabry disease disease
developmental defect during embryogenesis
sphingolipidosis
developmental anomaly of metabolic origin
rare genetic skin vascular disorder
rare genetic epilepsy
syndromic dyslipidemia
vascular skin disease
hypertrophic cardiomyopathy
sphingolipidosis with epilepsy
syndromic lymphedema
nephropathy secondary to a storage or other metabolic disease
cataract associated with a metabolic disease
metabolic disease with corneal opacity
lysosomal disease with restrictive cardiomyopathy
lysosomal disease with hypertrophic cardiomyopathy
rare hereditary metabolic disease with peripheral neuropathy
syndrome associated with hypertrophic cardiomyopathy
Human disease C10.228.140.163.100.435.825.200
C10.228.140.300.275.374
C14.907.253.329.374
C16.320.322.124
C16.320.565.189.435.825.200
C16.320.565.398.641.803.300
C16.320.565.595.554.825.200
C18.452.132.100.435.825.200
C18.452.584.687.803.300
C18.452.648.189.435.825.200
C18.452.648.398.641.803.300
C18.452.648.595.554.825.200
Fabry disease
facioscapulohumeral muscular dystrophy disease muscular dystrophy An autosomal dominant disorder affecting the skeletal muscles of the face, scapula, and upper arm. Patients present with muscle weakness in these anatomic areas. The muscle weakness eventually spreads to other skeletal muscles as well. C05.651.534.500.400
C10.668.491.175.500.400
C16.320.577.400
factitious disorder disease mental disorder disease of mental health where symptoms are deliberately produced, feigned or exaggerated in order to falsely demonstrate the presence of an illness F03.875.375
factor XI deficiency disease autosomal genetic disease
hemophilia
coagulation factor deficiency
rare hemorrhagic disorder due to a constitutional coagulation factors defect
Human disease C15.378.100.100.325
C15.378.100.141.325
C15.378.463.325
C16.320.099.325
factor XIII deficiency disease inherited blood coagulation disease
rare hemorrhagic disorder due to a constitutional coagulation factors defect
Human disease C15.378.100.100.335
C15.378.100.141.335
C15.378.463.335
C16.320.099.335
familial adenomatous polyposis disease autosomal dominant disease
polyposis
autosomal dominant disease that is has material basis in mutations in the APC gene and involves formation of numerous polyps in the epithelium of the large intestine which are initially benign and later transform into colon cancer C04.557.470.035.215.100
C04.588.274.476.411.307.089
C04.700.100
C06.301.371.411.307.090
C06.405.249.411.307.090
C06.405.469.158.356.090
C06.405.469.491.307.090
C06.405.469.578.249
C16.320.700.100
Familial adenomatous polyposis
 
Familial cold urticaria disease Cryopyrin-associated periodic syndrome
Cold urticaria
primary immunodeficiency disease
primary immunodeficiency disease characterized by recurrent episodes of maculopapular skin rash triggered by exposure to cold associated with low-grade fever, general malaise, eye redness and arthralgia/myalgia C16.320.382.500
C17.800.827.368.500
familial combined hyperlipidemia disease familial hyperlipidemia
mixed hyperlipidemia
Human disease C16.320.565.398.450
C18.452.584.500.500.438
C18.452.648.398.450
familial Mediterranean fever disease
Designated intractable/rare diseases
autoimmune disease
Urticarial syndromes
Human disease C16.320.382.625
Fanconi anemia disease congenital hypoplastic anemia Human disease C15.378.071.085.080.280
C15.378.190.196.080.280
C16.320.077.280
C18.452.284.280
Fanconi anemia
Fanconi syndrome disease renal tubular transport disease renal tubular transport disease of the proximal renal tubes characterized by glucosuria, phosphaturia, generalized aminoaciduria and HCO3 wasting C12.777.419.815.450
C13.351.968.419.815.450
C16.320.565.861.450
C18.452.648.861.450
Farber lipogranulomatosis disease
genetic disease
lipid storage disease Human disease C10.228.140.163.100.435.825.250
C16.320.565.189.435.825.250
C16.320.565.398.641.803.325
C16.320.565.595.554.825.250
C18.452.132.100.435.825.250
C18.452.584.687.803.325
C18.452.648.189.435.825.250
C18.452.648.398.641.803.325
C18.452.648.595.554.825.250
farmer's lung disease extrinsic allergic alveolitis An extrinsic allergic alveolitis which is induced by the inhalation of spores (Aspergillus sp and thermophilic actinomycetes) in dust from moldy hay or straw. It is characterized by sudden onset, fever, cough, expectoration, and breathlessness. C08.381.483.125.365
C08.674.055.365
C20.543.480.680.075.365
C24.080.365
fasciitis disease connective tissue disease Inflammation process in fascia C05.321
fasciolopsiasis disease parasitic helminthiasis infectious disease A parasitic helminthiasis infectious disease that involves parasitic infection of the intestine by Fasciolopsis buski. The symptoms include diarrhea, abdominal pain, fever, ascites, anasarca and intestinal obstruction. C03.335.865
fasciolosis disease
infectious disease
distomatosis
parasitic helminthiasis infectious disease
human disease C03.335.865.354
C03.518.424
C06.552.664.424
Fascioliasis
 
fatal familial insomnia disease transmissible spongiform encephalopathy
rare disease
inherited prion disease
insomnia
Fatal familial insomnia (FFI) is a very rare form of prion disease (see this term) characterized by subacute onset of insomnia showing as a reduced overall sleep time, autonomic dysfunction, and motor disturbances C10.228.228.800.392
C10.574.843.512
C10.886.425.800.800.400
favism disease glucose-6-phosphate dehydrogenase deficiency glucosephosphate dehydrogenase deficiency characterized by a hemolytic reaction to consumption of broad beans C15.378.071.141.150.480.370
C15.378.071.141.370
C16.320.070.480.370
C25.723.415.341
C25.723.756.375
fecal incontinence disease impairment of continence inability to refrain from defecation C06.405.469.860.300
Felty's syndrome disease
arthropathy
syndrome
rare bone disease
acquired neutropenia
rare rheumatologic disease
syndrome that results in rheumatoid arthritis, splenomegaly and neutropenia C05.550.114.154.389
C05.799.114.389
C17.300.775.099.389
C20.111.199.389
fetal erythroblastosis disease neonatal alloimmune disease
microcytic anemia
hematological disease of fetus and newborn
Human disease C13.703.277.060
C15.378.295
C16.300.060
C16.614.304
C20.306
Hemolytic disease of the newborn
fibrillary astrocytoma disease brain tumor
astrocytoma
astrocytoma that is characterized as a low grade astrocytoma and has material basis in neoplastic astrocytes C04.557.465.625.600.380.080
C04.557.470.670.380.080
C04.557.580.625.600.380.080
fibrodysplasia ossificans progressiva disease connective tissue disease
genetic disease
Heterotopic ossification
extremely rare connective tissue disease C05.651.594.638 Fibrodysplasia ossificans progressiva
fibromyalgia disease myositis
chronic pain syndrome
A chronic disorder of unknown etiology characterized by pain, stiffness, and tenderness in the muscles of neck, shoulders, back, hips, arms, and legs. Other signs and symptoms include headaches, fatigue, sleep disturbances, and painful menstruation. C05.651.324
C05.799.321
C10.668.491.425
Fibromyalgia
 
fibrosarcoma disease connective tissue neoplasm connective tissue cancer that has material basis in fibrous connective tissue and characterized by the presence of immature proliferating fibroblasts or undifferentiated anaplastic spindle cells in a storiform pattern C04.557.450.565.590.350
C04.557.450.795.350
C04.557.450.565.590
fibrous dysplasia disease bone remodeling disease bone remodeling disease that results in the destruction of normal bone and replacing it with fibrous bone tissue C05.116.099.708.375 Fibrous dysplasia
filarial elephantiasis disease filariasis
skin disease
tropical helminthiasis C03.335.508.700.750.361.350
C15.604.496.490
Elephantiasis
 
filariasis disease
infectious disease
nematode infection
parasitic helminthiasis infectious disease
parasitic disease caused by a family of nematode worms C03.335.508.700.750.361 Filariasis
 
fistula disease symptom abnormal connection between two hollow spaces (technically, two epithelialized surfaces), such as blood vessels, intestines, or other hollow organs C23.300.575 Fistulae
Flail chest disease C26.891.315 Flail chest
flat feet problems disease foot deformity human foot arch that is very low C05.330.488.655.250
C05.330.495.681.250
C05.660.585.512.380.813.250
C16.131.621.585.512.500.681.250
Flat feet
 
focal hand dystonia disease focal dystonia
occupational disease
focal dystonia that affects a single muscle or small group of muscles in the hand resulting from involuntary muscular contractions C10.228.662.300
focal segmental glomerulosclerosis disease glomerulosclerosis
nephrotic syndrome
kidney disease C12.777.419.570.363.660
C13.351.968.419.570.363.640
Focal segmental glomerulosclerosis
follicular lymphoma disease B-cell lymphoma non-Hodgkin lymphoma that is characterized as an indolent non-Hodgkin's lymphoma and has_material_basis_in follicle center B-cells (centrocytes and centroblasts). C04.557.386.480.350
C15.604.515.569.480.350
C20.683.515.761.480.350
Follicular lymphoma
 
folliculitis disease dermatitis
hair disease
Human disease C17.800.329.500 Folliculitis
food allergy disease food hypersensitivity
gastrointestinal allergy
hypersensitivity reaction type I disease that is an abnormal response to a food, triggered by the body's immune system C20.543.480.370 Food allergy
 
Foster-Kennedy syndrome disease Papilledema Human disease C10.292.700
C11.640
Fox-Fordyce disease disease sweat gland disease Human disease C17.800.946.492.285
fragile X syndrome disease X-linked mental retardation
overgrowth syndrome
X-linked disease
congenital disorder of nervous system C10.597.606.643.455.500
C16.131.260.830.300
C16.320.180.830.300
C16.320.322.500.500
C16.320.400.525.500
Fragile X syndrome
Fraser syndrome disease
head and neck disease
developmental defect during embryogenesis
Cryptophthalmos
autosomal recessive disease
syndromic genetic deafness
syndromic renal or urinary tract malformation
syndromic developmental defect of the eye
syndromic anorectal malformation
multiple congenital anomalies/dysmorphic syndrome without intellectual disability
Fraser syndrome is a rare clinical entity including as main characteristics cryptophthalmos and syndactyly C05.116.099.370.894.819.428
C05.660.585.800.428
C05.660.906.819.428
C11.250.390
C12.706.410
C13.351.875.397
C16.131.077.371
C16.131.384.442
C16.131.621.585.800.428
C16.131.621.906.819.428
C16.131.939.410
Fraser syndrome
freemartinism disease sex differentiation disease Human disease C12.706.316.795.124
C13.351.875.253.795.124
C16.131.939.316.795.124
C19.391.119.795.124
C22.196.339
Frey syndrome disease autonomic nervous system disease Human disease C10.177.825
C17.800.946.350.843
Frey's syndrome
Friedreich ataxia disease autosomal recessive cerebellar ataxia
autosomal recessive degenerative and progressive cerebellar ataxia
Human disease C10.228.140.252.700.150
C10.228.854.787.200
C10.574.500.825.200
C16.320.400.780.200
C18.452.660.300
Froelich syndrome disease Hypothalamic disease hypothalamic disease that is characterized by endocrine dysfunction of the hypothalamic gland resulting in delayed puberty, small testes, and obesity C10.228.140.617 Adiposogenital dystrophy
frostbite disease cold injury medical condition where localized damage is caused to skin and other tissues due to freezing C26.212.500
C26.417
Frostbite
 
Fuchs' endothelial dystrophy disease corneal endothelial dystrophy corneal dystrophy characterized by accumulation of focal outgrowths (guttae) and thickening of Descemet's membrane, leading to corneal edema and loss of vision C11.204.236.438
C11.270.162.438
C16.320.290.162.410
Fuchs' dystrophy
fucosidosis disease
developmental defect during embryogenesis
lysosomal storage disease
rare genetic developmental defect during embryogenesis
hypertrophic cardiomyopathy
oligosaccharidosis
lysosomal storage disease with skeletal involvement
lysosomal disease with hypertrophic cardiomyopathy
Human disease C10.228.140.163.100.435.295
C16.320.565.189.435.295
C16.320.565.202.303
C16.320.565.595.554.295
C18.452.132.100.435.295
C18.452.648.189.435.295
C18.452.648.202.303
C18.452.648.595.554.295
fungal infectious disease disease infectious disease
Bacterial Infections and Mycoses
fungal infection of animals, including humans C01.703 Diseases and disorders due to fungi
 
gait abnormality disease movement disorder C10.597.404
C23.888.592.413
galactosemia disease carbohydrate metabolic disorder carbohydrate metabolic disorder that involves a defect in galactose metabolism resulting in toxic levels of galactose 1-phosphate in various tissues C10.228.140.163.100.320
C16.320.565.189.320
C16.320.565.202.355
C18.452.132.100.320
C18.452.648.189.320
C18.452.648.202.355
 
gallbladder cancer disease biliary tract cancer
gallbladder disease
biliary tract cancer that is located in the gallbladder C04.588.274.120.401
C06.130.320.401
C06.130.564.401
C06.301.120.401
Gallbladder cancer
gamma chain deficiency disease severe combined immunodeficiency
T+ B+ severe combined immunodeficiency
Human disease C16.320.322.968
C16.614.815.500
C20.673.815.500
ganglioglioma disease cell type benign neoplasm cell type benign neoplasm that has material basis in glial-type cells C04.557.465.625.600.380.350
C04.557.470.670.380.350
C04.557.580.625.600.380.350
Ganglioglioma
ganglioneuroma disease autonomic nervous system neoplasm Human disease C04.557.465.625.600.355
C04.557.470.670.355
C04.557.580.625.600.355
Ganglioneuroma
gangliosidosis disease sphingolipidosis
rare genetic epilepsy
rare dyslipidemia
sphingolipidosis with epilepsy
Human disease C10.228.140.163.100.435.825.300
C16.320.565.189.435.825.300
C16.320.565.398.641.803.350
C16.320.565.595.554.825.300
C18.452.132.100.435.825.300
C18.452.584.687.803.350
C18.452.648.189.435.825.300
C18.452.648.398.641.803.350
C18.452.648.595.554.825.300
Gardner's syndrome disease congenital disorder of digestive system C04.557.470.035.215.100.500
C04.588.274.476.411.307.089.393
C04.700.100.392
C06.301.371.411.307.090.500
C06.405.249.411.307.090.500
C06.405.469.158.356.090.500
C06.405.469.491.307.090.500
C06.405.469.578.249.393
C16.131.077.393
C16.320.700.100.393
Gardner's syndrome
 
gas gangrene disease
infectious disease
commensal bacterial infectious disease
muscle tissue disease
bacterial skin disease
disease for all sorts of living things C01.252.410.222.440 Gas gangrene
 
gastric antral vascular ectasia disease capillary disease
Ectasia
vascular ectasia
Human disease C06.405.748.280
C14.907.075.280
gastric mucosal hypertrophy disease gastritis
rare gastroesophageal disease
genetic disease
rare genetic gastroenterological disease
Human disease C06.405.205.697.410
C06.405.748.398.410
Ménétrier's disease
gastrinoma disease neuroendocrine tumor neuroendocrine tumor that results in an overproduction of gastric acid C04.557.470.200.025.290.500
C04.588.274.761.500.124
C04.588.322.475.500.124
C06.301.761.500.124
C06.689.667.500.124
C19.344.421.500.124
Gastrinoma
gastritis disease stomach disease stomach disease that is an inflammation of the lining of the stomach. C06.405.205.697
C06.405.748.398
Gastritis
gastroenteritis disease gastrointestinal system disease medical condition characterized by inflammation of the stomach and/or small intestine C06.405.205 Gastroenteritis
 
gastroenterocolitis disease disease characterized by inflammation of the stomach, small intestines, and colon C02.782.600.550.200.400
C22.905.469
gastroesophageal reflux disease disease gastrointestinal system disease
esophageal disease
genetic disease
stomach disease
disease caused by stomach acid coming up from the stomach into the esophagus C06.405.117.119.500.484 Gastroesophageal reflux disease
 
gastrointestinal stromal tumor disease gastrointestinal system cancer
Stromal tumor
rare genetic intestinal disease
inherited digestive tract tumor
mesenchymal tumor of small intestine
Human disease C04.557.450.565.370
C06.301.371.308
C06.405.249.308
Gastrointestinal stromal tumors
gastroparesis disease functional gastric disease Human disease C06.405.748.543
C23.888.592.636.263
gastroschisis disease
developmental defect during embryogenesis
birth defect
Abdominal wall defect
rare genetic developmental defect during embryogenesis
primary short bowel syndrome
non-syndromic diaphragmatic or abdominal wall malformation
Human disease C05.660.417
C16.131.621.417
C23.300.707.374.500
Gastroschisis
Gaucher's disease disease sphingolipidosis human disease characterized by deficiency of the enzyme glucocerebrosidase which results in the accumulation of harmful quantities of the glycolipid glucocerebroside throughout the body C10.228.140.163.100.435.825.400
C16.320.565.189.435.825.400
C16.320.565.398.641.803.441
C16.320.565.595.554.825.400
C18.452.132.100.435.825.400
C18.452.584.687.803.441
C18.452.648.189.435.825.400
C18.452.648.398.641.803.441
C18.452.648.595.554.825.400
genetic disease disease hereditary disorder
disease
disease that has material basis in genetic variations in the human genome C16.320 Genetic diseases and disorders
geniculate herpes zoster disease herpes zoster
poliomyelitis
facial nerve disease
Human disease C02.256.466.423.733
C07.465.299.750
C09.218.513
C10.292.319.750
Ramsay Hunt syndrome type II
genu varum disease knee disorder
varus deformity
O-knees C05.116.511 Genu varum
 
geographic tongue disease inflammation
tongue disease
atrophic glossitis
atrophic glossitis that is characterized as an inflammatory condition of the mucous membrane of the tongue, usually on the dorsal surface C07.465.910.363.447 Geographic tongue
germinoma disease germ cell cancer A germ cell cancer that lacks histologic differentiation. It usually refers to a tumor in the brain. C04.557.465.330 Germinoma
Gerstmann syndrome disease neurological disorder nervous system disease that results from damage located in left parietal lobe, has symptom agraphia, has symptom acalculia, has symptom finger agnosia C10.597.606.762.100.300
C23.888.592.604.764.100.300
 
Gerstmann-Straussler-Scheinker syndrome disease transmissible spongiform encephalopathy
inherited prion disease
prion disease characterized by adult onset of memory loss, dementia, ataxia, and pathologic deposition of amyloid-like plaques in the brain C10.228.228.800.350
C10.574.500.425
C10.574.843.400
C16.320.400.350
Gerstmann–Sträussler–Scheinker syndrome
gestational diabetes disease diabetes mellitus
complication of pregnancy, childbirth and the puerperium
diabetes mellitus and pregnancy
condition in which a woman without diabetes develops high blood sugar levels during pregnancy C13.703.170
C18.452.394.750.448
C19.246.200
gestational trophoblastic neoplasm disease trophoblastic neoplasm Human disease C04.557.465.955.416
C04.850.908.416
C13.703.720.949.416
C04.557.465.955.416.812
C04.850.908.416.750
C13.703.720.949.416.875
Hydatidiform moles
Giant condyloma acuminatum disease C02.256.650.810.217.500
C02.800.801.220.500
C02.825.810.110.500
C02.928.914.217.500
C04.557.470.200.450.500
C04.557.470.700.450.500
C17.800.838.790.810.110.500
giardiasis disease parasitic protozoa infectious disease parasitic disease caused by Giardia lamblia C03.432.481
C03.752.400
C06.405.469.452.481
Giardiasis
 
gigantism disease tall stature Human disease C05.116.099.492
C05.116.132.479
C19.700.355.528
Gigantism
Gilbert syndrome disease bilirubin metabolic disorder metabolic disorder C16.320.565.300.528
C18.452.648.300.528
 
Gilles de la Tourette syndrome disease tic disorder
genetic disease
rare genetic movement disorder
congenital disorder of nervous system C10.228.140.079.898
C10.228.662.825.800
C10.574.500.850
C16.320.400.820
Tourette syndrome
gingivitis disease symptom
gingival disease
Human disease C07.465.714.258.480 Gingivitis
 
Gitelman syndrome disease renal tubular transport disease
inherited renal tubular disease
Human disease C12.777.419.815.491
C13.351.968.419.815.491
C16.320.565.861.491
C18.452.648.861.491
Gitelman syndrome
glanders disease
infectious disease
primary bacterial infectious disease Human disease C01.252.400.170.400
C22.488.409
Glanders
Glanzmann's thrombasthenia disease blood platelet disease
inherited blood coagulation disease
rare hemorrhagic disorder due to a qualitative platelet defect
Human disease C15.378.100.100.820
C15.378.140.810
C15.378.463.810
C16.320.099.820
glaucoma disease eye disease eye disease that is characterized by an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function C11.525.381 Glaucoma
glioblastoma multiforme disease astrocytoma Human disease C04.557.465.625.600.380.080.335
C04.557.470.670.380.080.335
C04.557.580.625.600.380.080.335
Glioblastoma
glioma disease cell type cancer a type of tumor that starts in the brain or spine C04.557.465.625.600.380
C04.557.470.670.380
C04.557.580.625.600.380
Gliomas
gliomatosis cerebri disease brain cancer Human disease C04.557.465.625.600
C04.557.470.670
C04.557.580.625.600
gliosarcoma disease glioblastoma multiforme Human disease C04.557.465.625.600.380.400
C04.557.470.670.380.400
C04.557.580.625.600.380.400
glomerulonephritis disease Sida por cojer mucho
glomerulopathy
nephritis that causes inflammation of the glomeruli located in kidney C12.777.419.570.363
C13.351.968.419.570.363
Glomerulonephritis
 
glossitis disease tongue disease
inflammatory disease
Human disease C07.465.910.363 Glossitis
 
glucagonoma disease C04.557.470.200.025.290.750
C04.588.274.761.500.249
C04.588.322.475.500.249
C06.301.761.500.249
C06.689.667.500.249
C19.344.421.500.249
glucose-6-phosphate dehydrogenase deficiency disease carbohydrate metabolic disorder carbohydrate metabolic disorder that is characterised by abnormally low levels of glucose-6-phosphate dehydrogenase (abbreviated G6PD or G6PDH) C15.378.071.141.150.480
C16.320.070.480
C16.320.565.202.402
C18.452.648.202.402
 
glycogen storage disease disease glycogen metabolism disorder
overload disease
carbohydrate metabolic disorder
glycogen metabolism disorder that has material basis in enzymes deficiencies necessary in the processing of glycogen synthesis or breakdown within muscles, liver, and other cell types C16.320.565.202.449
C18.452.648.202.449
Glycogen storage disease
glycogen storage disease I disease glycogen storage disease rare disease C16.320.565.202.449.448
C18.452.648.202.449.448
glycogen storage disease II disease glycogen storage disease
hypertrophic cardiomyopathy
muscular glycogenosis
lysosomal disease with restrictive cardiomyopathy
lysosomal disease with hypertrophic cardiomyopathy
glycogen storage disease with hypertrophic cardiomyopathy
lysosomal glycogen storage disease
autosomal recessive metabolic disorder C10.228.140.163.100.435.340
C16.320.565.189.435.340
C16.320.565.202.449.500
C16.320.565.595.554.340
C18.452.132.100.435.340
C18.452.648.189.435.340
C18.452.648.202.449.500
C18.452.648.595.554.340
Glycogen storage disease type II
glycogen storage disease III disease glycogen storage disease Human disease C16.320.565.202.449.520
C18.452.648.202.449.520
 
glycogen storage disease IV disease glycogen storage disease Human disease C16.320.565.202.449.540
C18.452.648.202.449.540
glycogen storage disease V disease glycogen storage disease
muscular glycogenosis
Human disease C16.320.565.202.449.560
C18.452.648.202.449.560
glycogen storage disease VI disease glycogen storage disease
rare metabolic liver disease
Glycogen storage disease C16.320.565.202.449.580
C18.452.648.202.449.580
 
glycoproteinosis disease lysosomal storage disease endocrine disease C05.116.198.371
C10.228.140.163.100.435.590
C16.320.565.189.435.590
C16.320.565.202.670
C16.320.565.595.554.590
C18.452.132.100.435.590
C18.452.648.189.435.590
C18.452.648.202.670
C18.452.648.595.554.590
Glycoprotein metabolism disorders
goiter disease thyroid gland disease swelling of the thyroid gland C19.874.283 Goiters
 
Goldenhar syndrome disease
head and neck disease
developmental defect during embryogenesis
syndrome
Hemifacial microsomia
skull cancer
cornea cancer
bulbar conjunctival dermoid or conjunctival dermolipoma
syndromic corneal dystrophy
lens shape anomaly
syndromic palpebral coloboma
syndromic developmental defect of the eye
Pierre robin syndrome associated with branchial archs anomalies
oculo-auriculo-vertebral spectrum
A syndrome that is characterized by incomplete development of the ear, nose, soft palate, lip, and mandible. It is associated with anomalous development of the first branchial arch and second branchial arch. C05.116.099.370.231.576.410
C05.660.207.231.576.410
C16.131.621.207.231.576.410
gonadal dysgenesis disease hypogonadism hypogonadism that is characterized by a progressive loss of germ cells on the developing gonads of an embryo C12.706.316.309
C13.351.875.253.309
C16.131.939.316.309
C19.391.119.309
gonorrhea disease primary bacterial infectious disease
gonococcal infectious diseases
sexually transmitted infection C01.252.400.625.391
C01.252.810.401
C01.539.778.281.401
C12.294.668.281.401
C13.351.500.711.281.401
Gonorrhea
File:SOA-gonorroe-male.jpg
Goodpasture syndrome disease autoimmune disease
secondary glomerular disease
secondary interstitial lung disease in childhood and adulthood associated with a systemic disease
predominantly small-vessel vasculitis
autoimmune vasculitis
hypersensitivity reaction type II disease that is characterized by glomerulonephritis located in kidney and hemorrhaging located in lung C08.381.483.156
C12.777.419.570.363.304
C13.351.968.419.570.363.304
C20.111.190
 
Gorham's disease disease syndrome
Osteolysis
A syndrome that is characterized by bone loss (osteolysis) which is often associated with swelling or abnormal blood vessel growth (angiomatous proliferation). Bone loss can occur in just one bone or spread to soft tissue and adjacent bones. C05.116.099.736
C05.116.264.579.704
Gorham's disease
gout disease arthritis
genetic disease
crystal arthropathy
disease of metabolism
condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals C05.550.114.423
C05.550.354.500
C05.799.414
C16.320.565.798.368
C18.452.648.798.368
C05.550.114.423.410
C05.550.354.500.500
C05.799.414.410
C16.320.565.798.368.410
C18.452.648.798.368.410
Gout
 
Gradenigo's syndrome disease disease C01.539.160.495.750
C05.116.165.495.500
C09.218.705.663.841
granular cell tumor disease skin benign neoplasm Human disease C04.557.450.590.350 Granular cell tumor
Granuloma disease C15.604.515.292
C23.550.382
Granuloma
 
granuloma annulare disease dermatitis
necrobiotic disorders
Human disease C17.300.200.495.380
C17.800.550.380
C23.550.382.375
Granuloma annulare
 
granuloma inguinale disease
infectious disease
primary bacterial infectious disease
bacterial sexually transmitted disease
Human disease C01.252.400.310.416
C01.252.810.451
C01.252.825.360
C01.539.778.281.451
C01.539.800.720.360
C12.294.668.281.451
C13.351.500.711.281.451
C17.800.838.765.360
Donovanosis
 
Guillain–Barré Syndrome disease autoimmune disease of peripheral nervous system
immune system disease
rare neuroinflammatory or neuroimmunological disease
acute and subacute inflammatory demyelinating polyneuropathy
autoimmune disease that causes the immune system to attack part of the peripheral nervous system C10.114.750.100
C10.314.750.450
C10.668.829.350
C10.668.829.800.750.300
C20.111.258.750.400
Guillain–Barré syndrome
Gulf War syndrome disease syndrome syndrome affecting returning military veterans and civilian workers of the Gulf War C24.653
gynatresia disease female reproductive system disease
atresia
Human disease C13.351.500.320
gynecomastia disease sex differentiation disease Human disease C17.800.090.875 Gynecomastia
Hailey-Hailey disease disease pemphigus Human disease C16.320.850.700
C17.800.827.700
C17.800.865.858
Hailey–Hailey disease
hairy cell leukemia disease chronic lymphocytic leukemia chronic lymphocytic leukemia that is characterized by over production of B cells (lymphocytes) by the bone marrow where the B cells appear hairy under a microscope C04.557.337.415
C15.604.515.553
C20.683.515.517
Hairy cell leukemia
hairy tongue disease tongue disease Human disease C07.465.910.791 Black hairy tongue
 
Hajdu-Cheney syndrome disease autosomal dominant disease rare disease C05.116.099.052
C05.116.264.579.052
C05.116.099.052.400
C05.116.264.579.052.400
C16.131.621.445
C16.320.355
Hallermann-Streiff syndrome disease
developmental defect during embryogenesis
syndrome
Slender bone dysplasia
congenital absence of the eyebrow/eyelashes
ectodermal malformation syndrome associated with ocular features
craniofacial anomaly with cataract
multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome
malformation syndrome with short stature
rare genetic syndromic intellectual disability
congenital disorder C05.116.099.370.231.427
C05.660.207.231.427
C16.131.621.207.231.427
hallux rigidus disease foot deformity disease C05.330.488.310
C05.550.450
Hallux rigidus
hamartoma disease A non cancerous growth made up of an abnormal mixture of cells and tissues normally found in the area of the body. C04.445 Hamartomas
Hartnup disease disease amino acid metabolic disorder
Amino acid transport disorder
neurometabolic disease
Photodermatosis
nephropathy secondary to a storage or other metabolic disease
disorder of neutral amino acid transport
genetic photodermatosis
Human disease C10.228.140.163.100.355
C12.777.419.815.885.457
C13.351.968.419.815.885.625
C16.320.565.151.355
C16.320.565.189.355
C16.320.565.861.885.457
C18.452.132.100.355
C18.452.648.151.355
C18.452.648.189.355
 
head and neck cancer disease organ system cancer
head neoplasm
organ system cancer that arises in the head or neck region (including the nasal cavity, sinuses, lips, mouth, salivary glands, throat, or larynx) C04.588.443 Head and neck cancer
heart cancer disease cardiovascular cancer
Primary tumors of the heart
heart disease
thoracic cancer
cardiovascular cancer located in the heart C04.588.894.309
C14.280.459
heart disease disease cardiovascular disease cardiovascular system disease that involves the heart C14.280 Diseases and disorders of the heart
heart failure disease cardiovascular disease condition in which the heart is unable to provide sufficient pump action C14.280.434 Heart failure
 
heart valve disease disease heart disease disease in the valves of the heart C14.280.484
C14.280.484.400
Diseases and disorders of the heart valves
heat illness disease hyperthermia condition caused by the failure of body to dissipate heat in an excessively hot environment C26.522.500
HELLP syndrome disease severe pre-eclampsia severe pre-eclampsia characterized by hemolysis, elevated liver enzyme and low platelet count C13.703.395.186
hemangioblastoma disease hemangioma
rare nervous system tumor
tumor of the central nervous system that originates from the vascular system C04.557.645.375.380.370 Hemangioblastoma
hemangioma disease cell type benign neoplasm
angioma
vascular tumor
cell type benign neoplasm that has physical basis in endothelial cells that line blood vessels and is characterised by increased number of normal or abnormal vessels filled with blood C04.557.645.375 Skin hemangioma
 
hemarthrosis disease
arthropathy
arthropathy
arthropathy associated with hematological disorder
Human disease C05.550.459
C23.550.414.794
Hemarthrosis
hematocele of tunica vaginalis testis disease male reproductive system disease Human disease C12.294.287
C23.550.414.817
Hematocele
hematopoietic system diseases disease symptom
disease of anatomical entity
disorder which primarily affects the blood C15.378 Diseases and disorders of the blood
Hemiplegia disease paralysis
central nervous system disease
paralysis of the arm, leg, and trunk on the same side of the body C10.597.622.295
C23.888.592.636.312
hemoglobin C disease hemoglobinopathy
rare constitutional hemolytic anemia
Human disease C15.378.071.141.150.490
C15.378.420.463
C16.320.070.490
C16.320.365.463
hemoglobinopathy disease congenital hemolytic anemia
genetic disease
hemolytic anemia
Human disease C15.378.420
C16.320.365
hemoglobinuria disease proteinuria
hemolytic anemia
Human disease C12.777.934.734.634
C13.351.968.934.734.634
C23.888.942.750.634
 
hemolytic anemia disease anemia
normocytic anemia
form of anemia due to hemolysis C15.378.071.141 Hemolytic diseases and disorders
hemolytic-uremic syndrome disease kidney disease Human disease C12.777.419.936.463
C13.351.968.419.936.463
C15.378.071.141.610
C15.378.140.855.925.500
 
hemophagocytic lymphohistiocytosis disease lymphatic system disease Human disease C15.604.250.410.575 Hemophagocytic lymphohistiocytosis
hemopneumothorax disease pneumothorax
hemothorax
medical term describing the combination of two conditions: pneumothorax, or air in the chest cavity, and hemothorax (also called hæmothorax), or blood in the chest cavity C08.528.338
C23.550.414.904.500
hemorrhagic disease disease blood coagulation disease Human disease C15.378.463
Henoch-Schoenlein purpura disease hypersensitivity vasculitis
nonthrombocytopenic purpura
Human disease C14.907.940.777
C15.378.100.802.375
C15.378.463.515.580
C20.543.520.600
C23.550.414.950.375
C23.888.885.687.375
Henoch–Schönlein purpura
 
hepatic encephalopathy disease brain disease brain disease that is characterized by loss of brain function, the occurrence of confusion, altered level of consciousness, and coma that results when the liver is unable to remove toxins from the blood C06.552.308.500.356
C10.228.140.163.360
C18.452.132.360
hepatic vein thrombosis disease hepatic vascular disease
venous thrombosis
Human disease C06.552.347
C14.907.355.830.925.275
Budd–Chiari syndrome
hepatitis disease liver disease inflammation of the liver tissue C06.552.380
C06.552.380.350
Hepatitis
 
hepatitis A disease
infectious disease
viral infectious disease
viral hepatitis
Skin infection
acute infectious disease of the liver C02.440.420
C02.782.687.359.500
C06.552.380.705.422
Hepatitis A
 
hepatitis C disease
infectious disease
viral infectious disease
viral hepatitis
Skin infection
human viral infection C02.440.440
C02.782.350.350
C06.552.380.705.440
C02.440.440.120
C02.782.350.350.120
C06.552.380.350.120
C06.552.380.705.440.120
Hepatitis C
 
hepatitis D disease
infectious disease
viral infectious disease
viral hepatitis
post-viral disorder
rare hepatic disease
rare skin disease
hepatitis B
Human disease C02.440.450
C02.782.450
C06.552.380.705.450
 
hepatitis E disease
infectious disease
viral infectious disease
Hepeviridae infectious disease
viral hepatitis
Skin infection
Human disease C02.440.470
C02.782.455
C06.552.380.705.470
Hepatitis E virus
 
hepatoblastoma disease liver cancer Human disease C04.557.435.380 Hepatoblastoma
hepatocellular adenoma disease adenoma
liver neoplasm
human disease C04.557.470.035.120
C04.588.274.623.040
C06.301.623.040
C06.552.697.040
hepatocellular carcinoma disease liver carcinoma liver carcinoma that has material basis in undifferentiated hepatocytes C04.557.470.200.025.255
C04.588.274.623.160
C06.301.623.160
C06.552.697.160
Hepatocellular carcinoma
hepatoerythropoietic porphyria disease acute porphyria
Erythropoietic porphyria
Human disease C06.552.830.437
C16.320.850.742.437
C17.800.827.742.437
C18.452.811.400.437
hepatopulmonary syndrome disease liver disease Human disease C06.552.455
C08.381.385
hepatorenal syndrome disease acute kidney injury
liver disease
Human disease C06.552.465
C12.777.419.291
C13.351.968.419.291
Hepatorenal syndrome
hereditary angioedema disease angioedema human disease C14.907.079.500
C16.320.078
C17.800.862.945.066.500
C20.543.480.904.066.500
Hereditary angioedema
 
hereditary coproporphyria disease acute porphyria Human disease C06.552.830.074
C16.320.850.742.074
C17.800.827.742.074
C18.452.811.400.074
hereditary fructose intolerance syndrome disease carbohydrate metabolic disorder
nephropathy secondary to a storage or other metabolic disease
disorder of carbohydrate absorption and transport
disorder of fructose metabolism
metabolic disease with intestinal involvement
rare metabolic liver disease
congenital intestinal transport defect
Human disease C16.320.565.202.251.271
C18.452.648.202.251.271
hereditary hemorrhagic telangiectasia disease autosomal dominant disease autosomal dominant disease characterized by tarteriovenous malformations that lack intervening capillaries and result in direct connections between arteries and veins C14.907.454.900
C14.907.823.780
C15.378.463.515.900
C16.131.240.850.968
Hereditary hemorrhagic telangiectasia
 
hereditary lymphedema disease lymphedema
Primary lymphedema
lymphedema commonly located in legs, caused by congenital abnormalities in the lymphatic system C15.604.496
hereditary multiple exostoses disease exostosis exostosis that has material basis in a mutation on the genes EXT1, EXT2 and EXT3 which results in multiple bony spurs throughout a child's growth C04.557.450.565.575.610.615.325
C04.700.330
C05.116.099.708.670.615.325
C05.116.540.310.500
C16.320.700.330
Hereditary multiple exostoses
hereditary spastic paraplegia disease paraplegia
genetic neurodegenerative disease
Hereditary spastic paraplegias (HSP) comprise a genetically and clinically heterogeneous group of neurodegenerative disorders characterized by progressive spasticity and hyperreflexia of the lower limbs C10.500.300.820
C10.574.500.495.820
C10.668.829.800.300.820
C16.131.666.300.820
C16.320.400.375.820
hereditary spherocytosis disease congenital hemolytic anemia
spherocytosis
congenital hemolytic anemia characterized by the production of red blood cells with a sphere shape, rather than the normal biconcave disk shape C15.378.071.141.150.785
C16.320.070.785
Hermansky-Pudlak syndrome disease autosomal recessive disease rare disease C11.270.040.545.400
C15.378.100.100.515
C15.378.100.685.400
C15.378.140.735.400
C15.378.463.735.400
C16.320.099.515
C16.320.290.040.100.400
C16.320.565.100.102.100.400
C16.320.850.080.100.400
C17.800.621.440.102.100.400
C17.800.827.080.100.400
C18.452.648.100.102.100.400
herpangina disease
infectious disease
viral infectious disease
coxsackievirus infectious disease
mouth disease
Human disease C02.782.687.359.213.466
C02.782.687.359.347.500
Herpangina
herpes simplex virus keratitis disease
health problem
keratitis
herpes simplex
Herpesviridae infectious disease
keratitis that has material basis in herpes simplex type infection C02.256.466.382.465.450
C02.325.465.450
C11.204.564.425.450
C11.294.800.475.450
C02.256.466.382.465
C02.325.465
C11.204.564.425
C11.294.800.475
Herpetic simplex keratitis
herpes zoster disease
infectious disease
viral infectious disease
Skin infection
varicella zoster infection
post-viral disorder
human disease caused by varicella zoster C02.256.466.423 Herpes zoster
 
hiatus hernia disease
hern
abdominal hernia
stomach disease
genetic disease
congenital disorder of digestive system C23.300.707.500.467 Hiatal hernia
 
hidradenitis suppurativa disease hidradenitis Human disease C01.252.825.420
C01.539.800.720.420
C01.539.830.499
C17.800.838.765.420
C17.800.946.315.320
Hidradenitis suppurativa
hidrocystoma disease apocrine sweat gland neoplasm
benign neoplasm of sweat gland
Human disease C04.557.470.035.175.375
C04.557.470.550.175.375
high pressure neurological syndrome disease central nervous system disease
diving disorder
neurological and physiological disorder experienced by divers C10.228.566
C24.410
hip dysplasia disease developmental dislocation of joint
genetic disease
human disease C05.660.449
C16.131.621.449
Hip dysplasia
Hirschsprung's disease disease megacolon
intestinal dysganglionosis
congenital disorder of digestive system C06.198.439
C06.405.469.158.701.439
C16.131.314.439
Hirschsprung's disease
hirsutism disease hypertricosis
virilism
hair growth on a woman, generally causing a full beard to grow (see bearded lady) C17.800.329.750
C23.888.971.468
 
histiocytosis disease lymphatic system disease lymphatic system disease that is characterized by an excessive number of histiocytes C15.604.250 Histiocytoses
histoplasmosis disease primary systemic mycosis
genetic disease
human disease C01.703.450 Histoplasmosis
 
Hodgkin's lymphoma disease lymphoma lymphoma that is marked by the presence of a type of cell called the Reed-Sternberg cell C04.557.386.355
C15.604.515.569.355
C20.683.515.761.355
Hodgkin's lymphoma
 
holoprosencephaly disease cephalic disorder congenital disorder of nervous system C05.660.207.410
C10.500.034.875
C16.131.077.410
C16.131.260.380
C16.131.621.207.410
C16.131.666.034.875
C16.320.180.380
Holoprosencephaly
homocystinuria disease amino acid metabolic disorder
sulfuraminoacidemia
amino acid metabolic disorder that involves an accumulation of homocysteine in the serum and an increased excretion of homocysteine in the urine C10.228.140.163.100.365
C16.320.565.100.480.500
C16.320.565.189.365
C17.300.428
C18.452.132.100.365
C18.452.648.100.480.500
C18.452.648.189.365
Homocystinuria
 
hordeolum disease eyelid disease
blepharitis
an infection of an oil gland in the eyelid. This results in a red tender bump at the edge of the eyelid. The outside or the inside of the eyelid can be affected C01.252.354.400
C01.539.375.354.400
C11.294.354.400
C11.338.648
Stye
 
Horner's syndrome disease autonomic neuropathy Human disease C10.177.350
C10.597.690.362.500
C11.710.528.500
C23.888.592.708.362.500
Horner's syndrome
 
hospital-acquired infection disease infection C01.539.248
C23.550.291.875.500
Huntington disease disease
Designated intractable/rare diseases
neurodegeneration
Huntington disease and related disorders
eye degenerative disease
genetic neurodegenerative disease with dementia
Huntington disease (HD) is a rare neurodegenerative disorder of the central nervous system characterized by unwanted choreatic movements, behavioral and psychiatric disturbances and dementia C10.228.140.079.545
C10.228.140.380.278
C10.228.662.262.249.750
C10.574.500.497
C16.320.400.430
F03.087.250.400
F03.087.400.390
Huntington's disease
 
hydrocele disease male reproductive system disease Human disease C12.294.882 Hydrocele
hydrocephalus disease cerebellar degeneration
intracranial hypertension
disorder characterized by an abnormal increase of cerebrospinal fluid in the ventricles of the brain C10.228.140.602 Hydrocephalus
 
hydronephrosis disease urinary tract obstruction
kidney disease
Human disease C12.777.419.307
C13.351.968.419.307
Hydronephrosis
hydrophthalmos disease primary congenital glaucoma Human disease C11.250.480
C11.525.381.407.480
C16.131.384.480
C16.614.438
hyperaldosteronism disease adrenal gland hyperfunction adrenal gland hyperfunction disease that results in the overproduction of aldosterone by the adrenal glands C19.053.800.367
C19.053.800.604
Hyperaldosteronism
hyperargininemia disease urea cycle disorder urea cycle disorder that involves arginase deficiency resulting in elevated levels of plasma arginine C10.228.140.163.100.937.500
C16.320.565.100.940.500
C16.320.565.189.937.500
C18.452.132.100.937.437
C18.452.648.100.940.437
C18.452.648.189.937.437
hypercalcemia disease calcium metabolism disease Human disease C18.452.174.451
C18.452.950.340
Hypercalcemia
hyperglycemia disease glucose metabolism disease Human disease C18.452.394.952 Hyperglycemia
hyperhomocysteinemia disease amino acid metabolic disorder
sulfuraminoacidemia
amino acid metabolic disorder that involves an abnormally large level of homocysteine in the blood C16.320.565.100.480
C18.452.603.378
C18.452.648.100.480
C18.654.521.500.133.699.418
hyperlipidemia disease lipid metabolism disorder abnormally elevated levels of any or all lipids and/or lipoproteins in the blood C18.452.584.500.500 Hyperlipidemias
hypermobility syndrome disease arthropathy Human disease C05.550.521 Hypermobility
 
hyperopia disease refractive error human eye system C11.744.479 Hyperopia
 
hyperostosis disease bone remodeling disease bone remodeling disease that results in an abnormal growth of located in bone C05.116.540 Hyperostosis
hyperparathyroidism disease parathyroid gland disease endocrine disease C19.642.355 Hyperparathyroidism
 
hyperphosphatemia disease phosphorus metabolism disease Human disease C18.452.750.199 Hyperphosphatemia
hyperplasia disease hypertrophy increase in the amount of organic tissue that results from cell proliferation C23.550.444 Hyperplasia
hyperprolactinemia disease acquired metabolic disease
rare hypothalamic or pituitary disease
rare genetic hypothalamic or pituitary disease
rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin
rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin
genetic nervous system disorder
acquired metabolic disease that has material basis in the presence of abnormally-high levels of prolactin in the blood C13.703.844.506.389.500
C17.800.090.937.439.500
C10.228.140.617.738.250.450
C19.700.355.600
hypersomnia disease sleep disorder excessive sleep C10.886.425.800.200
hypertensive emergency disease hypertension
Hypertensive crisis
Human disease C14.907.489.330
hypertensive retinopathy disease retinal disease Human disease C11.768.346
C14.907.489.815
Hypertensive retinopathy
hypertricosis disease hair disease
rare epidermal disease
genetic hair anomaly
hair disease characterized by hair growth that is abnormal in quantity or location C17.800.329.875 Hypertrichosis
hypertriglyceridemia disease inherited metabolic disorder
hyperlipidemia
disease of metabolism
the most abundant fatty molecule in most organisms C18.452.584.500.500.851
hypertrophic cardiomyopathy disease
Designated intractable/rare diseases
cardiomyopathy
intrinsic cardiomyopathy
disease in which a portion of the myocardium (heart muscle) is hypertrophic (enlarged) without any obvious cause, creating functional impairment of the heart. C14.280.238.100
C14.280.484.150.070.160
C14.280.238.100.500
C14.280.484.150.070.160.500
C16.320.160
Hypertrophic cardiomyopathy
hypertrophy disease increase in the volume of an organ or tissue due to the enlargement of its component cells C23.300.775 Hypertrophy
hypocalcaemia disease calcium metabolism disease C18.452.174.509
C18.452.950.509
Hypocalcemia
hypoglycemia disease
abnormally low value
endocrine pancreas disease
glucose metabolism disease
when blood sugar decreases to below normal levels C18.452.394.984 Hypoglycemia
 
hypogonadism disease gonadal disease endocrine disease C19.391.482 Hypogonadism
hypohidrotic ectodermal dysplasia disease Clouston syndrome
bone disease
Human disease C16.131.077.350.198
C16.131.831.350.198
C16.320.322.116
C16.320.850.250.198
C17.800.804.350.198
C17.800.827.250.198
Hypohidrotic ectodermal dysplasia
hypokalemia disease mineral metabolism disease
potassium deficiency
Human disease C18.452.950.565 Hypokalemia
hypokalemic periodic paralysis disease
channelopathy
periodic paralysis Human disease C05.651.701.450
C10.668.491.650.450
C16.320.565.618.711.550
C18.452.648.618.711.550
Hyponatremia disease
abnormally low value
Hyponatremia C18.452.950.620 Hyponatraemia
hypoparathyroidism disease
Designated intractable/rare diseases
parathyroid gland disease endocrine disease C19.642.482
hypopharynx cancer disease carcinoma
pharyngeal cancer
bone cancer
pharynx cancer that is located in the hypopharynx C04.588.443.665.710.485
C07.550.745.436
C09.647.710.485
C09.775.549.485
Hypopharyngeal cancer
hypophosphatasia disease autosomal dominant disease Human disease C16.320.565.618.482
C18.452.648.618.482
hypophosphatemia disease phosphorus metabolism disease Human disease C18.452.750.400 Hypophosphatemia
hypopituitarism disease pituitary gland disease pituitary gland disease characterized by the decreased secretion of one or more of the eight hormones normally produced by the pituitary gland C10.228.140.617.738.300
C19.700.482
hypoplastic left heart syndrome disease
Designated intractable/rare diseases
congenital heart disease
cyanotic heart defect
congenital heart disease characterized by abnormal development of the left-sided structures of the heart C14.240.400.625
C14.280.400.625
C16.131.240.400.625
Hypoplastic left heart syndrome
hypospadias disease birth defect congenital disorder of urinary system C12.294.494.400
C12.706.516
C13.351.875.466
C16.131.939.516
Hypospadias
File:Hypospadias3.jpg
hypothermia disease condition in which core temperature drops below the required temperature for normal metabolism and body functions C23.888.119.565 Hypothermia
 
hypotrichosis disease hair disease hair disease that is characterized by sparse hair on the scalp resulting from abnormal hair follicle development and has material basis in mutations in proteins involved in hair growth, division or proliferation of cells within hair follicles C17.800.329.937
hypovolemia disease low blood volume C23.550.455
hypoxia disease condition in which the body or a region of the body is deprived of adequate oxygen supply at the tissue level C23.888.852.079
 
idiopathic interstitial pneumonia disease pneumonia
interstitial lung disease
pneumonia located in the lung parenchyma of unknown cause C08.381.765
C08.381.483.487
IgA glomerulonephritis disease glomerulonephritis glomerulonephritis characterized by build up of IgA antibody in the glomerulus C12.777.419.570.363.608
C13.351.968.419.570.363.608
C20.111.525
ileus disease intestinal obstruction Human disease C06.405.469.531.492 Ileus
immunoglobulin A deficiency disease selective immunoglobulin deficiency disease
B cell deficiency
dysgammaglobulinemia characterized by a deficiency of immunoglobulin A C15.378.147.333.500
C20.673.430.500
imperforate anus disease birth defect
atresia
anus disease
congenital disorder of digestive system C06.198.050
C16.131.314.094
Imperforate anus
 
impotence disease sexual dysfunction Human disease C12.294.644.486 Erectile dysfunction
in situ carcinoma disease pre-malignant neoplasm carcinoma that is an early development defined by the absence of invasion of surrounding tissues C04.557.470.200.240 Carcinoma in situ
inappropriate ADH syndrome disease pituitary gland disease endocrine disease C10.228.140.617.738.320
C18.452.950.626
C19.700.490
Syndrome of inappropriate antidiuretic hormone secretion
inclusion body myositis disease
Designated intractable/rare diseases
myositis myositis that is characterized by slowly progressive weakness and wasting of both distal and proximal muscles, most apparent in the muscles of the arms and legs that can occur in a sporadic or hereditary forms C05.651.594.600
C10.668.491.562.500
inclusion-cell disease disease
developmental defect during embryogenesis
lysosomal storage disease
mucolipidosis
rare genetic developmental defect during embryogenesis
lysosomal storage disease with skeletal involvement
Human disease C05.116.198.371
C10.228.140.163.100.435.590
C16.320.565.189.435.590
C16.320.565.202.670
C16.320.565.595.554.590
C18.452.132.100.435.590
C18.452.648.189.435.590
C18.452.648.202.670
C18.452.648.595.554.590
incontinentia pigmenti achromians disease skin disease Human disease C17.800.621
C23.550.755
infant respiratory distress syndrome disease
health problem
respiratory failure
Respiratory Distress Syndrome, Newborn
Human disease C08.381.842.475
C08.618.842.475
C16.614.521.563.475
infectious mononucleosis disease
infectious disease
viral infectious disease
Epstein–Barr virus infection
viral infectious disease that results in inflammation, located in pharynx, has material basis in Human herpesvirus 4 and has symptom fever, has symptom fatigue, has symptom lymphadenopathy, and has symptom splenomegaly C02.256.466.313.400
C15.378.553.381
C15.604.515.516
C20.683.515.515
Infectious mononucleosis
 
infertility disease reproductive system disease inability of a person, animal or plant to reproduce by natural means that is no intervention of contraceptive techniques C12.294.365
C13.351.500.365
Infertility
inflammatory bowel disease disease intestinal disease
immune system disease
intestinal disease characterized by inflammation located in all parts of digestive tract C06.405.205.731
C06.405.469.432
inguinal hernia disease intestinal disease intestinal disease characterized by a protrusion of abdominal cavity contests through the inguinal canal C23.300.707.374.875 Inguinal hernia
 
inherited metabolic disorder disease genetic disease
rare disease
disease of metabolism
class of disease including endocrine diseases, nutritional diseases and metabolic diseases C16.320.565
C18.452.648
Inborn errors of metabolism
insomnia disease sleep disorder inability to sleep C10.886.425.800.800 Insomnia
insulinoma disease adenoma adenoma that is located in the pancreas and is characterized by overproduction of insulin C04.557.470.035.100.852
C04.588.274.761.249.500
C04.588.322.475.249.500
C06.301.761.249.500
C06.689.667.249.500
C19.344.421.249.500
C04.557.470.035.100
C04.588.274.761.249
C04.588.322.475.249
C06.301.761.249
C06.689.667.249
C19.344.421.249
Insulinoma
 
intellectual disability disease specific developmental disorder
cognitive deficit
generalized neurodevelopmental disorder C10.597.606.643
C23.888.592.604.646
Intellectual disability
internuclear ophthalmoplegia disease ophthalmoplegia
strabismus
Human disease C10.228.758
C10.292.562
C11.590
 
interstitial cystitis disease cystitis chronic inflammatory condition of the submucosal and muscular layers of the bladder C12.777.829.495.500
C13.351.968.829.495.500
interstitial lung disease disease lung disease
pneumonitis
alveolar lung disease
connective tissue disease
group of lung diseases affecting the interstitium (the tissue and space around the air sacs of the lungs) C08.381.483 Interstitial lung diseases
interstitial nephritis disease Sida por cojer mucho type of nephritis affecting the interstitium of the kidneys surrounding the tubules C12.777.419.570.643
C13.351.968.419.570.643
intestinal volvulus disease intestinal obstruction Human disease C06.405.469.531.568
C23.300.970.500
Volvulus
intracranial aneurysm disease aneurysm
cerebrovascular disease
cerebral arterial disease
cerebrovascular disorder C10.228.140.300.510.600
C14.907.055.635
C14.907.253.560.300
Cerebral aneurysms
 
intracranial sinus thrombosis disease venous thrombosis
intracranial thrombosis
presence of acute thrombosis (a blood clot) in the dural venous sinuses, which drain blood from the brain. C10.228.140.300.525.425.500
C14.907.253.566.350.500
C14.907.355.590.213.350.500
Cerebral venous sinus thrombosis
intrauterine growth restriction disease poor growth of fetus in mother's womb during pregnancy C13.703.277.370
C16.300.390
C23.550.393.450
intussusception disease intestinal obstruction
genetic disease
Human disease C06.405.469.531.577 Intussusception
invasive lobular carcinoma disease breast lobular carcinoma
invasive breast carcinoma
Human disease C04.557.470.200.025.305
C04.557.470.615.305
C04.588.180.437
C17.800.090.500.437
Histopathology of invasive lobular carcinoma (ILC)
iridocyclitis disease
health problem
anterior uveitis
ciliary body disease
iritis
Human disease C11.941.375.360
C11.941.879.780.880.400
iron deficiency anemia disease microcytic anemia
deficiency anemia
nutritional deficiency disease
iron deficiency
hypochromic anemia
anemia caused by a lack of iron C15.378.071.196.300
C18.452.565.100
Iron-deficiency anemia
 
iron overload disease iron metabolism disease
overload disease
metal metabolism disorder
human disease C18.452.565.500 Hemochromatosis
irritable bowel syndrome disease syndrome
functional colonic disease
syndrome that is a functional bowel disorder characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the absence of any detectable organic cause C06.405.469.158.272.608 Irritable bowel syndrome
irritant dermatitis disease contact dermatitis Human disease C17.800.174.255.400
C17.800.815.255.400
Irritant contact dermatitis
ischaemic heart disease disease heart disease C14.280.647
C14.907.585
ischemia disease vascular disease restriction in blood supply to tissues, causing a shortage of oxygen and glucose C23.550.513
C14.280.647.124
C14.907.585.124
Ischemia
ischemic colitis disease colitis colitis caused by inadequate blood supply to the colon C06.405.205.265.115
C06.405.469.158.188.115
C14.907.286
Ischemic colitis
Japanese encephalitis disease
infectious disease
horse disease
brain disease
viral infectious disease
infectious disease with epilepsy
Human disease C02.081.343.345
C02.182.525.300.250
C02.290.310.280
C02.782.310.345
C02.782.350.250.300
C10.228.140.430.520.750.300.400
C10.228.228.245.340.300.400
C10.228.228.399.750.300.400
Japanese encephalitis
jet lag disease circadian misalignment physiological condition C10.281.440
C10.886.425.200.500
C10.281
joint effusion disease
arthropathy
arthropathy effusion of watery liquid into the cavity of a joint C05.550.509
juvenile myoclonic epilepsy disease adolescence-adult electroclinical syndrome
Idiopathic generalized epilepsy
adolescence-adult electroclinical syndrome that is characterized by brief, involuntary twitching of a muscle or a group of muscles (myoclonus) early in the morning with onset between 12 and 18 years C10.228.140.490.250.670
juvenile neuronal ceroid lipofuscinosis disease neuronal ceroid lipofuscinosis extremely rare and fatal autosomal recessive neurodegenerative disorder in humans C10.574.500.550
C16.320.400.600
C16.320.565.398.641.509
C18.452.584.687.509
C18.452.648.398.641.509
Batten disease
juvenile rheumatoid arthritis disease
arthropathy
rheumatoid arthritis
childhood arthritis
polyarticular arthritis
rheumatoid arthritis that involves an autoimmune disease onset in children under 16 which attacks the healthy cells and tissue of located in joint C05.550.114.122
C05.799.056
C17.300.775.049
C20.111.198
 
Kallmann syndrome disease hypogonadotropic hypogonadism A form of hypogonadotropic hypogonadism which is also accompanied by a total lack or partial loss in the sense of smell. The condition affects both males and females and causes a failure in puberty and infertility. C12.706.316.096.750
C13.351.875.253.096.750
C16.131.939.316.096.750
C16.320.467
C19.391.119.096.750
C19.391.482.600
Kaposi's sarcoma disease
infectious disease
connective tissue neoplasm
human herpesvirus 8-related disorder
connective tissue cancer that derives from lymphatic endothelium, and derives from spindle cells, results in formation of vascular channels that fill with blood cells, has material basis in Human herpesvirus 8 (HHV8) C02.256.466.860
C04.557.450.795.850
C04.557.645.750
Kaposi's sarcoma
 
Kawasaki disease disease lymphadenitis
immune system disease
predominantly medium-vessel vasculitis
Human disease in which blood vessels throughout the body become inflamed C14.907.940.560
C15.604.560
C17.800.862.560
Kawasaki disease
 
Kennedy disease disease
Designated intractable/rare diseases
spinal muscular atrophy
nervous system heredodegenerative disease
rare male infertility due to testicular endocrine disorder
bulbospinal muscular atrophy of adult
Kennedy's disease, also known as bulbospinal muscular atrophy (BSMA), is a rare X-linked recessive motor neuron disease characterized by proximal and bulbar muscle wasting C10.228.854.468.399
C10.574.500.175
C10.574.562.500.374
C10.668.467.500.186
C16.320.322.076
keratitis disease corneal disease
eye inflammation
inflammatory disease
corneal disease that is characterized by inflammation of the cornea. C11.204.564 Keratitis
 
keratoacanthoma disease skin squamous cell carcinoma Human disease C17.800.417
 
keratoconjunctivitis disease eye disease
keratitis
conjunctivitis
Human disease C11.187.183.394
C11.204.564.585
 
keratoconjunctivitis sicca disease dry eye syndrome
keratoconjunctivitis
Human disease C11.187.183.394.550
C11.204.564.585.630
C11.496.260.394
Dry eye syndrome
keratoconus disease corneal disease
rare genetic eye disease
corneal disease characterized by structural changes within the cornea causing it to thin and change, leading to a protruding conical shape C11.204.627 Keratoconus
keratosis follicularis disease keratosis Human disease C16.320.850.190
C17.800.428.275
C17.800.827.190
Darier's disease
kernicterus disease brain disease congenital disorder of nervous system C10.228.140.163.480
C15.378.295.502
C16.614.304.502
C18.452.132.480
C20.306.502
C23.550.429.750
Kernicterus
kidney disease disease
health problem
urinary system disease a urinary system disease that is located in the kidney C12.777.419
C13.351.968.419
Kidney diseases
kidney failure disease urinary system disease
kidney disease
impaired renal function disease
disease where the kidneys fail to adequately filter waste products from the blood C12.777.419.780
C13.351.968.419.780
Klatskin's tumor disease intrahepatic cholangiocarcinoma Human disease C04.557.470.200.025.450.500
Kleine-Levin syndrome disease
syndrome
hypersomnia
genetic nervous system disorder
recurrent hypersomnia that is characterized by recurring periods of excessive amounts of sleep and altered behavior C10.886.425.800.200.500
Klinefelter's syndrome disease
developmental defect during embryogenesis
chromosomal disease
sex chromosome disorder
X chromosome number anomaly with male phenotype
male infertility due to gonadal dysgenesis
sex chromosome disorder of sex development
chromosomal anomaly with epilepsy as a major feature
Human disease C12.706.316.795.500
C13.351.875.253.795.500
C16.131.260.830.835.500
C16.131.939.316.795.500
C16.320.180.830.835.500
C19.391.119.795.500
C19.391.482.629
Klinefelter's syndrome
 
Klippel-Feil syndrome disease birth defect
spinal disease
physical disorder that has material basis in abnormal segmentation of the vertebra during fetal development which results in fusion located in cervical vertebra C05.116.099.370.535
C05.660.551
C16.131.621.551
Klippel–Feil syndrome
 
Klippel–Trénaunay–Weber syndrome disease overgrowth syndrome
syndrome
syndrome that is characterized by large cutaneous hemangiomata with hypertrophy of the related bones and soft tissues C14.907.077.410 Klippel–Trénaunay syndrome
Kluver-Bucy syndrome disease impulse control disorder Human disease C10.228.140.380.326
Knee osteoarthritis disease
arthropathy
osteoarthritis
knee disorder
C05.550.114.606.500
C05.799.613.500
Knee osteoarthritis
Korsakoff's syndrome disease nutritional deficiency disease
Wernicke encephalopathy
Effects of alcohol on memory
mental illness caused by a lack of thiamine in the brain C10.597.606.525.400
C10.720.112.100.500
C23.888.592.604.529.400
C25.723.705.150.100.500
C25.775.100.087.193.100.500
Korsakoff's syndrome
 
Krabbe disease disease sphingolipidosis
nervous system heredodegenerative disease
eye degenerative disease
Krabbe disease is a lysosomal disorder that affects the white matter of the central and peripheral nervous systems. It includes infantile, late-infantile/juvenile and adult forms. C10.228.140.163.100.362.500
C10.228.140.163.100.435.825.590
C10.228.140.695.625.500
C10.314.400.500
C16.320.565.189.362.500
C16.320.565.189.435.825.590
C16.320.565.398.641.803.585
C16.320.565.595.554.825.590
C18.452.132.100.362.500
C18.452.132.100.435.825.590
C18.452.584.687.803.585
C18.452.648.189.362.500
C18.452.648.189.435.825.590
C18.452.648.398.641.803.585
C18.452.648.595.554.825.590
Krukenberg carcinoma disease
secondary neoplasm
ovary epithelial cancer
ovarian metastasis
metastatic carcinoma
ovary adenocarcinoma
signet ring cell adenocarcinoma
Human disease C04.557.470.200.025.415.410
C04.557.470.590.415.410
Krukenberg tumor
kuru disease transmissible spongiform encephalopathy
human prion disease
Human disease C10.228.228.800.435
C10.574.843.625
Kuru (disease)
kwashiorkor disease protein-energy malnutrition Human disease C18.654.521.719.500 Kwashiorkor
 
Kyasanur forest disease disease
infectious disease
viral infectious disease
tick-borne disease
viral hemorrhagic fever
Human disease C02.081.885.475
C02.782.350.250.635
C02.782.417.475
kyphosis disease spinal disease
Spinal curvature
human disease C05.116.900.800.500 Kyphosis
lactic acidosis disease acidosis
metabolic acidosis
acquired metabolic disease that has material basis in low pH in body tissues and blood accompanied by the buildup of lactate especially D-lactate C18.452.076.176.180 Lactic acidosis
lactose intolerance disease carbohydrate metabolic disorder Human disease C06.405.469.637.506
C16.320.565.202.589
C18.452.603.506
C18.452.648.202.589
Lactose intolerance
 
Lafora disease disease neurodegeneration
Progressive myoclonus epilepsy
genetic neurodegenerative disease
progressive epilepsy and/or ataxia with myoclonus as a major feature
Lafora disease (LD) is a rare, inherited, severe, progressive myoclonic epilepsy characterized by myoclonus and/or generalized seizures, visual hallucinations (partial occipital seizures), and progressive neurological decline C10.228.140.490.250.650.500
C10.574.500.529
C16.320.400.480
Lambert-Eaton myasthenic syndrome disease neuromuscular junction disease
channelopathy
immune-mediated acquired neuromuscular junction disease
paraneoplastic neurologic syndrome
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune, presynaptic disorder of neuromuscular transmission characterized by fluctuating muscle weakness and autonomic dysfunction frequently associated with small-cell lung cancer (SCLC) C04.588.614.550.225
C04.730.856.225
C10.114.468
C10.574.781.500
C10.668.758.450
C20.111.258.350
 
Landau–Kleffner syndrome disease childhood electroclinical syndrome Human disease C10.228.140.490.535
Langerhans-cell histiocytosis disease histiocytosis disease involving clonal proliferation of Langerhans cells C08.381.483.375
C15.604.250.400
Langerhans cell histiocytosis
 
Laron syndrome disease autosomal recessive disease
Growth hormone insensitivity syndrome
Laron syndrome is a congenital disorder characterized by marked short stature associated with normal or high serum growth hormone (GH) and low serum insulin-like growth factor-1 (IGF-I) levels which fail to rise after exogenous GH administration C05.116.099.343.679
C16.320.240.750
C19.297.656
laryngeal cancer disease head and neck cancer
carcinoma
laryngeal disease
respiratory system cancer
respiratory system cancer that is located in the larynx C04.588.443.665.481
C08.360.369
C08.785.481
C09.400.369
C09.647.481
Laryngeal cancer
 
laryngitis disease laryngeal disease
inflammatory disease
inflammation of the larynx C08.360.535
C08.730.368
C09.400.535
Laryngitis
Lassa fever disease
infectious disease
viral infectious disease
arenavirus hemorrhagic fever
viral disease C02.782.082.545
C02.782.417.505
 
lateral medullary syndrome disease brain stem infarction Human disease C10.228.140.300.150.477.100.500
C10.228.140.300.775.200.100.500
C14.907.253.092.477.100.500
C14.907.253.855.200.100.500
Lateral medullary syndrome
 
latex allergy disease type I hypersensitivity hypersensitivity reaction type I disease triggered by latex C20.543.600
learning disability disease specific developmental disorder specific developmental disorder that involves difficulty in scholastic skills such as reading, writing, spelling, reasoning, recalling and/or organizing information resulting from the brain's inability to receive and process information C10.597.606.150.550
C23.888.592.604.150.550
Learning disabilities
Leber congenital amaurosis disease retinal disease retinal disease that is characterized by nystagmus, sluggish or no pupillary responses, and severe vision loss or blindness C11.270.516
C11.768.364
Leber's congenital amaurosis
Leber hereditary optic neuropathy disease
Designated intractable/rare diseases
developmental defect during embryogenesis
optic nerve disease
hereditary optic atrophy
genetic peripheral neuropathy
mitochondrial disease with eye involvement
hereditary optic neuropathy
mitochondrial disease with dilated cardiomyopathy
mitochondrial disease with hypertrophic cardiomyopathy
mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA
Human disease C10.292.700.225.500.400
C10.574.500.662.400
C11.270.564.400
C11.640.451.451.400
C16.320.290.564.400
C16.320.400.630.400
C18.452.660.670
Leber's hereditary optic neuropathy
left ventricular noncompaction disease intrinsic cardiomyopathy
cardiomyopathy
intrinsic cardiomyopathy characterized by distinctive (spongy) morphological appearance of the LV myocardium C14.240.400.660
C14.280.238.281.500
C14.280.400.660
C16.131.077.477
C16.131.240.400.655
C16.320.322.370
Left ventricular non-compaction
Legg-Calve-Perthes disease disease osteochondrosis
osteonecrosis
type 2 collagen-related bone disorder
osteochondrosis of genetic origin
osteochondrosis that results in death and fracture located in hip joint C05.116.852.175.570 Legg–Calvé–Perthes disease
 
legionnaires' disease disease
infectious disease
legionellosis
atypical pneumonia
bacterial pneumonia
rare respiratory disease
legionellosis that is characterized by severe form of infection producing pneumonia. Symptoms include fever, chills, and cough. C01.252.400.500.501
C08.730.382.380
Legionnaires' disease
Leigh disease disease mitochondrial disease A mitochondrial metabolism disease characterized by progressive loss of mental and movement abilities. Symptoms usually begin between ages of three months and two years and include loss of appetite, vomiting, irritability and seizure activity. C10.228.140.163.100.412
C16.320.565.189.412
C16.320.565.202.810.444
C18.452.132.100.412
C18.452.648.189.412
C18.452.648.202.810.444
C18.452.660.520
leiomyosarcoma disease smooth muscle cancer malignant smooth muscle cancer that can arise almost anywhere in the body, but is most common in the uterus, abdomen, or pelvis C04.557.450.590.455
C04.557.450.795.455
Leiomyosarcoma
leishmaniasis disease parasitic protozoa infectious disease disease caused by parasites of the Leishmania type C03.752.300.500
C03.858.560
C17.800.838.775.560
Leishmaniasis
 
Lemierre's syndrome disease commensal bacterial infectious disease
Fusobacterium infectious disease
Human disease: infectious thrombophlebitis of the internal jugular vein C01.252.400.388.350
Lennox-Gastaut syndrome disease
Designated intractable/rare diseases
childhood electroclinical syndrome a childhood-onset epilepsy with triad of signs including frequent seizures of multiple types, an abnormal EEG pattern of less than 2.5 Hz slow spike wave activity, and moderate to severe intellectual impairment C10.228.140.490.583
C16.320.495
LEOPARD syndrome disease autosomal dominant disease Human disease C05.660.207.525
C14.240.400.695
C14.280.400.695
C14.280.484.716.525
C16.131.077.525
C16.131.240.400.685
C16.131.621.207.525
C17.800.621.430.530.550.525
LEOPARD syndrome
leptospirosis disease primary bacterial infectious disease
spirochetal diseases
Human disease C01.252.400.511
C01.252.847.511
C01.252.400.511.739
C01.252.847.511.739
Leptospirosis
 
Lesch-Nyhan syndrome disease inborn errors of purine–pyrimidine metabolism rare disease C10.228.140.163.100.425
C10.597.606.643.455.625
C16.320.322.500.625
C16.320.400.525.625
C16.320.565.189.425
C16.320.565.798.594
C18.452.132.100.425
C18.452.648.189.425
C18.452.648.798.594
leukocyte-adhesion deficiency syndrome disease autosomal recessive disease Human disease C20.673.600
leukopenia disease leukocyte disease
cytopenia
decrease in the number of white blood cells C15.378.553.546
leukorrhea disease vaginal discharge type of vaginal discharge C13.351.500.894.700.500
Lewy body dementia disease synucleinopathy
dementia
Lewy body dementia
type of dementia C10.228.140.079.862.400
C10.228.140.380.422
C10.228.662.600.200
C10.574.531
Dementia with Lewy bodies
Li-Fraumeni syndrome disease autosomal dominant disease
disease with Cushing syndrome as a major feature
inherited nervous system cancer-predisposing syndrome
rare genetic endocrine disease
genetic nervous system disorder
hereditary cancers
autosomal dominant disease characterized by increases risk of developing several types of cancer, including breast cancer, osteosarcomata and soft tissue sarcomata C04.700.600
C16.320.700.600
C18.452.284.520
lice infestation disease
infectious disease
parasitic ectoparasitic infectious disease parasitic ectoparasitic infectious disease that involves infestation of lice, which are blood-feeding ectoparasitic insects of the order Phthiraptera C03.858.211.465
C17.800.838.775.580
Pediculus humanus capitis
 
lichen planus disease lichen disease lichen disease that is located in skin, located in tongue or located in oral mucosa, which presents itself in the form of papules, lesions or rashes C17.800.859.475.560 Lichen planus
 
Liddle syndrome disease renal tubular transport disease
Pseudohyperaldosteronism
genetic hypertension
Human disease C12.777.419.815.683
C13.351.968.419.815.683
C16.320.565.861.698
C18.452.648.861.698
limb-girdle muscular dystrophy disease muscular dystrophy
progressive muscular dystrophy
muscular dystrophy characterized by weakening of the muscles of the hip and shoulders which comprise the limb girdle muscles C05.651.534.500.280
C10.668.491.175.500.149
C16.320.577.280
linitis plastica disease gastric diffuse adenocarcinoma Human disease C04.557.470.200.025.095.410 Linitis plastica
Lipedema disease lymphatic system disease C17.300.451
lipid metabolism disorder disease inherited metabolic disorder An inherited acute metabolic disorder that involves the creation and degradation of lipids. C16.320.565.398
C18.452.584.562
C18.452.648.398
C18.452.584
C18.452.584.500
lipodystrophy disease connective tissue disease
disease of metabolism
Human disease C17.800.849.391
C18.452.584.625
C18.452.880.391
lipoid nephrosis disease nephrotic syndrome
glomerulonephritis
Human disease C12.777.419.630.477
C13.351.968.419.630.477
Minimal change disease
lipoma disease cell type benign neoplasm
adipose tissue neoplasm
cell type benign neoplasm that is composed of lipocytes C04.557.450.550
C04.557.450.550.400
Lipoma
 
lipomatosis disease skin disease Human disease C17.800.463
C18.452.584.718
Lipomatosis
liposarcoma disease lipomatous cancer lipomatous cancer that arises in fat cells in deep soft tissue retroperitoneum C04.557.450.550.420
C04.557.450.795.465
Liposarcoma
lissencephaly disease
developmental defect during embryogenesis
cephalic disorder
Neuronal migration disorder
syndrome with a central nervous system malformation as major feature
cerebral malformation with epilepsy
rare genetic developmental defect during embryogenesis
rare genetic syndromic intellectual disability
congenital disorder of nervous system C10.500.507.450.499
C16.131.666.507.450.499
Lissencephaly
listeriosis disease
infectious disease
primary bacterial infectious disease
bacterial infectious disease
bacterial infection C01.252.410.514 Listeriosis
Livedo reticularis disease Blanch
Livedo
C14.907.617.625
C17.800.862.355
C23.888.885.437
liver cancer disease gastrointestinal system cancer
liver tumor
endocrine gland cancer
liver disease
rare hepatic and biliary tract tumor
liver neoplasm
gastrointestinal system cancer, located in the liver C04.588.274.623
C06.301.623
C06.552.697
Liver cancer
liver cirrhosis disease liver disease long-term disease of the liver C06.552.630 Cirrhosis
 
liver disease disease hepatobiliary disease
endocrine system disease
Human disease C06.552 Diseases and disorders of liver
liver failure disease
clinical sign
C06.552.308.500
C06.552.308
locked-in syndrome disease neurological disorder nervous system disease that is characterized by complete paralysis of all voluntary muscles except for the ones that control the movements of the eyes C10.597.622.760
C23.888.592.636.786
 
loiasis disease
infectious disease
filariasis
parasitic helminthiasis infectious disease
eye disease
skin disease
parasitic skin disease
rare skin disease
Human disease C03.335.508.700.750.361.518 Loa loa filariasis
long QT syndrome disease heart arrhythmia
intrinsic cardiomyopathy
QT interval prolonged
rare congenital and inherited or acquired heart condition in which delayed repolarization of the heart following a heartbeat increases the risk of episodes of torsades de pointes C14.280.067.565
C16.131.240.400.715
C23.550.073.547
C14.280.067.565.720
C16.131.240.400.715.720
C23.550.073.547.720
 
lordosis disease Spinal curvature C05.116.900.800.750 Lordosis
louping ill disease
infectious disease
viral infectious disease
tick-borne disease
animal disease
Human disease C02.782.350.250.650
C22.836.435
Louping ill
low compliance bladder disease bladder disease Human disease C12.777.829.866
C13.351.968.829.813
C23.888.942.343.780
Lown-Ganong-Levine syndrome disease syndrome
pre-excitation syndrome
genetic cardiac rhythm disease
syndrome that involves pre-excitation of the ventricles due to an accessory pathway providing an abnormal electrical communication from the atria to the ventricles C14.280.067.780.560
Ludwig's angina disease
infectious disease
cellulitis
mouth disease
Human disease C01.539.535
C07.465.433
Ludwig's angina
lung abscess disease
thoracic disease
lung disease
abscess
lung disease characterized by microbial infection which causes a type of liquefactive necrosis of the pulmonary tissue and formation of cavities containing necrotic debris or fluid C01.539.830.025.490
C08.381.450
C08.730.407
Lung abscess
 
lupus nephritis disease glomerulonephritis lupus nephritis C12.777.419.570.363.680
C13.351.968.419.570.363.680
C17.300.480.680
C20.111.590.560
Lupus nephritis
Lyme disease disease primary bacterial infectious disease
borreliosis
Human disease C01.252.400.155.569
C01.252.400.825.480
C01.252.847.193.569
C01.252.200.450
C01.252.400.155.569.600
C01.252.400.825.480.700
C01.252.847.193.569.600
C10.228.228.180.437
Borreliosis
 
lymphangioleiomyomatosis disease lung disease
rare genetic respiratory disease
primary interstitial lung disease specific to adulthood
rare tumor
Human disease C04.557.375.460.465
C04.557.450.692.500
C15.604.515.562.465
C20.683.515.710.465
Lymphangioleiomyomatosis
lymphangioma disease cell type benign neoplasm
lymphatic abnormality
rare lymphatic system malformation
Human disease C04.557.375.450 Lymphangiomas
 
lymphangitis disease
infectious disease
lymphatic system disease
immune system disease
streptococcal infection
bacterial infectious disease
Human disease C15.604.406 Lymphangitis
lymphedema disease lymphatic system disease Human disease C15.604.496 Lymphedema
 
lymphocele disease lymphatic system disease Human disease C04.182.430
C15.604.510
lymphocytic choriomeningitis disease viral meningitis
Arenaviridae infectious disease
brain disease
viral infectious disease
Human disease C02.182.550.500
C02.782.082.580
C10.228.228.245.500.500
C10.228.614.400.500
 
lymphogranuloma venereum disease
sexually transmitted infection
infectious disease
commensal bacterial infectious disease
granuloma inguinale
chlamydia infection
Human disease C01.252.400.210.210.490
C01.252.810.301.490
C01.539.778.281.301.490
C12.294.668.281.301.490
C13.351.500.711.281.301.490
Lymphogranuloma venereum
lymphoma disease hematologic cancer
lymphatic system cancer
lymphoma and pseudolymphoma
hematologic cancer that affects lymphocytes that reside in the lymphatic system and in blood-forming organs C04.557.386
C15.604.515.569
C20.683.515.761
Lymphomas
 
lymphopenia disease leukopenia leukopenia that is the condition of having an abnormally low level of lymphocytes in the blood C15.378.553.546.605
C20.673.627
Lynch syndrome disease autosomal dominant disease Human disease C04.588.274.476.411.307.190
C04.700.250
C06.301.371.411.307.190
C06.405.249.411.307.190
C06.405.469.158.356.190
C06.405.469.491.307.190
C16.320.700.250
C18.452.284.255
lysosomal storage disease disease inherited metabolic disorder
overload disease
inherited metabolic disorder that involve an abnormal accumulation of substances inside the lysosome resulting from defects in lysosomal function C16.320.565.595
C18.452.648.595
Lysosomal storage diseases
macular holes disease retinal disease
retinal perforation
Human disease C11.768.740 Macular hole
macular retinal edema disease retinal edema Human disease C11.768.585.439.245 Macular edema
Maffucci syndrome disease syndrome
Ollier disease
syndrome characterized by the presence of multiple enchondromas (benign growths of cartilage) associated with multiple cavernous hemangiomas and phleboliths C05.116.099.708.338
Malakoplakia disease Xanthogranulomatous inflammation
intestinal disease
Malakoplakia is a chronic multisystem granulomatous inflammatory disease characterized by the presence of single or multiple soft plaques on various organs of the body C23.550.548
malaria disease parasitic protozoa infectious disease
vector-borne disease
mosquito-transmitted disease C03.752.530 Malaria
 
male infertility disease male reproductive system disease
infertility
Human disease C12.294.365.700 Male infertility
malignant histiocytosis disease histiocytosis Human disease C04.557.227
C15.604.250.390
malignant hyperthermia disease genetic disease
muscular channelopathy
rare disease with malignant hyperthermia
peripheral nervous system disease
genetic disease that is characterized by a drastic and uncontrolled increase in skeletal muscle oxidative metabolism, which overwhelms the body's capacity to supply oxygen, remove carbon dioxide, and regulate body temperature C23.550.505.700
C23.550.767.600
 
malignant peripheral nerve sheath tumor disease Nerve sheath tumor Human disease C04.557.465.625.650.595
C04.557.580.600.610.595
C04.557.580.625.650.595
Malignant peripheral nerve sheath tumor
Mallory–Weiss syndrome disease esophageal disease C06.405.117.468.524
 
MALT lymphoma disease marginal zone B-cell lymphoma non-Hodgkin lymphoma that has material basis in mucosal tissue involved in antibody production C04.557.386.480.150.570
C15.604.515.569.480.150.570
C20.683.515.761.480.150.570
mammary Paget's disease disease breast adenocarcinoma Human disease C04.557.470.200.240.187.500
C04.557.470.615.275.625
Paget's disease of the breast
mantle cell lymphoma disease B-cell lymphoma
aggressive B-cell non-Hodgkin lymphoma
B-cell lymphocytic neoplasm due to CD5 positive antigen-naive pregerminal center B-cell within the mantle zone that surrounds normal germinal center follicles C04.557.386.480.525
C15.604.515.569.480.525
C20.683.515.761.480.525
Mantle cell lymphoma
maple syrup urine disease disease
Designated intractable/rare diseases
organic acidemia Human disease C10.228.140.163.100.520
C16.320.565.100.608
C16.320.565.189.520
C18.452.132.100.520
C18.452.648.100.608
C18.452.648.189.520
marantic endocarditis disease
thoracic disease
endocarditis
thrombosis
endocarditis that results from the deposition of small sterile vegetations on valve leaflets C14.280.282.703
marasmus disease protein-energy malnutrition form of severe malnutrition characterized by energy deficiency C18.654.521.500.708.626 Marasmus
 
Marburg hemorrhagic fever disease
infectious disease
viral infectious disease
Filoviridae infectious disease
Human disease C02.782.417.560
C02.782.580.250.500
C22.735.500.500
Marfan syndrome disease
Designated intractable/rare diseases
marfanoid
connective tissue disease
eye disease
genetic disorder of the connective tissue C05.116.099.674
C14.240.400.725
C14.280.400.725
C16.131.077.550
C16.131.240.400.720
C16.320.540
C17.300.500
Marfan syndrome
 
mastitis disease breast disease
breastfeeding difficulties
inflammatory disease
reproductive system disease
inflammation of the breast C13.703.844.603
C17.800.090.968
Mastitis in animals
mastocytosis disease leukocyte disease a rare mast cell activation disorder of both children and adults caused by the presence of too many mast cells C04.557.450.565.465
C17.800.508
Mastocytosis
 
mastoiditis disease bone inflammation disease
middle ear disease
middle ear disease characterized by an inflammation of the mucosal lining of the mastoid antrum and the mastoid air cell system inside the mastoid process C01.539.160.495.500
C05.116.165.495.249
C09.218.705.663.652
Mastoiditis
maturity-onset diabetes of the young disease diabetes mellitus
genetic disease
genetic disease that has material basis in mutations in the MODY genes disrupting insulin production C18.452.394.750.149
C19.246.300
measles disease
infectious disease
viral infectious disease
Morbillivirus infectious disease
viral disease affecting humans C02.782.580.600.500.500 Measles
 
Meckel's diverticulum disease birth defect
genetic disease
congenital disorder of digestive system C06.198.859
C16.131.314.556
C23.300.415.750
Meckel's diverticulum
meconium aspiration syndrome disease lung disease
perinatal respiratory disorder
Human disease C08.381.520.687
C08.618.580
C13.703.277.785
C16.300.580
C16.614.580
Meconium aspiration syndrome
mediastinitis disease connective tissue disease
mediastinal disease
inflammatory disease
inflammatory process affecting the mediastinum C08.846.187.790
Medulloblastoma disease infratentorial cancer
embryonal tumor of neuroepithelial tissue
infratentorial cancer that is located in the lower part of the brain and is a type of primitive neuroectodermal tumor C04.557.465.625.600.380.515
C04.557.465.625.600.590.500
C04.557.470.670.380.515
C04.557.470.670.590.500
C04.557.580.625.600.380.515
C04.557.580.625.600.590.500
C04.557.465.625.600.590
C04.557.470.670.590
C04.557.580.625.600.590
Medulloblastoma
megacolon disease colonic disease colonic disease that is characterized by an abnormal dilation of the colon C06.405.469.158.701
megaesophagus disease esophageal disease abnormal dilation of the esophagus not due to obstruction C06.405.117.119.500.432
meibomian cyst disease blepharitis
internal hordeolum
blepharitis that is characterized as a cyst in the eyelid that is caused by inflammation of a blocked meibomian gland, usually on the upper eyelid C04.182.197
C11.338.300
Chalazion
 
Meige syndrome disease cranio-facial dystonia
focal, segmental or multifocal dystonia
cranio-facial dystonia that is accompanied by blepharospasm C10.228.140.079.590
C10.228.662.300.500
Meige's syndrome
 
melanoma disease skin cancer
cell type cancer
malignant neoplasm originating from melanocytes C04.557.465.625.650.510
C04.557.580.625.650.510
C04.557.665.510
Melanoma
 
melioidosis disease
infectious disease
primary bacterial infectious disease
bacterial infectious disease
Human disease C01.252.400.170.531 Melioidosis
Melkersson-Rosenthal syndrome disease facial nerve disease
cheilitis
genetic peripheral neuropathy
skin disease
Human disease C07.465.299.800
C07.465.466
C10.292.319.800
melorheostosis disease
developmental defect during embryogenesis
osteosclerosis osteosclerosis that has material basis in a mutation of the LEMD3 gene which results in a hyperdense bony cortex C05.116.099.708.702.593
membranous glomerulonephritis disease glomerulonephritis
lupus nephritis
Human disease C12.777.419.570.363.625
C13.351.968.419.570.363.625
C20.111.535
Meniere's disease disease
head and neck disease
endolymphatic hydrops
genetic otorhinolaryngologic disease
genetic disease
genetic nervous system disorder
disorder of the inner ear C09.218.568.217.500
 
meningioma disease central nervous system cancer
rare nervous system tumor
central nervous system cancer that are manifested in the central nervous system and arise from the arachnoid "cap" cells of the arachnoid villi in the meninges C04.557.580.520
C04.557.645.520
C04.588.614.250.580.500
C10.551.240.500.500
C04.588.614.250.580
C10.551.240.500
Meningioma
 
meningitis disease central nervous system disease
encephalomyelitis
inflammation of membranes around the brain and spinal cord C10.228.228.507
C10.228.566
Meningitis
 
Menkes disease disease
Designated intractable/rare diseases
hair disease
metal metabolism disorder
copper metabolism disease
syndromic neurometabolic disease with X-linked intellectual disability
rare genetic epilepsy
disorder of copper metabolism
syndromic hair shaft abnormality
eyebrow/eyelashes structural anomaly
rare epidermal disease
metal transport or utilization disorder with epilepsy
Human disease C10.228.140.163.100.540
C10.597.606.643.455.687
C16.320.322.500.687
C16.320.400.525.687
C16.320.565.189.540
C16.320.565.618.590
C17.800.329.968
C18.452.132.100.540
C18.452.648.189.540
C18.452.648.618.590
Menkes disease
 
mercury poisoning disease metal poisoning
chemical hazard
rare intoxication
poisoning caused by mercury chemicals C25.723.647
 
Merkel cell carcinoma disease skin carcinoma Human disease C02.256.721.150
C02.928.216
C04.557.465.625.650.240.325
C04.557.470.200.025.370.325
C04.557.580.625.650.240.325
Merkel cell carcinoma
MERRF syndrome disease
developmental defect during embryogenesis
mitochondrial encephalomyopathy
mitochondrial oxidative phosphorylation disorder due to a point mutation of mitochondrial DNA
neurometabolic disease
mitochondrial disease with epilepsy
mitochondrial disease with peripheral neuropathy
syndrome associated with hypertrophic cardiomyopathy
mitochondrial disease with eye involvement
mitochondrial disease with hypertrophic cardiomyopathy
mitochondrial disease with dilated cardiomyopathy
mitochondrial disease C05.651.460.620.530
C10.228.140.163.100.545
C10.228.140.490.250.650.700
C10.668.491.500.500.550
C16.320.565.189.545
C18.452.132.100.545
C18.452.648.189.545
C18.452.660.560.620.530
metabolic syndrome disease abdominal obesity-metabolic syndrome a clustering of medical conditions (giving a total of 16 possible combinations giving the syndrome) C18.452.394.968.500.570
C18.452.625
Metabolic syndrome
metachromatic leukodystrophy disease sphingolipidosis
rare hereditary metabolic disease with peripheral neuropathy
rare genetic epilepsy
unclassified primitive or secondary maculopathy
metabolic disease with dementia
hereditary retinal dystrophy
rare dyslipidemia
neurometabolic disease
sphingolipidosis with epilepsy
sphingolipidosis characterized by the accumulation of sulfatides in cells, especially the myelin producing cells of the nervous system C10.228.140.163.100.362.550
C10.228.140.163.100.435.825.850.500
C10.228.140.695.625.550
C10.314.400.550
C16.320.565.189.362.550
C16.320.565.189.435.825.850.500
C16.320.565.398.641.803.925.500
C16.320.565.595.554.825.850.500
C18.452.132.100.362.550
C18.452.132.100.435.825.850.500
C18.452.584.687.803.925.500
C18.452.648.189.362.550
C18.452.648.189.435.825.850.500
C18.452.648.398.641.803.925.500
C18.452.648.595.554.825.850.500
Metachromatic leukodystrophy
Methemoglobinemia disease hemoglobinopathy Human disease C15.378.619
microcephaly disease cephalic disorder
malformation of cortical development, Group I
medical condition in which the brain does not develop properly resulting in a smaller than normal head C05.660.207.620
C10.500.507.400.500
C16.131.621.207.620
C16.131.666.507.400.500
Microcephaly
 
microphthalmia disease eye disease
eye abnormalities
eye disease where one or both eyeballs are abnormally small C11.250.566
C16.131.384.666
Microphthalmia
Microscopic polyangiitis disease arterial occlusive disease
anti-neutrophil cytoplasmic antibody-associated vasculitis
systemic inflammatory disease associated with an acquired peripheral neuropathy
secondary glomerular disease
Microscopic polyangiitis (MPA) is an inflammatory, necrotizing, systemic vasculitis that affects predominantly small vessels (i.e. small arteries, arterioles, capillaries, venules) in multiple organs. C10.228.140.300.275.600
C14.907.253.329.600
C14.907.940.897.249.500
C20.111.193.750
microsporidiosis disease
infectious disease
opportunistic mycosis
immune system disease
fungal infectious disease
opportunistic mycosis that results in systemic fungal infection in immunocompromised people, has material basis in Microsporidia phylum members C01.703.617 Microsporidiosis
microtia disease congenital physical abnormalitie
pinna disease
C09.218.235
C16.131.287
Microtia
Middle cerebral artery syndrome disease cerebral arterial disease
cerebral infarction
cerebral artery occlusion
Human disease C10.228.140.300.150.477.200.450
C10.228.140.300.510.200.387
C10.228.140.300.775.200.200.450
C14.907.253.092.477.200.450
C14.907.253.560.200.387
C14.907.253.855.200.200.450
migraine disease brain disease brain disease characterized by recurrent headaches on one side C10.228.140.546.399.750 Migraine
Mikulicz disease disease
head and neck disease
lacrimal apparatus disease
benign lymphoepithelial lesion of salivary gland
autoimmune disease of eyes, ear, nose and throat
genetic otorhinolaryngologic disease
rare genetic immune disease
autoimmune disease of the nervous system
IgG4-related disease
Human disease C07.465.815.355
miliaria disease sweat gland disease Human disease C17.800.946.492 Miliaria (disease)
milk allergy disease food allergy type of food allergy caused by milk C20.543.480.370.500
Miller Fisher syndrome disease Guillain–Barré Syndrome
regional variant of Guillain-Barre syndrome
A Guillain-Barre syndrome that manifests as a descending paralysis. It usually affects the eye muscles first and presents with the triad of ophthalmoplegia, ataxia, and areflexia. C10.114.750.100.500
C10.228.140.252.500
C10.292.562.350
C10.314.750.450.500
C10.668.829.350.500
C10.668.829.800.750.300.500
C11.590.312
C20.111.258.750.400.500
mitochondrial disease disease
developmental defect during embryogenesis
inherited metabolic disorder
mitochondrial
developmental anomaly of metabolic origin
inborn disorder of energy metabolism
inherited disorder that involves mitochondrial dysfunction C18.452.660 Mitochondrial diseases
mitral valve insufficiency disease mitral valve disease disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood C14.280.484.461 Mitral valve insufficiency
mitral valve prolapse disease mitral valve disease
heart valve prolapse
mitral valve disease where one or both of the cusps of the mitral valve bulge or collapse backward in the left atrium during systole C14.280.484.400.500 Mitral valve prolapse
mitral valve stenosis disease mitral valve disease mitral valve disease that is characterized by the narrowing of the orifice of the mitral valve of the heart C14.280.484.517 Mitral valve stenosis
mixed connective tissue disease disease
Designated intractable/rare diseases
collagen disease
overlap syndrome
secondary interstitial lung disease in childhood and adulthood associated with a connective tissue disease
rare rheumatologic disease
secondary glomerular disease
systemic inflammatory disease associated with an acquired peripheral neuropathy
immune system disease
collagen disease that is considered an overlap of three diseases, systemic lupus erythematosus, scleroderma, and polymyositis with very high titers of circulating antinuclear antibody to a ribonucleoprotein antigen C17.300.540
Mobius syndrome disease
head and neck disease
developmental defect during embryogenesis
facial nerve disease
cranial nerve and nuclear aplasia
syndrome with a symptomatic strabismus
nuclear oculomotor paralysis
multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome
branchial arch or oral-acral syndrome
paralytic facial malformation
genetic peripheral neuropathy
rare disease C07.465.299.825
C10.292.319.825
C16.131.077.578
C16.614.595
Möbius syndrome
 
molluscum contagiosum disease
infectious disease
viral infectious disease
viral skin disease
viral infection of the skin C02.256.743.611
C02.825.550
C17.800.838.790.550
Molluscum contagiosum
 
Monckeberg arteriosclerosis disease arteriosclerosis
vascular calcification
Human pathology C18.452.174.130.780.500 Monckeberg's arteriosclerosis
Mongolian spot disease
medical finding
skin disease benign, flat, congenital birthmark C04.557.665.560.615.530 Mongolian spot
 
monilethrix disease autosomal dominant disease
hair disease
isolated genetic hair shaft abnormality
Human disease C16.131.077.592
C16.320.850.647
C17.800.329.984
C17.800.827.602
monkeypox disease viral infectious disease viral disease C02.256.743.615
C22.735.750
C22.795.600
motion sickness disease
head and neck disease
inner ear disease
genetic nervous system disorder
genetic otorhinolaryngologic disease
genetic disease
condition in which a disagreement exists between visually perceived movement and the vestibular system's sense of movement C23.888.571 Motion sickness
Moyamoya disease disease
Designated intractable/rare diseases
cerebral arterial disease A cerebral arterial disease characterized by constriction of certain arteries at the base of the brain. Blood flow is blocked by the constriction and also by blood clots. C10.228.140.300.200.600
C10.228.140.300.510.200.737
C14.907.137.615
C14.907.253.123.620
C14.907.253.560.200.737
 
Muckle-Wells syndrome disease Cryopyrin-associated periodic syndrome
autosomal dominant disease
Urticarial syndromes
secondary glomerular disease
rare genetic renal disease
Human disease C16.320.382.500
C17.800.827.368.500
mucocele of salivary gland disease salivary gland disease
Mucous cyst of the oral mucosa
Human disease C04.182.766
C07.465.780
Ranula
 
mucopolysaccharidosis disease
developmental defect during embryogenesis
lysosomal storage disease
rare genetic developmental defect during embryogenesis
rare disease with glaucoma as a major feature
developmental anomaly of metabolic origin
lysosomal storage disease that involves the accumulation of glycosaminoglycans in the tissues and their excretion in the urine C16.320.565.202.715
C16.320.565.595.600
C17.300.550.575
C18.452.648.202.715
C18.452.648.595.600
Mucopolysaccharidoses
mucopolysaccharidosis I disease mucopolysaccharidosis Lysosomal storage disease C16.320.565.202.715.640
C16.320.565.595.600.640
C17.300.550.575.640
C18.452.648.202.715.640
C18.452.648.595.600.640
Hurler syndrome
mucopolysaccharidosis II disease
developmental defect during embryogenesis
mucopolysaccharidosis
syndromic neurometabolic disease with X-linked intellectual disability
mucopolysaccharidosis with skin involvement
hypertrophic cardiomyopathy
lysosomal storage disease with skeletal involvement
ptosis
syndrome associated with hypertrophic cardiomyopathy
lysosomal disease with hypertrophic cardiomyopathy
mucopolysaccharidosis characterized by a deficiency of the lysosomal enzyme iduronate sulfatase C10.597.606.643.455.750
C16.320.322.500.750
C16.320.400.525.750
C16.320.565.202.715.645
C16.320.565.595.600.645
C17.300.550.575.645
C18.452.648.202.715.645
C18.452.648.595.600.645
mucopolysaccharidosis VI disease
developmental defect during embryogenesis
mucopolysaccharidosis
lysosomal storage disease with skeletal involvement
metabolic disease with corneal opacity
Lysosomal storage disease C16.320.565.202.715.670
C16.320.565.595.600.670
C17.300.550.575.670
C18.452.648.202.715.670
C18.452.648.595.600.670
Muir-Torre syndrome disease
head and neck disease
Lynch syndrome
rare skin tumor or hamartoma
palpebral sebaceous gland tumor
benign tumor of palpebral epidermis
benign neoplasm of sebaceous gland
Human disease C04.588.805.578.500
C04.700.250.500.500
C16.320.700.250.500.500
C17.800.794.712.500
C17.800.827.610
C17.800.882.712.500
multidrug-resistant tuberculosis disease
infectious disease
tuberculosis
MDR bacteria
tuberculosis that is resistant to isoniazid and rifampicin, the two most powerful first-line anti-TB drugs C01.252.410.040.552.846.775
multiple acyl-CoA dehydrogenase deficiency disease inherited metabolic disorder
acyl-CoA dehydrogenase deficiency
fatty acid oxidation and ketogenesis disorder with hypertrophic cardiomyopathy
Human disease C16.320.565.100.614
C18.452.648.100.614
C18.452.660.612
multiple chemical sensitivity disease
questionable disease
syndrome rare disease C20.543.312.500
C21.223.500
multiple endocrine neoplasia disease Endocrine gland neoplasm Human disease C04.588.322.400
C04.651.600
C04.700.630
C16.320.700.630
C19.344.400
Multiple endocrine neoplasia
multiple endocrine neoplasia type 2A disease autosomal dominant disease
multiple endocrine neoplasia
catecholamine-producing tumor
inherited renal tumor
autosomal dominant disease characterized by medullary carcinoma of the thyroid, pheochromocytoma, hyperparathyroidism, and occasionally cutaneous lichen amyloidosis C04.588.322.400.505
C04.651.600.505
C04.700.630.505
C16.320.700.630.505
C19.344.400.505
multiple endocrine neoplasia type 2B disease autosomal dominant disease
multiple endocrine neoplasia
inherited renal tumor
catecholamine-producing tumor
autosomal dominant disease characterized by medullary thyroid carcinoma, pheochromocytoma, multiple mucosal neuromas and intestinal ganglioneuromas, and often a marfanoid habitus and other skeletal abnormalities C04.588.322.400.510
C04.651.600.510
C04.700.630.510
C16.320.700.630.510
C19.344.400.510
multiple epiphyseal dysplasia disease
genetic disease
developmental defect during embryogenesis
osteochondrodysplasia An osteochondrodysplasia that has material basis in defective cartilage mineralization into bone which results in irregular ossification centers of the located in hip or located in knee. The disease has symptom fatigue, has symptom joint pain. C05.116.099.708
C16.320.728
 
multiple myeloma disease myeloid neoplasm
leukocyte disease
A myeloid neoplasm that is located in the plasma cells in bone marrow. C04.557.595.500
C14.907.454.460
C15.378.147.780.650
C15.378.463.515.460
C20.683.515.845
C20.683.780.650
Multiple myeloma
 
multiple system atrophy disease
Designated intractable/rare diseases
synucleinopathy
neurodegeneration
Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by autonomic failure (cardiovascular and/or urinary), parkinsonism, cerebellar impairment and corticospinal signs with a median survival of 6-9 years C10.177.575.550.750
C10.228.140.079.612.700
C10.228.662.550.700
C10.574.625.700
C14.907.514.741
C10.177.575.550
C10.228.140.079.612
C10.228.662.550
C10.574.625
Multiple system atrophy
mumps disease Mumps virus infectious disease
herpangina
salivary gland disease
Human disease caused by paramyxovirus C02.782.580.600.680.500
C07.465.815.470.800.630
Mumps
Munchausen by proxy disease factitious disorder
child abuse
behavioral disorder in which an adult fakes an illness in (mostly) a child or other proxy(s) F03.875.375.800
muscular dystrophy disease
Designated intractable/rare diseases
myopathy
genetic peripheral neuropathy
myopathy characterized by progressive skeletal muscle weakness degeneration C05.651.534.500
C10.668.491.175.500
C16.320.577
Muscular dystrophies
mutism disease
health problem
speech disorder inability to speak C10.597.606.150.500.800.500
C23.888.592.604.150.500.800.500
mycosis fungoides disease cutaneous T cell lymphoma
rare disease
mycosis fungoides and variants
Human disease C04.557.386.480.750.800.550
C15.604.515.569.480.750.800.550
C20.683.515.761.480.750.800.550
 
myelitis disease spinal cord disease spinal cord disease that is characterized by inflammation of the white matter or gray matter of the spinal cord C10.228.228.618
C10.228.854.525
myelodysplastic syndrome disease bone marrow cancer
neoplastic syndrome
diverse collection of hematological (blood-related) medical conditions that involve ineffective production of the myeloid class of blood cells C04.834.770
C15.378.800
C15.378.190.625
Myelodysplastic syndrome
myelofibrosis disease myeloid neoplasm
acquired aplastic anemia
rare genetic immune disease
myeloid neoplasm that is located in the bone marrow which results in bone marrow being replaced by fibrous (scar) tissue C15.378.190.636.765
myiasis disease
infectious disease
parasitic ectoparasitic infectious disease
rare skin disease
parasitic ectoparasitic infectious disease that is caused by parasitic dipterous fly larvae (maggots) feeding on the host's necrotic or living tissue C03.858.211.503 Myiasis
 
myocardial infarction disease coronary artery disease interruption of blood supply to a part of the heart C14.280.647.500
C14.907.585.500
Myocardial infarction
 
myocarditis disease extrinsic cardiomyopathy
myocardial disorder
inflammation of heart layer
extrinsic cardiomyopathy that is characterized as an inflammation of the heart muscle C14.280.238.625 Myocarditis
 
myofascial pain syndrome disease myopathy Human disease C05.651.550
myoglobinuria disease myopathy myopathy that is characterized by an increased urinary excretion of myoglobin C05.651.807.628
myoma disease muscle benign neoplasm
uterine benign neoplasm
Human disease C04.557.450.590.540 Uterine fibroids
myopathy disease muscle tissue disease muscular disease in which the muscle fibers do not function resulting in muscular weakness C05.651
C10.668.491
Diseases and disorders of the muscular system
myopia disease refractive error
visual impairment
problem with distance vision C11.744.636 Myopia
 
myositis disease myopathy
inflammation
myopathy characterized by muscle inflammation C05.651.594
C10.668.491.562
myotonia congenita disease muscle tissue disease
channelopathy
muscle tissue disease that is characterised by slow muscle relaxation associated with hyperexcitation of the muscle fibres C05.651.662.500
C10.574.500.545
C10.668.491.606.500
C16.320.400.540
myotonic dystrophy type 1 disease myotonic disease
hypertrophic cardiomyopathy
organic brain syndrome
ptosis
myopathy with eye involvement
syndrome associated with hypertrophic cardiomyopathy
musculoskeletal disease with cataract
Hypergonadotropic hypogonadism
Human disease C05.651.534.500.500
C05.651.662.750
C10.574.500.547
C10.668.491.175.500.500
C10.668.491.606.750
C16.320.400.542
C16.320.577.500
Myotonic dystrophy
myxedema disease hypothyroidism
mucinosis
Human disease C17.300.550.590
C19.874.482.638
Myxedema
myxoma disease cancer myxoid tumor of primitive connective tissue C04.557.450.565.550 Myxoma
narcolepsy disease sleep disorder sleep disorder that involves an excessive urge to sleep at inappropriate times, such as while at work C10.886.425.800.200.750 Narcolepsy
nasopharynx carcinoma disease
head and neck disease
carcinoma
pharyngeal cancer
nasopharyngeal disease
respiratory system cancer
common cancer originating in the nasopharynx C04.588.443.665.710.650
C07.550.350.650
C07.550.745.650
C09.647.710.650
C09.775.350.650
C09.775.549.650
Nasopharynx cancer
 
necrobiosis lipoidica disease skin disease
Diabetic dermadrome
necrobiotic disorders
Human disease C17.300.200.495.545
C17.800.550.545
C17.800.849.495
C18.452.880.495
Necrobiosis lipoidica
 
necrotizing fasciitis disease fasciitis
necrosis
Human disease C01.252.825.340
C05.321.550
Necrotizing fasciitis
necrotizing ulcerative gingivitis disease gingivitis Human disease C01.252.400.388.350.400
C01.539.424
C07.465.714.258.480.446
Acute necrotizing ulcerative gingivitis
Nelson syndrome disease
head and neck disease
adrenal cortex disease
functioning pituitary adenoma
Human disease C04.588.322.609.145.500
C10.228.140.617.738.675.149.500
C19.344.609.145.500
C19.700.734.145.500
nemaline myopathy disease congenital structural myopathy
non-dystrophic myopathy
congenital structural myopathy characterized by generally non-progressive muscle weakness of varying severity C05.651.575.290
C10.668.491.550.290
neonatal jaundice disease pigmentation disease pigmentation disease characterized by a high level of bilirubin in the blood, causing a yellowing of the skin and other tissues of a newborn infant C16.614.451.500
C23.550.429.249.500
C16.614.451
C23.550.429.249
Neonatal jaundice
nephroblastoma disease kidney cancer rare disease C04.557.435.595
C04.588.945.947.535.585
C04.700.635
C12.758.820.750.585
C12.777.419.473.585
C13.351.937.820.535.585
C13.351.968.419.473.585
C16.320.700.642
Wilms' tumor
nephrocalcinosis disease calcinosis
kidney disease
Human disease C12.777.419.590
C13.351.968.419.590
C18.452.174.130.560
nephrosclerosis disease renal hypertension Human disease C12.777.419.610
C13.351.968.419.610
nephrotic syndrome disease nephrosis Human disease C12.777.419.630.643
C13.351.968.419.630.643
nerve compression syndrome disease peripheral nervous system disease Human disease C10.668.829.550
Nesidioblastosis disease carbohydrate metabolic disorder
Hyperinsulinemic hypoglycemia
carbohydrate metabolic disorder that involves low blood glucose resulting from an excess of insulin C06.689.150.500
C16.614.200.500
C18.452.394.968.250.500
C18.452.394.984.200.500
neural tube defect disease
developmental defect during embryogenesis
birth defect
Congenital vertebral anomaly
rare genetic developmental defect during embryogenesis
genetic nervous system disorder
congenital disorder of nervous system C10.500.680
C16.131.666.680
neurilemmoma disease neuroma Human disease C04.557.465.625.650.595
C04.557.580.600.610.595
C04.557.580.625.650.595
 
neuroacanthocytosis disease
Designated intractable/rare diseases
neurodegeneration
genetic neurodegenerative disease with dementia
Huntington disease-like syndrome
Neuroacanthocytosis (NA) syndromes are a group of genetic diseases characterized by the association of red blood cell acanthocytosis (deformed erythrocytes with spike-like protrusions) and progressive degeneration of the basal ganglia C10.228.662.262.249.937
C16.320.400.550
neuroblastoma disease autonomic nervous system neoplasm An autonomic nervous system neoplasm that is derived from immature nerve cells. C04.557.465.625.600.590.650.550
C04.557.470.670.590.650.550
C04.557.580.625.600.590.650.550
Neuroblastoma
 
neurodegeneration disease central nervous system disease
degenerative disease
central nervous system disease C10.574 Neurodegenerative diseases and disorders
 
neurodermatitis disease dermatitis
lichen disease
Human disease C17.800.174.660
C17.800.815.660
Lichen simplex chronicus
neuroendocrine tumor disease endocrine gland cancer
rare disease
endocrine gland cancer that has material basis in neuroendocrine cells C04.557.465.625.650
C04.557.580.625.650
Neuroendocrine tumors
neurofibroma disease Nerve sheath tumor Human disease C04.557.580.600.580
C10.551.775.500.750
C10.668.829.725.500.600
Neurofibroma
 
neurofibromatosis disease autosomal dominant disease
peripheral nervous system neoplasm
overgrowth syndrome
human disease C04.557.465.625.650.595.610.500
C04.557.580.600.580.590.655
C04.557.580.600.610.595.610.500
C04.700.645.655
C09.218.807.800.675.500
C09.647.675.500
C10.292.225.750.500
C10.292.910.600.500
C10.562.600.750
C10.574.500.549.700
C16.320.400.560.700
C16.320.700.645.655
C04.557.580.600.580.590.650
C04.700.645.650
C10.562.600.500
C10.574.500.549.400
C10.668.829.675
C16.320.400.560.400
C16.320.700.645.650
C04.557.580.600.580.590
C04.700.645
C10.562.600
C10.574.500.549
C16.320.400.560
C16.320.700.645
Neurofibromatosis
neurofibromatosis type II disease
Designated intractable/rare diseases
neurofibromatosis type of neurofibromatosis disease C04.557.465.625.650.595.610.500
C04.557.580.600.580.590.655
C04.557.580.600.610.595.610.500
C04.700.645.655
C09.218.807.800.675.500
C09.647.675.500
C10.292.225.750.500
C10.292.910.600.500
C10.562.600.750
C10.574.500.549.700
C16.320.400.560.700
C16.320.700.645.655
Neurofibromatosis type 2
neurogenic arthropathy disease arthropathy Human disease C05.550.186 Neuropathic arthropathy
neuroleptic malignant syndrome disease
health problem
neurological disorder
adverse drug reaction
rare disease with malignant hyperthermia
nervous systm disease that is characterized by hyperthermia, muscular rigidity, autonomic dysfunction and altered consciousness and is associated with administration of antipsychotic and other central dopaminergic blockers C10.228.140.079.737
C10.720.737
C25.723.705.600
neuroma disease nervous system benign neoplasm nervous system benign neoplasm that is characterized as a nerve tissue tumor C04.557.580.600.610 Neuroma
neuromyelitis optica disease autoimmune disease of central nervous system
spinal cord disease
autoimmune disease of peripheral nervous system
optic nerve disease
neurodegeneration
multiple sclerosis
eye degenerative disease
immune system disease
multiple sclerosis variant
rare acquired eye disease
Neuromyelitis optica (NMO) and NMO spectrum disorders are inflammatory demyelinating diseases of the central nervous system characterized mainly by attacks of uni- or bilateral optic neuritis (ON) and acute myelitis C10.114.375.600.500
C10.114.375.800
C10.292.700.550.500
C10.314.350.600.500
C10.314.350.800
C11.640.576.695
C20.111.258.250.550.500
C20.111.258.250.775
Multiple sclerosis
neutropenia disease agranulocytosis abnormally low concentration of neutrophils in the blood C15.378.553.546.184.564
 
nevoid basal cell carcinoma syndrome disease autosomal dominant disease an autosomal dominant condition that can cause unusual facial appearances and a predisposition for basal-cell carcinoma C04.182.089.530.690.150
C04.557.470.200.165.150
C04.557.470.565.165.150
C04.700.175
C05.116.099.105
C05.500.470.690.150
C07.320.450.670.130
C16.131.077.130
C16.320.700.175
Niemann-Pick disease disease sphingolipidosis
non-Langerhans-cell histiocytosis
rare disease C10.228.140.163.100.435.825.700
C15.604.250.410.625
C16.320.565.189.435.825.700
C16.320.565.398.641.803.730
C16.320.565.595.554.825.700
C18.452.132.100.435.825.700
C18.452.584.687.803.730
C18.452.648.189.435.825.700
C18.452.648.398.641.803.730
C18.452.648.595.554.825.700
Niemann–Pick disease
night blindness disease eye disease
retinal disease
vision disorder
condition making it difficult or impossible to see in relatively low light C11.966.671
 
Nijmegen breakage syndrome disease
developmental defect during embryogenesis
autosomal recessive disease
rare genetic inherited tumor
multiple congenital anomalies/dysmorphic syndrome without intellectual disability
developmental anomaly of metabolic origin
DNA repair defect other than combined T-cell and B-cell immunodeficiencies
rare genetic developmental defect during embryogenesis
polymalformative genetic syndrome with increased risk of developing cancer
Human disease C18.452.284.600
nocardiosis disease
infectious disease
opportunistic bacterial infectious disease
bacterial infectious disease
Human disease C01.252.410.040.692 Nocardiosis
 
nocturnal enuresis disease enuresis disease C12.777.934.284.500
C13.351.968.934.252.500
nodding disease disease
rare disease
disease C10.228.140.490.375.525
noma disease
infectious disease
ulcerative stomatitis
aphthous stomatitis
bacterial infectious disease
Human disease C07.465.604 Noma (disease)
 
nominal aphasia disease aphasia type of aphasia that causes problems with recalling words or names C10.597.606.150.500.090
C23.888.592.604.150.500.090
Non-alcoholic fatty liver disease disease fatty liver disease fatty liver disease characterized by the storing of excess fat in liver cells which is is not caused by heavy alcohol use C06.552.241.519
non-Hodgkin lymphoma disease lymphoma
neoplasm
hematopoietic system diseases
cancer of lymph in humans C04.557.386.480
C15.604.515.569.480
C20.683.515.761.480
Hematologic neoplasms
 
Noonan syndrome disease
Designated intractable/rare diseases
rare disease
syndrome
syndrome that is characterized by mildly unusual facial features, short stature, heart defects, bleeding problems, skeletal malformations, and many other signs and symptoms C05.660.207.690
C14.240.400.787
C14.280.400.787
C16.131.240.400.784
C16.131.621.207.690
C17.300.690
Noonan syndrome
 
normal pressure hydrocephalus disease communicating hydrocephalus
genetic neurodegenerative disease
genetic dementia
Human disease C10.228.140.602.750 Normal pressure hydrocephalus
nutrition disorder disease acquired metabolic disease
nutritional and metabolic diseases
disease that results from excessive or inadequate intake of food and nutrients C18.654 Nutritional diseases and disorders
nutritional deficiency disease disease nutrition disorder Human disease C18.654.521.500 Diseases and disorders due to nutritional deficiencies
ochronosis disease connective tissue disease Human disease C23.550.744 Ochronosis
ocular albinism type 1 disease ocular albinism C11.270.040.090
C16.320.290.040.090
C16.320.565.100.102.090
C16.320.850.080.090
C17.800.621.440.102.090
C17.800.827.080.090
C18.452.648.100.102.090
oculocerebrorenal syndrome disease
developmental defect during embryogenesis
X-linked disease
developmental anomaly of metabolic origin
syndromic neurometabolic disease with X-linked intellectual disability
inherited renal tubular disease
Amino acid transport disorder
rare renal tubular disease
renal disease with cataract
rare disease with glaucoma as a major feature
metabolic disease with cataract
syndromic developmental defect of the eye
Human disease C10.228.140.163.100.640
C12.777.419.815.720
C13.351.968.419.815.720
C16.131.077.662
C16.320.322.750
C16.320.565.151.600
C16.320.565.189.640
C16.320.565.861.750
C16.320.709
C18.452.132.100.640
C18.452.648.151.600
C18.452.648.189.640
C18.452.648.861.750
oculocutaneous albinism disease
Wikimedia disambiguation page
autosomal recessive disease
albinism
autosomal recessive disease characterized by abnormal pigmentation of the skin, hair and eyes C11.270.040.545
C16.320.290.040.100
C16.320.565.100.102.100
C16.320.850.080.100
C17.800.621.440.102.100
C17.800.827.080.100
C18.452.648.100.102.100
oculomotor nerve paralysis disease third cranial nerve disease
paralytic squint
Human disease C10.292.562.700
C11.590.436
Oculomotor nerve palsy
oligodendroglioma disease glioma Human disease C04.557.465.625.600.380.590
C04.557.470.670.380.590
C04.557.580.625.600.380.590
Oligodendroglioma
oligohydramnios disease placenta disease placenta disease that is characterized by a deficiency of amniotic fluid sometimes resulting in an embryonic defect through adherence between embryo and amnion C13.703.560
Oligomenorrhea disease menstrual disorder C23.550.568.937
Omphalocele disease birth defect
Abdominal wall defect
physical disorder characterized by a defect in the development of the abdominal wall muscles, resulting in the intestines, liver and other organs to remain outside of the abdomen in a sac C16.614.378
C23.300.707.374.937.500
Omphalocele
onchocerciasis disease filariasis
parasitic helminthiasis infectious disease
Human helminthiasis C03.335.508.700.750.361.699
C03.858.650
C17.800.838.775.690
Onchocerciasis
 
onychomycosis disease fungal infectious disease
nail disease
Human and animal disease C01.539.800.200.720.550
C01.703.295.872.458
C17.800.529.550
C17.800.838.208.883.458
Onychomycosis
 
ophthalmoplegia disease ocular motility disease Human disease C10.292.562.750
C10.597.622.447
C11.590.472
C23.888.592.636.447
Ophthalmoparesis
opisthorchiasis disease
infectious disease
parasitic helminthiasis infectious disease
distomatosis
Human helminthiasis C03.335.865.685
Opportunistic infection disease superinfection C01.539.597
C02.597
C03.684
Opportunistic infections
optic neuritis disease optic nerve disease
eye disease
encephalomyelitis
optic nerve disease that results in inflammation located in optic nerve which may cause a complete or partial loss of vision C10.292.700.550
C11.640.576
oral cavity cancer disease gastrointestinal system cancer
mouth disease
gastrointestinal system cancer that is located in the oral cavity C04.588.443.591
C07.465.565
Oral cancer
 
oral hairy leukoplakia disease mouth disease
leukoplakia
mouth disease characterized by a white patch on the lateral sides of the tongue with a corrugated or hairy appearance; caused by Epstein-Barr virus C02.256.466.313.500
C04.588.443.591.545.500
C04.834.512.513.500
C07.465.565.545.500
C23.300.816.513.500
orbital cellulitis disease
health problem
infectious disease
acute orbital inflammation
cellulitis
Human disease C11.675.387
C17.300.185.500
orchitis disease testicular disease
inflammatory disease
inflammation of the testes C12.294.829.493
C19.391.829.493
Orchitis
ornithosis disease
animal disease
infectious disease
primary bacterial infectious disease
Chlamydophila infectious disease
Human disease C01.252.400.210.250.600 Psittacosis
 
oromandibular dystonia disease focal dystonia
lingual-facial-buccal dyskinesia
focal, segmental or multifocal dystonia
focal dystonia that is characterized by distortions of the mouth and tongue. C10.228.662
oropharynx cancer disease
head and neck disease
pharyngeal cancer
carcinoma
neoplasm of oropharynx
pharynx cancer that is located in the oropharynx A03.556.750
Osgood-Schlatter's disease Mohamed disease disease bone inflammation disease
knee disorder
osteochondrosis C05.116.821 Osgood–Schlatter disease
osteitis fibrosa disease bone resorption disease bone resorption disease that has material basis in hyperparathyroidism which results in hyperactivity in osteoclasts, deformity, and loss of mass located in bone C05.116.132.684
osteoblastoma disease bone benign neoplasm Human disease C04.557.450.565.575.600
osteochondritis dissecans disease ischemic bone disease ischemic bone disease that results_in necrosis located_in epiphysis. C05.116.791
C05.182.520
C17.300.182.520
C05.116.791.668
Osteochondritis dissecans
 
osteochondrosis disease ischemic bone disease ischemic bone disease that results in necrosis followed by regrowth in children and teens located in bone C05.116.821 Osteochondrosis
osteogenesis imperfecta disease osteochondrodysplasia osteochondrodysplasia that has material basis in a deficiency in type-I collagen which results in brittle bones and defective connective tissue C05.116.099.708.685
C16.320.737
C17.300.200.540
Osteogenesis imperfecta
osteoid osteoma disease osteoma
inherited syndrome with bone tumors as a major feature
C04.557.450.565.575.625.625 Osteoid osteoma
 
osteomalacia disease bone remodeling disease bone remodeling disease that has material basis in a vitamin D deficiency which results in softening located in bone C05.116.198.816.640
C18.452.104.816.640
C18.452.174.845.640
C18.654.521.500.133.770.734.640
 
osteomyelitis disease bone inflammation disease bone inflammation disease that has material basis in infection located in bone or located in bone marrow C01.539.160.495
C05.116.165.495
Osteomyelitis
osteonecrosis disease necrosis
ischemic bone disease
bone death caused when the bone no longer receives blood supply C05.116.852
C23.550.717.732
Aseptic osteonecrosis
 
osteopetrosis disease osteosclerosis inherited disorder C05.116.099.708.702.678 Osteopetrosis
 
osteophyte disease exostosis C05.116.540.310.800 Osteophyte
osteopoikilosis disease osteosclerosis osteosclerosis that results in numerous bone islands located in skeleton C05.116.099.708.702.685
C17.300.705
Osteopoikilosis
osteoporosis disease bone resorption disease bone resorption disease characterized by decreased density of normally mineralized bone which results in the thinning of bone tissue and decreased mechanical strength C05.116.198.579
C18.452.104.579
C05.116.198.579.610
C18.452.104.579.610
Osteoporosis
osteosarcoma disease bone cancer
sarcoma
bone cancer that is located in bone that has material basis in cells of mesenchymal origin C04.557.450.565.575.650
C04.557.450.795.620
C04.557.450.565.575
Osteosarcoma
osteosclerosis disease bone remodeling disease bone remodeling disease that results in abnormal elevated bone density or mass C05.116.099.708.702
 
otitis externa disease
head and neck disease
infectious disease
external ear disease
ear infection
post-infectious disorder
An external ear disease that involves inflammation of the outer ear and ear canal. It can be caused by active bacterial or fungal infections. C09.218.705.496 Otitis externa
otitis media disease
head and neck disease
middle ear disease
inflammatory disease
otitis which involves inflammation of the middle ear C09.218.705.663 Otitis media
otomycosis disease otitis externa
cutaneous mycosis
Human disease C01.703.658
C09.218.736
otosclerosis disease inner ear disease otitis interna characterized by an abnormal bone growth in the middle ear C09.218.768
 
ovarian Brenner tumor disease ovarian benign neoplasm ovarian benign neoplasm that has material basis in the surface epithelium of the ovary C04.557.450.565.590.595.150
C04.557.470.625.150
C13.351.500.056.630.705.265
C13.351.937.418.685.265
C19.391.630.705.265
Brenner tumour
ovarian cancer disease female reproductive organ cancer
ovarian tumor
ovarian disease
endocrine gland cancer
rare genetic endocrine disease
inherited gynecological tumor
female reproductive organ cancer that is located_in the ovary. C04.588.322.455
C13.351.500.056.630.705
C13.351.937.418.685
C19.344.410
C19.391.630.705
Ovarian cancer
 
ovarian cyst disease ovarian disease
ovarian tumor
fluid-filled sac in the ovary C04.182.612
C13.351.500.056.630.580
C19.391.630.580
Ovarian cysts
 
ovarian hyperstimulation syndrome disease ovarian disease
rare genetic endocrine disease
rare genetic gynecological and obstetrical diseases
rare non-malformative uterine adnexal disease
Human disease C13.351.500.056.630.642
C19.391.630.642
oxyphilic adenoma disease endocrine organ benign neoplasm
oncocytic neoplasm
benign epithelial neoplasm
Human disease C04.557.470.035.140 Oncocytoma
Pancoast tumor disease lung cancer Human disease C04.588.894.797.520.734
C08.381.540.734
C08.785.520.734
 
pancreatic cancer disease endocrine gland cancer
pancreas disease
pancreatic tumor
gastrointestinal system cancer
endocrine gland cancer located in the pancreas C04.588.274.761
C04.588.322.475
C06.301.761
C06.689.667
C19.344.421
Pancreatic cancer
 
pancreatitis disease pancreas disease
inflammatory disease
Human disease C06.689.750 Pancreatitis
pancytopenia disease anemia Human disease C15.378.700
panniculitis disease fibromyalgia
dermatomyositis
connective tissue disease
Inflammation of the subcutaneous adipose tissue C17.300.710
C17.800.566
 
panophthalmitis disease
infectious disease
scleritis
purulent endophthalmitis
Human disease C01.252.354.900.675
C01.539.375.354.900.675
C01.539.375.450.900.675
C01.703.343.900.675
C11.294.354.900.675
C11.294.450.900.675
C11.941.879.960.580
pantothenate kinase-associated neurodegeneration disease neurodegeneration with brain iron accumulation
neuroacanthocytosis
nervous system heredodegenerative disease
eye degenerative disease
A neurodegeneration with brain iron accumulation that has_material_basis_in autosomal recessive inheritance of mutation in the PANK2 gene on chromosome 20p13. C10.228.140.079.800
C10.228.140.744.320
C10.228.662.575
C10.574.500.700
C16.320.400.650
Papilledema disease optic nerve disease Human disease C10.292.700.900
C11.640.710
Papilledema
 
papilloma disease cell type benign neoplasm cell type benign neoplam that is composed of epithelial tissue on papillae of vascularized connective tissue C04.557.470.700.600 Papillomas
Papillomatosis disease disease C04.557.470.700.600
paracoccidioidomycosis disease
infectious disease
primary systemic mycosis
cutaneous mycosis
bone disease
lymph node disease
lung disease
cellulitis
fungal infectious disease
primary systemic mycosis that results in systemic fungal infection located in mucosa, located in lymph nodes, located in bone, located in skin or located in lungs, has material basis in Paracoccidioides brasiliensis C01.703.700 Paracoccidioidomycosis
paraganglioma disease neuroendocrine tumor Human disease C04.557.465.625.650.700
C04.557.580.625.650.700
Paraganglioma
parakeratosis disease keratinization characterized by the retention of nuclei in the stratum corneum C17.800.428.736
parametritis disease pelvic inflammatory diseases
inflammatory disease
uterine disease
Human disease C13.351.500.056.750.750
paraneoplastic syndrome disease C04.730
paraphimosis disease phimosis Human disease C12.294.494.684.587 Paraphimosis
paraplegia disease central nervous system disease
paralysis
impairment in motor or sensory function of the lower extremities C10.597.622.669
C23.888.592.636.637
parasitic helminthiasis infectious disease disease
infectious disease
parasitic infectious diseases macroparasitic disease in which a part of the body is infected with parasitic worms C03.335 Helminthiases
parasitic infectious diseases disease
infectious disease
infectious disease infectious disease caused or transmitted by a parasite C03 Parasitic diseases
parasitic protozoa infectious disease disease parasitic infectious diseases parasitic disease caused by a protozoan C03.752
paratyphoid fever disease
infectious disease
primary bacterial infectious disease
Salmonella infectious disease
salmonellosis
Human disease C01.252.400.310.821.438
parkinsonian syndrome disease extrapyramidal symptoms
movement disorder
symptoms that resemble Parkinson's disease C10.228.140.079.862.800
C10.228.662.600.700
C10.228.140.079.862
C10.228.662.600
Parkinson's disease
parotitis disease parotid disease
inflammatory disease
parotid disease characterized by the inflammation of one or both parotid glands C07.465.815.470.800
C07.465.815.793.500
paroxysmal nocturnal hemoglobinuria disease
Designated intractable/rare diseases
hemoglobinuria Human disease C15.378.071.141.560
C15.378.190.625.460
Parry–Romberg syndrome disease facial nerve disease
brain inflammatory disease
inflammatory and autoimmune disease with epilepsy
genetic peripheral neuropathy
rare genetic epilepsy
a rare disease characterized by progressive shrinkage and degeneration of the tissues beneath the skin, usually on only one side of the face (hemifacial atrophy) but occasionally extending to other parts of the body C07.465.284
C07.465.299.375
C10.292.319.375
Parry–Romberg syndrome
 
Pathologic fracture disease bone fracture C26.404.374 Pathologic fractures
Pelger-Huet anomaly disease autosomal dominant disease
leukocyte disease
Human disease C15.378.553.696
C16.320.784
Pelizaeus-Merzbacher disease disease hypomyelinating leukodystrophy
nervous system heredodegenerative disease
eye degenerative disease
hypomyelinating leukodystrophy characterized by impaired myelin formation, nystagmus, spastic quadriplegia, ataxia, and developmental delay that has material basis in mutation in the PLP1 gene on chromosome Xq22 C10.228.140.163.100.362.775
C10.228.140.695.625.775
C10.314.400.775
C16.320.322.906
C16.320.565.189.362.775
C18.452.132.100.362.775
C18.452.648.189.362.775
pellagra disease nutritional deficiency disease
other acquired skin disease
skin disease
Human disease C18.654.521.500.133.699.529 Pellagra
pelvic inflammatory diseases disease female reproductive system disease infection of uterus, fallopian tubes, ovaries or the inner surface of pelvis C01.539.635.500
C13.351.500.056.750
Pelvic inflammatory disease
pemphigus disease
Designated intractable/rare diseases
bullous skin disease Human disease C17.800.865.716
C20.111.736
Pemphigus
penile cancer disease penile disease
male reproductive organ cancer
human disease C04.588.945.440.715
C12.294.260.500
C12.294.494.591
C12.758.409.500
Penile cancer
peptic esophagitis disease peptic ulcer disease
esophagitis
gastroesophageal reflux disease
Human disease C06.405.117.620.420
C06.405.205.663.420
C06.405.469.275.800.523
peptic ulcer disease disease gastrointestinal system disease Ulcer of an area of the gastrointestinal tract C06.405.469.275.800
C06.405.748.586
Peptic ulcers
 
periapical periodontitis disease inflammation
periodontitis
dental pulp disease
periapical disease
Human disease C07.320.830.700
C07.465.714.306.700
C07.465.714.533.487
pericardial effusion disease pericardium disease pericardium disease that is characterized by an abnormal accumulation of fluid in the pericardial cavity C14.280.695 Pericardial effusion
pericarditis disease pericardium disease
inflammation
inflammatory disease
heart disease
pericardium disease that is characterized by an inflammation of the pericardium and has symptom chest pain C14.280.720 Pericarditis
pericoronitis disease gingival disease Human disease C07.465.714.258.771 Pericoronitis
perineurioma disease Nerve sheath tumor Human disease C04.557.580.600
C10.551.775.500
C10.668.829.725.500
periodic paralysis disease myopathy
metal metabolism disorder
Human disease C05.651.701
C10.668.491.650
C16.320.565.618.711
C18.452.648.618.711
periodontal disease disease tooth disease
jaw disease
Human disease C07.465.714
periodontitis disease periodontal disease Human disease C07.465.714.533 Periodontitis
 
periostitis disease connective tissue disease
inflammatory disease
bone disease
human disease C01.539.160.595
C05.116.165.595
peripheral artery disease disease artery disease artery disease characterized by build up of plaque in the arteries that carry blood to your head, organs, and limbs C14.907.137.126.307.500
C14.907.617.671
Peripheral vascular diseases
 
peritoneal carcinoma disease gastrointestinal system cancer
peritoneal neoplasm
carcinoma that is located in the inside of the abdomen C04.588.033.513
C04.588.274.780
C06.301.780
C06.844.620
peritonitis disease gastrointestinal system disease
intraabdominal infection
inflammatory disease
inflammation of the peritoneum, the lining of the inner wall of the abdomen C01.539.463.600
C06.844.640
Peritonitis
Peritonsillar abscess disease Human disease C01.539.830.025.675
C07.550.781.750.500
C08.730.561.750.500
C09.775.649.750.500
Peritonsillar abscess
 
periventricular leukomalacia disease encephalomalacia Human disease C10.228.140.300.700
C10.228.140.461.550
C14.907.253.612
C16.614.521.450
pernicious anemia disease deficiency anemia
nutritional deficiency disease
vitamin B12 deficiency anemia
Human disease C15.378.071.252.196.500
C18.654.521.500.133.699.923.280
pertussis disease commensal bacterial infectious disease human disease caused by the bacteria Bordetella pertussis C01.252.400.143
C01.252.400.143.740
C01.539.739.969
C08.730.969
Pertussis
 
petechia disease C15.378.100.802
C23.550.414.950
C23.888.885.687
Petechiae
petrositis disease osteomyelitis osteomyelitis that has material basis in infection located in petrous part of temporal bone C01.539.160.495.750
C05.116.165.495.500
C09.218.705.663.841
Peutz-Jeghers syndrome disease intestinal disease Human disease C04.700.705
C06.405.469.578.750
C16.320.700.705
C17.800.621.430.530.550.625
Peutz–Jeghers syndrome
 
Peyronie's disease disease penile disease
fibromatosis
Human disease C12.294.494.508
C17.300.715
Peyronie's disease
File:Peyronie disease.jpg
Pfeiffer syndrome disease acrocephalosyndactylia acrocephalosyndactylia that has material basis in mutations in the FGFR1 and FGFR2 gene which results in premature fusion located in skull C05.116.099.370.894.232.015
C05.116.099.370.894.819.100
C05.660.207.240.100
C05.660.585.800.100
C05.660.906.364.100
C05.660.906.819.100
C16.131.621.207.240.100
C16.131.621.585.800.100
C16.131.621.906.364.100
C16.131.621.906.819.100
Pfeiffer syndrome
phaeochromocytoma disease neuroendocrine tumor
cell type benign neoplasm
type of neuroendocrine tumor C04.557.465.625.650.700.725
C04.557.580.625.650.700.725
Pheochromocytoma
 
phakomatosis disease Multisystem disorders that involve the ectodermal structures like central nervous system, skin and eyes. C10.562
C16.131.077.350.712
C16.131.831.350.712
C16.320.850.250.712
C17.800.804.350.712
C17.800.827.250.712
Phakomatoses
phenylketonuria disease amino acid metabolic disorder
enzymopathy
hyperphenylalaninemia
amino acid metabolic disorder that is characterized by a mutation in the gene for the hepatic enzyme phenylalanine hydroxylase (PAH), rendering it nonfunctional C10.228.140.163.100.687
C16.320.565.100.766
C16.320.565.189.687
C18.452.132.100.687
C18.452.648.100.766
C18.452.648.189.687
C10.228.140.163.100.687.500
C13.703.575
C16.320.565.100.766.500
C16.320.565.189.687.500
C18.452.132.100.687.500
C18.452.648.100.766.500
C18.452.648.189.687.500
 
phimosis disease penile disease A condition in which there is constriction in the tip of the foreskin resulting in inability to fully retract the foreskin over the glans penis. Causes include balanoposthitis, balanitis xerotica obliterans, and untreated diabetes. C12.294.494.684 Phimosis
 
phlebitis disease vein disorder
venous thromboembolism
vein disease that is characterized by inflammation of a vein C14.907.617.718
C14.907.940.740
Phlebotomus fever disease
infectious disease
viral infectious disease Human disease C02.081.700
C02.782.147.700
phosphofructokinase deficiency disease glycogen storage disease
muscular glycogenosis
hemolytic anemia due to a disorder of glycolytic enzymes
disorder of glycolysis
Human disease C05.651.534.500.149
C10.668.491.175.500.112
C16.320.565.202.449.600
C16.320.577.149
C18.452.648.202.449.600
Phosphofructokinase deficiency
photosensitivity disease disease dermatitis
Photodermatosis
Human disease C17.800.600
pica disease disease eating disorder eating disorder that is characterized by an appetite for non-nutritive substances or food ingredients C23.888.821.825
 
piebaldism disease autosomal dominant disease
pigmentation disorder with eye involvement, excluding albinism
eyebrow/eyelashes pigmentation anomaly
rare genetic developmental defect during embryogenesis
hypopigmentation of the skin
Human disease C16.320.290.040.600
C16.320.565.100.102.600
C16.320.850.080.600
C17.800.621.440.102.600
C17.800.827.080.600
C18.452.648.100.102.600
Piebaldism
Pierre Robin syndrome disease sequence
first arch syndrome
C05.500.460.606
C05.660.207.540.460.606
C07.320.440.606
C07.650.500.460.606
C16.131.621.207.540.460.606
C16.131.850.500.460.606
pigeon toe disease foot deformity a condition which causes the toes to point inward when walking C05.330.711 Pigeon-toed
pilomatrixoma disease hair follicle neoplasm
rare genetic epidermal disorder
rare skin tumor or hamartoma
Human disease C04.557.470.565.625 Pilomatricoma
pilonidal cyst disease genetic disease hair-containing cyst or sinus, occurring chiefly in the coccygeal region C04.182.710 Sinus pilonidalis
 
Pinealoblastoma disease Pinealoma pineal gland neoplasm located in the brain C04.557.465.625.600.657
C04.557.470.670.657
C04.557.580.625.600.657
C04.588.614.250.195.766
C10.228.140.211.788
C10.551.240.250.625
Pinealoma disease endocrine gland cancer
thalamic disease
brain cancer
endocrine gland located in the pineal gland located in the brain C04.557.465.625.600.657
C04.557.470.670.657
C04.557.580.625.600.657
C04.588.614.250.195.766
C10.228.140.211.788
C10.551.240.250.625
pinguecula disease conjunctival degeneration Human disease C11.187.631 Pinguecula
pinta disease disease treponematosis
primary bacterial infectious disease
Human disease C01.252.400.840.558
C01.252.825.630
C01.252.847.840.558
C01.539.800.720.630
C17.800.838.765.630
Pinta (disease)
pituitary adenoma disease endocrine organ benign neoplasm
pituitary gland disease
adenoma
Human disease C04.588.322.609
C04.588.614.250.195.885.500.600
C10.228.140.211.885.500.600
C10.228.140.617.477.600
C10.228.140.617.738.675
C10.551.240.250.700.500.500
C19.344.609
C19.700.734
Pituitary adenoma
 
pituitary apoplexy disease pituitary infarct
acquired pituitary hormone deficiency
Human disease C10.228.140.300.535.625
C10.228.140.617.738.350
C14.907.253.573.600
C19.700.725
pityriasis rosea disease psoriasis Human disease C17.800.859.600.675 Pityriasis rosea
 
pityriasis rubra pilaris disease psoriasis
Erythrokeratodermia
Human disease C17.800.859.600.685
pityriasis versicolor disease
infectious disease
superficial mycosis
Skin infection
condition characterized by a rash on the trunk and proximal extremities C01.539.800.200.860
C01.703.295.936
C17.800.838.208.941
Tinea versicolor
 
placenta accreta disease placenta disease placenta disease that is characterized by an abnormally deep attachment of the placenta, through the endometrium and into the myometrium C13.703.420.643
C13.703.590.609
Placenta accreta
placenta praevia disease placenta disease placenta disease that is characterized by placenta attachment to the uterine wall close to or covering the cervix C13.703.420.714
C13.703.590.734
Placenta previa
placental abruption disease placenta disease placenta disease that is characterized by separation of the placental lining from the uterus of the mother C13.703.039.339
C13.703.420.078
C13.703.590.132
Placental abruption
placental insufficiency disease placenta disease
complication of pregnancy, childbirth and the puerperium
placenta disease that is characterized by insufficient blood flow to the placenta during pregnancy C13.703.590.800
plague disease primary bacterial infectious disease
yersiniosis
Dangerous human disease C01.252.400.310.980.745 Plague
 
plantar fascial fibromatosis disease connective tissue disease
foot disease
fibromatosis
non-malignant thickening of the feet's deep connective tissue C04.557.450.565.590.340.705
C05.360.375
C05.651.197.369
C17.300.349
C17.800.321.063
Plantar fibromatosis
pleural empyema disease pleural disease
empyema
pleural effusion
lung disease
empyema (an accumulation of pus) in the pleural cavity that can develop when bacteria invade the pleural space, usually in the context of a pneumonia C01.539.739.484
C01.539.830.305.310
C08.528.240
C08.730.265
Pleural empyema
 
pneumoconiosis disease occupational disease
interstitial lung disease
interstitial lung disease that is caused by the inhalation of dust C08.381.483.581
C08.381.520.702
C24.800
Pneumoconiosis
pneumoperitoneum disease C06.844.670 Pneumoperitoneum
pneumothorax disease pleural disease an abnormal collection of air in the pleural space that causes an uncoupling of the lung from the chest wall C08.528.778 Pneumothorax
 
Poland syndrome disease
developmental defect during embryogenesis
birth defect
syndromic breast hypoplasia/aplasia
rare genetic gynecological and obstetrical diseases
syndrome with brachydactyly
Human disease C05.116.099.370.894.819.756
C05.660.585.800.756
C05.660.906.819.756
C16.131.621.585.800.756
C16.131.621.906.819.756
Poland syndrome
polyarteritis nodosa disease
Designated intractable/rare diseases
vasculitis Human disease C14.907.940.090.720
C14.907.940.897.500
C17.800.862.625
polycystic ovary syndrome disease syndrome
endocrine system disease
genetic disease
syndrome characterized by hyperandrogenism, polycystic ovaries, hirsutism, oligomenorrhea or amenorrhea, anovulation and excessive body weight C04.182.612.765
C13.351.500.056.630.580.765
C19.391.630.580.765
Polycystic ovary syndrome
 
polycythemia disease bone marrow disease
immune system disease
rare bone disease
Human disease C15.378.738 Polycythemias
polycythemia vera disease polycythemia Human disease C04.588.448.200.500
C15.378.190.250.500
C15.378.190.636.753
C15.378.400.200.500
Polycythemia vera
 
polydactyly disease
developmental defect during embryogenesis
birth defect
congenital limb deformities
non-syndromic polydactyly, syndactyly and/or hyperphalangy
Physical anomaly C05.660.585.600
C16.131.621.585.600
Polydactyly
 
polyhydramnios disease placenta disease placenta disease that is characterized by an excess of amniotic fluid in the amniotic sac C13.703.610 Polyhydramnios
polymyalgia rheumatica disease myopathy
collagen disease
rare rheumatologic disease
immune system disease
human disease C05.651.742
C05.799.720
C17.300.775.720
polyneuropathy disease peripheral nervous system disease peripheral system disease that is characterized by is damage affecting peripheral nerves (peripheral neuropathy) in roughly the same areas on both sides of the body, featuring weakness, numbness, pins-and-needles, and burning pain C10.668.829.800
pompholyx disease sweat gland disease Human disease C17.800.174.620.300
C17.800.815.620.300
C17.800.865.385
Dyshidrosis
 
porencephaly disease brain disease
Central nervous system cyst
Malformations of Cortical Development, Group III
congenital disorder of nervous system characterized by cysts or cavities within the cerebral hemisphere. C05.660.207.620.500
C10.500.507.500.625
C16.131.621.207.620.500
C16.131.666.507.500.625
Porencephaly
porphyria disease
Designated intractable/rare diseases
inherited metabolic disorder
inborn disorder of porphyrin and haem metabolism
genetic photodermatosis
metabolic disease with skin involvement
Photodermatosis
nephropathy secondary to a storage or other metabolic disease
An inherited metabolic disorder that involves certain enzymes in the heme bio-synthetic pathway resulting in the overproduction and accumulation of porphyrins. C18.452.811 Porphyrias
porphyria cutanea tarda disease acute porphyria
porphyria
acute porphyria characterized by painful, blistering skin lesions that develop on sun-exposed skin C06.552.830.250
C16.320.850.742.250
C17.800.827.742.250
C18.452.811.400.250
portal hypertension disease hepatic vascular disease hypertension in the hepatic portal system, which are the portal vein and its branches, which drain from most of the intestines to the liver C06.552.494 Portal hypertension
 
Post-polio syndrome disease
infectious disease
poliomyelitis Human disease C02.782.687.359.764.650
C05.651.534.750
C10.228.228.618.750.750
C10.228.854.525.850.750
C10.574.827
C10.668.491.175.750
C10.668.864.500
post-thrombotic syndrome disease venous insufficiency venous insufficiency that is characterized by aching pain, heaviness, swelling, cramps, itching, or tingling in the affected limb and is a chronic complication of deep venous thrombosis C14.907.617.718.760
C14.907.952.760
C14.907.355.830.925.462
C14.907.952.880
postcholecystectomy syndrome disease biliary tract disease
bladder disease
Human disease C06.130.825
C23.550.767.775
postoperative nausea and vomiting disease adverse reactions to anesthesia
nausea
C23.550.767.859
C23.888.821.712.700
C23.888.821.937.059
postpartum depression disease endogenous depression
puerperal disorder
mental disorder complicating pregnancy, childbirth, or the puerperium
endogenous depression that involves intense, sustained and sometimes disabling depression experienced by women after giving birth C13.703.844.253
Postural orthostatic tachycardia syndrome disease autonomic nervous system disease
orthostatic intolerance
heart conduction disease
symptoms: difficulty with digestion, migraines, stroke like symptoms, difficulty breathing, chest pain, eye throbbing C10.177.575.600.625
Prader-Willi syndrome disease chromosomal disease
syndrome
Genetic disorder C10.597.606.643.690
C16.131.077.730
C16.131.260.700
C16.320.180.700
C18.654.726.500.740
Prader-Willi syndrome
pre-malignant neoplasm disease disease of cellular proliferation
Q17321238
cellular proliferation that results in abnormal growths in the body, which do not invade or destroy the surrounding tissue, but in time will transform into a cancer C04.834
Precocious puberty disease disorder of puberty Human disease C19.391.693
premature contraction disease heart arrhythmia
Ectopic beat
C14.280.067.325
C23.550.073.325
premature ejaculation disease psychosexual disorder
ejaculatory dysfunction
Human disease C12.294.644.743
premature ovarian failure disease ovarian disease
Poor ovarian reserve
ovarian disease where ovaries do not produce estrogen despite high levels of circulating gonadotropins in women under 40 C13.351.500.056.630.750
C19.391.630.750
premenstrual tension disease female reproductive system disease symptoms that occur before a woman's period C23.550.568.968 Premenstrual syndrome
presbyopia disease eye accommodation disease
refractive error
medical condition associated with aging of the eye C11.744.786 Presbyopia
preterm birth disease obstetric labor complication
parturition
birth at less than a specified gestational age C13.703.420.491.500 Incubators (neonatal)
 
priapism disease arterial occlusive disease
penile disease
peripheral vascular disease characterized by blood trapped in the penis that is unable to drain. C12.294.494.786
primary biliary cirrhosis disease autoimmune disease of urogenital tract
liver cirrhosis
liver cirrhosis characterized by chronic and slow progressive destruction of intrahepatic bile ducts C06.130.120.135.250.250
C06.552.150.250
C06.552.630.400
Primary biliary cirrhosis
primary ciliary dyskinesia disease ciliopathy ciliopathy that is characterized by impaired function of the cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear) and fallopian tube C08.200
C09.150
C16.131.077.245.500
C16.320.184.500
Primary ciliary dyskinesia
Primary polydipsia disease polydipsia
eating disorder
Dry mouth and excessive fluid consumption in the absence of physiological stimuli to drink C23.550.759.500
C23.888.663.500
Prinzmetal's angina disease angina pectoris
coronary disease
coronary artery vasospasm
cardiac chest pain at rest that occurs in cycles C10.597.617.192.500.150.150
C14.280.647.187.150.150
C14.907.585.187.150.500
C23.888.592.612.233.500.150.150
proctitis disease rectal disease
inflammatory disease
Human disease C06.405.205.865
C06.405.469.860.622
Prodrome disease part of disease C23.888.672
progeria disease
developmental defect during embryogenesis
autosomal recessive disease
progeroid syndrome
disease
malformation syndrome with skin/mucosae involvement
primary osteolysis
Human disease C16.320.565.753
C18.452.648.753
Progeria
progressive multifocal leukoencephalopathy disease
Designated intractable/rare diseases
infectious disease
viral infectious disease
Polyomavirus infectious disease
infectious encephalitis
viral disease affecting human brains C02.182.525.500
C02.256.721.500
C02.290.575
C02.839.550
C10.228.140.430.520.750.500
C10.228.140.695.750
C10.228.228.245.340.500
C10.228.228.399.750.500
C10.314.450
Progressive multifocal leukoencephalopathy
 
progressive supranuclear palsy disease
Designated intractable/rare diseases
movement disorder
frontotemporal degeneration with dementia
genetic neurodegenerative disease with dementia
eye degenerative disease
Progressive supranuclear palsy (PSP) is a rare late-onset neurodegenerative disease characterized by supranuclear gaze palsy, postural instability, progressive rigidity, and mild dementia C10.228.140.079.882
C10.228.662.700
C10.292.562.750.500
C10.574.945.500
C10.597.622.447.690
C11.590.472.500
C23.888.592.636.447.690
Progressive supranuclear palsy
 
prolactinoma disease
head and neck disease
functioning pituitary adenoma
genetic nervous system disorder
rare male infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin
rare female infertility due to hypothalamic-pituitary-gonadal axis disorder of genetic origin
prolactin producing pituitary tumor
rare genetic endocrine disease
inherited gynecological tumor
rare genetic bone disease
Human disease C04.557.470.035.625
C04.588.322.609.792
C10.228.140.617.738.675.800
C19.344.609.792
C19.700.734.792
prolapse of female genital organ disease female reproductive system disease portion of the vaginal canal protruding from the opening of the vagina C23.300.842.624 Female genital prolapse
 
prolymphocytic leukemia disease lymphoid leukemia
chronic lymphocytic leukemia
chronic leukemia
Human disease C04.557.337.428.565
C15.604.515.560.550
C20.683.515.528.565
prosopagnosia disease cognitive disorder
associative agnosia
agnosia
cognitive disorder which impairs the ability to recognise faces C10.597.606.762.100.650
C23.888.592.604.764.100.650
prostate cancer disease male reproductive organ cancer
prostate disease
male reproductive cancer C04.588.945.440.770
C12.294.260.750
C12.294.565.625
C12.758.409.750
Prostatic adenocarcinoma
 
prostatitis disease prostate disease
inflammatory disease
Human disease C12.294.565.750 Prostatitis
 
protein C deficiency disease inherited blood coagulation disease Human disease C15.378.100.100.690
C15.378.147.880
C15.378.925.795
C16.320.099.690
protein-losing enteropathy disease intestinal disease
genetic disease
Human disease C06.405.469.818
proteinuria disease kidney disease
urinalysis
presence of an excess of serum proteins in the urine C12.777.934.734
C13.351.968.934.734
C23.888.942.750
Proteus syndrome disease
head and neck disease
developmental defect during embryogenesis
birth defect
multiple hamartoma syndrome
head and neck cancer
brain cancer
rare genetic vascular tumor
complex vascular malformation with associated anomalies
rare nervous system tumor
syndrome or malformation associated with head and neck malformations
neurocutaneous syndrome with epilepsy
rare genetic skin vascular disorder
rare genetic bone disease
skull cancer
overgrowth syndrome
A human disease characterized by an overgrowth of skin, bones, muscles, fatty tissues, and blood and lymphatic vessels. C04.445.435.500
C04.651.435.500
C05.116.099.750
C05.660.585.620
C16.131.077.740
C16.131.621.585.620
Prune belly syndrome disease
developmental defect during embryogenesis
urinary system disease
syndrome
fetal lower urinary tract obstruction
syndromic renal or urinary tract malformation
syndromic urogenital tract malformation
congenital disorder of urinary system C16.131.077.745 Prune belly syndrome
 
Pseudarthrosis disease C26.404.468.627 Pseudarthrosis
 
pseudobulbar palsy disease brain disease
motor neuron disease
Human disease C10.597.622.714
C23.888.592.636.711
pseudohermaphroditism disease sex differentiation disease Human disease C12.706.316
C13.351.875.253
C16.131.939.316
C19.391.119
Pseudohermaphroditism
pseudohypoaldosteronism disease renal tubular transport disease Human disease C12.777.419.815.770
C13.351.968.419.815.770
C16.320.565.861.770
C18.452.648.861.770
pseudohypoparathyroidism disease
Designated intractable/rare diseases
metal metabolism disorder human disease C05.116.198.709
C16.320.565.618.815
C18.452.104.709
C18.452.174.766
C18.452.648.618.815
Pseudohypoparathyroidism
pseudolymphoma disease benign neoplasm
lymphoma and pseudolymphoma
a benign nepolasm that resembles a malignant lymphoma C15.604.613
pseudomyxoma peritonei disease
colonic disease
appendix cancer
peritoneal neoplasm
primary peritoneal tumor
mucinous adenocarcinoma of the appendix
appendix cancer that is characterized by progressive accumulation of mucus-secreting tumor cells within the abdomen and pelvis C04.557.470.590.782
pseudopseudohypoparathyroidism disease
developmental defect during embryogenesis
pseudohypoparathyroidism
pseudohypoparathyroidism with Albright hereditary osteodystrophy
human disease C05.116.198.709.628
C16.320.565.618.815.815
C18.452.104.709.628
C18.452.174.766.815
C18.452.648.618.815.815
pseudotumor cerebri disease intracranial hypertension
cerebrovascular disease
Human disease C10.228.140.631.750
pseudoxanthoma elasticum disease
Designated intractable/rare diseases
developmental defect during embryogenesis
autosomal recessive disease
connective tissue disease
genetic central nervous system and retinal vascular disease
rare central nervous system and retinal vascular disease
dermis elastic tissue disorder
familial restrictive cardiomyopathy
connective tissue disease with eye involvement
malformation syndrome with skin/mucosae involvement
rare developmental defect with connective tissue involvement
pseudoxanthoma elasticum (inherited or acquired)
genetic hypertension
Human disease C14.907.454.530
C15.378.463.515.530
C16.131.831.766
C16.320.850.750
C17.300.766
C17.800.804.766
C17.800.827.750
psoriasis disease skin disease Human disease C17.800.859.675 Psoriasis
 
psoriatic arthritis disease arthritis
syndrome
syndrome that occurs in humans with psoriasis who also experience symptoms similar to arthritis C05.116.900.853.625.800.424
C05.550.114.145
C05.550.114.865.800.424
C17.800.859.675.175
Psoriatic arthritis
pterygium disease
head and neck disease
pinguecula
corneal disease
conjunctival disease
benign conjunctival neoplasm
benign neoplasm of cornea
Human disease C11.187.781 Pterygium (conjunctiva)
ptosis disease eye disease
eyelid disease
eye disease characterized by the drooping or falling of the upper or lower eyelid C11.338.204 Ptosis (eyelid)
 
Pudendal nerve entrapment disease neuropathic pain
nerve compression syndrome
acquired peripheral neuropathy
neuralgia
Pudendal neuralgia (PN) is a chronic neuropathic pain, aggravated by sitting and for which no organic cause can be found by imaging studies. It is often associated with pelvic dysfunction. C10.597.617.682.737
C10.668.829.550.650
C10.668.829.600.737
C23.888.592.612.664.737
pulmonary alveolar proteinosis disease lung disease
alveolar lung disease
lung disease that is characterized by abnormal accumulation of surfactant occurs within the alveoli, interfering with gas exchange C08.381.719 Pulmonary alveolar proteinosis
 
pulmonary edema disease respiratory failure fluid accumulation in the air spaces and parenchyma of the lungs C08.381.742 Pulmonary edema
pulmonary embolism disease artery disease blockage of the main artery of the lung or one of its branches by a substance that has travelled from elsewhere in the body C08.381.746
C14.907.355.350.700
Pulmonary embolism
 
pulmonary emphysema disease respiratory system disease
chronic obstructive pulmonary disease
Human disease C08.381.495.389.750 Pulmonary emphysema
 
pulmonary hypertension disease hypertension hypertension characterized by an increase of blood pressure in the pulmonary artery, pulmonary vein or pulmonary capillaries C08.381.423 Pulmonary hypertension
 
pulmonary valve stenosis disease pulmonary valve disease
congenital heart disease
Human disease C14.280.484.716
C14.280.955.750
Pulmonary valve stenosis
pulpitis disease
infectious disease
dental pulp disease Human disease C07.793.237.820
pure red-cell aplasia disease aplastic anemia
erythroblastopenia
Human disease C15.378.071.750
purpura disease hemorrhagic disease Human disease C15.378.100.802
C23.550.414.950
C23.888.885.687
Purpura (dermatology)
pycnodysostosis disease
developmental defect during embryogenesis
osteochondrodysplasia
developmental anomaly of metabolic origin
osteochondrodysplasia that has material basis in a mutation in the CTSK gene which results in dwarfism, brittle bones, osteopetrosis, shortening of the distal phalanges C05.116.099.708.779
C16.320.565.595.800
C16.320.812
C18.452.648.595.800
pyelonephritis disease
infectious disease
pyelitis
urinary tract infection
Human disease C12.777.419.570.643.790
C12.777.419.570.821.717
C13.351.968.419.570.643.790
C13.351.968.419.570.821.717
Pyelonephritis
 
pyloric stenosis disease gastric outlet obstruction congenital disorder of digestive system C06.405.748.340.690 Pyloric stenosis
pyoderma disease dermatitis Pyoderma is a skin infectious disease where the infection is pyogenic causing the formation of pus C17.800.695
pyoderma gangrenosum disease pyoderma
Reactive neutrophilic dermatoses
pyogenic autoinflammatory syndrome
rare skin disease
autoinflammatory syndrome with skin involvement
Human disease C17.800.695.675
C17.800.862.675
C17.800.893.675
Pyoderma gangrenosum
 
pyometritis disease metritis
uterine disease
Human disease C13.351.500.852.544
pyomyositis disease
infectious disease
myositis
bacterial infectious disease
Human disease C01.539.830.767
C05.651.594.909
C10.668.491.562.787
 
pyuria disease urinary system disease Human disease C01.539.895.719
C12.777.892.719
C13.351.968.892.719
Pyuria
 
Q fever disease primary bacterial infectious disease disease caused by infection with Coxiella burnetii, a bacterium that affects humans and other animals; the most common manifestation is flu-like symptoms; the name Q stands for “query”, so named when the pathogen was unknown C01.252.400.755 Q fever
 
radial neuropathy disease mononeuropathy
brachial plexus neuropathy
Human disease C10.668.829.500.650
radiation burn disease burn
dermatitis
damage to the skin or other biological tissue caused by exposure to radiation C17.800.174.826
C26.733.804
Radiation burns
radiculopathy disease polyradiculopathy
nerve root and plexus disorder
Human disease C10.668.829.820
Raynaud disease disease arterial occlusive disease Human disease C14.907.617.812
reactive arthritis disease
arthropathy
arthritis
rare rheumatologic disease
rare bone disease
arthritis that is an autoimmune disease which develops due to an infection located elsewhere in the body C01.539.100.500
C05.116.900.853.625.800.637
C05.550.114.099.500
C05.550.114.865.800.637
Reactive arthritis
receptive aphasia disease acute aphasia C10.597.606.150.500.800.100.166
C23.888.592.604.150.500.800.100.166
 
red color blindness disease dichromacy
color blindness
red–green color blindness
Human disease C10.597.751.941.256
C11.966.256
C23.888.592.763.941.256
refractive error disease eye disease
visual impairment
vision disorder
rare genetic eye disease
cause of vision problems C11.744
relapsing fever borreliosis disease
infectious disease
primary bacterial infectious disease
borreliosis
bacterial infectious disease
primary bacterial infectious disease that results in infection, has material basis in Borrelia, which is transmitted by tick or transmitted by body louse C01.252.400.155.644
C01.252.400.825.750
C01.252.847.193.644
Relapsing fever
relapsing polychondritis disease
Designated intractable/rare diseases
arthropathy
chondromalacia
immune system disease
Autoimmune connective tissue disorder
secondary glomerular disease
Human disease C05.182.531
C17.300.182.531
 
REM sleep behavior disorder disease sleep disorder sleep disorder that involves abnormal behavior including the acting out of violent or dramatic dreams during the sleep phase with rapid eye movement C10.886.659.633.700
renal artery obstruction disease renal artery disease narrowing of one of the renal arteries, most often caused by atherosclerosis or fibromuscular dysplasia C12.777.419.775
C13.351.968.419.775
C14.907.137.727
Renal artery stenosis
 
renal cell carcinoma disease renal carcinoma renal carcinoma that has material basis in the lining of the proximal convoluted renal tubule of the kidney C04.557.470.200.025.390
C04.588.945.947.535.160
C12.758.820.750.160
C12.777.419.473.160
C13.351.937.820.535.160
C13.351.968.419.473.160
Renal cell carcinomas
 
renal glycosuria disease renal tubular transport disease
glucose transport disorder
nephropathy secondary to a storage or other metabolic disease
Human disease C12.777.419.815.532
C12.777.934.363.450
C13.351.968.419.815.532
C13.351.968.934.363.450
C16.320.565.861.532
C18.452.394.937.450
C18.452.648.861.532
renal osteodystrophy disease impaired renal function disease
chronic kidney disease-mineral and bone disorder
Human disease C05.116.198.816.750
C12.777.419.795
C13.351.968.419.795
C18.452.104.816.750
C18.452.174.845.750
C18.654.521.500.133.770.734.750
C19.642.355.480.500
renal tubular acidosis disease renal tubular transport disease renal tubular transport disease characterized by excess levels of acid in the blood, due to a failure of the kidneys to appropriately acidify the urine C12.777.419.815.093
C13.351.968.419.815.093
C16.320.565.861.093
C18.452.076.176.210
C18.452.648.861.093
respiratory failure disease lung disease inadequate gas exchange by the respiratory system C08.618.846
restless legs syndrome disease central nervous system disease central nervous system disease characterized by throbbing, pulling creeping or other unpleasant sensations in the legs and the irresistible urge to move them C10.803
C10.886.425.800.700
C10.886.659.634
Restless leg syndrome
 
restrictive cardiomyopathy disease
Designated intractable/rare diseases
intrinsic cardiomyopathy form of cardiomyopathy in which the walls are rigid,and the heart is restricted from stretching and filling with blood properly C14.280.238.160
retinal detachment disease retinal disease
rare genetic eye disease
genetic disease
Human disease C11.768.648 Retinal detachment
 
retinal disease disease eye disease eye disease that is located in the retina C11.768 Retinopathy
retinitis disease retinal disease Human disease C11.768.773
retinitis pigmentosa disease
Designated intractable/rare diseases
retinal degeneration retinal degeneration characterized by the gradual deterioration of the photoreceptors or the retinal pigment epithelium of the retina leading to progressive sight loss C11.270.684
C11.768.585.658.500
C16.320.290.684
Retinitis pigmentosa
 
retinoblastoma disease retinal cell cancer retinal cell cancer and malignant neoplasm of retina and neuroblastoma and neuroendocrine tumors that derives from the tissues of the retina C04.557.465.625.600.725
C04.557.470.670.725
C04.557.580.625.600.725
C04.588.364.818.760
C11.319.475.760
C11.768.717.760
Retinoblastoma
 
retinopathy of prematurity disease retinal disease
premature infant disease
Human disease C11.768.836
C16.614.521.731
Retinopathy of prematurity
retinoschisis disease retinal degeneration
retinoschisis and retinal cysts
Human disease C11.768.585.865
retrognathism disease
Wikimedia disambiguation page
malocclusion C05.500.460.827
C05.660.207.540.460.827
C07.320.440.827
C07.320.610.827
C07.650.500.460.827
C16.131.621.207.540.460.827
C16.131.850.500.460.827
Retrognathism
retrograde amnesia disease amnesia loss of memory of events that in occurred before the onset of amnesiac condition C10.597.606.525.100.150
C23.888.592.604.529.100.150
Retroverted uterus disease C13.351.500.852.952
C23.300.970.750
Rett syndrome disease
Designated intractable/rare diseases
pervasive developmental disorder
neurological disorder
Human disease C10.597.606.643.455.937
C16.320.322.500.937
C16.320.400.525.937
 
Reye syndrome disease syndrome
brain disease
systemic disease
A syndrome characterized by acute brain damage and liver function problems. It has been associated with aspirin consumption by children with viral illness, although it also occurs in the absence of aspirin use. C06.552.241.649
C10.228.140.163.780
C18.452.132.780
Reye's syndrome
 
rhabdomyosarcoma disease skeletal muscle cancer skeletal muscle cancer that arise from skeletal muscle progenitors C04.557.450.590.550.660
C04.557.450.795.550.660
Rhabdomyosarcoma
rheumatic fever disease bacterial infectious disease inflammatory disease that can involve the heart, joints, skin, and brain C01.252.410.890.731
C05.550.114.843
C05.799.825
Rheumatic fever
 
rheumatoid arthritis disease arthritis
autoimmune disease
chronic condition
collagen disease
Felty's syndrome
An arthritis that is an autoimmune disease which attacks healthy cells and tissue located in joint. C05.550.114.154
C05.799.114
C17.300.775.099
C20.111.199
Rheumatoid arthritis
 
Rheumatoid nodule disease
arthropathy
rheumatoid arthritis
polyarticular arthritis
a particular variant of polyarthritis associated with early manifestations of palindromic rheumatism, radiologic subchondral bone cysts, and subcutaneous rheumatoid nodules C05.550.114.154.683
C05.799.114.683
C17.300.775.099.683
Rheumatoid nodule
rhinitis disease
infectious disease
nasal cavity disease
tracheitis
bacterial infectious disease
infectious disease of the nervous system
rare respiratory disease
irritation and inflammation of the mucous membrane inside the nose C08.460.799
C08.730.674
C09.603.799
rickets disease bone remodeling disease human disease C05.116.198.816
C18.452.104.816
C18.452.174.845
C18.654.521.500.133.770.734
Rickets
 
rickettsialpox disease spotted fever Human disease C01.252.400.780
Rift Valley fever disease
infectious disease
viral infectious disease Human disease C02.081.810
C02.407.810
C02.782.147.810
C02.782.417.762
C06.552.380.315.430.812
C22.467.435.812
Rift Valley fever virus
 
ring chromosome disease
developmental defect during embryogenesis
chromosome abnormality
autosomal monosomy
chromosome whose arms fused into a ring C23.550.210.760
Ritter's disease disease commensal bacterial infectious disease
staphylococcal infection
skin disease
Human disease C01.252.410.868.820.770
C01.252.825.770.770
C01.539.800.720.770.770
C17.800.838.765.770.770
Staphylococcal scalded skin syndrome
 
Rocky Mountain spotted fever disease
infectious disease
spotted fever Human disease C01.252.400.780.790.700
C01.252.400.825.775
Rocky Mountain spotted fever
rosacea disease skin disease long-term human skin disease C17.800.716 Rosacea (disease)
 
Rothmund-Thomson syndrome disease
developmental defect during embryogenesis
DNA repair-deficiency disorder
skin disease
Photodermatosis
hereditary cancers
rare genetic developmental defect during embryogenesis
hereditary poikiloderma
ectodermal malformation syndrome associated with ocular features
dentocutaneous disease with cataract
progeroid syndrome
genetic photodermatosis
human disease C16.131.831.775
C16.320.850.765
C16.614.760
C17.800.804.775
C17.800.827.775
C18.452.284.760
Rothmund–Thomson syndrome
 
rubella disease
infectious disease
viral infectious disease
Rubella virus infectious disease
Human viral disease C02.782.930.700.700 Rubella
 
Rubinstein-Taybi syndrome disease
Designated intractable/rare diseases
autosomal dominant disease rare disease C05.116.099.370.797
C05.660.207.850
C10.597.606.643.700
C16.131.077.804
C16.131.260.790
C16.131.621.207.850
C16.320.180.790
Rubinstein-Taybi syndrome
 
sacroiliitis disease inflammation inflammation of pelvis C05.550.114.854 Sacroiliitis
salmonellosis disease
infectious disease
Salmonella infectious disease
primary bacterial infectious disease
bacterial infectious disease
infection caused by Salmonella bacteria C01.252.400.310.821.606
C25.723.415.738
Salmonellosis
 
salpingitis disease fallopian tube disease
inflammatory disease
infection and inflammation in the fallopian tubes C13.351.500.056.390.890
C13.351.500.056.750.875
Salpingitis
Salter–Harris fracture disease bone fracture C05.116.359.336.875
C26.289.336.875
C26.404.026.500
Salter–Harris fracture
Sandhoff disease disease GM2 gangliosidosis
eye degenerative disease
Sandhoff disease is a lysosomal storage disorder from the GM2 gangliosidosis family and is characterised by central nervous system degeneration C10.228.140.163.100.435.825.300.300.249
C16.320.565.189.435.825.300.300.249
C16.320.565.398.641.803.350.300.700
C16.320.565.595.554.825.300.300.800
C18.452.132.100.435.825.300.300.249
C18.452.584.687.803.350.300.700
C18.452.648.189.435.825.300.300.249
C18.452.648.398.641.803.350.300.700
C18.452.648.595.554.825.300.300.800
SAPHO syndrome disease syndrome
autoinflammatory syndrome with skin involvement
pyogenic autoinflammatory syndrome
Human disease C05.116.099.708.025
sarcoidosis disease
Designated intractable/rare diseases
type IV hypersensitivity hypersensitivity reaction type IV disease characterized by the growth of collections of inflammatory cells (granulomas) in multiple organs C15.604.515.827 Sarcoidosis
 
scabies disease
infectious disease
Acarodermatitis
acariasis
skin infection
Human disease C03.858.211.480.708
C17.800.838.775.800
Scabies
 
scarlet fever disease
infectious disease
upper respiratory tract disease
streptococcal infection
infectious disease C01.252.410.890.823 Scarlet fever
 
Scheuermann's disease disease osteochondrosis
kyphosis
spinal osteochondrosis
osteochondrosis of genetic origin
osteochondrosis that results in abnormal bone growth and curvature located in thoracic vertebral column C05.116.821.500.500
C05.116.900.800.500.500
C05.116.900.808.500
Scheuermann's disease
 
Schimmelpenning syndrome disease
head and neck disease
developmental defect during embryogenesis
syndrome
phakomatosis
epidermal nevus
benign conjunctival neoplasm
malformation syndrome with hamartosis
bulbar conjunctival dermoid or conjunctival dermolipoma
palpebral nevus
A neurocutaneous syndrome with anomalies of the central nervous system, ocular system, skeletal system, cardiovascular system, and genitourinary system. A triad of sebaceous nevi, seizures, and mental retardation. C04.557.665.560.700
C10.562.700
C16.131.077.633
schistosomiasis disease trematode infection
parasitic helminthiasis infectious disease
Human disease C03.335.865.859 Schistosoma
 
Schizencephaly disease
developmental defect during embryogenesis
Malformations of Cortical Development, Group III
Encephaloclastic disorder
cerebral malformation with epilepsy
a rare birth defect characterized by abnormal clefts lined with grey matter that form the ependyma of the cerebral ventricles to the pia mater. C10.500.507
C16.131.666.507
C10.500.507.500.750
C16.131.666.507.500.750
Schizencephaly
Schnitzler syndrome disease type IV hypersensitivity
autoimmune urticaria
unexplained periodic fever syndrome
Human disease C20.683.780.640.700
scleritis disease scleral disease Human disease C11.790.500 Scleritis
scleroderma disease rheumatic disease
collagen disease
rheumatic disease and collagen disease that involves the abnormal growth of connective tissue, which supports the skin and internal organs C17.300.787
C17.800.767
Systemic sclerosis
sclerosing hemangioma disease
fibrous histiocytoma
hemangioma Human disease C04.557.450.565.590.425.350 Benign fibrous histiocytoma
scoliosis disease bone structure disease
spinal disease
Spinal curvature
spinal medical condition C05.116.900.800.875 Scoliosis
 
scotoma disease Anopsia
eye disease
Human disease C10.597.751.941.811
C11.966.811
C23.888.592.763.941.811
Scotoma
scrub typhus disease
infectious disease
typhus Human disease C01.252.400.780.850
 
scurvy disease nutritional deficiency disease
ascorbic acid deficiency
deficiency
human disease C14.907.454.800
C15.378.463.515.800
C18.654.521.500.133.115.661
Scurvy
seborrheic infantile dermatitis disease seborrhoeic dermatitis Human disease C17.800.174.146
C17.800.738.353
Cradle cap
seborrheic keratosis disease keratosis Human disease C17.800.428.580 Seborrheic keratosis
 
seborrhoeic dermatitis disease dermatitis long-term skin disorder C17.800.174.580
C17.800.794.230
C17.800.815.580
C17.800.859.350
Seborrhoeic dermatitis
secondary hypertrophic osteoarthropathy disease arthropathy Human disease C05.116.758
C05.550.684
Hypertrophic osteoarthropathy
 
seminoma disease germ cell cancer germinoma that has material basis in cells that make sperm and eggs C04.557.465.330.800 Testicular seminoma
sensorineural hearing loss disease deafness
inner ear disease
Human disease C09.218.458.341.887.432
C09.218.807.186.432
C10.228.140.068.432
C10.597.751.418.341.887.432
C23.888.592.763.393.341.887.432
C09.218.458.341.812
C10.597.751.418.341.812
C23.888.592.763.393.341.812
C09.218.458.341.887
C10.597.751.418.341.887
C23.888.592.763.393.341.887
septic arthritis disease
arthropathy
arthritis arthritis that involves infection by a pathogen located in joint C01.539.100
C05.550.114.099
Septic arthritis
septic shock disease circulatory shock Septic shock is a serious medical condition that occurs when sepsis, which is organ injury or damage in response to infection, leads to dangerously low blood pressure C01.539.757.800
C23.550.470.790.500.800
C23.550.835.900.712
Sertoli cell-only syndrome disease male infertility Human disease C12.294.365.700.754
severe acute respiratory syndrome disease viral infectious disease viral respiratory disease C02.782.600.550.200.750
C08.730.730
SARS
 
severe combined immunodeficiency disease combined immunodeficiency combined T cell and B cell immunodeficiency that is caused by a defect in several genes encoding for B and T lymphocytes resulting in individuals with non-functional immune systems C16.614.815
C18.452.284.800
C20.673.815
sexual dysfunction disease sexual disorder
psychosexual disorder
Human disease C12.294.644
C13.351.500.665
Sexual disorders
Sezary's disease disease cutaneous T cell lymphoma
aggressive primary cutaneous T-cell lymphoma
Human disease C04.557.386.480.750.800.775
C15.604.515.569.480.750.800.775
C15.604.515.841
C20.683.515.761.480.750.800.775
C20.683.515.920
Sézary's disease
Sheehan's syndrome disease puerperal disorder
necrosis of pituitary
Simmonds' cachexia
hypopituitarism
human disease C10.228.140.617.738.300
C19.700.482
shigellosis disease
infectious disease
primary bacterial infectious disease
colonic disease
intestinal disease
bacterial infectious disease
Human disease C01.252.400.310.229
C06.405.205.331.479
C06.405.469.300.479
short bowel syndrome disease intestinal disease Human disease C06.405.469.637.832
C23.550.767.882
shoulder impingement syndrome disease
arthropathy
arthropathy Human disease C05.550.840
C26.803.500
Subacromial impingement
sialadenitis disease salivary gland disease
artery disease
lymphadenitis
Human disease C07.465.815.793
 
sialolithiasis disease salivary gland disease
calculus
Human disease C07.465.815.497.500
C23.300.175.700.500
C07.465.815.497
C23.300.175.700
C07.465.815.497.325
C23.300.175.700.325
Sialolithiasis
 
sick building syndrome disease extrinsic allergic alveolitis
rare allergic respiratory disease
Human disease C20.543.312.750
C21.223.750
sick sinus syndrome disease sinoatrial node disease
bradycardia
group of abnormal heart rhythms (arrhythmias) presumably caused by a malfunction of the sinus node, the heart's primary pacemaker C14.280.067.093.249
C14.280.067.558.536
C23.550.073.093.249
C23.550.073.425.440
sickle-cell disease disease hematopoietic system diseases
autosomal recessive disease
hemoglobinopathy
rare constitutional hemolytic anemia
type of hereditary blood disorder C15.378.071.141.150.150
C15.378.420.155
C16.320.070.150
C16.320.365.155
C15.378.071.141.150.150.440
C15.378.420.155.440
C16.320.070.150.440
C16.320.365.155.440
Sickle-cell anemia
 
Sida por cojer mucho disease kidney disease inflammation of the kidneys C12.777.419.570
C13.351.968.419.570
Nephritis
siderosis disease pneumoconiosis Human disease C08.381.483.581.750
C08.381.520.702.750
C24.800.773
signet ring cell adenocarcinoma disease adenocarcinoma adenocarcinoma that derives from epithelial cells originating in glandular tissue, which have signet ring appearance C04.557.470.200.025.415
C04.557.470.590.415
Signet ring cell carcinoma
silicosis disease pneumoconiosis pneumoconiosis that is an inflammation and scarring of the uper lobes of the lungs causing nodular lesions resulting from inhalation of silica, quartz or slate particles C08.381.483.581.760
C08.381.520.702.760
C24.800.834
Silicosis
Silver-Russell syndrome disease
developmental defect during embryogenesis
chromosomal disease
primordial dwarfism
rare genetic inherited tumor
multiple congenital anomalies/dysmorphic syndrome-variable intellectual disability syndrome
malformation syndrome with short stature
polymalformative genetic syndrome with increased risk of developing cancer
growth disorder C05.660.207.925
C16.131.077.855
C16.131.260.870
C16.320.180.870
C16.320.240.937
Silver–Russell syndrome
sinusitis disease paranasal sinus disease
inflammatory disease
Human disease C08.460.692.752
C08.730.749
C09.603.692.752
Sinusitis
 
situs inversus disease visceral heterotaxy
state of physical system
congenital condition in which the major visceral organs are reversed or mirrored from their normal positions (the normal arrangement of internal organs is known as situs solitus while situs inversus is generally the mirror image of situs solitus) C16.131.810 Situs inversus
 
Sjögren's syndrome disease autoimmune disease
autoimmune disease of exocrine system
hypersensitivity reaction type II disease that involves attack of immune cells which destroy the exocrine glands that produce tears and saliva C05.550.114.154.774
C05.799.114.774
C07.465.815.929.669
C11.496.260.719
C17.300.775.099.774
C20.111.199.774
Sjögren's syndrome
 
skin cancer disease integumentary system cancer
tumor of the skin
skin disease
class of skin illnesses, tumor or cancer of the skin C04.588.805
C17.800.882
Skin cancers
 
skin disease disease integumentary system disease
skin and connective tissue diseases
class of disorder that affects skin, hair or nails C16.320.850
C17.800.827
C17.800
Diseases and disorders of the skin
sleep apnea disease sleep disorder
apnea
sleep disorder characterized by repeated cessation and commencing of breathing that repeatedly disrupts sleep C08.618.085.852
C10.886.425.800.750
Sleep apnea
 
sleep paralysis disease phenomenon C10.886.659.633.800
sleeping sickness disease trypanosomiasis parasitic disease C03.752.300.900.719 African trypanosomiasis
 
sleepwalking disease parasomnia phenomenon of combined sleep and wakefulness C10.886.659.635.700 Sleepwalking
 
Sly syndrome disease
developmental defect during embryogenesis
mucopolysaccharidosis
lysosomal storage disease with skeletal involvement
mucopolysaccharidosis characterized by a deficiency of the lysosomal enzyme beta-glucuronidase resulting in the inability to degrade glucuronic acid-containing glycosaminoglycans C16.320.565.202.715.675
C16.320.565.595.600.675
C17.300.550.575.675
C18.452.648.202.715.675
C18.452.648.595.600.675
small cell carcinoma disease carcinoma type of carcinoma that commonly arises within lung and sometime other body sites C04.557.470.200.380 Small-cell carcinoma
Smith-Lemli-Opitz syndrome disease
developmental defect during embryogenesis
lipid metabolism disorder
syndrome
sterol biosynthesis disorder
syndromic renal or urinary tract malformation
dysostosis with limb and face anomalies as a major feature
syndrome with limb duplication, polydactyly, syndactyly, and/or hyperphalangy
craniofacial anomaly with cataract
metabolic disease with cataract
ptosis
syndromic epicanthus
46,XY disorder of sex development due to a cholesterol synthesis defect
malformation syndrome with short stature
multiple congenital anomalies/dysmorphic syndrome-intellectual disability
syndromic developmental defect of the eye
syndromic neurometabolic disease with non-X-linked intellectual disability
syndromic dyslipidemia
an inborn error of cholesterol synthesis. It is an autosomal recessive, multiple malformation syndrome caused by a mutation in the enzyme 7-Dehydrocholesterol reductase, or DHCR7. C16.131.077.860
C16.320.565.398.850
C16.320.565.925.875
C18.452.584.500.937
C18.452.648.398.850
C18.452.648.925.875
Sneddon syndrome disease artery disease
vascular skin disease
autoimmune disease of skin and connective tissue
Autoimmune connective tissue disorder
autoimmune disease of the nervous system
rare genetic skin vascular disorder
rare genetic immune disease
genetic nervous system disorder
rare central nervous system and retinal vascular disease
other acquired skin disease
genetic systemic or rheumatologic disease
Human disease C10.228.140.300.750
C14.907.253.774
C17.800.862.775
sodoku disease primary bacterial infectious disease Human disease C01.252.400.771
soft-tissue sarcoma disease soft tissue disorder human disease C04.557.450
somatostatinoma disease neuroendocrine tumor
pancreatic neuroendocrine tumor G1
Human disease C04.557.465.625.650.240.695
C04.557.470.200.025.370.695
C04.588.274.761.500.500
C04.588.322.475.500.500
C06.301.761.500.500
C06.689.667.500.500
C19.344.421.500.500
Sotos syndrome disease
developmental defect during embryogenesis
autosomal recessive disease
overgrowth syndrome
autosomal recessive disease that occurs rarely and is characterized by excessive physical growth during the first 2 to 3 years of life C16.131.077.889
C16.131.260.905
C16.320.180.905
space motion sickness disease
head and neck disease
motion sickness Human disease C23.888.571.800
speech disorder disease communication disorder communication disorder that involves difficulty with the act of speech production. C10.597.606.150.500.800
C23.888.592.604.150.500.800
Speech impediments
spermatic cord torsion disease testicular disease
organ torsion
genetic disease
Human disease C12.294.693
spermatocele disease male reproductive system disease
epididymal cyst
Human disease C12.294.731
C23.300.306.750
Spermatocele
spina bifida disease neural tube defect congenital disorder of nervous system C10.500.680.800
C16.131.666.680.800
Spina bifida
 
spinal disc herniation disease Intervertebral disc disorder disease C05.116.900.307
C23.300.707.952
Spinal disc herniation
 
spinal muscular atrophy disease
Designated intractable/rare diseases
motor neuron disease
spinal muscular atrophy
rare congenital neuromuscular disorder C10.228.854.468
C10.574.562.500
C10.668.467.500
Spinal muscular atrophy
 
spinal stenosis disease bone deterioration disease bone deterioration disease that has material basis in bony spurs, disc degeneration, or thickened ligaments which results in narrowing located in spinal cord C05.116.900.825 Spinal stenosis
splenic infarction disease splenic disease condition in which oxygen supply to the spleen is interrupted C14.907.795
C15.604.744.617
Splenic infarction
Splenomegaly disease splenic disease C23.300.775.750 Splenomegaly
spondylitis disease
arthropathy
spondyloarthropathy
Intervertebral disc disorder
inflammatory disease
bone disease
inflammation of the vertebra C01.539.160.762
C05.116.165.762
C05.116.900.853
Spondylitis
spondylolisthesis disease bone structure disease
genetic disease
bone structure disease that has material basis in displacement located in set of vertebrae C05.116.900.938.500.500 Spondylolisthesis
 
spondylolysis disease bone structure disease bone structure disease that involves a defect located in lumbar vertebral column. C05.116.900.938.500 Spondylolysis
spondylosis disease bone structure disease degenerative osteoarthritis of the joints between the center of the spinal vertebrae and/or neural foramina C05.116.900.938 Spondylosis
sporotrichosis disease
infectious disease
primary systemic mycosis
subcutaneous mycosis
fungal infectious disease
primary systemic mycosis that results in a systemic fungal infection, has material basis in Sporothrix schenckii in animals and humans and results in formation of red papule at the site of inoculation C01.539.800.200.675
C01.703.295.675
C17.800.838.208.675
Sporotrichosis
squamous cell carcinoma disease Q3542023
carcinoma
carcinoma that derives from squamous epithelial cells C04.557.470.200.400
C04.557.470.700.400
C04.557.470.700
Squamous-cell carcinomas
 
St. Louis encephalitis disease
infectious disease
viral infectious disease
infectious disease with epilepsy
Human disease C02.081.343.350
C02.182.525.300.300
C02.290.310.406
C02.782.310.350
C02.782.350.250.450
C10.228.140.430.520.750.300.550
C10.228.228.245.340.300.550
C10.228.228.399.750.300.550
 
status asthmaticus disease asthma type of asthma C08.127.108.880
C08.674.095.880
C20.543.480.680.095.880
status epilepticus disease epilepsy Human disease C10.228.140.490.690
steatorrhea busuk disease intestinal disease Human disease C06.405.469.637.887
C18.452.603.887
Stevens-Johnson syndrome disease skin disease
erythema
Disease C07.465.864.500
C17.800.174.600.900
C17.800.229.400.683
C17.800.865.475.683
C20.543.206.380.900
C25.100.468.380.900
Stevens–Johnson syndrome
 
Stiff-Person syndrome disease movement disorder movement disease that is of unknown etiology characterized by progressive rigidity C10.114.812
C10.228.854.790
C10.668.900
C20.111.258.850
Stiff person syndrome
stomach cancer disease gastrointestinal system cancer
stomach disease
gastrointestinal system cancer that is located in the stomach C04.588.274.476.767
C06.301.371.767
C06.405.249.767
C06.405.748.789
Stomach cancer
 
stomach disease disease gastrointestinal system disease gastrointestinal system disease that is located in the stomach. C06.405.748 Diseases and disorders of the stomach
stomatitis disease mouth disease
inflammation
Mucositis
inflammatory disease
inflammation of the mouth and lips C07.465.864 Stomatitis
strabismus disease ocular motility disease
hyperopia
Human disease C10.292.562.887
C11.590.810
Strabismus
 
stupor disease altered level of consciousness disease C10.597.606.358.800.500
C23.888.592.604.359.800.500
stuttering disease articulation disorder
speech disorder
articulation disorder characterized by involuntary sound repetition and disruption or blocking of speech C10.597.606.150.500.800.750
C23.888.592.604.150.500.800.750
Stuttering
subarachnoid hemorrhage disease intracranial hemorrhage
brain disease
bleeding into the subarachnoid space C10.228.140.300.535.800
C14.907.253.573.800
C23.550.414.913.850
Subarachnoid hemorrhage
 
subclavian steal syndrome disease syndrome constellation of signs and symptoms that arise from retrograde (reversed) blood flow in the vertebral artery or the internal thoracic artery, due to a proximal stenosis (narrowing) and/or occlusion of the subclavian artery C10.228.140.300.150.956.700
C14.907.253.092.956.700
C14.280.647.250.647
C14.907.585.250.647
C23.550.767.115
Subclavian steal syndrome
subependymal giant cell astrocytoma disease fibrillary astrocytoma
subependymal glioma
low-grade astrocytic brain tumor (astrocytoma) that arises within the ventricles of the brain C04.557.465.625.600.380.080
C04.557.470.670.380.080
C04.557.580.625.600.380.080
 
substance dependence disease substance-related disorder
addiction
substance-related disorder that involves the continued use of alcohol or other drugs despite problems related to use of the substance. C25.775 Substance dependence
sudden infant death syndrome disease syndrome
sudden cardiac death
infant death
genetic disease
syndrome that is characterized by the sudden death of an infant that is not predicted by medical history and remains unexplained after a thorough forensic autopsy and detailed death scene investigation. C23.550.260.322.625
C23.550.260.657.500
Sudden infant death syndrome
sulfhemoglobinemia disease blood protein disease Human disease C15.378.896
superior mesenteric artery syndrome disease duodenal obstruction
artery disease
syndrome
aortic disease
Human disease C06.405.469.275.395.890 Superior mesenteric artery syndrome
sweating sickness disease C23.888.119.344.672 Sweating sickness
syndactyly disease synostosis synostosis that results in the fusion of two or more digits C05.116.099.370.894.819
C05.660.585.800
C05.660.906.819
C16.131.621.585.800
C16.131.621.906.819
Syndactyly
 
syndrome disease physiological condition
disease
association of several clinically recognizable features C23.550.288.500 Syndromes
synostosis disease dysostosis dysostosis that results in abnormal fusing of adjacent bones C05.116.099.370.894
C05.660.906
C16.131.621.906
Synostosis
synovitis disease connective tissue disease connective tissue disease that results in inflammation located in synovial membrane that lines a synovial joint which causes pain and swelling C05.550.870
syringomyelia disease
Designated intractable/rare diseases
spinal cord disease
syrinx
congenital disorder of nervous system C10.228.854.833 Syringomyelia
 
systemic lupus erythematosus disease
Designated intractable/rare diseases
lupus erythematosus
rheumatic disease
inflammation of connective tissue marked by skin rashes, joint pain and swelling, inflammation of the kidneys and inflammation of the tissue surrounding the heart. C17.300.480
C20.111.590
Systemic lupus erythematosus
 
Takayasu's arteritis disease
Designated intractable/rare diseases
syndrome
artery disease
secondary glomerular disease
predominantly large-vessel vasculitis
syndrome that involves inflammation of the aorta that carries blood from the heart to the rest of the body C14.907.109.239
C14.907.109.239.650
C14.907.940.090.800
C17.800.862.875
Takayasu arteritis
Tangier disease disease hypolipoproteinemia
neurometabolic disease
Hypoalphalipoproteinemia
rare hereditary metabolic disease with peripheral neuropathy
rare hereditary systemic disease with peripheral neuropathy
Human disease C10.668.829.800.875
C16.320.565.398.500.330.750
C18.452.584.500.875.330.750
C18.452.648.398.500.330.750
Tangier disease
tarsal tunnel syndrome disease tibial neuropathy Human disease C10.668.829.500.700.800
C10.668.829.550.800
Tay-Sachs disease disease lysosomal storage disease
GM2 gangliosidosis
eye degenerative disease
GM2 gangliosidosis, variant B or Tay-Sachs disease is marked by accumulation of G2 gangliosides due to hexosaminidase A deficiency C10.228.140.163.100.435.825.300.300.500
C16.320.565.189.435.825.300.300.500
C16.320.565.398.641.803.350.300.850
C16.320.565.595.554.825.300.300.840
C18.452.132.100.435.825.300.300.500
C18.452.584.687.803.350.300.850
C18.452.648.189.435.825.300.300.500
C18.452.648.398.641.803.350.300.850
C18.452.648.595.554.825.300.300.840
Tay–Sachs disease
 
Telangiectasia disease arterial occlusive disease Human disease C14.907.823 Telangiectasia
temporal arteritis disease
Designated intractable/rare diseases
central nervous system vasculitis
predominantly large-vessel vasculitis
secondary glomerular disease
Human disease C10.114.875.700
C10.228.140.300.850.500
C14.907.253.946.700
C14.907.940.090.530
C14.907.940.907.700
C17.800.862.252
C20.111.258.962.800
 
temporal lobe epilepsy disease focal epilepsy Human disease C10.228.140.490.360.290
tendinitis disease myositis
tendinopathy
Human disease C05.651.869
C26.874.800
tenosynovitis disease
health problem
arthropathy
arthropathy
tendinitis
synovitis
tendon sheath disorder
human disease C05.651.869.870
teratoma disease germ cell and embryonal cancer germ cell and embryonal cancer that is an encapsulated tumor with tissue or organ components resembling normal derivatives of all three germ layers C04.557.465.910 Teratoma
testicular cancer disease male reproductive organ cancer
endocrine gland cancer
testicular disease
male reproductive system cancer that is located in the testicles C04.588.322.762
C04.588.945.440.915
C12.294.260.937
C12.758.409.937
C19.344.762
C19.391.829.782
Testicular cancer
tetany disease
clinical sign
medical sign consisting of the involuntary contraction of muscles C10.597.613.875
C18.452.174.509.700
C23.888.592.608.875
Tetany (medical sign)
tethered spinal cord syndrome disease
developmental defect during embryogenesis
spinal cord disease
malformation of the neurenteric canal, spinal cord and column
Human disease C10.500.680.800
C16.131.666.680.800
tetralogy of Fallot disease
Designated intractable/rare diseases
developmental defect during embryogenesis
congenital heart disease
cyanotic heart defect
rare genetic developmental defect during embryogenesis
genetic disease
rare genetic cardiac disease
congenital heart defect that is present at birth. Symptoms include episodes of bluish color to the skin embryology includes the displacement of the inphondibulor septem anterio superiorly C14.240.400.849
C14.280.400.849
C16.131.240.400.849
Tetralogy of Fallot
 
tetraplegia disease central nervous system disease paralysis of all four limbs and torso C10.597.622.760
C23.888.592.636.786
thalassemia disease autosomal recessive disease
hemoglobinopathy
Human disease C15.378.071.141.150.875
C15.378.420.826
C16.320.070.875
C16.320.365.826
Thalassemia
thanatophoric dysplasia disease
developmental defect during embryogenesis
osteochondrodysplasia
FGFR3-related chondrodysplasia
primary bone dysplasia with micromelia
osteochondrodysplasia that results in short arms and legs with excess folds of skin C05.116.099.343.110.500
C05.116.099.708.017.500
C05.660.585.984
C16.131.621.585.984
C16.320.240.500.500
C16.614.890
Thanatophoric dysplasia
 
theileriasis disease
infectious disease
parasitic protozoa infectious disease parasitic protozoa infectious disease that involves infection of humans and cattle caused by a genus of parasitic protozoa Theileria, which is transmitted by ixodid ticks C03.701.688.735
C03.752.625.735
C03.752.875.850
C22.196.831
C22.674.710.735
Thoracic Outlet Syndrome disease vascular disease
rare surgical thoracic disease
vascular disease that is characterized by compression at the superior thoracic outlet resulting from excess pressure placed on a neurovascular bundle passing between the anterior scalene and middle scalene muscles C10.668.829.550.850
C14.907.863
 
thromboangiitis obliterans disease
Designated intractable/rare diseases
arterial occlusive disease
predominantly medium-vessel vasculitis
secondary glomerular disease
Human disease C14.907.137.870
C14.907.940.905
Thromboangiitis obliterans
 
thrombocytopenia disease blood platelet disease
clinical sign
A blood platelet disease characterized by a low platelet count in the blood. C15.378.140.855
thrombogavitis disease blood platelet disease blood platelet disease that is characterized by the presence of high platelet counts in the blood C15.378.140.860
C15.378.190.636.860
thrombophilia disease blood coagulation disease Human disease C15.378.925
thrombophlebitis disease phlebitis phlebitis that results from a blood clot in the vessel C14.907.355.830.925.770
C14.907.617.718.788
C14.907.940.740.910
thrombosis disease hematopoietic system diseases
vascular disease
vascular occlusion
embolism and thrombosis
vascular disease caused by the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system C14.907.355.830 Thrombosis
thrombotic thrombocytopenic purpura disease
Designated intractable/rare diseases
thrombophilia
thrombocytopenic purpura
rare thrombotic disorder due to a platelet anomaly
thrombotic microangiopathy
Human disease C15.378.100.802.687.680
C15.378.140.855.925.750.680
C15.378.925.850
C23.550.414.950.687.680
C23.888.885.687.687.680
Thrombotic thrombocytopenic purpura
thymoma disease thymus cancer A thymus cancer that derives from epithelial cells located in the thymus. The tumor cells in a thymoma look similar to the normal cells of the thymus, grow slowly, and rarely spread beyond the thymus. C04.557.435.850
C04.588.894.949.500
C15.604.861.800
Thymoma
thyroid cancer disease endocrine gland cancer
thyroid gland disease
endocrine gland cancer located in the thryoid gland located in the neck below the thyroid cartilage C04.588.322.894
C04.588.443.915
C19.344.894
C19.874.788
Thyroid cancer
 
thyroid hormone resistance syndrome disease hypothyroidism Human disease C19.874.410.500
tic disorder disease specific developmental disorder
motor disorder
specific developmental disorder that is characterized by the persistent presence of involuntary brief movements or sounds occuring intermittently and unpredictably out of a background of normal motor activity C10.228.662.825
tick-borne encephalitis disease
infectious disease
viral infectious disease
infectious disease with epilepsy
tick-borne disease
viral infectious disease involving the central nervous system C02.081.343.360
C02.081.885.400
C02.182.525.300.350
C02.290.310.530
C02.782.310.360
C02.782.350.250.500
C10.228.140.430.520.750.300.775
C10.228.228.245.340.300.775
C10.228.228.399.750.300.775
Tick-borne encephalitis
tinea capitis disease
infectious disease
dermatophytosis Human disease C01.539.800.200.720.730
C01.703.295.872.541
C17.800.738.708
C17.800.838.208.883.558
Tinea capitis
tinea favosa disease
infectious disease
tinea capitis
skin infection
Human disease C01.539.800.200.720.730.740
C01.703.295.872.541.500
C17.800.738.708.708
C17.800.838.208.883.558.708
Favus
Todd's paresis disease C10.597.622
C23.888.592.636
tolosa-hunt syndrome disease ocular motility disease
genetic peripheral neuropathy
rare strabismus and restriction syndrome
nuclear oculomotor paralysis
Human disease C10.292.562.900
C11.590.905
Tolosa–Hunt syndrome
tonsillitis disease upper respiratory tract disease Human disease C07.550.781.750
C08.730.561.750
C09.775.649.750
Tonsillitis
 
tooth agenesis disease tooth disease tooth disease characterized by failure to develop on or more missing teeth C07.650.800.100
C07.793.700.100
C16.131.850.800.100
Hypodontia
toothache disease pain medical condition C07.793.929
C10.597.617.203.500
C23.888.592.612.330.500
Toothache
Torticollis disease dystonic condition defined by an abnormal, asymmetrical head or neck position, which may be due to a variety of causes C10.228.662.300.750
C10.597.350.300.800
C23.888.592.350.300.800
Torticollis
toxic megacolon disease megacolon Human disease C06.405.469.158.701.591 Toxic megacolon
toxic shock syndrome disease commensal bacterial infectious disease Human disease C01.539.757.800
C23.550.470.790.500.800
C23.550.835.900.712
toxocariasis disease parasitic helminthiasis infectious disease
nematode infection
zoonosis
liver disease
eye disease
lung disease
brain disease
muscle tissue disease
heart disease
Human disease C03.335.508.523.780
C03.335.508.700.100.868.420
C03.335.349.868
C03.335.508.700.100.868
C03.701.377.868
C22.674.377.868
toxoplasmosis disease
infectious disease
coccidiosis
zoonosis
parasitic human disease C03.752.250.800 Toxoplasma
 
tracheitis disease
infectious disease
tracheal disease
inflammatory disease
inflammation of the trachea C08.730.848
C08.907.763
tracheomalacia disease
head and neck disease
developmental defect during embryogenesis
tracheal disease
genetic otorhinolaryngological malformation
rare genetic respiratory disease
non-syndromic respiratory or mediastinal malformation
tracheal anomaly
respiratory malformation
tracheal disease C05.182.895.500
C08.907.796.500
C16.131.621.953.500
C17.300.182.895.500
Tracheomalacia
trachoma disease commensal bacterial infectious disease
eye disease
Human disease C01.252.354.225.800
C01.252.400.210.210.800
C01.539.375.354.220.800
C11.187.183.220.889
C11.204.813
C11.294.354.220.800
Trachoma
 
transient cerebral ischemia disease brain ischemia neurological dysfunctio by transient ischemia C10.228.140.300.150.836
C14.907.253.092.836
transient tic disorder disease tic disorder tic disorder that consists of multiple motor and/or phonic tics with duration of at least 4 weeks, but less than 12 months C10.228.662.825
transmissible spongiform encephalopathy disease
Designated intractable/rare diseases
brain disease brain disease that is characterized by brain damage resulting from the abnormal folding, clumping and accumulation of cellular proteins in the brain induced by prion proteins C10.228.228.800
C10.574.843
Transmissible spongiform encephalopathies
transposition of great vessels disease
thoracic disease
congenital heart disease group of congenital heart defects involving an abnormal spatial arrangement of any of the great vessels: superior and/or inferior venae cavae, pulmonary artery, pulmonary veins, and aorta C14.240.400.915
C14.280.400.915
C16.131.240.400.915
Transposition of the great vessels
 
Treacher Collins syndrome disease autosomal dominant disease
first arch syndrome
Human disease C05.116.099.370.231.576
C05.660.207.231.576
C16.131.621.207.231.576
Treacher Collins syndrome
trench fever disease
infectious disease
bartonellosis
bacterial infectious disease
Human disease C01.252.400.126.100.800
trichinosis disease nematode infection
zoonosis
parasitic helminthiasis infectious disease
parasitic disease due to invasion by Trichinella spp. C03.335.508.100.275.882 Trichinosis
 
trichomoniasis disease parasitic protozoa infectious disease parasitic protozoa infectious disease that is caused by singled-celled protozoan parasites Trichomonas vaginalis or Trichomonas tenax, which infect the urogenital tract and mouth respectively C03.752.890 Trichomoniasis
tricuspid atresia disease
Designated intractable/rare diseases
developmental defect during embryogenesis
congenital heart disease
cyanotic heart defect
tricuspid valve disease
genetic disease
rare genetic cardiac disease
congenital tricuspid malformation
rare genetic developmental defect during embryogenesis
A tricuspid valve disease characterized by a missing or abnormally developed tricuspid heart value at birth. C14.240.400.920
C14.280.400.920
C14.280.484.845
C16.131.240.400.920
Tricuspid atresia
Tricuspid insufficiency disease tricuspid valve disease A tricuspid valve disease that is characterized by failure of the heart's tricuspid valve to close properly during systole. As a result, with each heart beat, blood is pumped out from the right side of the heart in the opposite direction to normal. C14.280.484.856 Tricuspid valve insufficiency
trigeminal neuralgia disease trigeminal nerve disease
facial neuralgia
neuropathic disorder C07.465.299.625.500.700
C10.292.319.625.700.700
tropical spastic paraparesis disease
infectious disease
viral infectious disease
spinal cord disease
genetic nervous system disorder
infectious disease of the nervous system
Human disease C02.782.815.200.470.710
C10.228.228.618.500
C10.228.854.525.700
tropical sprue disease intestinal disease Human disease C06.405.469.637.850
C18.452.603.850
Tuberous sclerosis disease autosomal dominant disease
phakomatosis
malformation of cortical development, Group I
a rare multisystem genetic disease that causes benign tumors to grow in the brain and on other vital organs such as the kidneys, heart, liver, eyes, lungs, and skin. C04.445.810
C04.651.800
C04.700.632
C10.500.507.400.750
C10.562.850
C10.574.500.865
C16.131.666.507.400.750
C16.320.400.880
C16.320.700.636
Tuberous sclerosis
 
tularemia disease primary bacterial infectious disease primary bacterial infectious disease that has material basis in Francisella tularensis, which is transmitted by dog tick bite (Dermacentor variabilis), transmitted by deer flies (Chrysops sp) or transmitted by contact with infected animal tissues. C01.252.400.939 Tularemia
 
tungiasis disease
infectious disease
parasitic ectoparasitic infectious disease
Pulicosis
rare skin disease
Human disease C03.858.211.250.800
 
Turner syndrome disease gonadal dysgenesis
sex chromosome disorder
Human disease C12.706.316.309.872
C12.706.316.795.750
C13.351.875.253.309.872
C13.351.875.253.795.750
C14.240.400.980
C14.280.400.980
C16.131.240.400.970
C16.131.260.830.835.750
C16.131.939.316.309.872
C16.131.939.316.795.750
C16.320.180.830.835.750
C19.391.119.309.872
C19.391.119.795.750
Turner syndrome
 
twin-to-twin transfusion syndrome disease neonatal anemia
Diseases in Twins
anemia
immune system disease
Human disease C15.378.071.363.344
C16.614.053.344
type 1 diabetes mellitus disease diabetes mellitus form of diabetes mellitus C18.452.394.750.124
C19.246.267
C20.111.327
Diabetes mellitus type 1
typhoid fever disease primary bacterial infectious disease
Salmonella infectious disease
A bacterial infectious disorder contracted by consumption of food or drink contaminated with Salmonella typhi. This disorder is common in developing countries and can be treated with antibiotics. C01.252.400.310.821.873 Typhoid fever
 
typhus disease primary bacterial infectious disease
rickettsiosis
group of infectious diseases C01.252.400.780.790.800
C01.252.400.780.790.805
Typhus
 
tyrosinemia disease amino acid metabolic disorder
inborn disorder of phenylalanin or tyrosine metabolism
amino acid metabolic disorder that involves impaired break down of the amino acid tyrosine C10.228.140.163.100.875
C16.320.565.100.880
C16.320.565.189.875
C18.452.132.100.875
C18.452.648.100.880
C18.452.648.189.875
tyrosinemia type I disease tyrosinemia tyrosinemia that has material basis in deficiency of the enzyme fumarylacetoacetate hydrolase resulting in an increase in fumarylacetoacetate which inhibits previous steps in tyrosine degradation leading to an accumulation of tyrosine in the body C10.228.140.163.100.875
C16.320.565.100.880
C16.320.565.189.875
C18.452.132.100.875
C18.452.648.100.880
C18.452.648.189.875
unstable angina disease coronary artery disease
angina pectoris
type of angina pectoris that is irregular. It is also classified as a type of acute coronary syndrome C10.597.617.192.500.150
C14.280.647.187.150
C14.907.585.187.150
C23.888.592.612.233.500.150
urea cycle disorder disease amino acid metabolic disorder amino acid metabolic disorder that involves a deficiency of one of the enzymes in the urea cycle which is responsible for removing ammonia from the blood stream C10.228.140.163.100.937
C16.320.565.100.940
C16.320.565.189.937
C18.452.132.100.937
C18.452.648.100.940
C18.452.648.189.937
ureterocele disease ureteral disease
genetic disease
bladder disease
Human disease C12.777.725.876
C13.351.968.725.876
Ureteroceles
urethral stricture disease urethral obstruction Human disease C12.777.767.700.700
C13.351.968.767.700.700
Urethral stricture
urethritis disease
infectious disease
urethral disease
inflammatory disease
urinary tract infection
Inflammation of the urethra C12.777.767.851
C13.351.968.767.851
Urethritis
urinary incontinence disease impairment of continence
urination disorder
uncontrolled leakage of urine C12.777.934.852
C13.351.968.934.814
C23.888.942.343.800
Urinary incontinence
urolithiasis disease urinary system disease
urolithiasis
Urolithiasis C12.777.967.500
C13.351.968.967.500
C23.300.175.850
C12.777.967
C13.351.968.967
Lithiasis
urticaria disease skin disease skin disease characterized by skin rash notable for pale red, raised and itchy bumps, located in the upper dermis C17.800.862.945
C20.543.480.904
Urticaria
 
Usher syndrome disease autosomal recessive disease syndrome characterized by a combination of hearing loss and visual impairment C09.218.458.341.186.500.500
C09.218.458.341.887.886
C10.597.751.418.341.186.500.500
C10.597.751.418.341.887.886
C10.597.751.941.162.625.500
C11.768.585.658.500.813
C11.966.075.375.500
C16.131.077.299.500
C16.320.290.684.500
C23.888.592.763.393.341.887.886
uterine cancer disease female reproductive organ cancer
uterine disease
female reproductive organ cancer that is located in the uterus C04.588.945.418.948
C13.351.500.852.762
C13.351.937.418.875
Uterine cancer
uterine fibroid disease uterine benign neoplasm
leiomyoma
fibroma
uterine benign neoplasm derived from the smooth muscle layer of the uterus C04.557.450.590.450 Uterine fibroids
 
uveitis disease uveal disease
eye inflammation
inflammatory disease
Human disease C11.941.879 Uveitis
uveoparotid fever disease sarcoidosis
Uveoparotitis
Human disease C15.604.515.827.865
vaginal cancer disease female reproductive organ cancer
vaginal disease
female reproductive system cancer that is located in the vagina C04.588.945.418.955
C13.351.500.894.834
C13.351.937.418.937
Vaginal cancer
vaginal discharge disease vaginal disease
body fluid
fluid that comes out of the vagina C13.351.500.894.700 Vaginal discharge
vaginitis disease vaginal disease Human disease C13.351.500.894.906 Vaginitis
varicocele disease pelvic varices abnormal enlargement of the pampiniform venous plexus in the scrotum C12.294.936
C14.907.903
Varicocele
varicose veins disease vein disorder vein disease that is characterized by swollen, twisted veins visible just under the surface of the skin C14.907.927 Varicose veins
 
variegate porphyria disease acute porphyria
porphyria
acute hepatic porphyria
Human disease C06.552.830.625
C16.320.850.742.625
C17.800.827.742.625
C18.452.811.400.625
vascular dementia disease dementia dementia that involves impairments in cognitive function caused by problems in blood vessels that feed the brain C10.228.140.300.400
C10.228.140.300.510.800.500
C10.228.140.380.230
C10.228.140.695.500
C14.907.137.126.372.500
C14.907.253.560.350.500
C10.228.140.300.150.477.200.199
C10.228.140.300.400.408
C10.228.140.300.775.200.200.199
C10.228.140.380.230.250
C14.907.253.092.477.200.199
C14.907.253.855.200.200.199
Vascular dementia
vascular disease disease cardiovascular disease cardiovascular system disease that primarily affects the blood vessels C14.907.055
C14.907
C10.228.854.785
C14.907.790
C10.228.854.785.650
C14.907.790.550
Vascular diseases
vascular malformation disease vascular anomaly
vascular disease
disease C14.240.850
C16.131.240.850
 
vasculitis disease vascular disease
angiitis
vascular disease that is characterized by inflammation of the blood vessels C14.907.940 Vasculitis
 
Venous ulcer disease wound
ulcer of lower limbs
C17.800.893.592
C14.907.927.730
C17.800.893.592.730
Venous ulcer
 
ventricular fibrillation disease
thoracic disease
tachycardia
ventricular dyssynchrony
disorganized electrical activity in the ventricles. It is a type of cardiac arrhythmia Ventricular fibrillation results in cardiac arrest C14.280.067.922
C23.550.073.922
Ventricular fibrillation
ventricular septal defect disease heart septal defect heart septal defect characterized by an opening in the interventricular septum, causing a shunt between ventricles C14.240.400.560.540
C14.280.400.560.540
C16.131.240.400.560.540
Ventricular septal defect
 
vesicoureteral reflux disease ureteral disease ureteral disease characterized by backward flow of urine from the urinary bladder into the ureter C12.777.829.920
C13.351.968.829.920
Vesicoureteral reflux
vestibular neuronitis disease vestibulocochlear nerve disease Human disease C09.218.807.800.837
C10.292.910.850
vibration white finger disease occupational disease C10.668.829.380
C14.907.440
C24.400
VIPoma disease neuroendocrine tumor Human disease C04.557.465.625.650.240.847
C04.557.470.200.025.370.847
C04.588.274.761.500.750
C04.588.322.475.500.750
C06.301.761.500.750
C06.689.667.500.750
C19.344.421.500.750
viral hepatitis disease hepatitis
viral infectious disease
hepatitis that involves viral infection causing inflammation of the liver C02.407
C06.552.380.315.430
C22.467.435
C02.440
C06.552.380.705
Viral hepatitis
viral infectious disease disease
infectious disease
infectious disease
rare infectious disease
Human, animal or plant disease resulting from a viral infection C02.081 Viral diseases
visceral heterotaxy disease birth defect rare disease C14.240.400.592
C14.280.400.592
C15.604.744.146
C16.131.077.401
C16.131.240.400.592
visual verbal agnosia disease reading disorder
agnosia
An agnosia that is a loss of the ability to comprehending the meaning of written words. C10.597.606.150.500.300
C10.597.606.150.550.200
C23.888.592.604.150.500.300
C23.888.592.604.150.550.200
C10.597.606.150.500.300.200
C10.597.606.150.550.200.500
C23.888.592.604.150.500.300.200
C23.888.592.604.150.550.200.500
vitelliform macular dystrophy disease macular degeneration A macular degeneration that can cause progressive vision loss, it is characterized by the disruption of cells in a small area near the center of the retina, the macula. C11.768.585.439.433
C16.320.290.763
vitiligo disease autoimmune disease
autoimmune disease of skin and connective tissue
hypersensitivity reaction type II disease that causes depigmentation of patches of skin resulting from loss of function or death of melanoctyes. C17.800.621.440.895 Vitiligo
vitreous detachment disease vitreous disease
Vitreoretinopathy
condition of the eye in which the vitreous membrane separates from the retina C11.980
Vitreous hemorrhage disease intraocular hemorrhage
vitreous disease
C11.290.960
C23.550.414.756.887
Vitreous hemorrhage
Vogt–Koyanagi–Harada syndrome disease
head and neck disease
autoimmune disease
panuveitis
genetic otorhinolaryngologic disease
eyebrow/eyelashes pigmentation anomaly
autoimmune disease of skin and connective tissue
autoimmune uveitis
rare genetic immune disease
rare neuroinflammatory or neuroimmunological disease
multisystem disease C10.114.843
C11.941.879.980
C20.111.258.925
Vogt–Koyanagi–Harada disease
Volkmann's contracture disease connective tissue disease Human disease C05.550.323.734
C05.651.180.531
C05.651.197.734
C14.907.303.531
von Hippel-Lindau disease disease
head and neck disease
developmental defect during embryogenesis
hemangioblastoma
multiple polyglandular tumor
syndromic developmental defect of the eye
inherited nervous system cancer-predisposing syndrome
genetic central nervous system and retinal vascular disease
inherited renal tumor
hereditary eye tumor
rare central nervous system and retinal vascular disease
catecholamine-producing tumor
familial cystic renal disease
malformation syndrome with hamartosis
rare disease with glaucoma as a major feature
a rare genetic disorder characterized by visceral cysts and benign tumors in multiple organ systems with potential for subsequent malignant change. C10.562.925
C14.907.077.925
Von Hippel-Lindau disease
von Willebrand's disease disease inherited blood coagulation disease Human disease C15.378.100.100.900
C15.378.100.141.900
C15.378.140.900
C15.378.463.920
C16.320.099.920
vulvitis disease vulvar disease
inflammatory disease
vulva disease C13.351.500.944.902
vulvovaginal candidiasis disease
infectious disease
candidiasis
vulvovaginitis
excessive growth of yeast in the vagina that results in irritation C01.703.160.190
C13.351.500.894.906.820.500
C13.351.500.944.902.737.500
Vaginal yeast infection
 
Waardenburg's syndrome disease autosomal dominant disease
genetic deafness
autosomal disease characterized by varying degrees of deafness, minor defects in structures arising from the neural crest and pigmentation anomalies of the hair, the skin and/or the iris of both eyes C16.131.077.938 Waardenburg syndrome
WAGR syndrome disease
developmental defect during embryogenesis
chromosomal deletion syndrome
rare disease with glaucoma as a major feature
syndromic obesity
syndrome with disorder of sex development of gynecological interest
partial deletion of the short arm of chromosome 11
polymalformative genetic syndrome with increased risk of developing cancer
syndromic renal or urinary tract malformation
syndrome with 46,XY disorder of sex development
syndromic aniridia
Human disease C04.557.435.595.950
C04.588.945.947.535.585.950
C04.700.635.950
C10.597.606.643.969
C11.250.060.950
C11.270.060.950
C11.941.375.060.950
C12.706.316.096.875
C12.758.820.750.585.950
C12.777.419.473.585.950
C13.351.875.253.096.875
C13.351.937.820.535.585.950
C13.351.968.419.473.585.950
C16.131.260.940
C16.131.384.079.950
C16.131.939.316.096.875
C16.320.180.940
C16.320.290.078.950
C16.320.700.642.950
C19.391.119.096.875
Waldenström's macroglobulinemia disease B-cell lymphoma B-cell lymphocytic neoplasm characterized by an uncontrolled increase of B-cells C04.557.595.925
C14.907.454.960
C15.378.147.780.925
C15.378.463.515.960
C15.604.515.925
C20.683.780.925
Walker–Warburg syndrome disease congenital muscular dystrophy
autosomal recessive
a rare form of autosomal recessive congenital muscular dystrophy. C10.500.507.450.499.249.500
C11.270.881
C16.131.666.507.450.499.249.500
C16.320.577.750
Waterhouse-Friderichsen syndrome disease adrenal gland disease
Adrenal crisis
adrenal gland disease that is characterized by failure of the adrenal gland due to bleeding into the gland C01.252.200.500.550.800
C01.252.400.625.549.449.800
C10.228.228.180.500.750.500
C10.228.614.280.505.904
C15.378.100.802.843
C15.378.463.950
C19.053.500.740
C23.550.414.950.843
C23.888.885.687.843
Waterhouse–Friderichsen syndrome
Wegener's granulomatosis disease autoimmune disease
anti-neutrophil cytoplasmic antibody-associated vasculitis
kidney disease
lung disease
skin disease
inflammatory and autoimmune disease with epilepsy
immune system disease
secondary glomerular disease
systemic inflammatory disease associated with an acquired peripheral neuropathy
autoimmune disease affecting blood vessels in the lungs, kidneys, and skin C08.381.483.950
C14.907.940.897.249.750
C20.111.193.875
Wegener's granulomatosis
Werner syndrome disease
Designated intractable/rare diseases
developmental defect during embryogenesis
autosomal recessive disease
progeroid syndrome
ectodermal malformation syndrome associated with ocular features
hereditary poikiloderma
malformation syndrome with skin/mucosae involvement
polymalformative genetic syndrome with increased risk of developing cancer
Human disease. Common in 1 in 2 children. Death is inevitable. C16.320.925
C18.452.284.960
West syndrome disease infancy electroclinical syndrome A severe epilepsy syndrome with triad of infantile spasms, an interictal electroencephalogram (EEG) pattern termed hypsarrhythmia, and mental retardation. C10.228.140.490.375.760
Whipple disease disease
infectious disease
intestinal disease
bacterial infectious disease
rare disease with myoclonus as a major feature
infectious disease of the nervous system
Human disease C01.252.410.040.137.631
C06.405.469.637.925
C18.452.603.925
Whipple's disease
 
Williams-Beuren syndrome disease
developmental defect during embryogenesis
chromosomal deletion syndrome
supravalvular aortic stenosis
syndromic developmental defect of the eye
multiple congenital anomalies/dysmorphic syndrome-intellectual disability
malformation syndrome with short stature
genetic hypertension
partial deletion of the long arm of chromosome 7
rare syndrome with cardiac malformations
rare abdominal surgical disease
rare genetic syndromic intellectual disability
organic brain syndrome
syndromic epicanthus
motor stereotypies
neurodevelopmental disorder C10.597.606.643.970
C14.280.484.150.535.960
C16.131.260.970
C16.320.180.970
Williams syndrome
Wilson disease disease
Designated intractable/rare diseases
liver disease
metal metabolism disorder
copper metabolism disease
organic brain syndrome
rare hereditary metabolic disease with peripheral neuropathy
metabolic disease with cataract
metabolic disease with corneal opacity
supranuclear oculomotor palsy
disorder of copper metabolism
tremor
rare genetic tremor disorder
rare metabolic liver disease
metal transport or utilization disorder with epilepsy
rare genetic epilepsy
neurometabolic disease
rare disorder with dystonia and other neurologic or systemic manifestation
nephropathy secondary to a storage or other metabolic disease
Human disease C06.552.413
C10.228.140.079.493
C10.228.140.163.100.360
C10.228.662.400
C10.574.500.487
C16.320.400.361
C16.320.565.189.360
C16.320.565.618.403
C18.452.132.100.360
C18.452.648.189.360
C18.452.648.618.403
Wilson's disease
 
Wiskott-Aldrich syndrome disease X-linked disease
polymalformative genetic syndrome with increased risk of developing cancer
immune deficiency with skin involvement
skin disease
syndrome with combined immunodeficiency
combined immunodeficiency
dense granule disease
rare disease C15.378.100.100.970
C15.378.463.960
C15.378.553.546.605.900
C16.320.099.970
C16.320.322.937
C20.673.627.900
Wolf-Hirschhorn syndrome disease chromosomal deletion syndrome chromosome abnormality C16.131.077.944
C16.131.260.985
C16.320.180.985
Wolf–Hirschhorn syndrome
 
Wolff-Parkinson-White syndrome disease pre-excitation syndrome
heart conduction disease
genetic disease
disorder due to a specific type of problem with the electrical system of the heart which has resulted in symptoms C14.280.067.780.977
C16.131.240.400.980
Wolff–Parkinson–White syndrome
Wolfram syndrome disease
Designated intractable/rare diseases
genetic disease
syndrome
hereditary optic atrophy
Human disease C09.218.458.341.186.500.750
C10.292.700.225.500.980
C10.574.500.662.980
C10.597.751.418.341.186.500.750
C10.597.751.941.162.625.750
C11.270.564.980
C11.640.451.451.980
C11.966.075.375.750
C12.777.419.135.875
C13.351.968.419.135.875
C16.131.077.299.750
C16.320.290.564.980
C16.320.400.630.980
C18.452.394.750.124.960
C19.246.267.960
C19.700.159.875
Wolfram syndrome
 
X-linked hypophosphatemic rickets disease rickets
familial hypophosphatemia
Human disease C05.116.198.816.875.500
C12.777.419.815.647.500
C13.351.968.419.815.647.500
C16.320.565.618.544.500
C16.320.565.861.647.500
C18.452.104.816.875.500
C18.452.174.845.875.500
C18.452.648.618.544.500
C18.452.648.861.647.500
C18.452.750.400.500.500
C18.452.750.400.750.500
C18.654.521.500.133.770.734.875.500
xeroderma pigmentosum disease
Designated intractable/rare diseases
autosomal recessive disease
autosomal recessive cerebellar ataxia due to a DNA repair defect
autosomal recessive disease that is characterized by a deficiency in the ability to repair ultraviolet damage that has material basis in autosomal recessive inheritance of DNA repair C04.834.867
C16.131.831.936
C16.320.850.970
C17.800.600.925
C17.800.621.936
C17.800.804.936
C17.800.827.970
C18.452.284.975
Xeroderma pigmentosum
xerophthalmia disease conjunctival degeneration
dry eye syndrome
Human disease C11.187.810
C11.496.260.892
Xerophthalmia
XY gonadal dysgenesis disease gonadal dysgenesis gonadal dysgenesis that is characterized by a normal 46,XY karyotype along with a progressive loss of germ cells on the developing gonads of an embryo C12.706.316.096.687
C12.706.316.309.388
C13.351.875.253.096.687
C13.351.875.253.309.388
C16.131.939.316.096.687
C16.131.939.316.309.388
C19.391.119.096.687
C19.391.119.309.388
C12.706.316.096
C13.351.875.253.096
C16.131.939.316.096
C19.391.119.096
XYY syndrome disease
developmental defect during embryogenesis
sex chromosome disorder
Y chromosome number anomaly
C23.550.210.024.500
C23.550.210.815.970
XYY syndrome
yaws disease
infectious disease
primary bacterial infectious disease
treponematosis
bone disease
cellulitis
Human disease: tropical infection of the skin, bones and joints caused by the spirochete bacterium Treponema pallidum pertenue C01.252.400.840.892
C01.252.825.910
C01.252.847.840.892
C01.539.800.720.910
C17.800.838.765.910
Yaws
 
yellow fever disease
infectious disease
viral infectious disease
rare skin disease
arbovirosis
Skin infection
viral disease C02.081.980
C02.782.350.250.980
C02.782.417.881
Yellow fever
 
yellow nail syndrome disease syndrome
nail disease
skin disease
primary lymphedema with associated anomalies
rare genetic respiratory disease
syndromic lymphedema
rare genetic skin vascular disorder
syndromic nail anomaly
primary interstitial lung disease specific to childhood due to alveolar vascular disorder
Human disease C16.320.962
C17.800.529.819
C17.800.621.968
C23.300.820.500
Yellow nail syndrome
Zellweger syndrome disease peroxisomal disease
Zellweger spectrum disorder
eye degenerative disease
congenital disorder of nervous system C06.552.970
C10.228.140.163.100.968
C12.777.419.978
C13.351.968.419.978
C16.131.077.970
C16.320.565.189.968
C16.320.565.663.970
C18.452.132.100.968
C18.452.648.189.968
C18.452.648.663.970
Zollinger-Ellison syndrome disease syndrome syndrome that is haracterized by the development of a one or more tumors (gastrinoma) in the pancreas, duodenum, or both that secrete excessive levels of gastrin, a hormone that stimulates production of acid by the stomach C04.730.713.988
C06.301.371.883
C06.405.249.883
C06.405.469.275.800.924
C06.405.469.965
C06.405.748.586.924
C06.405.748.947
Zollinger–Ellison syndrome
 


dural venous sinuses edit

Article instance of subclass of description MeSH Code Commons category image
cavernous sinus dural venous sinuses A07.231.908.224 Cavernous sinus
Inferior sagittal sinus dural venous sinuses A07.231.908.224
Occipital sinus dural venous sinuses A07.231.908.224
Sigmoid sinus dural venous sinuses A07.231.908.224
Superior petrosal sinus dural venous sinuses A07.231.908.224
superior sagittal sinus dural venous sinuses A07.231.908.224
Transverse sinuses dural venous sinuses A07.231.908.224


embryonic structure edit

Article instance of subclass of description MeSH Code Commons category image
foramen ovale embryonic structure In the fetal heart allows blood to enter the left atrium from the right atrium. A07.541.459.500 Foramen ovale
metencephalon embryonic structure
brain region
secondary cerebral vesicle A08.186.211.132.810.428 Metencephalon
myelencephalon embryonic structure
brain region
secondary cerebral vesicle posterior region of the embryonic hindbrain A08.186.211.132.810.406
rhombencephalon embryonic structure
brain region
primary cerebral vesicle A08.186.211.132.810 Rhombencephalon


eye disease edit

Article instance of subclass of description MeSH Code Commons category image
Aphakia eye disease disorder of lens C11.510.103
conjunctivitis eye disease
disease
eye inflammation
eye disease
disease
conjunctival disease
inflammatory disease
inflammation of the outermost layer of the eye and the inner surface of the eyelids C11.187.183 Conjunctivitis
 


facial feature edit

Article instance of subclass of description MeSH Code Commons category image
cheek facial feature anatomical region
facial feature
part of the head A01.456.505.173 Cheeks
 
forehead facial feature facial feature area of the head between the eyebrows and the hairline A01.456.505.580 Foreheads


flat bone edit

Article instance of subclass of description MeSH Code Commons category image
frontal bone flat bone bone bone in the human skull A02.835.232.781.375 Frontal bones
 
rib flat bone bone long curved bone surrounding the chest A02.835.232.904.567 Ribs (skeleton)
 
sternum flat bone flat bone in the middle front part of the rib cage A02.835.232.904.766 Sternum


food ingredient edit

Article instance of subclass of description MeSH Code Commons category image
Dietary Sucrose food ingredient Nutritive Sweeteners
sugar
Sucrose present in the diet. It is added to food and drinks as a sweetener D27.720.372.300.353.609.750.250
high fructose corn syrup food ingredient
sweetener
syrup
corn syrup
Nutritive Sweeteners
processed corn syrup D27.720.372.300.353.609.750.500
 
vitamin food ingredient organic compound
Micronutrients
organic compound and a vital nutrient that an organism requires in limited amounts D27.505.696.377.605.600 Vitamins
 


government program edit

Article instance of subclass of description MeSH Code Commons category image
Medicare government program
publicly funded health care
health insurance in the United States
United States single-payer national social insurance program N03.219.521.346.506.564.663
N03.219.521.576.343.840
N03.706.615.696
Medicare (United States)
 
Medicare Part D government program N03.219.521.576.343.575.500
N03.219.521.576.343.840.938
N03.706.615.752


group of chemical substances edit

Article instance of subclass of description MeSH Code Commons category image
cephalosporin antibiotic group of chemical substances chemical compound
cephem antibiotic
class of pharmaceutical drugs D02.065.589.099.249
D02.886.665.074
D03.633.100.300.249
Cephalosporin antibiotics
glucocorticoid group of chemical substances chemical substance
corticosteroid
hormone
class of corticosteroids D27.505.696.399.472.488 Glucocorticoids


gyrus edit

Article instance of subclass of description MeSH Code Commons category image
dentate gyrus gyrus A08.186.211.577.405.200 Dentate gyrus
parahippocampal gyrus gyrus A08.186.211.577.710 Parahippocampal gyrus


head and neck disease edit

Article instance of subclass of description MeSH Code Commons category image
Laryngomalacia head and neck disease
developmental defect during embryogenesis
laryngeal disease
genetic otorhinolaryngological malformation
larynx anomaly
congenital disorder of upper respiratory system C05.182.310
C08.360.563
C09.400.563
C16.131.621.568
C17.300.182.310
Laryngomalacia
 
macroglossia head and neck disease
developmental defect during embryogenesis
tongue disease
rare head and neck malformation
genetic head and neck malformation
rare maxillo-facial surgical disease
enlargement of the tongue C07.465.910.460 Macroglossia


health problem edit

Article instance of subclass of description MeSH Code Commons category image
Acute generalized exanthematous pustulosis health problem pustulosis
adverse drug reaction
toxic dermatosis
widespread acute rash characterized by fever and multiple small pustules on a reddish background C17.800.174.600.174
C20.543.206.380.174
C25.100.468.380.174
Femoral acetabular impingement health problem skeletal disease C05.550.384
C23.550.347
Femoroacetabular impingement
Perioral dermatitis health problem skin disease C17.800.174.550
C17.800.271.250
Perioral dermatitis
progressive disease health problem disease C23.550.291.656
tinnitus health problem hearing disorder perception of sound within the human ear ("ringing of the ears") when no external sound is present C09.218.458.670
C10.597.751.418.670
C23.888.592.763.393.670
Tinnitus
tympanosclerosis health problem
disease
tympanic membrane disease Human disease C09.218.636 Tympanosclerosis


hereditary disorder edit

Article instance of subclass of description MeSH Code Commons category image
Becker myotonia hereditary disorder myotonia congenita C05.651.662.500
C10.574.500.545
C10.668.491.606.500
C16.320.400.540
hereditary cancers hereditary disorder cancer
causes of cancer
genetic disease
rare genetic disease
neoplastic syndrome
Human disease C04.700
C16.320.700
Hereditary cancers


horse disease edit

Article instance of subclass of description MeSH Code Commons category image
Covering sickness horse disease trypanosomiasis horses disease C03.701.688.367
C03.752.300.900.226
C03.752.625.367
C22.674.710.367
Covering sickness
lameness horse disease limp
animal disease
departure from the normal gait in animals C22.510


infectious disease edit

Article instance of subclass of description MeSH Code Commons category image
bluetongue disease infectious disease animal disease
sheep disease
type of disease that afflicts ruminants C02.081.125
C02.782.791.315
C22.836.120
Bluetongue disease
 
Intestinal parasite infectious disease parasitic infectious diseases
intestinal disease
Infections of the INTESTINES with PARASITES, commonly involving PARASITIC WORMS. Infections with roundworms (NEMATODE INFECTIONS) and tapeworms (CESTODE INFECTIONS) are also known as HELMINTHIASIS. C03.432
C06.405.469.452
Meningococcal disease infectious disease gram-negative bacterial infection Human disease C01.252.400.625.549 Meningococcal infections
swine vesicular disease infectious disease infectious disease
swine disease
Human disease C02.782.687.359.855
C22.905.850
zoonosis infectious disease vector-borne disease
animal disease
infectious disease that is transmitted between species (sometimes by a vector) from animals other than humans to humans or from humans to other animals C01.908
C02.968
C03.908
C22.969
Zoonoses
 


ink blot test edit

Article instance of subclass of description MeSH Code Commons category image
Holtzman Inkblot Test ink blot test projective personality test F04.711.647.622.341.387
Rorschach test ink blot test
projective test
Psychological test in which subjects' perceptions of inkblots are recorded and analyzed using psychological interpretation and/or complex algorithims F04.711.647.622.341.736 Rorschach inkblots


joint edit

Article instance of subclass of description MeSH Code Commons category image
Atlanto-axial joint joint intervertebral joint
joints of the neck
articulation between the cervical atlas and the axis A02.835.583.097 Atlanto-axial joint
Atlanto-occipital joint joint joints of the neck articulation between the occiptal bone and the cervical atlas A02.835.583.101
shoulder joint joint A02.835.583.748 Glenohumeral joint
 
Sternoclavicular articulation joint A02.835.583.781 Sternoclavicular joint
temporomandibular joint joint A02.835.583.861 Temporomandibular joint
wrist joint part of the arm between the lower arm and the hand A02.835.583.405.930 Wrists
 
Zygapophysial joint joint intervertebral joint A02.835.583.979


medical finding edit

Article instance of subclass of description MeSH Code Commons category image
bradycardia medical finding heart arrhythmia
finding of heart rate
heart rate that is below the normal range C14.280.067.319
C23.550.073.300
Bradycardia
 
hyperbilirubinemia medical finding disease of metabolism medical condition C23.550.429


medical specialty edit

Article instance of subclass of description MeSH Code Commons category image
blood substitute medical specialty surgery
Hematologic Agents
Substances that are used in place of blood, for example, as an alternative to blood transfusions after blood loss to restore blood volume and oxygen-carrying capacity to the blood circulation, or to perfuse isolated organs D27.505.954.502.140
forensic medicine medical specialty forensic science
legal medicine
branch of medicine that deals with application of medical knowledge to aid in the administration and furthering of justice. H02.403.330
I01.198.780.937
Forensic medicine
 
forensic psychiatry medical specialty medical specialty F04.096.544.335
H02.403.690.208
I01.198.780.937.469
I01.880.604.583.310
N03.706.535.351
psychiatry medical specialty medicine medical specialty devoted to the study, diagnosis, treatment, and prevention, of mental disorders F04.096.544
H02.403.690
Psychiatry


muscle edit

Article instance of subclass of description MeSH Code Commons category image
deltoid muscle muscle human shoulder muscle A02.633.567.300 Deltoid muscle
 
intercostal muscle muscle A02.633.567.900.500 Intercostal muscles
Lateral pterygoid muscle muscle A02.633.567.600.700 Lateral pterygoid muscles
 
Medial pterygoid muscle muscle A02.633.567.600.700 Medial pterygoid muscles
 
pectoralis major muscle main human chest muscle A02.633.567.775 Pectoralis major muscle
 
Psoas major muscle muscle long fusiform muscle located on the side of the lumbar region of the vertebral column and brim of the lesser pelvis A02.633.567.825 Psoas major muscles
 
Psoas minor muscle muscle long, slender skeletal muscle located anterior to the psoas major muscle A02.633.567.825 Psoas minor muscles
 
quadriceps femoris muscle muscle human leg muscle A02.633.567.850 Quadriceps femoris muscles
 
rectus abdominis muscle muscle paired muscle running vertically on each side of the anterior wall of the human (of some other mammals) abdomen A02.633.567.050.800 Rectus abdominis muscle
 
stylopharyngeus muscle muscle A02.633.567.800 Stylopharyngeus muscles


neurological disorder edit

Article instance of subclass of description MeSH Code Commons category image
brain abscess neurological disorder intracranial abscess C01.395.250
C01.539.830.025.160
C10.228.140.116
C10.228.228.090
Brain abscesses
cerebellar disease neurological disorder
disease
brain disease Human disease C10.228.140.252


neuropsychological test edit

Article instance of subclass of description MeSH Code Commons category image
Luria-Nebraska neuropsychological battery neuropsychological test F04.711.513.300
Trail Making Test neuropsychological test F04.711.513.838


organ edit

Article instance of subclass of description MeSH Code Commons category image
human heart organ heart
human organ
human organ A07.541 Human heart
 
mesentery organ human organ A01.047.025.600.451 Mesentery


physiological finding edit

Article instance of subclass of description MeSH Code Commons category image
deficiency physiological finding nutrition disorder
nutritional deficiency disease
Human disease C18.654.521.500.133 Diseases and disorders due to vitamin deficiencies
magnesium deficiency physiological finding disorder of magnesium metabolism
mineral deficiency
nutritional deficiency disease
human disease C18.654.521.500.439


protein family edit

Article instance of subclass of description MeSH Code Commons category image
Gliadin protein family prolamin class of proteins D12.776.765.725.500.500.400 Gliadin
gluten protein family
adhesive
protein protein composite found in wheat and related grains, including barley and rye D12.776.765.725.500.500 Gluten
 
prolamin protein family protein D12.776.765.725.500
Zein seed storage protein protein family prolamin InterPro Family D12.776.765.725.500.750


rare disease edit

Article instance of subclass of description MeSH Code Commons category image
Anti-NMDA receptor encephalitis rare disease encephalitis rare disease C04.588.614.550.112
C04.730.856.112
C10.228.140.430.124
C10.574.781.249
C20.111.258.124
Arnold-Chiari malformation rare disease rare disease C10.500.680.291
C16.131.666.680.291
Chiari malformation
 
Castleman's disease rare disease
disease
Lymphoproliferative disorders lymphoproliferative syndrome characterized by one or more enlarged lymph nodes containing cells with hyaline-vascular, plasmacytic, or mixed appearance microscopically C15.604.515.245
C20.683.515.250
Castleman's disease
 
congenital insensitivity to pain with anhidrosis rare disease
Designated intractable/rare diseases
hereditary sensory neuropathy
absence of pain sensation
anhidrosis
rare disease C10.500.310
C10.574.500.496
C10.668.829.800.175
C16.131.666.310
C16.320.400.415
Congenital insensitivity to pain with anhidrosis
Degos disease rare disease rare disease C14.907.137.520
C14.907.940.530
C17.800.862.457
Degos disease
Dejerine–Sottas disease rare disease Charcot–Marie–Tooth disease rare disease C10.500.300
C10.574.500.495
C10.668.829.800.300
C16.131.666.300
C16.320.400.375
Ectodermal dysplasia rare disease Human disease C16.131.077.350
C16.131.831.350
C16.320.850.250
C17.800.804.350
C17.800.827.250
Ectodermal dysplasia
 
ichthyosis rare disease
disease
skin disease
rare epidermal disease
skin disease in which dry, scaly skin accumulates C16.131.831.512
C16.614.492
C17.800.428.333
C17.800.804.512
Ichthyosis
Idiopathic CD4+ lymphocytopenia rare disease rare disease C15.378.553.546.605.800
C20.673.627.800
Jacobsen syndrome rare disease
developmental defect during embryogenesis
syndromic constitutional thrombocytopenia
ptosis
partial deletion of the long arm of chromosome 11
Jacobsen syndrome is a multiple congenital anomaly/mental retardation (MCA/MR) contiguous gene syndrome caused by partial deletion of the long arm of chromosome 11 C15.378.140.855.440
C16.131.260.440
C16.320.180.440
Jacobsen syndrome
 
Kashin–Beck disease rare disease osteochondrodysplasia chronic, endemic osteochondropathy C05.116.099.708.534 Kashin–Beck disease
McCune–Albright syndrome rare disease rare disease C05.116.099.708.375.381
Morquio Syndrome rare disease
disease
mucopolysaccharidosis Rare Disease C16.320.565.202.715.655
C16.320.565.595.600.655
C17.300.550.575.655
C18.452.648.202.715.655
C18.452.648.595.600.655
Mucolipidosis type IV rare disease
developmental defect during embryogenesis
mucolipidosis
rare genetic epilepsy
lysosomal disease with epilepsy
metabolic disease with corneal opacity
unclassified primitive or secondary maculopathy
hereditary retinal dystrophy
rare genetic developmental defect during embryogenesis
Lysosomal storage disease C05.116.198.371
C10.228.140.163.100.435.590
C16.320.565.189.435.590
C16.320.565.202.670
C16.320.565.595.554.590
C18.452.132.100.435.590
C18.452.648.189.435.590
C18.452.648.202.670
C18.452.648.595.554.590
Opsoclonus myoclonus syndrome rare disease paraneoplastic neurologic syndrome
rare disease with myoclonus as a major feature
rare acquired eye disease
brain inflammatory disease
rare disease C04.588.614.550.600
C04.730.856.596
C10.228.758.500
C10.292.562.831
C10.574.781.662
C10.597.350.500.500
C11.590.725
Rotor syndrome rare disease bilirubin metabolic disorder
rare metabolic liver disease
rare disease C16.320.565.300
C18.452.648.300
Sanfilippo syndrome rare disease
disease
mucopolysaccharidosis mucopolysaccharidosis characterized by a deficiency of the lysosomal enzyme resulting in incomplete breakdown of the heparan sulfate sugar chain C16.320.565.202.715.650
C16.320.565.595.600.650
C17.300.550.575.650
C18.452.648.202.715.650
C18.452.648.595.600.650
Sanfilippo syndrome
slipped capital femoral epiphysis rare disease chondropathy
genetic disease
rare disease C05.116.099.708.928
C05.116.425.500
Slipped capital femoral epiphysis
 
Sturge–Weber syndrome rare disease
head and neck disease
developmental defect during embryogenesis
phakomatosis
overgrowth syndrome
cerebral diseases of vascular origin with epilepsy
neurocutaneous syndrome with epilepsy
syndrome or malformation associated with head and neck malformations
skull cancer
brain cancer
rare capillary malformation with associated anomalies
palpebral tumor with a vascular malformation
rare genetic vascular tumor
conjunctival cancer
conjunctival hemangioma or hemolymphangioma
rare disease with glaucoma as a major feature
neurovascular malformation
syndromic developmental defect of the eye
a rare congenital neurological and skin disorder associated with port-wine stains of the face, glaucoma, seizures, mental retardation, and ipsilateral leptomeningeal angioma (cerebral malformations and tumors). C04.557.645.375.850
C10.562.800
C14.907.077.850
Sturge–Weber syndrome
Tarlov cyst rare disease neurological disorder Perineural (or Tarlov) cysts are cerebrospinal fluid-filled nerve root cysts most commonly found at the sacral level of the spine, although they can be found in any section of the spine, which can cause progressively painful radiculopathy C04.182.872
C10.668.829.900
Tarlov cyst
trisomy 9 rare disease trisomy partial or complete triplication of chromosome 9 C23.550.210.050.750
C23.550.210.182.500
X-linked adrenoleukodystrophy rare disease
disease
Designated intractable/rare diseases
leukodystrophy
nervous system heredodegenerative disease
X-linked adrenoleukodystrophy (X-ALD) is a peroxisomal disorder resulting in cerebral demyelination, axonal dysfunction in the spinal cord leading to spastic paraplegia, adrenal insufficiency and in some cases testicular insufficiency C10.114.375.112
C10.228.140.400
C10.228.140.695.562.112
C10.314.350.112
C20.111.258.250.175
C10.228.140.163.100.084
C10.228.140.163.100.362.250
C10.228.140.695.625.250
C10.314.400.250
C10.597.606.643.455.124
C16.320.322.500.124
C16.320.400.525.124
C16.320.565.189.084
C16.320.565.189.362.250
C16.320.565.663.100
C18.452.132.100.084
C18.452.132.100.362.250
C18.452.648.189.084
C18.452.648.189.362.250
C18.452.648.663.100
C19.053.500.270
Adrenoleukodystrophy


sexually transmitted infection edit

Article instance of subclass of description MeSH Code Commons category image
Adult T-cell leukemia/lymphoma sexually transmitted infection
disease
T-cell leukemia Human disease C04.557.337.428.580.100
C15.604.515.560.575.100
C20.683.515.528.582.100
Syphilitic aortitis sexually transmitted infection aortitis
syphilis
inflammation of the aorta C01.252.400.840.744.657
C01.252.847.840.744.657
C01.539.190.500
C14.260.500


sheep disease edit

Article instance of subclass of description MeSH Code Commons category image
ovine pulmonary adenocarcinoma sheep disease
cancer in animals
sheep disease Animal disease C02.782.815.725
C02.928.740
C04.557.470.200.025.715
C22.836.715
scrapie sheep disease
disease
transmissible spongiform encephalopathy disease that affects sheep and goats C10.228.228.800.717
C10.574.843.850
C22.836.799
Scrapie


state of the United States edit

Article instance of subclass of description MeSH Code Commons category image
North Carolina state of the United States state of the United States of America Z01.107.567.875.075.475
Z01.107.567.875.750.530
North Carolina
 
South Carolina state of the United States state of the United States of America Z01.107.567.875.075.662
Z01.107.567.875.750.700
South Carolina
Virginia state of the United States state of the United States of America Z01.107.567.875.075.837
Z01.107.567.875.750.870
Virginia


symptom edit

Article instance of subclass of description MeSH Code Commons category image
angina pectoris symptom coronary disease chest pain due to ischemia of the heart muscle C10.597.617.192.500
C14.280.647.187
C14.907.585.187
C23.888.592.612.233.500
Angina pectoris
 
chemical burn symptom occupational disease
burn
medical condition C26.200.156 Chemical burns
cyanosis symptom abnormal skin coloration medical diagnosis C23.888.248 Cyanosis
 
erythema symptom flushing symptom C17.800.229 Erythemas
 
heart arrhythmia symptom
medical finding
heart disease
clinical sign
finding of cardiac rhythm
group of conditions in which the heartbeat is irregular, too fast, or too slow C14.280.067
C23.550.073
Cardiac arrhythmias
 
hyperpigmentation symptom health problem
pigmentation disease
darkening of an area of skin or nails caused by increased melanin C17.800.621.430 Hyperpigmentation
inflammation symptom disease signs of activation of the immune system C23.550.470 Inflammation
 
intermittent claudication symptom
disease
arteriosclerosis
claudication
symptom that describes muscle pain on mild exertion (ache, cramp, numbness or sense of fatigue) C14.907.137.126.669
C23.888.531
necrolytic migratory erythema symptom erythema C17.800.551
C23.888.885.468
rash symptom clinical sign
skin disease
C17.800.257 Diseases and disorders of the skin
tachycardia symptom
medical finding
heart arrhythmia
finding of heart rate
heart rate that exceeds the normal resting rate C14.280.067.845
C23.550.073.845
Tachycardia
tension headache symptom headache C10.228.140.546.399.875 Tension headache
tremor symptom
rhythmic process
movement disorder involuntary muscle contraction C10.597.350.850
C23.888.592.350.850
Tremor


syndrome edit

Article instance of subclass of description MeSH Code Commons category image
circulatory shock syndrome circulatory collapse medical emergency characterized by decreased tissue perfusion and impaired cellular metabolism resulting from failure of circulatory system C23.550.835
C23.550.835.888
C26.797
Shock (circulatory)
LAMB Syndrome syndrome C04.557.450.565.550.312
C04.588.894.309.500
C14.280.459.500
C16.131.077.229
C16.131.831.108
NAME syndrome syndrome C04.557.450.565.550.312
C04.588.894.309.500
C14.280.459.500
C16.131.077.229
C16.131.831.108
overweight syndrome overnutrition having more body fat than is optimally healthy C23.888.144.699 Obesity
 


taxon edit

Article instance of subclass of description MeSH Code Commons category image
Escherichia coli taxon
model organism
Gram-negative, rod-shaped bacterium B03.440.450.425.325.300
B03.660.250.150.180.100
Escherichia coli
 
Henipavirus taxon genus of viruses B04.820.455.600.650.400 Henipavirus
 
Morbillivirus taxon genus of viruses B04.820.455.600.650.500 Morbillivirus
 
moringa taxon fast-growing, drought-resistant tree B01.650.940.800.575.912.250.752.500 Moringa oleifera
 
Xylella taxon genus of prokaryotes B03.440.400.425.967.950
B03.660.250.915.950
 


tissue edit

Article instance of subclass of description MeSH Code Commons category image
bone marrow tissue tissue flexible tissue in the interior of bones A15.382.216 Bone marrow
 
corneal epithelium tissue stratified squamous epithelium A09.371.060.217.325


vein edit

Article instance of subclass of description MeSH Code Commons category image
axillary vein vein A07.231.908.077 Axillary vein
azygos vein vein A07.231.908.106
 
brachiocephalic vein vein A07.231.908.130
femoral vein vein A07.231.908.314 Femoral vein
Great saphenous vein vein large, subcutaneous, superficial vein of the leg A07.231.908.819
hepatic portal vein vein
portal vein
A07.231.908.670.567 Body
inferior vena cava vein vena cava A07.231.908.949.648
 
internal jugular vein vein jugular vein paired vein collecting the blood from the brain, the superficial parts of the face, and the neck A07.231.908.498
jugular vein vein vein veins that bring deoxygenated blood from the head back to the heart A07.231.908.498 Jugular vein
popliteal vein vein A07.231.908.641
pulmonary vein vein
umbrella term
A07.231.908.713
renal vein vein A07.231.908.752
splenic vein vein A07.231.908.670.730
subclavian vein vein paired large vein A07.231.908.877
superior vena cava vein vena cava A07.231.908.949.815


website edit

Article instance of subclass of description MeSH Code Commons category image
International HapMap Project website website H01.158.273.180.350.162
H01.158.273.343.249.199
H01.158.273.343.350.130
H01.770.644.145.350.249
International HapMap Project
MedlinePlus website
medical database
online information service produced by the United States National Library of Medicine L01.313.500.750.280.730 MedlinePlus
PubMed website
search engine
medical database
bibliographic database
online database with abstracts of medical articles, hosted by US National Library of Medicine L01.313.500.750.280.750
L01.313.500.750.300.188.300.650
L01.313.500.750.300.742.650
L01.470.750.500.650
PubMed


Misc edit

Article instance of subclass of description MeSH Code Commons category image
14-alpha Demethylase Inhibitors Steroid Synthesis Inhibitors
Cytochrome P-450 Enzyme Inhibitors
Compounds that specifically inhibit sterol 14-demethylase. A variety of azole-derived antifungal agents act through this mechanism D27.505.696.399.450.855.100
D27.505.389.500.059
D27.505.519.389.870.100
D27.505.519.389.335.059
5-alpha Reductase Inhibitors Steroid Synthesis Inhibitors Drugs that inhibit 3-oxo-5-alpha-steroid 4-dehydrogenase. They are commonly used to reduce the production of dihydrotestosterone D27.505.519.389.870.200
D27.505.696.399.450.855.200
5-HT2c receptor agonist serotonin receptor agonist Endogenous compounds and drugs that specifically stimulate serotonin 5-ht2 receptors. Included under this heading are agonists for one or more of the specific 5-ht2 receptor subtypes D27.505.696.577.850.800.200
D27.505.519.625.850.800.200
5-Lipoxygenase-Activating Protein Inhibitors enzyme inhibitor Compounds that bind to and inhibit the action of 5-lipoxygenase-activating proteins D27.505.519.389.086
abdominal obesity obesity
clinical sign
excessive abdominal fat around the stomach and abdomen C18.654.726.500.697 Abdominal obesity
abdominal pregnancy ectopic pregnancy C13.703.733.536 Abdominal pregnancy
abortifacient Agents Reproductive Control Agents Chemical substances that interrupt pregnancy after implantation. D27.505.954.705.131
D27.505.696.875.131
Abortifacients
Abortifacient Agents, Nonsteroidal abortifacient Agents Non-steroidal chemical compounds with abortifacient activity. D27.505.696.875.131.100
D27.505.954.705.131.100
Abortifacient Agents, Steroidal abortifacient Agents Steroidal compounds with abortifacient activity D27.505.696.875.131.200
D27.505.954.705.131.200
Abuse-Deterrent Formulations Central Nervous System Agents
Sensory System Agents
Physiological Effects of Drugs
Drug formulations or delivery systems intended to discourage the abuse of controlled substances. These may include physical barriers to prevent chewing or crushing the drug; chemical barriers that prevent extraction of psychoactive ingredients; agon D27.505.696.663.850.007
D27.505.696.034
D27.505.954.427.005
Acaricide zoocide
pesticide
agent that kills members of the arachnid subclass Acari D27.720.031.700.071
D27.888.723.071
Acaricides
ACE inhibitor drug class Protease inhibitor pharmaceutical drug used primarily for the treatment of hypertension (elevated blood pressure) and congestive heart failure D27.505.519.389.745.085 ACE inhibitors
Acetaldehyde Dehydrogenase Inhibitors enzyme inhibitor Compounds that bind to and inhibit the enzymatic activity of acetaldehyde dehydrogenases D27.505.519.389.089
Acetylcholine Release Inhibitors Cholinergic Agents
Membrane Transport Modulators
Compounds that block release of the neurotransmitter acetylcholine D27.505.696.577.120.069
D27.505.519.625.120.069
D27.505.519.562.061
Acetylcholinesterase inhibitor enzyme inhibitor
Cholinergic Agents
Drugs that inhibit cholinesterases. The neurotransmitter acetylcholine is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses D27.505.519.389.275
D27.505.519.625.120.300
D27.505.696.577.120.300
Achilles tendon tendon type of tendon in the lower leg A02.880.176 Achilles tendon
Acid Sensing Ion Channel Blockers Sodium channel blocker A subclass of sodium channel blockers that are specific for acid-sensing sodium channels D27.505.519.562.750.100
Acne conglobata acne C17.800.030.150.500
C17.800.794.111.500
Acromioclavicular joint A02.835.583.032 Acromioclavicular joints
Activated protein C resistance thrombophilia C15.378.100.100.037
C15.378.100.141.036
C15.378.925.050
C16.320.099.037
acute bronchitis bronchitis short-term inflammation of the bronchi (large and medium-sized airways) of the lungs C08.127.446
C08.381.495.146
C08.730.099
Acute bronchitis
acute disease disease disease with a rapid onset and/or a short course C23.550.291.125
acute radiation syndrome intoxication health effect of radiation C26.733.188 Acute radiation syndrome
Adams–Stokes syndrome brain ischemia periodic fainting spell in which there is a periodic onset and offset of blockage of heart due to disorder of heart rhythm C14.280.067.558.137
C23.550.073.425.025
adenoidectomy lymphatic ectomy surgical removal of the adenoids E04.580.068
 
Adenosine A1 Receptor Agonists Purinergic P1 Receptor Agonists Compounds that bind to and stimulate adenosine a1 receptors D27.505.696.577.725.200.100.100
D27.505.519.625.725.200.100.100
Adenosine A1 Receptor Antagonists Purinergic P1 Receptor Antagonists Compounds that bind to and block the stimulation of adenosine a1 receptors D27.505.519.625.725.400.100.100
D27.505.696.577.725.400.100.100
Adenosine A2 Receptor Agonists Purinergic P1 Receptor Agonists Compounds that selectively bind to and activate adenosine a2 receptors D27.505.696.577.725.200.100.200
D27.505.519.625.725.200.100.200
Adenosine A2 Receptor Antagonists Purinergic P1 Receptor Antagonists Compounds that selectively bind to and block the activation of adenosine a2 receptors D27.505.519.625.725.400.100.200
D27.505.696.577.725.400.100.200
Adenosine A3 Receptor Agonists Purinergic P1 Receptor Agonists Drugs that selectively bind to and activate adenosine a3 receptors D27.505.519.625.725.200.100.300
D27.505.696.577.725.200.100.300
Adenosine A3 Receptor Antagonists Purinergic P1 Receptor Antagonists Compounds that selectively bind to and block the activation of adenosine a3 receptors D27.505.696.577.725.400.100.300
D27.505.519.625.725.400.100.300
Adenosine Deaminase Inhibitors enzyme inhibitor Drugs that inhibit adenosine deaminase activity D27.505.519.389.092
Adenylyl Cyclase Inhibitors enzyme inhibitor Compounds that bind to and inhibit the action of Adenylyl Cyclase D27.505.519.389.108
adhesive Specialty Uses of Chemicals
process material
material which is used for bonding of various materials D27.720.013 Adhesives
 
Adjuvants, Anesthesia Central Nervous System Agents Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage D27.505.954.427.010
Adjuvants, Pharmaceutic Adjuvant
Pharmaceutic Aids
Agents that aid or increase the action of the principle drug (drug synergism) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (pharmacokinetics) in such a way as to enhance its effects D27.720.744.064
Adrenergic Agents neurotransmitter Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitter D27.505.519.625.050
D27.505.696.577.050
Adrenergic alpha-1 Receptor Agonists Alpha-adrenergic agonist Compounds that bind to and activate adrenergic alpha-1 receptors D27.505.696.577.050.100.100.100
D27.505.519.625.050.100.100.100
Adrenergic alpha-1 Receptor Antagonists Alpha blocker Drugs that bind to and block the activation of adrenergic alpha-1 receptors D27.505.696.577.050.200.100.100
D27.505.519.625.050.200.100.100
Adrenergic alpha-2 Receptor Agonists Alpha-adrenergic agonist Compounds that bind to and activate adrenergic alpha-2 receptors D27.505.696.577.050.100.100.200
D27.505.519.625.050.100.100.200
Adrenergic alpha-2 Receptor Antagonists Alpha blocker Drugs that bind to and block the activation of adrenergic alpha-2 receptors D27.505.696.577.050.200.100.200
D27.505.519.625.050.200.100.200
Adrenergic antagonist Adrenergic Agents Drugs that bind to but do not activate adrenergic receptors. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters epinephrine and norepinephrine D27.505.519.625.050.200
D27.505.696.577.050.200
Adrenergic beta-1 Receptor Agonists Adrenergic beta-Agonists Compounds that bind to and activate adrenergic beta-1 receptors D27.505.696.577.050.100.200.100
D27.505.519.625.050.100.200.100
Adrenergic beta-1 Receptor Antagonists Adrenergic beta-antagonist Drugs that bind to and block the activation of adrenergic beta-1 receptors D27.505.696.577.050.200.200.100
D27.505.519.625.050.200.200.100
Adrenergic beta-2 Receptor Antagonists Adrenergic beta-antagonist Drugs that bind to and block the activation of adrenergic beta-2 receptors D27.505.519.625.050.200.200.200
D27.505.696.577.050.200.200.200
Adrenergic beta-3 Receptor Agonists Adrenergic beta-Agonists Compounds that bind to and activate adrenergic beta-3 receptors D27.505.696.577.050.100.200.300
D27.505.519.625.050.100.200.300
Adrenergic beta-3 Receptor Antagonists Adrenergic beta-antagonist Drugs that bind to and block the activation of adrenergic beta-3 receptors D27.505.696.577.050.200.200.300
D27.505.519.625.050.200.200.300
Adrenergic beta-Agonists adrenergic agonist Drugs that selectively bind to and activate beta-adrenergic receptors. D27.505.519.625.050.100.200
D27.505.696.577.050.100.200
Adrenergic beta-antagonist Adrenergic antagonist Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine h D27.505.696.577.050.200.200
D27.505.519.625.050.200.200
Affinity Labels Indicators and Reagents Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of D27.720.470.410.080
age group group of humans
social group
set of persons classified by age from birth (infant, newborn) to octogenarians and older (aged, 80 and over) M01.060
ageusia taste disorder
sensory loss
total loss of the sense of taste C10.597.751.861.184
C23.888.592.763.861.184
agrochemical chemical substance
Specialty Uses of Chemicals
Chemicals used in agriculture. These include pesticides, fumigants, fertilizers, plant hormones, steroids, antibiotics, mycotoxins, etc D27.720.031 Agricultural chemistry
Air Pollutants Environmental Pollutants Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include gases; particulate matter; and volatile organic chemicals D27.888.284.101
Air Pollutants, Occupational Air Pollutants Toxic air-borne matter related to work performed they are usually produced by the specific nature of the occupation D27.888.284.101.268
Air Pollutants, Radioactive Air Pollutants Pollutants present in air which exhibit radioactivity D27.888.284.101.393
albinism disease congenital disorder causing skin to lack pigmentation C11.270.040
C16.320.290.040
C16.320.565.100.102
C16.320.850.080
C17.800.621.440.102
C17.800.827.080
C18.452.648.100.102
Albinism
 
albuminuria urinary system disease
proteinuria
urologic disease typically indicating kidney malfunction C12.777.934.734.269
C13.351.968.934.734.269
C23.888.942.750.269
Alcohol Deterrents Central Nervous System Agents Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism D27.505.954.427.020
alcoholic liver disease liver disease
long-term effects of alcohol
C06.552.645
C25.775.100.087.645
Alkylating antineoplastic agent alkylating agent
antineoplastic
pharmaceutical drugs D27.505.519.124.035
D27.888.569.035.035
D27.505.954.248.150
Alkylating antineoplastic agents
allantois A10.615.284.147
Alpha blocker Adrenergic antagonist pharmaceutical drugs, neutral antagonist of alpha-adrenergic receptors D27.505.696.577.050.200.100
D27.505.519.625.050.200.100
Alpha blockers
Alpha-adrenergic agonist adrenergic agonist Drugs that selectively bind to and activate alpha adrenergic receptors. D27.505.696.577.050.100.100
D27.505.519.625.050.100.100
Amaurosis fugax Amaurosis C10.597.751.941.162.125
C11.966.075.125
C23.888.592.763.941.162.125
Amebicide antiprotozoal Agents which are destructive to amebae, especially the parasitic species causing amebiasis in man and animal D27.505.954.122.250.100.055
Amnion A10.615.284.277
amniotic band syndrome congenital abnormality Human disease C16.614.042
Ampholyte Mixtures buffer solution Such mixtures of amphoteric electrolytes or buffers that provide a continuous range of ph in an electric field; used for separating proteins by their isoelectric points, i.e., by isoelectric focusing D27.720.470.280.060
Amylin Receptor Agonists anti-diabetic medication
mechanism of action
Compounds that stimulate the activity of amymin receptors. Included under this heading is the endogenous form of islet amyloid polypeptide and synthetic compounds that mimic its effect D27.505.696.422.374
D27.505.519.143
Anabolic Agents hormone These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power D27.505.696.399.472.080
Analgesics, Short-Acting analgesic Pain-alleviating drugs characterized by rapid action time. D27.505.954.427.040.381
D27.505.696.663.850.014.580
anaphylaxis hypersensitivity severe allergic reaction C20.543.480.099 Anaphylaxis
 
Anatomy of the cerebellum A08.186.211.132.810.428.200 Cerebellum
androgen sex steroid
hormone
type of sex steroid D27.505.696.399.472.161 Anabolic-androgenic steroids
Androgen Antagonists Hormone Antagonists Compounds which inhibit or antagonize the biosynthesis or actions of androgens D27.505.696.399.450.065
Androgen Receptor Antagonists Androgen Antagonists Compounds that bind to and inhibit the activation of androgen receptors D27.505.696.399.450.065.249
anesthesia awareness adverse reactions to anesthesia C23.550.505.400
Anesthesia dolorosa trigeminal neuralgia C07.465.299.625.500.349
C10.292.262.875
C10.292.319.625.700.349
C10.900.300.218.775
C26.915.300.400.825
Anesthetics, Combined anesthetic The use of two or more chemicals simultaneously or sequentially to induce anesthesia. The drugs need not be in the same dosage form D27.505.696.277.100.017
D27.505.954.427.210.100.017
Anesthetics, Dissociative Anesthetics, Intravenous Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to neuroleptanalgesia, but is brough D27.505.696.277.100.035.075.035
D27.505.954.427.210.100.035.075.035
Anesthetics, General anesthetic Agents that induce various degrees of analgesia; depression of consciousness, circulation, and respiration; relaxation of skeletal muscle; reduction of reflex activity; and amnesia. There are two types of general anesthetics, inhalation and intraven D27.505.696.277.100.035
D27.505.954.427.210.100.035
Anesthetics, Inhalation Anesthetics, General Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenou D27.505.954.427.210.100.035.060
D27.505.696.277.100.035.060
Anesthetics, Intravenous Anesthetics, General Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulatio D27.505.696.277.100.035.075
D27.505.954.427.210.100.035.075
Aneugens Mutagen Agents which affect cell division and the mitotic spindle apparatus resulting in the loss or gain of whole chromosomes, thereby inducing an aneuploidy D27.888.569.468.060
Angiogenesis Inducing Agents Angiogenesis Modulating Agents Agents that induce or stimulate physiologic angiogenesis or pathologic angiogenesis D27.505.696.377.077.077
Angiogenesis Modulating Agents Growth Substances Agents that modulate the physiologic angiogenesis process. This is accomplished by endogenous angiogenic proteins and a variety of other chemicals and pharmaceutical agents D27.505.696.377.077
Angiotensin II Type 1 Receptor Blockers Angiotensin Receptor Antagonists Agents that antagonize angiotensin ii type 1 receptor. Included are angiotensin ii analogs such as saralasin and biphenylimidazoles such as losartan. Some are used as antihypertensive agents D27.505.519.162.500
Angiotensin II Type 2 Receptor Blockers Angiotensin Receptor Antagonists Agents that antagonize the angiotensin ii type 2 receptor D27.505.519.162.750
Angiotensin Receptor Antagonists mechanism of action Agents that antagonize angiotensin receptors. Many drugs in this class specifically target the angiotensin type 1 receptor D27.505.519.162
Anion Exchange Resins Ion Exchange Resins High-molecular-weight insoluble polymers that contain functional cationic groups capable of undergoing exchange reactions with anions D27.720.470.420.050
Anisocoria pupil disease C10.597.690.150
C11.710.090
C23.888.592.708.150
Anisocoria
 
anophthalmia agenesis
microphthalmia
C11.250.080
C16.131.384.159
Anophthalmia
anosmia olfaction disorder
sensory loss
the inability to smell C10.597.751.600
C23.888.592.763.550
Anosmia
Antacid drugs for acid-related disorders
Gastrointestinal Agents
mechanism of action
a substance which neutralizes stomach acidity, used to relieve heartburn, indigestion or an upset stomach D27.505.954.483.080
D27.505.519.170
Antacids
Anterior root of spinal nerve nerve A08.800.800.720.725
Anti-Allergic Agents Therapeutic Uses Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (from ama drug evaluations annual, 1994, p475) D27.505.954.016
Anti-Asthmatic Agents Respiratory System Agents Drugs that are used to treat asthma D27.505.954.796.050
Anti-Dyskinesia Agents Central Nervous System Agents Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of parkinson disease (antiparkinson agents) and those for the D27.505.954.427.090
Anti-HIV Agents Anti-Retroviral Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. D27.505.954.122.388.077.088
Anti-Infective Agents Therapeutic Uses
drug
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. D27.505.954.122
Anti-Infective Agents, Local Anti-Infective Agents Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. D27.505.954.122.187
Anti-Infective Agents, Urinary Anti-Infective Agents
Renal Agents
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. D27.505.954.613.056
D27.505.954.122.237
anti-inflammatory agent drug
Therapeutic Uses
substance that reduces or suppresses inflammation D27.505.954.158 Anti-inflammatory agents
Anti-Obesity Agents Central Nervous System Agents Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (niddm) to treat obesit D27.505.954.427.140
Anti-Retroviral Agents antiviral agent Agents used to treat retroviridae infections D27.505.954.122.388.077
antibiotic drug
Anti-Infective Agents
antimicrobial drug
drug used in the treatment and prevention of bacterial infections D27.505.954.122.085 Antibiotics
 
Antibiotics, Antineoplastic antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. D27.505.954.248.106
Antibiotics, Antitubercular antituberculous drug Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and D27.505.954.122.085.255.135
Anticarcinogenic Agents antineoplastic
Protective Agents
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved D27.505.696.706.018
D27.505.954.248.125
D27.720.799.018
Anticestodal Agents Antiplatyhelmintic Agents Agents used to treat tapeworm infestations in man or animals D27.505.954.122.250.075.100.040
Anticholesteremic Agents hypolipidemic Substances used to lower plasma cholesterol levels D27.505.519.186.071.202
D27.505.954.557.500.202
anticoagulant drug
Hematologic Agents
chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. D27.505.954.502.119 Anticoagulants
antidepressant drug
Psychotropic Drugs
drugs used for the treatment of major depressive disorders and other conditions D27.505.954.427.700.122 Antidepressants
Antidepressive Agents, Second-Generation antidepressant A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake D27.505.954.427.700.122.050
Antidiarrheals Gastrointestinal Agents Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition D27.505.954.483.161
Antidiuretic Agents Natriuretic Agents Agents that reduce the excretion of urine, most notably the octapeptide vasopressins D27.505.696.560.249
Antidiuretic Hormone Receptor Antagonists Natriuretic Agents
mechanism of action
Endogenous compounds and drugs that inhibit or block the activity of antiduiretic hormone receptors D27.505.696.560.311
D27.505.519.174
antidote drug
Protective Agents
substance which counteracts poisoning D27.720.799.037
D27.505.696.706.037
Antidotes
Antifibrinolytic Hemostatics
Fibrin Modulating Agents
Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders D27.505.954.502.270.463.091
D27.505.519.421.500
Antifibrinolytics
antifoaming agent food additive
surfactant
mechanism of action
chemical additive that reduces and hinders the formation of foam in liquids D27.720.877.048
D27.505.519.178
Antihyperkalemic Agents Natriuretic Agents Compounds used to lower excessive potassium levels in the body D27.505.696.560.374
antimalarial antiprotozoal Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (from ama, drug evaluations annual, 1992, p1585) D27.505.954.122.250.100.085 Antimalarial agents
Antimanic Agents tranquilizer Agents that are used to treat bipolar disorders or mania associated with other affective disorders D27.505.696.277.950.025
D27.505.954.427.700.872.025
D27.505.954.427.210.950.025
Antimetabolites drug
Noxae
mechanism of action
Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (from ama drug evaluations annual, 1994, p2033) D27.888.569.042
D27.505.519.186
Antimetabolites
Antimetabolites, Antineoplastic Antimetabolites
antineoplastic
Antimetabolites that are useful in cancer chemotherapy D27.505.519.186.144
D27.505.954.248.144
D27.888.569.042.030
Antimitotic Agents antineoplastic
Mitosis Modulators
Agents that arrest cells in mitosis, most notably tubulin modulators D27.505.954.248.147
D27.505.519.593.249
Antimutagenic Agents Protective Agents Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved D27.505.696.706.080
D27.720.799.042
antinematodal agent anthelmintic Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice D27.505.954.122.250.075.080
Antineoplastic Agents, Hormonal antineoplastic Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacolog D27.505.954.248.169
Antineoplastic Agents, Immunological antineoplastic Antineoplastic agents containing immunological agents (e.g. Mabs). These pharmacologic preparations inhibit or prevent the proliferation of neoplasms D27.505.954.248.384
Antineoplastic Agents, Phytogenic antineoplastic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. D27.505.954.248.179
antioxidant food additive
food ingredient
Protective Agents
mechanism of action
molecule that inhibits the oxidation of other molecules D27.505.696.706.125
D27.505.519.217
D27.720.799.047
Antioxidants
Antiparkinson Agents Anti-Dyskinesia Agents Agents used in the treatment of parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists D27.505.954.427.090.050
Antiperspirants cosmetics Agents that are put on the skin to reduce sweating or prevent excess sweating (hyperhidrosis) D27.720.269.189
Antiplatyhelmintic Agents anthelmintic Agents used to treat cestode, trematode, or other flatworm infestations in man or animals D27.505.954.122.250.075.100
Antisense Elements (Genetics) Nucleic Acid Probes Nucleic acids which hybridize to complementary sequences in other target nucleic acids causing the function of the latter to be affected D27.720.470.530.600.150
Antisense oligonucleotide Antisense Elements (Genetics) Short fragments of dna or rna that are used to alter the function of target rnas or dnas to which they hybridize D27.720.470.530.600.150.640
Antisense RNA non-coding RNA
Antisense Elements (Genetics)
Rna molecules which hybridize to complementary sequences in either rna or dna altering the function of the latter. Endogenous antisense rnas function as regulators of gene expression by a variety of mechanisms. Synthetic antisense rnas are used to e D27.720.470.530.600.150.760
Antisickling Agents Hematologic Agents Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions D27.505.954.502.135
Antispermatogenic Agents Contraceptive Agents, Male
Noxae
Physiological Effects of Drugs
Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis D27.505.696.138
D27.505.696.875.360.443.068
D27.888.569.071
D27.505.954.705.360.443.068
antistatic agent Specialty Uses of Chemicals compound used for treatment of materials or their surfaces in order to reduce or eliminate buildup of static electricity D27.720.066
Antithrombins anticoagulant
Serine Proteinase Inhibitors
Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects D27.505.954.502.119.500
D27.505.519.389.745.800.449
Antithyroid Agents Hormone Antagonists Agents that are used to treat hyperthyroidism by reducing the excessive production of thyroid hormones D27.505.696.399.450.100
Antitreponemal Agents antibiotic Agents used to treat infections with bacteria of the genus treponema. This includes syphilis & yaws D27.505.954.122.085.222
Antitrichomonal Agents antiprotozoal Agents used to treat trichomonas infections D27.505.954.122.250.100.115
antituberculous drug antibacterial
antibiotic
Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs u D27.505.954.122.085.255
anxiety emotion emotion characterized by an unpleasant state of inner turmoil F01.470.132 Anxiety
 
Aortic body one of several small clusters of peripheral chemoreceptors known as glomus cells, baroreceptors, and supporting cells located along the aortic arch A08.675.650.915.500.600.050
aphonia voice disorder medical condition leading to loss of voice C08.360.940.160
C09.400.940.160
C10.597.975.100
C23.888.592.979.100
aphrodisiac stimulant Chemical agents or odorants that stimulate sexual desires. (mcgraw-hill dictionary of scientific and technical terms, 4th ed) D27.505.954.427.220.045
D27.505.696.282.045
Aphrodisiacs
apocrine sweat gland mostly limited to the axilla (armpits) and perianal areas in humans; they are not significant for cooling in humans, but are the sole effective sweat glands in hoofed animals, such as the camels, donkeys, horses, and cattle A10.336.899.206
Appetite Depressants Anti-Obesity Agents Agents that are used to suppress appetite D27.505.954.427.140.155
Appetite Stimulants stimulant Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and aids D27.505.954.427.220.050
D27.505.696.282.050
arachnoid mater leptomeninx weblike middle layer of the three meninges A08.186.566.166 Arachnoid mater
Area postrema medullary structure in the brain that controls vomiting A08.186.211.132.810.406.286
Aromatase inhibitor Estrogen Antagonists
Steroid Synthesis Inhibitors
medicine D27.505.519.389.870.300
D27.505.696.399.450.855.300
D27.505.696.399.450.327.149
Aromatase inhibitors
Aromatic Amino Acid Decarboxylase Inhibitors Antiparkinson Agents
enzyme inhibitor
Compounds and drugs that block or inhibit the enzymatic action of aromatic amino acid decarboxylases. Pharmaceutical agents in this category are used in conjunction with levodopa in order to slow its metabolism D27.505.519.389.124
D27.505.954.427.090.050.249
arsenic poisoning intoxication C10.720.475.150
C25.723.097
arteriole blood vessel small-diameter blood vessel in the microcirculation that extends and branches out from an artery and leads to capillaries. A07.231.114.060
arteritis angiitis inflammation of the walls of arteries, usually as a result of infection or autoimmune response. C14.907.940.090
artery blood vessel blood vessels that carry blood away from the heart A07.231.114 Arteries
 
arthrosis of hip arthropathy osteoarthritis C05.550.114.606.400
C05.799.613.400
Coxarthrosis
articular cartilage hyaline cartilage A02.165.407.150
Artificial tears eye drop
lubricant
Ophthalmic solutions that include lubricants and wetting agents such as polyethylene glycol; hypromellose; glycerol; propylene glycol. They are used to treat conditions caused by deficient tear production such as dry eye syndrome D27.505.954.578.645.500
D27.720.556.249
D27.720.752.608.500
arytenoid cartilage A02.165.507.083 Arytenoid cartilages
astringent dermatologic drug
Physiological Effects of Drugs
chemical compound that tends to shrink or constrict body tissues D27.505.696.207
D27.505.954.444.100
Athetosis movement disorder C10.597.350.110
C23.888.592.350.110
attention mental process behavioral and cognitive process of selectively concentrating on a discrete aspect of information, whether deemed subjective or objective, while ignoring other perceivable information F02.830.104.214 Attention
attentional bias bias F02.830.104.214.500
Attentional blink F02.463.593.932.145
Auditory processing disorder hearing disorder
hearing disorder
C09.218.807.186.094
C10.228.140.068.094
C10.597.606.762.200
C23.888.592.604.764.200
Autonomic Agents Peripheral Nervous System Agents Agents affecting the function of, or mimicking the actions of, the autonomic nervous system and thereby having an effect on such processes as respiration, circulation, digestion, body temperature regulation, certain endocrine gland secretions, etc D27.505.696.663.050
Aversive Agents Abuse-Deterrent Formulations
Pharmaceutic Aids
mechanism of action
Chemicals added to pharmacologic preparations, poisonous household goods, and other chemicals to discourage their abuse or consumption D27.720.744.179
D27.505.519.241
D27.505.696.663.850.007.500
D27.505.954.427.005.500
D27.505.696.034.500
bacteremia hematopoietic system diseases
bacterial infectious disease
presence of bacteria in the blood C01.252.100
C01.539.757.100
C23.550.470.790.500.100
Bacteremia
Bankart lesion shoulder problem C26.404.625.500
C26.803.250.500
Bankart lesion
Bartholin's gland exocrine gland two glands located slightly posterior and to the left and right of the opening of the vagina A05.360.319.887.220
 
basal ganglia A08.186.211.730.885.105 Basal ganglia
basilar membrane A09.246.631.246.125
Behavioral game theory E05.385
Bender-Gestalt Test psychological test
neuropsychological test
psychological test that assesses visual-motor functioning, developmental disorders, and neurological impairments F04.711.513.180
F04.711.647.138
Beta-lactamase inhibitor chemical compound
antibiotic
enzyme inhibitor
Endogenous substances and drugs that inhibit or block the activity of beta-lactamases D27.505.954.122.085.516
D27.505.519.389.400
Beta-lactamase inhibitors
Beta2-adrenergic agonist Adrenergic beta-Agonists Compounds bind to and activate adrenergic beta-2 receptors D27.505.696.577.050.100.200.200
D27.505.519.625.050.100.200.200
binge drinking alcohol abuse modern epithet for drinking alcoholic beverages with an intention of becoming intoxicated by heavy consumption of alcohol over a short period of time C25.775.100.437
biocompatible material Biomedical and Dental Materials substance that has been engineered to interact with biological systems for a medical purpose D27.720.102.130
Biomedical and Dental Materials Specialty Uses of Chemicals Substances used in biomedicine or dentistry predominantly for their physical, as opposed to chemical, properties. D27.720.102
Bitemporal hemianopsia hemianopia
heteronymous hemianopsia
C10.597.751.941.512
C11.966.075.500
C23.888.592.763.941.512
blastocyst embryo A16.254.085 Blastocyst
Bleaching Agents oxidizing agent Chemicals that are used to oxidize pigments and thus effect whitening D27.720.642.315
blister Q371226 small pocket of fluid within the upper layers of the skin C17.800.865.187
C23.300.122
Blisters
Blood–air barrier A04.411.715.025
Blowout fracture Zygoma fracture
eye adnexa disease
C10.900.300.284.500.550
C26.404.750.684
C26.915.300.425.500.550
body temperature temperature
vital signs
temperature, vital sign, measurement E01.370.600.120 Body temperature
Boerhaave syndrome esophageal rupture syndrome characterized by spontaneous longitudinal transmural rupture of the esophagus, usually in its distal part C06.405.117.468
C26.348
Boerhaave syndrome
Bone cement Biomedical and Dental Materials Adhesives used to fix prosthetic devices to bones and to cement bone to bone in difficult fractures. Synthetic resins are commonly used as cements. A mixture of monocalcium phosphate, monohydrate, alpha-tricalcium phosphate, and calcium carbonate wi D27.720.102.158
Bone Density Conservation Agents Physiological Effects of Drugs Agents that inhibit bone resorption and/or favor bone mineralization and bone regeneration. They are used to heal bone fractures and to treat metabolic bone diseases such as osteoporosis D27.505.696.242
bone tumor tumor C04.588.149
C05.116.231
Cancers of bone and articular cartilage
brachial plexus nerve plexus A08.800.800.720.050 Brachial plexus
 
brachytherapy radiation therapy E02.815.150 Brachytherapy
 
Bradykinin B1 Receptor Antagonists Bradykinin Receptor Antagonists Compounds and drugs that inhibit ligand binding or cellular signaling by bradykinin b1 receptors D27.505.519.265.249
Bradykinin B2 Receptor Antagonists Complement Inactivating Agents
Bradykinin Receptor Antagonists
Compounds and drugs that inhibit ligand binding or cellular signaling by bradykinin b2 receptors D27.505.519.265.500
D27.505.696.477.656.500.500
Bradykinin Receptor Antagonists mechanism of action Compounds and drugs that inhibit ligand binding or cellular signaling by bradykinin receptors D27.505.519.265
brain animal organ organ that serves as the center of the Nervous System in all vertebrate and most invertebrate animals A08.186.211 Brain
 
brain stem posterior part of the brain, adjoining and structurally continuous with the spinal cord A08.186.211.132 Brain stem
brain tumor tumor
intracranial neoplasm
type of tumor C04.588.614.250.195
C10.228.140.211
C10.551.240.250
Brain neoplasms
 
Branchial cleft cyst branchial cleft anomalies
Cutaneous columnar cyst
C04.182.117 Branchial cleft cyst
Breech birth Presentation obstructed labor C13.703.420.183
 
Bronchoconstrictor Agents Autonomic Agents
Respiratory System Agents
Agents causing the narrowing of the lumen of a bronchus or bronchiole D27.505.696.663.050.100
D27.505.954.796.170
buffer solution aqueous solution
acidity regulator
Laboratory Chemicals
aqueous solution consisting of a mixture of a weak acid and its conjugate base, which resists pH change when a strong acid or base is added D27.720.470.280 Buffers (chemical)
bulbourethral gland exocrine gland small exocrine gland in the reproductive system of many male mammals A05.360.444.123 Bulbourethral gland
bunion foot deformity deformity characterized by lateral deviation of the great toe C05.330.488.050
C05.330.610
Bunion
buttocks anatomical structure two rounded portions of the anatomy, traditionally located on the posterior of various organisms A01.378.610.100 Buttocks
Caecitis cecal disease
intraabdominal infection
caecitis C01.539.463.850
C06.405.205.932
C06.405.469.110.708
calcaneus bone
short bone
bone of the foot A02.835.232.043.300.710.300 Calcaneus
 
Calcimimetic Agents Hormone Antagonists Small organic molecules that act as allosteric activators of the calcium sensing receptor (casr) in the parathyroid glands and other tissues. They lower the threshold for casr activation by extracellular calcium ions and diminish parathyroid hormone D27.505.696.399.450.230
Calcineurin Inhibitors enzyme inhibitor Compounds that inhibit or block the phosphatase activity of calcineurin D27.505.519.389.174
Calcium Channel Agonists Vasoconstrictor Agents
Membrane Transport Modulators
Agents that increase calcium influx into calcium channels of excitable tissues. This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-se D27.505.519.562.124
D27.505.954.411.793.205
calcium channel blocker antihypertensive drug
Cardiovascular Agents
Membrane Transport Modulators
several medications that disrupt the movement of calcium (Ca2+) through calcium channels D27.505.954.411.192
D27.505.519.562.249
Calcium channel blockers
Calcium Chelating Agents Chelating Agents Substances that bind to and sequester calcium ions D27.720.832.500.204
D27.505.519.914.500.204
Calcium Ionophores Ionophore Chemical agents that increase the permeability of cell membranes to calcium ions D27.720.395.100
D27.505.519.562.374.100
calculus dental plaque form of hardened dental plaque C07.793.208.250
C23.300.175.350
Dental calculus
call centre centralised office used for the purpose of receiving or transmitting a large volume of requests by telephone N02.421.297.036 Call centres
 
callosity keratosis C17.800.428.200
canaliculitis lacrimal apparatus disease C11.496.221.500
canine distemper Morbillivirus infectious disease species of virus C02.782.580.600.500.285
C22.268.265
Canine distemper
 
canine hip dysplasia dog disease hip dysplasia
animal genetic disease
A hereditary disease of the hip joints in dogs. Signs of the disease may be evident any time after 4 weeks of age. C22.268.485
canine tooth tooth tooth A14.549.167.860.200 Canine teeth
Cannabinoid Receptor Agonists Cannabinoid Receptor Modulators Compounds that interact with and stimulate the activity of cannabinoid receptors D27.505.519.625.085.500
D27.505.696.399.472.188.500
Cannabinoid receptor antagonist Cannabinoid Receptor Modulators Compounds that inhibit or block the activity of cannabinoid receptors D27.505.519.625.085.750
D27.505.696.399.472.188.750
Cannabinoid Receptor Modulators hormone
neurotransmitter
Compounds that interact with and modulate the activity of cannabinoid receptors D27.505.696.399.472.188
D27.505.519.625.085
capitate bone bone bone of the wrist A02.835.232.087.319.150.150 Capitate bone
Carbamoyl Phosphate Synthetase I Activators Enzyme activator Substances and drugs that stimulate the synthesis or increase the activity of carbamoyl phosphate synthetase i. Drugs in this class of compounds have been used to treat the genetic disorder, carbamoyl-phosphate synthase i deficiency disease D27.505.519.374.099
carbon monoxide poisoning intoxication
chemical hazard
death due to exposure to carbon monoxide C25.723.455.245 Carbon monoxide
Carbonic anhydrase inhibitor enzyme inhibitor A class of compounds that reduces the secretion of h+ ions by the proximal kidney tubule through inhibition of carbonic anhydrases D27.505.519.389.200 Carbonic anhydrase inhibitors
carcinogen causes of cancer
substance
Noxae
substance, radionuclide, or radiation directly involved in causing cancer D27.888.569.100 Carcinogens
Carcinogens, Environmental carcinogen Carcinogenic substances that are found in the environment D27.888.569.100.125
Cardiac asthma heart disease medical diagnosis of wheezing, coughing or shortness of breath due to congestive heart failure C08.618.326.396
C14.280.434.313
C23.888.852.371.396
Cardioplegic Solutions Cardiovascular Agents
Pharmaceutical Solutions
Solutions which, upon administration, will temporarily arrest cardiac activity. They are used in the performance of heart surgery D27.505.954.411.207
D27.720.752.322
D27.505.954.578.322
Cardiotonic Agents Cardiovascular Agents
Protective Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in D27.505.954.411.222
D27.720.799.080
Cardiotoxins Noxae Agents that have a damaging effect on the heart. Such damage can occur from alkylating agents; free radicals; or metabolites from oxidative stress and in some cases is countered by cardiotonic agents. Induction of long qt syndrome or torsades de poi D27.888.569.142
Cardiovascular Agents Therapeutic Uses Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume D27.505.954.411
Cariogenic Agents Biomedical and Dental Materials Substances that promote dental caries D27.720.102.187
Cariostatic Agents Biomedical and Dental Materials
Protective Agents
Substances that inhibit or arrest dental caries formation. (boucher's clinical dental terminology, 4th ed) D27.505.696.706.222
D27.720.799.113
D27.720.102.223
Caspase Inhibitors Cysteine Proteinase Inhibitors Endogenous and exogenous compounds and that either inhibit caspases or prevent their activation D27.505.519.389.745.325.500
Catechol O-Methyltransferase Inhibitors Antiparkinson Agents
enzyme inhibitor
Compounds and drugs that inhibit or block the activity of catechol o-methyltransferase enzymes. Drugs in this class are used in management of central nervous system disorders such as parkinson disease D27.505.519.389.237
D27.505.954.427.090.050.500
Cathartics Gastrointestinal Agents Agents that are used to stimulate evacuation of the bowels D27.505.954.483.396
Cation Exchange Resins Ion Exchange Resins High molecular weight insoluble polymers which contain functional anionic groups that are capable of undergoing exchange reactions with cations D27.720.470.420.275
Cauda equina A08.800.800.720.725.150
 
CCR5 Receptor Antagonists Anti-HIV Agents
mechanism of action
Compounds and drugs that inhibit or block the activity of ccr5 receptors D27.505.519.275
D27.505.954.122.388.077.088.104
celiac ganglia ganglion part of nervous system A08.340.315.350
Celiac plexus A complex network of nerves (a nerve plexus) located in the abdomen. A08.800.050.050.150
Central gelatinous substance of spinal cord A08.186.854.697.500.500
Central Nervous System Agents Therapeutic Uses A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for tha D27.505.954.427
Central Nervous System Depressants Central Nervous System Agents
Physiological Effects of Drugs
A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and ant D27.505.696.277
D27.505.954.427.210
Central serous retinopathy retinal disease
rare acquired eye disease
C11.768.175 Central serous retinopathy
cerebral peduncle A08.186.211.132.659
Cerumenolytic Agents mechanism of action
Physiological Effects of Drugs
Emulsifying Agents
Compounds that disintegrate natural waxy exudates such as ear wax D27.505.519.295
D27.505.696.305
D27.720.877.383.500
cervical plexus nerve plexus A08.800.800.720.150
cervix the lower part of the uterus in the human female reproductive system A05.360.319.679.256 Cervix uteri
 
Charcot–Bouchard aneurysm intracranial aneurysm C14.907.055.817
Chelating Agents Sequestering Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. D27.505.519.914.500
D27.720.832.500
chemical database database L01.313.500.750.300.188.400.300
L01.470.750.750.300
chemical warfare agent chemical substance
poison
Chemicals that are used to cause the disturbance, disease, or death of humans during warfare D27.720.777.300
D27.888.569.612.150
Chilaiditi syndrome colonic disease C06.405.469.158.093 Chilaiditi syndrome
child abuse occurrence
abuse
physical, sexual or emotional maltreatment or neglect of a child I01.198.240.856.350.250
I01.880.735.900.350.250
Child abuse
chin facial feature facial feature A01.456.505.259 Chins
Chloride Channel Agonists Membrane Transport Modulators A class of drugs that stimulate chloride ion influx through cell membrane channels D27.505.519.562.311
Cholagogues and Choleretics Gastrointestinal Agents Gastrointestinal agents that stimulate the flow of bile into the duodenum (cholagogues) or stimulate the production of bile by the liver (choleretic) D27.505.954.483.508
Cholinergic Agents drug neurotransmitter Any drug used for its actions on cholinergic systems. Included here are agonists and antagonists, drugs that affect the life cycle of acetylcholine, and drugs that affect the survival of cholinergic neurons. The term cholinergic agents is sometimes D27.505.519.625.120
D27.505.696.577.120
Cholinergic Agonists Cholinergic Agents Drugs that bind to and activate cholinergic receptors D27.505.696.577.120.140
D27.505.519.625.120.140
Cholinesterase Reactivators Enzyme Reactivators
Cholinergic Agents
Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. D27.505.519.405.347
D27.505.696.577.120.400
D27.505.519.625.120.400
chorda tympani nerve A08.800.800.120.250.120
Chorioallantoic membrane A16.254.300.400
chorion A10.615.284.473
choroid plexus plexus structure in the ventricles of the brain A08.186.211.276.298 Choroid plexus
Chromogenic Compounds food coloring
Indicators and Reagents
dye
Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogen D27.720.470.410.200
D27.720.233.174
chronic bronchitis bronchitis Lung disease that involves excessive mucus production and is accompanied by a continuous cough C08.127.446.567
C08.381.495.146.567
C08.381.495.389.500
C08.730.099.567
chronic condition disease human health condition or disease that is persistent or otherwise long-lasting in its effects C23.550.291.500
chronic pancreatitis pancreatitis Human disease C06.689.750.830
cingulate gyrus gyrus A08.186.211.577.330 Cingulate cortex
Circle of Willis circulatory anastomosis that supplies blood to the brain and surrounding structures A07.231.114.228.351 Circle of Willis
Cisterna magna A08.186.566.166.686.351
clitoris sex organ female sex organ A05.360.319.887.436 Clitoris
 
Cloaca A13.223
Coagulants Hematologic Agents Agents that cause clotting D27.505.954.502.270
Coccidiostats antiprotozoal Agents useful in the treatment or prevention of coccidiosis in man or animals D27.505.954.122.250.100.170
cochlear nerve nerve A08.800.800.120.910.120
 
Coenurosis zoonosis parasitic helminthiasis infectious disease
zoonosis
tapeworm infection
Helminthiasis C03.335.190
 
cognitive therapy therapy F04.754.137.428 Cognitive therapy
coma disorder of consciousness
clinical sign
state of unconsciousness C10.597.606.358.800.200
C23.888.592.604.359.800.200
Coma
Commotio cordis cardiac arrest
Traumatic cardiac arrest
C14.280.067.441
C26.891.375.750.500
C26.974.250.875.500
Community-acquired pneumonia pneumonia
community acquired infection
C01.539.234
Complement Inactivating Agents immunosuppressive drug Compounds that negatively regulate the cascade process of complement activation. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host D27.505.696.477.656.500
Complementary DNA DNA
DNA Probes
Single-stranded complementary dna synthesized from an rna template by the action of rna-dependent dna polymerase. Cdna (i.e., complementary dna, not circular dna, not c-dna) is used in a variety of molecular cloning experiments as well as serving as D27.720.470.530.600.223.260
conduction aphasia receptive aphasia C10.597.606.150.500.800.100.111
C23.888.592.604.150.500.800.100.111
connective tissue tissue type of biological tissue A10.165 Connective tissue
 
consanguinity property property of being from the same kinship as another person; quality of being descended from the same ancestor as another person G05.090.403.180
G05.180
Consanguinity
Contact Lens Solutions disinfectant Sterile solutions used to clean and disinfect contact lenses D27.720.274.150
D27.505.954.122.425.150
Contraceptive Agents Reproductive Control Agents Chemical substances that prevent or reduce the probability of conception D27.505.696.875.360
D27.505.954.705.360
Contraceptive Agents, Female Contraceptive Agents Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading D27.505.696.875.360.276
D27.505.954.705.360.276
Contraceptive Agents, Male Contraceptive Agents Chemical substances or agents with contraceptive activity in males. Use for male contraceptive agents in general or for which there is no specific heading D27.505.954.705.360.443
D27.505.696.875.360.443
Contraceptives, Oral Contraceptive Agents, Female Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both D27.505.954.705.360.276.210
D27.505.696.875.360.276.210
Contraceptives, Oral, Combined Contraceptives, Oral Fixed drug combinations administered orally for contraceptive purposes D27.505.954.705.360.276.210.100
D27.505.696.875.360.276.210.100
Contraceptives, Oral, Hormonal Contraceptives, Oral Oral contraceptives which owe their effectiveness to hormonal preparations D27.505.954.705.360.276.210.277
D27.505.696.875.360.276.210.277
Contraceptives, Oral, Sequential Contraceptives, Oral Drugs administered orally and sequentially for contraceptive purposes D27.505.696.875.360.276.210.400
D27.505.954.705.360.276.210.400
Contraceptives, Oral, Synthetic Contraceptives, Oral Oral contraceptives which owe their effectiveness to synthetic preparations D27.505.954.705.360.276.210.443
D27.505.696.875.360.276.210.443
Contraceptives, Postcoital Contraceptive Agents, Female Contraceptive substances to be used after coitus. These agents include high doses of estrogenic drugs; progesterone-receptor blockers; antimetabolites; alkaloids, and prostaglandins D27.505.696.875.360.276.310
D27.505.954.705.360.276.310
Contraceptives, Postcoital, Hormonal Contraceptives, Postcoital Postcoital contraceptives which owe their effectiveness to hormonal preparations D27.505.954.705.360.276.310.235
D27.505.696.875.360.276.310.235
Contraceptives, Postcoital, Synthetic Contraceptives, Postcoital Postcoital contraceptives which owe their effectiveness to synthetic preparations D27.505.696.875.360.276.310.360
D27.505.954.705.360.276.310.360
Contrast medium Specialty Uses of Chemicals
Diagnostic Uses of Chemicals
A substance used in medical imaging to enhance the contrast of structures or fluids within the body. D27.505.259.500
D27.720.259
Contrast agents
Convulsant stimulant Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most common D27.505.696.282.224
D27.505.954.427.220.224
Convulsants
coronary circulation circulation of blood in the blood vessels of the heart muscle (myocardium) G09.330.190.163.324 Coronary circulation
 
Corrosive substance Noxae
Specialty Uses of Chemicals
Strong alkaline chemicals that destroy soft body tissues resulting in a deep, penetrating type of burn, in contrast to corrosives, that result in a more superficial type of damage via chemical means or inflammation. Caustics are usually hydroxides o D27.888.569.185
D27.720.185
Corrosive materials labelling
Cosmeceutical cosmetics Cosmetics that are associated with therapeutic effects D27.720.269.285
cosmetics chemical substance
Specialty Uses of Chemicals
substances used to enhance the appearance or odor of the human body D27.720.269 Cosmetics
 
COX-2 inhibitor cyclooxygenase inhibitor A subclass of cyclooxygenase inhibitors with specificity for cyclooxygenase-2 D27.505.696.663.850.014.040.500.500.500
D27.505.954.329.030.500.500
D27.505.954.158.030.500.500
D27.505.519.389.310.500
COX-2 inhibitors
coxis bone bone of the pelvis A02.835.232.834.229 Coccyx
Cracked tooth syndrome dental trauma
Enamel infraction
C07.793.850.750.300
C26.900.750.300
cretinism birth defect
thyroid gland disease
disease C05.116.099.343.347
C05.116.132.256
C16.320.240.625
C19.297.155
C19.874.482.281
Cretinism
cricoid cartilage It is a signet ring shape cartilage A02.165.507.211 Cricoid cartilage
CRISPR repeated sequence family of DNA sequences in bacteria, contain snippets of DNA from viruses that have attacked the bacterium, are used by the bacterium to detect and destroy DNA from further attacks by similar viruses G02.111.570.080.708.800.325.500
G05.360.080.708.800.325.500
G05.360.340.024.850.069
CRISPR
Cross-Linking Reagents Indicators and Reagents Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can D27.720.470.410.210
Cryoprotective Agents Protective Agents Substances that provide protection against the harmful effects of freezing temperatures D27.505.696.706.320
D27.720.799.180
Culture media, conditioned body fluid growth medium Cell culture growth medium retrieved from certain cultured cells D27.720.470.305.250
Culture Media, Serum-Free growth medium Culture media free of serum proteins but including the minimal essential substances required for cell growth. This type of medium avoids the presence of extraneous substances that may affect cell proliferation or unwanted activation of cells D27.720.470.305.255
cuneiform bones set of bones in the human foot A02.835.232.043.300.710 Cuneiform bones
cyclooxygenase inhibitor non-steroidal anti-inflammatory drug
enzyme inhibitor
class of drug D27.505.696.663.850.014.040.500.500
D27.505.954.329.030.500
D27.505.954.158.030.500
D27.505.519.389.310
Cysteine Proteinase Inhibitors Protease inhibitor Exogenous and endogenous compounds which inhibit cysteine endopeptidases D27.505.519.389.745.325
Cystine Depleting Agents mechanism of action Compounds and drugs that react with cystine and convert it into a compound that can be more easily metabolized or intracellularly transported. Drugs in this class have been used to treat cystinosis D27.505.519.334
Cytochrome P-450 CYP1A2 Inducers Cytochrome P-450 Enzyme Inducers Drugs and compounds that induce the synthesis of cytochrome p-450 cyp1a2 D27.505.389.249.120
D27.505.519.349.120
Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 cyp1a2 D27.505.389.500.120
D27.505.519.389.335.120
Cytochrome P-450 CYP2B6 Inducers Cytochrome P-450 Enzyme Inducers Drugs and compounds that induce the synthesis of cytochrome p-450 cyp2b6 D27.505.519.349.260
D27.505.389.249.260
Cytochrome P-450 CYP2B6 Inhibitors Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 cyp2b6 D27.505.389.500.260
D27.505.519.389.335.260
Cytochrome P-450 CYP2C19 Inducers Cytochrome P-450 Enzyme Inducers Drugs and compounds that induce the synthesis of cytochrome p-450 cyp2c19 D27.505.519.349.350
D27.505.389.249.350
Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 cyp2c19 D27.505.519.389.335.319
D27.505.389.500.319
Cytochrome P-450 CYP2C8 Inducers Cytochrome P-450 Enzyme Inducers Drugs and compounds that induce the synthesis of cytochrome p-450 cyp2c8 D27.505.519.349.308
D27.505.389.249.308
Cytochrome P-450 CYP2C8 Inhibitors Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 cyp2c8 D27.505.519.389.335.308
D27.505.389.500.308
Cytochrome P-450 CYP2C9 Inducers Cytochrome P-450 Enzyme Inducers Drugs and compounds that induce the synthesis of cytochrome p-450 cyp2c9 D27.505.519.349.320
D27.505.389.249.320
Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 cyp2c9 D27.505.519.389.335.329
D27.505.389.500.315
Cytochrome P-450 CYP2D6 Inducers Cytochrome P-450 Enzyme Inducers Drugs and compounds that induce the synthesis of cytochrome p-450 cyp2d6 D27.505.389.249.500
D27.505.519.349.500
Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 cyp2d6 D27.505.389.500.368
D27.505.519.389.335.368
Cytochrome P-450 CYP2E1 Inducers Cytochrome P-450 Enzyme Inducers Drugs and compounds that induce the synthesis of cytochrome p-450 cyp2e1 D27.505.389.249.600
D27.505.519.349.600
Cytochrome P-450 CYP2E1 Inhibitors Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 cyp2e1 D27.505.519.389.335.421
D27.505.389.500.421
Cytochrome P-450 CYP3A Inducers Cytochrome P-450 Enzyme Inducers Drugs and compounds that induce the synthesis of cytochrome p-450 cyp3a D27.505.389.249.700
D27.505.519.349.700
Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 Enzyme Inhibitors Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 cyp3a D27.505.519.389.335.503
D27.505.389.500.503
Cytochrome P-450 Enzyme Inducers mechanism of action
Metabolic Side Effects of Drugs and Substances
Drugs and compounds that induce the synthesis of cytochrome p-450 enzymes D27.505.519.349
D27.505.389.249
Cytochrome P-450 Enzyme Inhibitors enzyme inhibitor
Metabolic Side Effects of Drugs and Substances
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of cytochrome p-450 enzymes D27.505.389.500
D27.505.519.389.335
Cytostatic Agents Noxae Compounds that inhibit or prevent the proliferation of cells D27.888.569.199
cytotoxin poison
Noxae
Term for substances that have a harmful or destructive effect on a biological cell D27.888.569.213
Cytotrophoblast A16.254.085.162
dangerous goods transportable goods
Modes of Toxic Action
Dangerous goods or hazardous goods are solids, liquids, or gases that can harm people, other living organisms, property, or the environment D27.888.426 Dangerous goods
 
deafblindness deafness
blindness
sensation disorder
decreased audio-visual performance
condition of little or no useful sight and little or no useful hearing C09.218.458.341.186.500
C10.597.751.418.341.186.500
C10.597.751.941.162.625
C11.966.075.375
C16.131.077.299
C23.888.592.763.393.341.186.500
C23.888.592.763.941.162.625
Deafblindness
 
Decidua A16.759.289
decompression sickness decompression illness condition arising on depressurisation of the body C26.120.248 Decompression sickness
defence mechanism behavior
psychological phenomenon
unconscious psychological mechanism that reduces anxiety arising from unacceptable or potentially harmful stimuli F01.393 Ego defence mechanisms
Defoliants, Chemical herbicide Herbicides that remove leaves from trees and growing plants. They may be either organic or inorganic. Several of the more persistent types have been used in military operations and many are toxic. (from hawley's condensed chemical dictionary, 11th e D27.720.031.700.366.181
D27.888.723.366.181
Degloving Avulsion injury
Soft tissue injury
type of avulsion in which an extensive section of skin is completely torn off the underlying tissue C26.808.500
Delayed puberty disorder of puberty Human disease C19.391.690
Demulcents anti-inflammatory agent
Gastrointestinal Agents
surfactant
Respiratory System Agents
Compounds that form soothing films on the surface of mucous membranes. They are generally used as agents to protect the integrity of internal epithelium D27.720.877.156
D27.505.954.796.210
D27.505.954.483.534
D27.505.954.158.515
dental attrition tooth wear C07.793.818.249
 
Dental Disinfectants disinfectant Chemicals especially for use on instruments to destroy pathogenic organisms. (boucher, clinical dental terminology, 4th ed) D27.505.954.122.425.300
D27.720.274.300
Dental insurance health insurance N03.219.521.576.343.450
Dental Materials Biomedical and Dental Materials Materials used in the production of dental bases, restorations, impressions, prostheses, etc D27.720.102.339
Dental papilla A14.549.167.900.720.250
dental plaque dental deposits C07.793.208.377 Dental plaque
dental pulp A14.549.167.900.260 Pulp (tooth)
 
Dentifrices cosmetics Any preparations used for cleansing teeth; they usually contain an abrasive, detergent, binder and flavoring agent and may exist in the form of liquid, paste or powder; may also contain medicaments and caries preventives D27.720.269.380
Dentin Desensitizing Agents analgesic Substances which reduce or eliminate dentinal sensitivity or the pain associated with a source of stimulus (such as touch, heat, or cold) at the orifice of exposed dentinal tubules causing the movement of tubular fluid that in turn stimulates tooth D27.505.696.663.850.014.640
D27.505.954.427.040.437
deodorant Personal hygiene item product
cosmetics
substance applied to the body to prevent body odor D27.720.269.385 Deodorants
 
Dermal Fillers Biomedical and Dental Materials Materials such as collagen or hyaluronic acid that are injected or deposited into the dermis for the purpose of skin augmentation D27.720.102.461
dermis layer layer of skin between the epidermis (with which it makes up the cutis) and subcutaneous tissues, that primarily consists of dense irregular connective tissue and cushions the body from stress and strain A17.815.180
Dermotoxins Noxae Specific substances elaborated by plants, microorganisms or animals that cause damage to the skin; they may be proteins or other specific factors or substances; constituents of spider, jellyfish or other venoms cause dermonecrosis and certain bacter D27.888.569.242
detergent chemical product
surfactant
cleaning product
Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties D27.720.877.265 Detergents
Diabetic coma complications of diabetes mellitus
coma
C19.246.099.750
diabetic nephropathy kidney disease
complications of diabetes mellitus
disease C12.777.419.192
C13.351.968.419.192
C19.246.099.875
Diabetic nephropathy
Diagnostic Uses of Chemicals Pharmacologic Actions Chemicals administered to patients in order to diagnose or study the pathology of medical conditions, diseases, or syndromes. D27.505.259
Diagonal band of Broca A08.186.211.730.885.380
Dialysis Solutions Pharmaceutical Solutions Solutions prepared for exchange across a semipermeable membrane of solutes below a molecular size determined by the cutoff threshold of the membrane material D27.505.954.578.483
D27.720.752.483
diaphragmatic hernia abdominal hernia
diaphragm disease
defect or hole in the diaphragm that allows the abdominal contents to move into the chest cavity C23.300.707.500 Diaphragmatic hernia
diaphysis zone of long bone A02.835.232.169
Diastema tooth disease C07.650.800.320
C07.793.700.320
C16.131.850.800.320
Diastema (dentistry)
dichromacy color vision
congenital color blindness
C10.597.751.941.256
C11.966.256
C23.888.592.763.941.256
differential diagnosis diagnostic procedure E01.171 Differential diagnosis
diffusion-tensor imaging diffusion magnetic resonance imaging imaging method E01.370.350.578.750
E01.370.376.537.500
E05.629.750
 
digital dermatitis bacterial infectious disease
bovine disease
infectious disease
animal disease
bacterial skin disease
cattle disease C01.252.825.180
C01.539.800.720.180
C17.800.838.765.180
C22.214
Dipeptidyl peptidase-4 inhibitor anti-diabetic medication
Protease inhibitor
Compounds that suppress the degradation of incretins by blocking the action of dipeptidyl-peptidase iv. This helps to correct the defective insulin and glucagon secretion characteristic of type 2 diabetes mellitus by stimulating insulin secretion an D27.505.696.422.500
D27.505.519.389.745.335
Dipeptidyl peptidase-4 inhibitors
diphyllobothriasis fish disease
disease
infectious disease
parasitic helminthiasis infectious disease
zoonosis
Q4505372
helminthiasis C03.335.190.304
Diplopia vision disorder
binocular vision disease
Human disease C10.597.751.941.339
C11.966.339
C23.888.592.763.941.339
Diplopia
 
Direct Xa inhibitor Antithrombins Endogenous factors and drugs that inhibit or block the activity of factor xa D27.505.954.502.119.500.500
D27.505.519.389.745.800.449.500
Discoid lupus erythematosus lupus erythematosus
chronic cutaneous lupus erythematosus
C17.300.475.479
C17.800.480.479
Discoid lupus erythematosus
disease health problem abnormal condition negatively affecting organisms C Diseases and disorders
 
disease-modifying antirheumatic drug Therapeutic Uses Drugs that are used to treat rheumatoid arthritis D27.505.954.329
disinfectant engineering process
cleaning
Anti-Infective Agents
Specialty Uses of Chemicals
antimicrobial agent that is applied to non-living objects (compare: antisepsis) to reduce the number of microorganisms (unwanted germs and parasites) on them (compare:sterilization) D27.720.274
D27.505.954.122.425
Disinfectants
 
dislocated shoulder shoulder problem C05.116.359.750
C26.289.750
C26.803.125
Shoulder luxation
 
Diuretics, Osmotic diuretic Compounds that increase urine volume by increasing the amount of osmotically active solute in the urine. Osmotic diuretics also increase the osmolarity of plasma D27.505.696.560.500.453
diverticulosis intestinal disease
Diverticulum, Colon
condition of having diverticula (outpocketings) in the wall of the intestine C06.405.469.158.587 Diverticulosis
 
DNA Primers DNA Probes Short sequences (generally about 10 base pairs) of dna that are complementary to sequences of messenger rna and allow reverse transcriptases to start copying the adjacent sequences of mrna. Primers are used extensively in genetic and molecular biolo D27.720.470.530.600.223.600
DNA Probes Nucleic Acid Probes Species- or subspecies-specific dna (including complementary dna; conserved genes, whole chromosomes, or whole genomes) used in hybridization studies in order to identify microorganisms, to measure dna-dna homologies, to group subspecies, etc. The d D27.720.470.530.600.223
D27.505.259.750.600.223
DNA Probes, HLA DNA Probes Dna probes specific for the human leukocyte antigen genes, which represent the major histocompatibility determinants in humans. The four known loci are designated as a, b, c, and d. Specific antigens are identified by a locus notation and number, e D27.720.470.530.600.223.615
D27.505.259.750.600.223.615
DNA Probes, HPV DNA Probes Dna probes specific for the identification of human papilloma virus D27.505.259.750.600.223.620
D27.720.470.530.600.223.620
DNA, Antisense Antisense Elements (Genetics) Dna that is complementary to the sense strand. (the sense strand has the same sequence as the mrna transcript. The antisense strand is the template for mrna synthesis.) synthetic antisense dnas are used to hybridize to complementary sequences in tar D27.720.470.530.600.150.200
domestication evolution sustained multi-generational relationship in which one group of organisms assumes a significant degree of influence over the reproduction and care of another group to secure a more predictable supply of resources from that second group J01.040.330 Domesticated animals
Dopamine agonist Dopaminergic Drugs that bind to and activate dopamine receptors D27.505.696.577.150.151
D27.505.519.625.150.151
Dopamine agonists
Dopamine antagonist Dopaminergic Drugs that bind to but do not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (antipsychotic agents) are dopamine antagonists, although their therap D27.505.696.577.150.175
D27.505.519.625.150.175
Dopamine antagonists
Dopamine D2 Receptor Antagonists Dopamine antagonist Compounds and drugs that bind to and inhibit or block the activation of dopamine d2 receptors D27.505.519.625.150.175.500
D27.505.696.577.150.175.500
Dopamine reuptake inhibitor Neurotransmitter Uptake Inhibitors
Dopaminergic
type of drug that acts as a reuptake inhibitor for the neurotransmitter dopamine D27.505.696.577.150.800
D27.505.519.625.150.800
D27.505.519.625.600.220
D27.505.696.577.600.220
D27.505.519.562.437.220
Dopamine reuptake inhibitors
Dopaminergic neurotransmitter Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons D27.505.696.577.150
D27.505.519.625.150
dorsal root ganglion A08.340.390.340 Dorsal root ganglion
dorsomedial hypothalamic nucleus A08.186.211.730.385.357.352.270
drug eruption exanthem
adverse drug reaction
adverse drug reaction of the skin C17.800.174.600
C20.543.206.380
C25.100.468.380
drunkenness substance intoxication psychological state induced by the ingestion of ethanol (alcohol) C25.775.100.175 Drunken people
dura mater meninx There are 4 processes of dura mater A08.186.566.395 Dura mater
dural venous sinuses A07.231.908.224
dwarfism disease a condition affecting a person or animal short in stature, caused by slow or delayed growth C05.116.099.343
C16.320.240
C19.297
Dwarfism
 
dye material
colourant
Specialty Uses of Chemicals
colored substance that has an affinity to the substrate to which it is being applied D27.720.233 Dyes
 
dyskinesia movement disorder human disease C10.228.662.262
C10.597.350
C23.888.592.350
dysphonia voice disorder voice disorder C08.360.940.490
C08.618.490
C09.400.940.490
C10.597.975.550
C23.888.592.979.550
C23.888.852.490
C08.360.940.325
C09.400.940.325
C10.597.975.325
C23.888.592.979.325
dyssomnia sleep disorder broad classification of sleeping disorders involving difficulty getting to sleep, remain sleeping, or of excessive sleepiness C10.886.425
eccrine sweat gland sweat gland distributed almost all over the human body, in varying densities; its water-based secretion represents a primary form of cooling in humans A10.336.899.480
 
ectoderm germ layer A16.254.425.273 Ectoderm
Ectromelia congenital amputation C05.660.585.350
C16.131.621.585.350
eczema skin disease cutaneous disease C17.800.174.620
C17.800.815.620
C17.800.815
Eczema
 
Edinger–Westphal nucleus nucleus A08.186.211.132.659.413.875.381.500
ejaculatory duct A05.360.444.251
electronic health record medical software
personal health record
a program used to document a patient's medical history on a computer E05.318.308.940.968.249.500
E05.318.308.940.968.625.500
Electronic health record
embolism vascular disease embolism and thrombosis disease of arteries, arterioles and capillaries C14.907.355.350 Embolism
emerging infectious disease infectious disease C01.539.221.500
emetic drug
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Physiological Effects of Drugs
drug that induces vomiting D27.505.696.663.050.225
D27.505.954.483.560
D27.505.954.427.270
D27.505.696.329
Emetics
Emollients dermatologic drug Oleagenous substances used topically to soothe, soften or protect skin or mucous membranes. They are used also as vehicles for other dermatologic agents D27.505.954.444.200
Emulsifying Agents surfactant Surface-active agents that induce a dispersion of undissolved material throughout a liquid D27.720.877.383
endocrine disruptor Modes of Toxic Action
Physiological Effects of Drugs
chemicals that can interfere with endocrine (or hormone) systems at certain doses D27.505.696.353
D27.888.141
Endocrinology
endoderm germ layer A16.254.425.407 Endoderm
endolymph labyrinthine fluid A12.207.270.517.324
endometrium mucus membrane inner mucous membrane of the mammalian uterus A05.360.319.679.490 Endometrium
Endoneurium A08.800.800
Endothelin A Receptor Antagonists Endothelin receptor antagonist Compounds and drugs that bind to and inhibit or block the activation of endothelin a rececptors D27.505.519.364.500
Endothelin B Receptor Antagonists Endothelin receptor antagonist Compounds and drugs that bind to and inhibit or block the activation of endothelin b receptors D27.505.519.364.750
Endothelin receptor antagonist mechanism of action chemical compound blocks the endotelin receptor D27.505.519.364
Endothelium-Dependent Relaxing Factors vasodilator agent Paracrine substances produced by the vascular endothelium with vascular smooth muscle relaxation (vasodilation) activities. Several factors have been identified, including nitric oxide and prostacyclin D27.505.954.411.918.500
enteritis intestinal infectious disease
inflammation
intestinal infectious disease C06.405.205.462
C06.405.469.326
entorhinal cortex brain area A08.186.211.577.710.225 Entorhinal cortex
Environmental Pollutants Modes of Toxic Action Substances or energies, for example heat or light, which when introduced into the air, water, or land threaten life or health of individuals or ECOSYSTEMS. D27.888.284
Enzyme activator mechanism of action Compounds or factors that act on a specific enzyme to increase its activity D27.505.519.374
enzyme inhibitor mechanism of action molecule that binds to an enzyme and decreases its activity D27.505.519.389 Enzyme inhibitors
Enzyme Reactivators mechanism of action Compounds which restore enzymatic activity by removing an inhibitory group bound to the reactive site of the enzyme D27.505.519.405
ependymoblastoma tumor
disease
central nervous system primitive neuroectodermal neoplasm Human disease C04.557.465.625.600.590
C04.557.470.670.590
C04.557.580.625.600.590
epididymis sex organ Epididim A05.360.444.371 Epididymis
epiglottis thin flap in the oesophagus A02.165.257.625.411 Epiglottis
Epineurium A08.800.800
epiphysis zone of long bone end part of long bones A02.835.232.251
Epithelial Sodium Channel Agonists Sodium Channel Agonists Compounds that either stimulate the opening or prevent closure of epithelial sodium ion channels D27.505.519.562.625.249
Epithelial Sodium Channel Blockers Sodium channel blocker
Potassium-sparing diuretic
A subclass of sodium channel blockers that are specific for epithelial sodium channels D27.505.519.562.750.374
D27.505.696.560.500.726.100
ergotism food poisoning
Mycotoxicosis
C25.723.680.262 Ergotism
Erythema induratum panniculitis C01.252.410.040.552.846.583.260
C01.252.825.820.260
C01.539.800.720.820.260
C17.300.710.329
C17.800.229.329
C17.800.566.329
C17.800.838.765.820.320
Escherichia coli O157:H7 strain serotype of the bacterial species Escherichia coli and is one of the Shiga toxin–producing types of E. coli B03.440.450.425.325.300.800.250.500
B03.660.250.150.180.100.800.250.500
 
estrogen sex steroid
hormone
primary female sex hormone as well as a medication, is responsible for the development and regulation of the female reproductive system and secondary sex characteristics D27.505.696.399.472.277 Estrogens
Estrogen Antagonists Hormone Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds D27.505.696.399.450.327
Estrogen Receptor Antagonists Estrogen Antagonists Compounds and drugs that bind to and block or inhibit the activation of estrogen receptors D27.505.696.399.450.327.650
Estrogen Receptor Modulators Hormone Antagonists Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure D27.505.696.399.450.360
Estrogens, Non-Steroidal estrogen Non-steroidal compounds with estrogenic activity D27.505.696.399.472.277.540
excipient chemical substance
Pharmaceutical Vehicles
substance formulated alongside the active ingredient of a medication D27.720.744.770.419
Excitatory Amino Acid Agents neurotransmitter Drugs used for their actions on any aspect of excitatory amino acid neurotransmitter systems. Included are drugs that act on excitatory amino acid receptors, affect the life cycle of excitatory amino acid transmitters, or affect the survival of neur D27.505.519.625.190
D27.505.696.577.190
Excitatory Amino Acid Agonists Excitatory Amino Acid Agents Drugs that bind to and activate excitatory amino acid receptors D27.505.696.577.190.200
D27.505.519.625.190.200
Excitatory amino acid antagonist Excitatory Amino Acid Agents Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists D27.505.696.577.190.300
D27.505.519.625.190.300
Expectorants Respiratory System Agents Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here D27.505.954.796.250
explosive material chemical substance
Specialty Uses of Chemicals
reactive substance that contains a great amount of potential energy that can produce an explosion D27.720.317 Explosives
 
Extensively drug-resistant tuberculosis multidrug-resistant tuberculosis C01.252.410.040.552.846.775.500
External fixation E07.858.442.660.430 External fixation
 
extracellular matrix cellular component extracellular region part A structure lying external to one or more cells, which provides structural support for cells or tissues. A11.284.295.310 Extracellular matrix proteins
eye drop Pharmaceutical Solutions A saline-containing liquid drug, administered through the eye. D27.720.752.608
D27.505.954.578.645
Eye drops
Faith healing miracle
healing
healing through spiritual means E02.190.901.155 Faith healing
fascia connective tissue layer of fibrous connective tissue that surrounds muscles, blood vessels and nerves A02.340 Fascia (tissue)
fast food industry dish food prepared and served in a small amount of time G07.203.300.477
J02.500.477
Fast food
 
Fat Substitutes food additive Compounds used in food or in food preparation to replace dietary fats. They may be carbohydrate-, protein-, or fat-based. Fat substitutes are usually lower in calories but provide the same texture as fats D27.720.372.300.350
Fatty Acid Synthesis Inhibitors hypolipidemic Compounds that interfere with fatty acid synthase resulting in a reduction of fatty acids. This is a target mechanism in humans of some antineoplastic agents and anti-obesity agents and of some anti-infective agents which interfere with cell wall an D27.505.519.186.071.401
Fazio-Londe disease infantile progressive bulbar palsy a very rare inherited motor neuron disease of children and young adults C10.574.562.300
C10.668.467.300
febrile neutrophilic dermatosis Reactive neutrophilic dermatoses
erythema
rare rheumatologic disease
other acquired skin disease
C17.800.229.800 Febrile neutrophilic dermatosis
fecal impaction constipation
intestinal obstruction
C06.405.469.531.424 Fecal impaction
female genital mutilation ablation
Genital modification and mutilation
controversial cultural ritual E02.218.085.165
E04.085.165
E04.950.300.200
I01.076.201.450.199
Female genital mutilation
 
female infertility infertility Diminished or absent ability of a female to achieve conception C13.351.500.365.700
femoral nerve nerve A08.800.800.720.450.250 Femoral nerve
Fertility Agents Reproductive Control Agents Drugs used to increase fertility or to treat infertility D27.505.696.875.552
D27.505.954.705.552
Fertility Agents, Female Fertility Agents Compounds which increase the capacity to conceive in females D27.505.954.705.552.344
D27.505.696.875.552.344
Fertility Agents, Male Fertility Agents Compounds which increase the capacity of the male to induce conception D27.505.954.705.552.510
D27.505.696.875.552.510
fertilizer use chemical substance
agrochemical
any material of natural or synthetic origin (other than liming materials) that is applied to soils or to plant tissues (usually leaves) to supply one or more plant nutrients essential to the growth of plants D27.720.031.400 Fertilizers
Fibrin Modulating Agents mechanism of action Agents that affect the function of fibrin in blood coagulation. They used as coagulants for hemorrhage or anticoagulants for thrombosis D27.505.519.421
Fibrinolytic Agents Cardiovascular Agents
Hematologic Agents
Fibrin Modulating Agents
Fibrinolysin or agents that convert plasminogen to fibrinolysin D27.505.519.421.750
D27.505.954.411.320
D27.505.954.502.427
fibula bone bone of the leg A02.835.232.043.650.321 Fibula (bone)
 
Fifth metacarpal bone A02.835.232.087.319.550 Fifth metacarpal bone
Filaricides antinematodal agent Pharmacological agents destructive to nematodes in the superfamily filarioidea D27.505.954.122.250.075.080.275
finger digit organ of manipulation and sensation found in the hands of humans and other primates A01.378.800.667.430 Fingers
Fixatives Specialty Uses of Chemicals Agents employed in the preparation of histologic or pathologic specimens for the purpose of maintaining the existing form and structure of all of the constituent elements. Great numbers of different agents are used; some are also decalcifyi D27.720.355
Flame retardant chemical substance
Specialty Uses of Chemicals
Materials applied to fabrics, bedding, furniture, plastics, etc. To retard their burning; many may leach out and cause allergies or other harm D27.720.361 Flame retardants
flavoring agent food additive
Pharmaceutic Aids
substance added to foods and medicine to improve the taste D27.720.372.300.353
D27.720.744.294
Fluorophore food coloring
Luminescent Agents
dye
Agents that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label othe D27.720.470.410.505.500
D27.720.233.348
Fluorescent dyes
Focal infection theory disease
infection
C01.539.392
Focal nodular hyperplasia liver neoplasm C06.552.270
Folic Acid Antagonists enzyme inhibitor Inhibitors of the enzyme, dihydrofolate reductase (tetrahydrofolate dehydrogenase), which converts dihydrofolate (fh2) to tetrahydrofolate (fh4). They are frequently used in cancer chemotherapy. (from ama, drug evaluations annual, 1994, p2033) D27.505.519.389.350
food additive additive
food ingredient
substances added to food to preserve flavor or enhance its taste, appearance, or other qualities D27.720.372.300 Food additives
food coloring food additive
dye
Specialty Uses of Chemicals
substance that imparts color when it is added to food or drink D27.720.233.674
D27.720.372.300.355
Food colorings
food ingredient ingredient
Specialty Uses of Chemicals
ingredient used in food product D27.720.372
food poisoning intoxication illness resulting from food that is spoiled or contaminated by pathogenic bacteria, viruses, parasites, or toxins C25.723.415 Foodborne illness
Food Preservatives food additive Substances capable of inhibiting, retarding or arresting the process of fermentation, acidification or other deterioration of foods D27.720.372.300.385
foot anatomical structure anatomical structure found in vertebrates A01.378.610.250 Feet
 
foot-and-mouth disease animal disease
bovine disease
infectious and sometimes fatal viral disease (only in young animals) that affects cloven-hoofed animals and caused by apthovirus which is a non enveloped, single stranded RNA (ss RNA) virus. C02.782.687.484
C22.380
Foot-and-mouth disease
foreskin prepuce retractable fold of skin which covers and protects the glans of the penis A05.360.444.492.362 Foreskin
founder effect phenomenon loss of genetic variation that occurs when a new population is established by a very small number of individuals G05.285 Founder effect
Fourier analysis harmonic analysis E05.377
G17.226
L01.224.800.625
Fourier analysis
Fournier gangrene necrotizing fasciitis C01.252.377
C12.294.229
Fournier gangrene
Fourth metacarpal bone metacarpal bone A02.835.232.087.319.550 Fourth metacarpal bone
Free Radical Scavengers antioxidant Substances that eliminate free radicals. Among other effects, they protect PANCREATIC ISLETS against damage by CYTOKINES and prevent myocardial and pulmonary REPERFUSION INJURY. D27.505.519.217.500
frenulum of tongue A14.549.885.431 Tongue
Fungicides, Industrial Fungicide
pesticide
Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. D27.720.031.700.288
D27.888.723.288
GABA Agents neurotransmitter Substances used for their pharmacological actions on gabaergic systems. Gabaergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function D27.505.696.577.240
D27.505.519.625.240
GABA agonist GABA Agents GABA receptor agonist medication D27.505.696.577.240.200
D27.505.519.625.240.200
GABA receptor agonists
GABA Antagonists GABA Agents Drugs that bind to but do not activate gaba receptors, thereby blocking the actions of endogenous gamma-aminobutyric acid and gaba receptor agonists D27.505.519.625.240.300
D27.505.696.577.240.300
GABA Modulators GABA Agents Substances that do not act as agonists or antagonists but do affect the gamma-aminobutyric acid receptor-ionophore complex. Gaba-a receptors (receptors, gaba-a) appear to have at least three allosteric sites at which modulators act: a site at which D27.505.519.625.240.500
D27.505.696.577.240.500
GABA Uptake Inhibitors Neurotransmitter Uptake Inhibitors
GABA Agents
Compounds that suppress or block the plasma membrane transport of gamma-aminobutyric acid by gaba plasma membrane transport proteins D27.505.696.577.600.535
D27.505.519.625.600.535
D27.505.696.577.240.750
D27.505.519.562.437.535
D27.505.519.625.240.750
GABA-A Receptor Agonists GABA agonist Endogenous compounds and drugs that bind to and activate gaba-a receptors D27.505.696.577.240.200.500
D27.505.519.625.240.200.500
GABA-A Receptor Antagonists GABA Antagonists Drugs that bind to but do not activate gaba-a receptors thereby blocking the actions of endogenous or exogenous gaba-a receptor agonists D27.505.696.577.240.300.500
D27.505.519.625.240.300.500
GABA-B Receptor Agonists GABA agonist Endogenous compounds and drugs that bind to and activate gaba-b receptors D27.505.519.625.240.200.750
D27.505.696.577.240.200.750
GABA-B Receptor Antagonists GABA Antagonists Drugs that bind to but do not activate gaba-b receptors thereby blocking the actions of endogenous or exogenous gaba-b receptor agonists D27.505.696.577.240.300.750
D27.505.519.625.240.300.750
Galactogogues Physiological Effects of Drugs Substances that induce lactation D27.505.696.365
gallbladder animal organ
anatomical structure
organ in humans and other vertebrates A03.159.439 Gallbladder
 
gallstone gallbladder disease
calculus
Human disease C06.130.409.633
C06.130.564.332.500
C23.300.175.525
Gallstones
 
Ganglionic Blockers Autonomic Agents Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeu D27.505.696.663.050.340
Ganglionic Stimulants Autonomic Agents Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non- D27.505.696.663.050.400
Gasotransmitters neurotransmitter Endogenously produced lipid-soluble gaseous molecules which function as neurotransmitters and signal mediators targeting ion channels and transporters D27.505.519.625.270
Gastrointestinal Agents Therapeutic Uses Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. D27.505.954.483
Genodermatosis skin disease
genetic disease
skin disease that is caused by a modification of the individual's genome C16.320.850
C17.800.827
Genodermatoses
genomics branch of biology genetics
computational biology
discipline in genetics H01.158.273.180.350
H01.158.273.343.350
Genomics
genu valgum knee disorder
valgus deformity
C05.116.482 Genu valgum
 
Gingival and periodontal pocket periodontitis C07.465.714.258.480.360
C07.465.714.533.750
global warming climate change climate change rise in the average temperature of Earth's atmosphere and oceans since the late 19th century and its projected continuation G16.500.240.135.374.500 Global warming
 
glossalgia tongue disease C07.465.910.280
C10.597.617.217
C23.888.592.612.414
Glossoptosis tongue disease C07.465.910.411
glottis A04.329.364 Glottis
gluten-free diet diet diet that excludes gluten E02.642.249.265
G07.203.650.240.265
Gluten-free diet
 
Glycine Agents neurotransmitter Substances used for their pharmacological actions on glycinergic systems. Glycinergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function D27.505.519.625.300
D27.505.696.577.300
Glycoside Hydrolase Inhibitors enzyme inhibitor
anti-diabetic medication
Compounds that inhibit or block the activity of glycoside hydrolases such as alpha-amylases and alpha-glucosidases D27.505.696.422.249
D27.505.519.389.320
Gout Suppressants disease-modifying antirheumatic drug Agents that increase uric acid excretion by the kidney (uricosuric agents), decrease uric acid production (antihyperuricemics), or alleviate the pain and inflammation of acute attacks of gout D27.505.954.329.337
granulosa cell tumour ovarian cancer C04.557.475.750.656
C04.588.322.455.398
C13.351.500.056.630.705.398
C13.351.937.418.685.398
C19.344.410.398
C19.391.630.705.398
Graves' ophthalmopathy toxic diffuse goiter
eye and adnexa disease
C11.270.842
C11.675.349.500.500
C19.874.283.605.500
C19.874.397.370.500
C20.111.555.500
Graves' ophthalmopathy
greater omentum A01.923.047.025.600.573 Epiploon
greenhouse effect process atmosopheric phenomenon G16.500.240.135.827
N06.230.265
Greenhouse effect
greenhouse gas Air Pollutants gas in an atmosphere that absorbs and emits radiation within the thermal infrared range D27.888.284.101.696 Greenhouse gases
Growth hormone deficiency dwarfism Human disease C05.116.099.343.445
C05.116.132.358
C10.228.140.617.738.300.300
C19.297.312
C19.700.482.311
Growth Inhibitors Growth Substances Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= plant growth regulators) D27.505.696.377.450
growth medium reagent
laboratory equipment
liquid
gel
Laboratory Chemicals
liquid or gel used for the growth of microorganisms or cells D27.720.470.305 Petri dishes cultures
Growth Substances Physiological Effects of Drugs Signal molecules that are involved in the control of cell growth and differentiation D27.505.696.377
GTP Phosphohydrolase Activators Enzyme activator Agents and factors that activate gtp phosphohydrolase activity D27.505.519.374.200
Guanylyl Cyclase C Agonists Gastrointestinal Agents
Enzyme activator
Compunds that bind to and activate guanylyl cyclase-c receptors D27.505.519.374.400
D27.505.954.483.590
gums animal structure A14.549.167.646.480 Gingiva
 
H1 antagonist histamine antagonist Drugs that selectively bind to but do not activate histamine h1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate h D27.505.696.577.375.425.400
D27.505.519.625.375.425.400
H2 antagonist drugs for acid-related disorders
histamine antagonist
Drugs that selectively bind to but do not activate histamine h2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth musc D27.505.519.625.375.425.425
D27.505.696.577.375.425.425
H2 receptor antagonists
haemorrhagic disease of the newborn perinatal disease
hematological disease of fetus and newborn
blood coagulation disease
Human disease C15.378.100.920.360
C15.378.463.841.464
C16.614.940
C18.654.422.360
C18.654.521.500.133.912.360
Hair Bleaching Agents Hair Preparations
Bleaching Agents
Chemicals that are used to oxidize pigments in hair D27.720.642.315.249
D27.720.269.430.214
hair dye dye
Hair Preparations
dye used as a cosmetic to change hair color either permanently or temporarily D27.720.269.430.430
D27.720.233.837
Hair Preparations cosmetics Hair grooming, cleansing and modifying products meant for topical application to hair, usually human. They include sprays, bleaches, dyes, conditioners, rinses, shampoos, nutrient lotions, etc D27.720.269.430
hallucinogen psychoactive drug
Psychotropic Drugs
Physiological Effects of Drugs
general group of pharmacological agents D27.505.696.388
D27.505.954.427.700.372
Psychedelics
hallux varus foot deformity C05.330.612 Hallux varus
hamate bone bone
carpal bone
bone of the wrist A02.835.232.087.319.150.400 Hamate bone
hammer toe foot deformity deformity of the proximal joint of the second, third or fourth toe C05.330.615 Hammer toes
hand anatomical region extremity at the end of an arm or forelimb A01.378.800.667 Hands
 
hand sanitizer essential medicine Anti-Infective Agents, Local
disinfectant
Preparations used as alternatives or supplements to hand washing with soap and water to destroy microorganisms and prevent transmission of pathogens. The active ingredient may be ethanol; 1-propanol; or povidone-iodine in a gel, foam, or liquid solu D27.505.954.122.425.650
D27.720.274.650
D27.505.954.122.187.500
Hand sanitizers
Hazardous waste waste
hazard
pollutant
dangerous goods
waste that poses substantial or potential threats to public health or the environment D27.888.426.500 Hazardous waste
head anatomical region
anatomical structure
cephalic part of an animal A01.456 Heads
 
head of femur zone of femur A02.835.232.043.650.247.343
health information exchange E05.318.308.940.968.625.500.500
L01.313.500.500
L01.399.500.500
health information management L01.399.500
health insurance insurance insurance for medical and health care costs N03.219.521.576.343 Health insurance
health insurance exchange N03.219.521.576.343.918.500 Health insurance marketplace
health maintenance organization managed care organization part of the health system and the social security N03.219.521.576.343.800.400
N03.219.521.576.343.925.400
N04.452.758.244.425
N04.590.374.410.400
hearing disorder disability
sensation disorder
human disease C09.218.458
C10.597.751.418
C23.888.592.763.393
heart valve prolapse heart valve disease Human disease C14.280.484.400
hemagglutinin membrane protein
Agglutinin
substance that causes red blood cells to agglutinate D27.505.696.477.136.377
Hemangiosarcoma angiosarcoma C04.557.450.795.390
C04.557.645.390
Hematinics Hematologic Agents Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias D27.505.954.502.543
Hematologic Agents Therapeutic Uses Drugs that act on blood and blood-forming organs and those that affect the hemostatic system D27.505.954.502
heme heterocyclic compound chemical substance metal complex of ferrous ion and porphyrin; component of hemoglobin and some other biologically important hemoproteins D03.383.129.578.840.500.640.587
D03.633.400.909.500.640.587
D04.345.783.500.640.587
D23.767.727.640.587
hemianopia Anopsia decreased vision or blindness (anopsia) in half the visual field, usually on one side of the vertical midline. The most common causes of this damage are stroke, brain tumor, and trauma, and stop the fight ref. C10.597.751.941.512
C11.966.075.500
C23.888.592.763.941.512
Hemianopsia
Hemifacial spasm movement disorder C07.465.364
C10.597.613.750.400
C23.888.592.608.750.400
Hemodialysis Solutions Dialysis Solutions Solutions prepared for hemodialysis. The composition of the pre-dialysis solution may be varied in order to determine the effect of solvated metabolites on anoxia, malnutrition, acid-base balance, etc. Of principal interest are the effect of the cho D27.505.954.578.483.651
D27.720.752.483.651
Hemolytic Agents cytotoxin Substances that are toxic to blood in general, including the clotting mechanism; hematotoxins may refer to the hematopoietic system D27.888.569.213.444
Hemostatics Coagulants Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents D27.505.954.502.270.463
hemothorax pleural effusion type of pleural effusion in which blood accumulates in the pleural cavity C08.528.380
C23.550.414.904
Hemothorax
 
Heparin Antagonists Coagulants
mechanism of action
Coagulant substances inhibiting the anticoagulant action of heparin D27.505.954.502.270.546
D27.505.519.452
herbicide phytopharmaceuticals
pesticide
chemical used to kill unwanted plants D27.720.031.700.366
D27.888.723.366
Herbicides
hern disease type of digestive system disease C23.300.707.374.937 Hernias
 
heteronymous hemianopsia hemianopia C10.597.751.941.512
C11.966.075.500
C23.888.592.763.941.512
Histamine agonist histaminergic Drugs that bind to and activate histamine receptors. Although they have been suggested for a variety of clinical applications histamine agonists have so far been more widely used in research than therapeutically D27.505.696.577.375.400
D27.505.519.625.375.400
histamine antagonist histaminergic Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine h1 receptors only D27.505.519.625.375.425
D27.505.696.577.375.425
Antihistamines
Histamine H1 Antagonists, Non-Sedating H1 antagonist A class of non-sedating drugs that bind to but do not activate histamine receptors (drug inverse agonism), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differi D27.505.519.625.375.425.400.500
D27.505.696.577.375.425.400.500
Histamine H3 Antagonists histamine antagonist Drugs that selectively bind to but do not activate histamine h3 receptors. They have been used to correct sleep wake disorders and memory disorders D27.505.696.577.375.425.712
D27.505.519.625.375.425.712
Histone deacetylase inhibitor enzyme inhibitor Compounds that inhibit histone deacetylases. This class of drugs may influence gene expression by increasing the level of acetylated histones in specific chromatin domains D27.505.519.389.360
HIV Fusion Inhibitors Anti-HIV Agents
Viral Fusion Protein Inhibitors
Inhibitors of the fusion of hiv to host cells, preventing viral entry. This includes compounds that block attachment of hiv envelope protein gp120 to cd4 receptors D27.505.954.122.388.077.088.209
D27.505.519.957.500
D27.505.954.122.388.538.500
HIV Integrase Inhibitors Integrase inhibitor
Anti-HIV Agents
Inhibitors of HIV INTEGRASE, an enzyme required for integration of viral DNA into cellular DNA. D27.505.519.389.375.400
D27.505.954.122.388.077.088.314
HIV Protease Inhibitors Protease inhibitor
Anti-HIV Agents
Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. D27.505.519.389.745.420
D27.505.954.122.388.077.088.420
homonymous hemianopsia hemianopia C10.597.751.941.512
C11.966.075.500
C23.888.592.763.941.512
Homonymous hemianopsia
 
hormone signaling molecule
Semiochemical
chemical compound
Hormones, Hormone Substitutes, and Hormone Antagonists
drug
chemical released by a cell or a gland in one part of the body that sends out messages that affect cells in other parts of the organism D27.505.696.399.472 Hormones
Hormone Antagonists Hormones, Hormone Substitutes, and Hormone Antagonists Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites D27.505.696.399.450
Hormones, Hormone Substitutes, and Hormone Antagonists Physiological Effects of Drugs A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists D27.505.696.399
hospital gown clothing short washable garment worn by patients in a hospital E07.325.877
E07.858.594
Hospital gowns
 
human body body entire structure of a human organism I01.076.201.450.560 Human body
 
human leg leg
human anatomical structure
lower extremity or limb of the human body (foot, lower leg, thigh and hip) A01.378.610.500 Human legs
 
human lung lung primary organs of respiration in humans A04.411 Respiratory system
human mouth mouth mouth of a human being; consists of the orbicularies oris muscles which also called kissing muscles A01.456.505.631 Human mouths
 
human penis penis human male sexual organ A05.360.444.492 Human penis
File:HQ SAM F.jpg
human skin skin
human body
the outer covering of the human body A17.815.180
human trafficking crime
trade
trade of humans for the purpose of forced labor, sexual slavery, or commercial sexual exploitation for the trafficker or others I01.198.240.748.470
I01.880.735.384.399
Human trafficking
hydrops fetalis fetal disease Human disease C13.703.277.060.480
C15.378.295.480
C15.378.420.826.100.350
C16.300.060.480
C16.320.365.826.100.350
C20.306.480
C23.888.277.395
hydrothorax pleural effusion pleural effusion containing serous liquid C08.528.476
Hygroscopic Agents Specialty Uses of Chemicals Materials that readily absorb moisture from their surroundings. D27.720.375
hymen segment of vagina membrane that surrounds or partially covers the external vaginal opening A05.360.319.779.479 Hymen
hyoid bone bone horseshoe-shaped bone situated in the anterior midline of the neck between the chin and the thyroid cartilage A02.835.232.409 Hyoid bones
hyperacusis hearing disorder hearing disorder characterized by a sensitivity to sound C09.218.458.505
C10.597.751.418.505
C23.888.592.763.393.505
Hyperalgesia somatosensory disorder
Pain out of proportion
C10.597.751.791.400
C23.888.592.763.770.400
Hyperammonemia amino acid metabolic disorder C23.550.421
hypercholesterolemia hyperlipidemia high levels of cholesterol in the blood C18.452.584.500.500.396 Hypercholesterolemia
Hyperdontia tooth disease
genetic disease
An extra tooth, erupted or unerupted, resembling or unlike the other teeth in the group to which it belongs. Its presence may cause malposition of adjacent teeth or prevent their eruption. C07.650.800.850
C07.793.700.850
C16.131.850.800.850
Hyperdontia
 
hyperemesis gravidarum complication Complications of pregnancy
morning sickness
human disorder of pregnancy C13.703.407.500
C23.888.821.937.049.500
Hyperinsulinism Phenotype an above normal level of insulin in the blood C18.452.394.968
hyperkalemia mineral metabolism disease elevated level of potassium (K+) in the blood serum. C18.452.950.396 Hyperkalemia
Hyperkinesia movement disorder C10.597.350.350
C23.888.592.350.350
Hyperosmolar hyperglycemic state Diabetic coma
Hyperosmolar syndrome
Human disease C19.246.099.750.490
hypersalivation salivary gland disease excessive production of saliva C07.465.815.815
Hypertelorism Craniofacial abnormality
genetic disease
condition in which there is an abnormally increased distance between two organs or bodily parts; most often, this term is referring to an increased distance between the orbits (orbital hypertelorism) C05.116.099.370.231.480
C05.660.207.231.480
C16.131.621.207.231.480
Hypertelorism
hyphema intraocular hemorrhage
iris disease
Human disease C11.290.484
C23.550.414.756.550
Hyphema
Hypnotics and Sedatives Central Nervous System Depressants Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. D27.505.696.277.350
D27.505.954.427.210.350
hypoesthesia somatosensory disorder C10.597.751.791.500
C23.888.592.763.770.500
Iliotibial band syndrome occupational disease C26.558.554.425
C26.844.150.425
Iliotibial band syndrome
 
immune reconstitution inflammatory syndrome immune system disease C20.608
Immunologic adjuvant Immunologic Factors
Adjuvant
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are end D27.505.696.477.067
Immunologic Factors Physiological Effects of Drugs Biologically active substances whose activities affect or play a role in the functioning of the immune system. D27.505.696.477
Immunosorbents surfactant An insoluble support for an antigen or antibodies that is used in affinity chromatography to adsorb the homologous antibody or antigen from a mixture. Many different substances are used, among them sepharose; glutaraldehyde; copolymers of anhydrides D27.720.877.501
immunosuppressive drug Immunologic Factors Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting dna synthesis. Others may act through activation of t-cells or by inhibiting the activation of helper cells. While D27.505.696.477.656 Immunosuppressants
Immunotoxin Noxae Semisynthetic conjugates of various toxic molecules, including radioactive isotopes and bacterial or plant toxins, with specific immune substances such as immunoglobulins; monoclonal antibodies; and antigens. The antitumor or antiviral immune substa D27.888.569.271 Immunotoxins
inbreeding production of offspring from closely related organism E05.820.150.520
G05.090.403
incisor tooth A14.549.167.860.425 Incisors
 
Incretins hormone Peptides which stimulate insulin release from the pancreatic beta cells following oral nutrient ingestion, or postprandially D27.505.696.399.472.580
Indicators and Reagents Laboratory Chemicals Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a D27.720.470.410
inferior colliculus Inferior colliculus A08.186.211.132.659.237.364 Inferior colliculus
Inferior ganglion of vagus nerve A08.340.390.550
informatics academic field L01.313 Computer science
information science science
academic discipline
field primarily concerned with the analysis, collection, classification, manipulation, storage, retrieval and dissemination of information L
L01
Information science
ingrown nail nail disease C17.800.529.406 Ingrown nail
 
Inguinal canal A01.047.412 Inguinal canal
ink blot test projective test F04.711.647.622.341
insect bite Arthropod bites and stings
diseases caused by insect
wound caused by the bite of an insect C25.723.127.071
C26.176.143
insect repellent pesticide
Protective Agents
Animal repellent
substance which repels insects D27.888.723.441
D27.505.696.706.434
D27.720.031.700.441
Insect repellents
insecticide phytopharmaceuticals
zoocide
pesticide
pesticide used against insects D27.888.723.491
D27.720.031.700.491
Insecticides
Insulin Antagonists Hormone Antagonists Compounds which inhibit or antagonize the biosynthesis or action of insulin D27.505.696.399.450.420
insulin resistance diabetes mellitus
drug resistance
human disease C18.452.394.968.500 Insulin resistance
Integrase inhibitor enzyme inhibitor Compounds which inhibit or antagonize biosynthesis or actions of integrase D27.505.519.389.375 Integrase inhibitors
Intercalating Agents Indicators and Reagents Agents that are capable of inserting themselves between the successive bases in dna, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of dna D27.720.470.410.360
Intercarpal articulations A02.835.583.405.174
Interferon Inducers Immunologic Factors Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. D27.505.696.477.828
interneuron cell type neuron A08.663.358
Intertarsal articulations A02.835.583.378.831
Interventricular foramina A08.186.211.276 Interventricular foramina
intervertebral disc fastener cartilage of spine A02.165.308.410 Intervertebral discs
 
Intraductal carcinoma breast carcinoma in situ C04.557.470.200.025.275
C04.557.470.200.240.187.250
C04.557.470.615.275
 
Intralipid medical food
Parenteral Nutrition Solutions
pharmaceutical product D27.505.954.578.733.500
D27.720.752.733.500
Intrathecal route of administration route of administration A08.186.566.166.686
involuntary commitment hospitalization legal process through which an individual who is deemed to have symptoms of severe mental disorder is court-ordered into treatment F04.096.544.335.200
N03.706.535.351.200
Ion Exchange Resins Laboratory Chemicals High molecular weight, insoluble polymers which contain functional groups that are capable of undergoing exchange reactions (ion exchange) with either cations or anions D27.720.470.420
Ionic Liquids solvent Salts that melt below 100 c. Their low volatilization can be an advantage over volatile organic solvents D27.720.844.500
Ionophore Specialty Uses of Chemicals
Membrane Transport Modulators
Chemical agents that increase the permeability of biological or artificial lipid membranes to specific ions. Most ionophores are relatively small organic molecules that act as mobile carriers within membranes or coalesce to form ion permeable channe D27.505.519.562.374
D27.720.395
Ionophores
IQ test psychological test F04.711.141.493
Iron Chelating Agents Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in bi D27.505.519.914.500.410
D27.720.832.500.410
Irritants Noxae
Specialty Uses of Chemicals
Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscess D27.720.400
D27.888.569.300
Islands of Calleja A08.186.211.577.699.400
itch symptom
somatosensory disorder
disease C17.800.685
C23.888.885.625
Janus kinase inhibitor Protein kinase inhibitor Agents that inhibit janus kinases D27.505.519.389.755.500
Jewish people people
ethnic group
ethnoreligious group
nation
Semitic ancient nation, race, and ethnoreligious group from the Levant M01.686.754.600 Jews
 
joint instability hypermobility syndrome D007593
Kasabach–Merritt syndrome hemangioma A rare disease usually seen in infants C04.557.645.375.617
C15.378.140.855.645
Kasabach–Merritt syndrome
 
ketosis disease of metabolism C18.452.076.176.652
knee synovial joint synovial joint
joint
joint between the thigh and lower leg A01.378.610.450 Knee
 
kombucha tea
fermented beverage
D20.215.784.844.500 Kombucha
 
Kraurosis vulvae vulvar disease
Lichen sclerosus
C13.351.500.944.815
Laboratory Chemicals Specialty Uses of Chemicals Chemicals necessary to perform experimental and/or investigative procedures and for the preparation of drugs and other chemicals. D27.720.470
lacrimal gland exocrine gland paired, almond-shaped exocrine gland, one for each eye, that secretes the aqueous layer of the tear film A09.371.463
Lamellar corpuscle Q1648747 A08.675.650.915.750.700 Lamellar corpuscle
Laryngopharyngeal reflux gastroesophageal reflux disease retrograde flow of gastric contents to the upper aero-digestive tract, which causes a variety of symptoms, such as cough, hoarseness, and wheezing C06.405.117.119.500.484.500
C08.360.577
Latent autoimmune diabetes type 1 diabetes mellitus C18.452.394.750.714
C19.246.656
C20.111.576
lathyrism food poisoning C25.723.756.558
 
laxative purgative
Gastrointestinal Agents
Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve constipation D27.505.954.483.620 Laxatives
lead poisoning metal poisoning
occupational disease
chemical hazard
rare intoxication
C25.723.589 Lead poisoning
 
Leprostatic Agents antibiotic Substances that suppress mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions D27.505.954.122.085.777
lesser omentum A01.047.025.600.573
leukocytosis leukocyte disease C15.378.553.475
C23.550.526
Leukotriene Antagonists Hormone Antagonists A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level D27.505.696.399.450.565
Lhermitte–Duclos disease gangliocytoma C04.445.435
C04.651.435
C04.700.435
C16.320.700.435
Lhermitte–Duclos disease
life style activity
human behaviour
typical way of life of an individual, group, or culture F01.829.458
 
Ligamenta flava A02.513.514.287
ligand Laboratory Chemicals molecule or functional group that binds or can bind to the central atom in a coordination complex D27.720.470.480 Ligands
lingual nerve nerve A08.800.800.120.760.500.450
Lipid Regulating Agents Therapeutic Uses Substances that alter the metabolism of lipids D27.505.954.557
lipoblastoma lipoma
connective tissue benign neoplasm
C04.557.450.550.400.500
Lipoprotein Lipase Activators Lipotropic Agents
Enzyme activator
Compounds that increase the enzymatic activity of lipoprotein lipase. Lipoprotein lipase activators have a potential role in the treatment of obesity by increasing lipid metabolism. Note that substances that increase the synthesis of lipoprotein lip D27.505.954.557.500.601.500
D27.505.519.374.600
Lipotropic Agents hypolipidemic
Gastrointestinal Agents
Endogenous factors or drugs that increase the transport and metabolism of lipids including the synthesis of lipoproteins by the liver and their uptake by extrahepatic tissues D27.505.954.557.500.601
D27.505.519.186.071.601
D27.505.954.483.680
Lipoxygenase inhibitor enzyme inhibitor Compounds that bind to and inhibit that enzymatic activity of lipoxygenases. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of leukotrienes D27.505.519.389.480
List of thalamic nuclei Wikimedia list article Wikimedia list article A08.186.211.730.385.826.701
liver animal organ vital organ in vertebrates and some other animals A03.620 Livers
 
liver abscess abdominal abscess
liver disease
C01.539.830.025.020.455
C06.552.597
Liver abscesses
liver tumor tumor
liver disease
C04.588.274.623
C06.301.623
C06.552.697
Ultrasound images of liver tumors
long-term care insurance health insurance N03.219.521.576.343.508
long-term effects of alcohol Alcohol and health health effects of drinking alcoholic beverages C25.775.100
lower back pain back pain
low back disorder
disorder involving muscles, nerves, bones of the back C10.597.617.140.400
C23.888.592.612.107.400
Back pain
 
lubricant type of chemical components for an application mixture
Specialty Uses of Chemicals
substance, usually organic, introduced to reduce friction between surfaces in mutual contact, which ultimately reduces the heat generated when the surfaces move D27.720.556 Lubricants
 
lumbar plexus nerve plexus A08.800.800.720.450 Lumbar plexus
Lumbosacral plexus A08.800.800.720.450
Luminescent Agents Indicators and Reagents Compound such as luminescent proteins that cause or emit light (physical luminescence) D27.720.470.410.505
lunate bone bone
short bone
carpal bone
bone of the carpus A02.835.232.087.144.663 Lunate bone
lung animal organ essential respiration organ in many air-breathing animals A04.411 Lungs
Luteolytic Agents Contraceptive Agents, Female
Reproductive Control Agents
Chemical compounds causing luteolysis or degeneration D27.505.954.705.610
D27.505.954.705.360.276.450
D27.505.696.875.360.276.450
D27.505.696.875.610
lymphadenopathy immune system disease
lymph node disease
clinical sign
disorder of lymph nodes C15.604
C15.604.338
Lymphadenopathy
 
Lymphocytosis leukocytosis C15.378.553.475.604
machiavellianism philosophy
personality trait
political philosophy sometimes measured as a personality trait F01.752.650
macula of retina A09.371.729.522 Macula lutea
Major duodenal papilla A03.159.183.079.300.950
mammary gland exocrine gland exocrine gland in mammals that produces milk to feed young offspring A01.236.249 Mammary glands
managed care health insurance a type of health insurance system N03.219.521.576.343.800
N04.590.374.410
mandibular fracture bone fracture
mandibular injury
break through the mandibular bone C10.900.300.284.500.400.255
C26.404.750.467.441
C26.915.300.425.500.400.255
C10.900.300.284.500.400
C26.404.750.467
C26.915.300.425.500.400
Fractures of the human mandible
mandibular nerve nerve A08.800.800.120.760.500
 
Marchiafava-Bignami disease demyelinating disease C10.228.140.163.510
C10.314.475
Matrix metalloproteinase inhibitor Protease inhibitor Compounds that inhibit the enzyme activity or activation of matrix metalloproteinases D27.505.519.389.745.610
maxilla bone upper jawbone formed from the fusion of two maxillary bones; includes the frontal portion of the palate of the mouth A02.835.232.781.324.502.645 Maxilla
maxillary nerve nerve A08.800.800.120.760.550
May–Thurner syndrome vascular malformation C14.240.850.906
C14.907.617.648
C16.131.240.850.890
mechanism of action means
biochemistry
Pharmacologic Actions
biochemical interaction through which a drug produces its pharmacological effect D27.505.519
Medial collateral ligament A02.513.514.162.600
Median eminence A08.186.211.730.385.357.352.435.249
Medicaid publicly funded health care United States social health care program for families and individuals with limited resources N03.219.521.346.506.564.655
N03.706.615.693
Medical savings account health insurance N03.219.151.170.650
N03.219.521.576.090.650
N03.219.521.576.343.830
N03.219.559.500
Medigap health insurance in the United States supplemental health insurance that pays for costs not covered by Medicare or private health insurance N03.219.521.576.343.539
Mediterranean diet intangible cultural heritage diet intangible cultural heritage E02.642.249.270
G07.203.650.240.270
Mediterranean diet
 
MEDLINE bibliographic database
medical database
medical bibliographical database L01.313.500.750.280.710.500
L01.313.500.750.280.750.500
L01.313.500.750.300.188.300.650.500
L01.313.500.750.300.710.500
L01.313.500.750.300.742.650.500
L01.470.750.500.650.500
medulla oblongata A08.186.211.132.810.406 Medulla oblongata
Meibomian gland A09.371.337.614
Meigs syndrome ovarian tumor
neoplastic syndrome
A rare syndrome affecting females. It is characterized by pleural effusion, ascites and non-malignant ovarian neoplasm. This syndrome usually follows a benign course. Prognosis is favorable following surgical resection of the ovarian mass. C04.588.322.455.531
C13.351.500.056.630.705.531
C13.351.937.418.685.531
C19.344.410.531
C19.391.630.705.531
Meissner's plexus plexus part of the enteric nervous system A08.800.050.050.850
Melanocytic nevus nevus Human disease C04.557.665.560.615 Melanocytic nevus
 
Membrane Transport Modulators mechanism of action Agents that affect ion pumps; ion channels; abc transporters; and other membrane transport proteins D27.505.519.562
meninges membranes that envelop the brain and spinal cord A08.186.566 Meninges
menorrhagia dysfunctional uterine bleeding C13.351.500.852.691.449
C23.550.568.875
Menorrhagia
Menstruation-Inducing Agents Contraceptive Agents, Female
Reproductive Control Agents
Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (from dorland, 27th ed) D27.505.696.875.650
D27.505.696.875.360.276.500
D27.505.954.705.650
D27.505.954.705.360.276.500
mesenteric ischemia infarction
Bowel infarction
C06.405.469.656
C06.844.460
C14.907.549
Mesenteric ischemia
mesoderm germ layer A16.254.425.660 Mesoderm
mesonephros A16.254.500
messenger RNA transcript RNA large family of RNA molecules that convey genetic information from DNA to the ribosome, where they specify the amino acid sequence of the protein products of gene expression D13.444.735.544 MRNA
Metabolic Side Effects of Drugs and Substances adverse drug reaction
Pharmacologic Actions
Specific effects of drugs and substances on metabolic pathways such as those occurring through the CYTOCHROME P-450 ENZYME SYSTEM. These include effects that often result in DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; and HERB-DRUG INTERACTI D27.505.389
metatarsalgia ankle or tarsus enthesopathy C05.360.500
C05.550.610
C10.597.617.560
C23.888.592.612.540
metathalamus A08.186.211.730.385.826.701.444
Metrorrhagia dysfunctional uterine bleeding C13.351.500.852.691.622
C23.550.414.993.700
micrognathism minor physical anomaly C05.500.460.457
C05.660.207.540.460.457
C07.320.440.457
C07.650.500.460.457
C16.131.621.207.540.460.457
C16.131.850.500.460.457
Micrognathism
Micronutrients Growth Substances Essential dietary elements or organic compounds that are required in only small quantities for normal physiologic processes to occur D27.505.696.377.605
Midbrain tegmentum A08.186.211.132.659.822
mindfulness technique meditation meditation practice F02.463.551
F04.754.137.428.500
Mindfulness
mineralocorticoid hormone hormone A group of corticosteroids primarily associated with water and electrolyte balance. This is accomplished through the effect on ion transport in renal tubules, resulting in retention of sodium and loss of potassium. Mineralocorticoid secretion is its D27.505.696.399.472.673 Mineralocorticoids
Mineralocorticoid Receptor Antagonists Hormone Antagonists
Potassium-sparing diuretic
Drugs that bind to and block the activation of mineralocorticoid receptors by mineralocorticoids such as aldosterone D27.505.696.399.450.600
D27.505.696.560.500.726.249
Minnesota Multiphasic Personality Inventory personality test personality test used in clinical psychology evaluations F04.711.647.513.607
Miotics Autonomic Agents Agents causing contraction of the pupil of the eye. Some sources use the term miotics only for the parasympathomimetics but any drug used to induce miosis is included here D27.505.696.663.050.495
Mirizzi's syndrome cholestasis C06.130.120.135.812 Mirizzi's syndrome
mitochondrial DNA DNA DNA located in organelles called mitochondria D13.444.308.283.225 Mitochondrial DNA
Mitogens Mitosis Modulators Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with lectins, but also substances from streptococci (associated with streptolysin s) and from strains of alpha-toxin-producing staphylococci D27.505.519.593.624
Mitosis Modulators mechanism of action Agents that affect mitosis of cells D27.505.519.593
Mixed Müllerian tumor Complex and mixed tumor C04.557.435.540
Modes of Toxic Action chemical Actions and Uses chemical actions with harmful or deadly effect on living organisms D27.888
Molecular Probes business Laboratory Chemicals
Diagnostic Uses of Chemicals
A group of atoms or molecules attached to other molecules or cellular structures and used in studying the properties of these molecules and structures. Radioactive dna or rna sequences are used in molecular genetics to detect the presence of a compl D27.720.470.530
D27.505.259.750
Molluscacides pesticide Agents destructive to snails and other mollusks D27.888.723.596
D27.720.031.700.596
Monoamine oxidase inhibitor chemical substance
enzyme inhibitor
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (from gilman, et al., goodman and gilman's the pharmacological basis of therapeutics, 8th ed, p414) D27.505.519.389.616 Monoamine oxidase inhibitors
Monteggia fracture Ulna Fractures
fracture dislocation
C05.116.359.336.750
C26.289.336.750
C26.404.937.547
Monteggia fractures
morning sickness Symptoms and discomforts of pregnancy
nausea
C13.703.407
C23.888.821.937.049
Morton's neuroma foot disease Pie isquierdo C05.360.500.500
C05.550.610.500
C10.597.617.560.500
C10.597.617.682.275
C10.668.829.600.375
C23.888.592.612.540.500
C23.888.592.612.664.275
Morton's neuroma
 
mouth animal organ first portion of the alimentary canal that receives food A01.456.505.631 Mouths
mouthwash product
Biomedical and Dental Materials
cosmetics
rinse for oral hygiene or cosmetic purposes D27.720.269.583
D27.720.102.583
Mouthwash
moxibustion Chinese medicine therapy E02.190.044.588 Moxibustion
 
Münchausen syndrome factitious disorder Psychiatric Factitious Disorder F03.875.375.600
muscarinic agonist Cholinergic Agonists activating agent of the muscarinic acetylcholine receptor D27.505.696.577.120.140.500
D27.505.519.625.120.140.500
Muscarinic agonists
Muscarinic antagonist anticholinergic A drug that binds to but does not activate muscarinic cholinergic receptors, thereby blocking the actions of endogenous acetylcholine or exogenous agonists D27.505.696.577.120.200.500
D27.505.519.625.120.200.500
Muscarinic antagonists
Muscle Relaxants, Central Central Nervous System Agents
Neuromuscular Agents
Physiological Effects of Drugs
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, an D27.505.954.427.525
D27.505.696.510
D27.505.696.663.700.600
mushroom poisoning poisoning
food poisoning
Mycotoxicosis
harmful effects from ingestion of toxic substances present in a mushroom C25.723.415.551
C25.723.680.551
Amanita
 
Mutagen Noxae Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes D27.888.569.468 Mutagens
Mydriatics Autonomic Agents Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics D27.505.696.663.050.500
Myeloablative Agonists antineoplastic
immunosuppressive drug
Agents that destroy bone marrow activity. They are used to prepare patients for bone marrow transplantation or stem cell transplantation D27.505.696.477.656.750
D27.505.954.248.589
Myelolipoma adipose tissue neoplasm C04.557.450.550.710 Myelolipoma
Myenteric plexus plexus part of the enteric nervous system A08.800.050.050.500
myotonia myotonic disease C10.597.613.700
C23.888.592.608.700
myxomatosis rabbit disease rabbit disease C02.256.743.665
C22.627
Myxomatosis
 
narcotic psychoactive drug
analgesic
Central Nervous System Depressants
chemical substance with psycho-active properties D27.505.954.427.210.600
D27.505.696.277.600
D27.505.696.663.850.014.760
D27.505.954.427.040.550
Drugs
Narcotic Antagonists Central Nervous System Agents
Sensory System Agents
Physiological Effects of Drugs
Agents inhibiting the effect of narcotics on the central nervous system D27.505.696.543
D27.505.696.663.850.512
D27.505.954.427.550
nasal cavity anatomical cavity A04.531.449 Nasal cavity
Nasal Decongestants Vasoconstrictor Agents
Respiratory System Agents
Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that l D27.505.954.411.793.610
D27.505.954.796.560
nasolacrimal duct duct carries tears from the lacrimal sac of the eye into the nasal cavity. A09.371.463.640
Natriuretic Agents Cardiovascular Agents
Physiological Effects of Drugs
Endogenous or exogenous chemicals that regulate the water-electrolyte balance in the body. They consist of peptides and non-peptide compounds D27.505.954.411.455
D27.505.696.560
navicular bone bone bone of the ankle A02.835.232.043.300.710 Navicular bone
neck of femur zone of femur A02.835.232.043.650.247.510
neglected tropical disease tropical disease
diseases of poverty
C23.550.291.890
 
neonatal conjunctivitis conjunctivitis C01.252.354.225.625
C01.252.400.625.391.658
C01.539.375.354.220.625
C11.187.183.220.538
C11.294.354.220.625
C16.614.677
Neonatal conjunctivitis
 
nephrogenic systemic fibrosis fibrosis
skin disease
other acquired skin disease
C17.800.553
C23.550.355.550
nerve agent chemical compound
organophosphate
chemical warfare agent
Specialty Uses of Chemicals
class of organophosphates; classified as weapons of mass destruction D27.720.777.300.500
D27.720.599
Nerve agents
Neuroborreliosis Lyme disease C01.252.200.450
C01.252.400.155.569.600
C01.252.400.825.480.700
C01.252.847.193.569.600
C10.228.228.180.437
Neurolemma A08.561.600
Neuromuscular Agents Peripheral Nervous System Agents Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (neuromuscular blocking agents), and drugs that act centrally as skeletal muscle relaxants (muscle D27.505.696.663.700
Neuromuscular Blocking Agents Neuromuscular Agents Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (neuromuscular nondepolarizing agents) or noncompetitive, depolarizing agents (neuromuscular depo D27.505.696.663.700.710
Neuromuscular Depolarizing Agents Neuromuscular Blocking Agents Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarization of the motor end plate. These agents are primarily used as adjuvants in surgical anesthesia to cause skeletal muscle relaxation D27.505.696.663.700.710.550
Neuromuscular Nondepolarizing Agents Neuromuscular Blocking Agents Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatm D27.505.696.663.700.710.575
neuromyotonia Designated intractable/rare diseases peripheral nerve hyperexcitability C05.651.392
C10.668.829.425
Neuronal Tract-Tracers Indicators and Reagents
Diagnostic Uses of Chemicals
Substances used to identify the location and to characterize the types of neural pathways D27.505.259.812
D27.720.470.410.577
Neuroprotective Agents Central Nervous System Agents
Protective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, bu D27.505.696.706.548
D27.505.954.427.575
neuropsychological test psychological test F04.711.513 Neuropsychological tests
neurotoxin toxin
Noxae
substance poisonous or destructive to nerve tissue D27.888.569.504 Neurotoxins
neurotransmitter chemical compound
mechanism of action
Physiological Effects of Drugs
endogenous chemicals that transmit signals across a synapse from one neuron to another D27.505.519.625
D27.505.696.577
Neurotransmitters
Neurotransmitter Uptake Inhibitors neurotransmitter
Membrane Transport Modulators
Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the tra D27.505.519.625.600
D27.505.696.577.600
D27.505.519.562.437
nevus skin benign neoplasm
rare genetic developmental defect during embryogenesis
rare skin tumor or hamartoma
Human disease C04.557.665.560 Nevus
 
Nicotinic agonist Cholinergic Agonists Drugs that bind to and activate nicotinic cholinergic receptors (receptors, nicotinic). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the cent D27.505.519.625.120.140.700
D27.505.696.577.120.140.700
Nicotinic agonists
Nicotinic antagonist anticholinergic Drugs that bind to nicotinic cholinergic receptors (receptors, nicotinic) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, an D27.505.696.577.120.200.700
D27.505.519.625.120.200.700
Nicotinic antagonists
night horror sleep disorder C10.886.659.635.600
Nitric Oxide Donors Cardiovascular Agents
mechanism of action
A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarcti D27.505.954.411.590
D27.505.519.656
nitrogen narcosis effect
hazard
diving disorder narcotic effect of high partial pressure respired nitrogen C24.426
C25.723.455.571
NK1 receptor antagonist neurotransmitter Compounds that inhibit or block the activity of neurokinin-1 receptors D27.505.519.625.487
D27.505.696.577.487
noise-induced hearing loss occupational disease
sensorineural hearing loss
Health effects from noise
C09.218.458.341.887.460
C10.597.751.418.341.887.460
C23.888.592.763.393.341.887.460
Non-24-hour sleep-wake disorder obsolete chronobiology disease C10.281
non-opioid analgesic analgesic A subclass of analgesic agents that typically do not bind to opioid receptors and are not addictive. Many non-narcotic analgesics are offered as nonprescription drugs D27.505.954.427.040.100
D27.505.696.663.850.014.040
Nonsteroidal Anti-Androgens Androgen Antagonists Nonsteroidal agents which block the action or downregulate the synthesis of androgens D27.505.696.399.450.065.500
nonverbal communication communication process of communication through sending and receiving wordless (mostly visual) cues between people F01.145.209.530
L01.143.649
Non-verbal communication
Norepinephrine reuptake inhibitor antidepressant
Neurotransmitter Uptake Inhibitors
Adrenergic Agents
Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (antidepressive agents, tricyclic) and amphetamines are among the therapeutically important drugs D27.505.696.577.600.050
D27.505.519.625.600.050
D27.505.519.562.437.050
D27.505.696.577.050.601
D27.505.519.625.050.601
Norepinephrine reuptake inhibitors
notochord flexible rod-shaped body found in embryos of all chordates A16.254.610
Noxae Modes of Toxic Action Agents capable of exerting a harmful effect on the body. D27.888.569
nucleic acid inhibitor enzyme inhibitor Compounds that inhibit cell production of dna or rna D27.505.519.389.675
Nucleic Acid Probes Molecular Probes Nucleic acid which complements a specific mrna or dna molecule, or fragment thereof; used for hybridization studies in order to identify microorganisms and for genetic studies D27.505.259.750.600
D27.720.470.530.600
nucleus accumbens A08.186.211.730.885.105.683 Nucleus accumbens
Nucleus raphe magnus nucleus raphe magnus A08.186.211.132.810.428.600.650.562.500
Nutritive Sweeteners sweetener Any agent that adds not only sweet taste but some energy value to food. They include natural sugars such as sucrose; fructose; and galactose; and certain sugar alcohols D27.720.372.300.353.609.750
nystagmus eye and adnexa disease
eye movement
condition of involuntary eye movement C10.292.562.675
C11.590.400
Nystagmus
 
Obstetrical brachial plexus palsy brachial plexus lesion
obstetric paralysis
neurological injury in newborns C10.668.829.100
obstructed labor obstetric labor complication human disease C13.703.420.288
occipital lobe cerebral lobe part of the brain A08.186.211.730.885.213.571 Occipital lobe
Ointment Bases Pharmaceutic Aids Various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons; vehicles for medicinal substances intended for external application; there are four classes: hydrocarbon base, absorption base, water-removable base and water- D27.720.744.523
olfactory bulb organism substance
anatomical structure
help with smell A08.186.211.577.699.573 Olfactory bulb
Olfactory epithelium A04.531.520.573 Olfactory epithelium
Oligodeoxyribonucleotides, Antisense DNA, Antisense
Antisense oligonucleotide
Short fragments of dna that are used to alter the function of target rnas or dnas to which they hybridize D27.720.470.530.600.150.640.640
D27.720.470.530.600.150.200.640
Oligonucleotide Probes Nucleic Acid Probes Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., dna segments near or within a specific gene locus or gene. The probe hybridizes with a specific mrna, if presen D27.505.259.750.600.650
D27.720.470.530.600.650
Oligoribonucleotides, Antisense Antisense RNA
Antisense oligonucleotide
Short fragments of rna that are used to alter the function of target rnas or dnas to which they hybridize D27.720.470.530.600.150.760.645
D27.720.470.530.600.150.640.645
olivary body A08.186.211.132.810.406.574
omental bursa A01.047.025.600.678
onycholysis nail disease C17.800.529.478 Onycholysis
oocyte germ cell female gametocyte or germ cell involved in reproduction. In other words, it is an immature ovum, or egg cell. An oocyte is produced in the ovary during female gametogenesis A05.360.490.690.680 Oocytes
Oogonium A05.360.490.690.700
ophthalmic nerve sensory nerve nerve sensory nerve A08.800.800.120.760.650
orbit The cavity or socket of the skull in which the eye and its appendages are situated. A02.835.232.781.324.690 Orbit (anatomy)
Orexin Receptor Antagonists Sleep Aids, Pharmaceutical
neurotransmitter
Substances that bind to and inhibit the action of orexin receptors. Drugs in this class have been used as sleep aids D27.505.696.577.663
D27.505.519.625.663
D27.505.954.842.500
Ornithine Decarboxylase Inhibitors enzyme inhibitor Substances and drugs that inhibit or block the activity of ornithine decarboxylase D27.505.519.389.705
Osseous spiral lamina A09.246.631.246.930
osteoma benign neoplasm
bone tumor
C04.557.450.565.575.625 Osteoma
osteopenia Demineralization
bone disease
C05.116.198.247
C18.452.104.247
Osteopenia
otalgia auditory system disease pain in the ear C09.218.350
C10.597.617.199
C23.888.592.612.302
outlier N03.219.521.710.305.200.080.550 Outliers
oval window A09.246.631.909.551
overcrowding determinants of health condition where more people are located within a given space than is considered tolerable from a safety and health perspective which will depend on current environment and local cultural norms F01.145.875.281
Oxidants, Photochemical oxidizing agent Compounds that accept electrons in an oxidation-reduction reaction. The reaction is induced by or accelerated by exposure to electromagnetic radiation in the spectrum of visible or ultraviolet light D27.888.569.540.631
D27.720.642.631
oxidizing agent chemical substance electron acceptor
Noxae
Specialty Uses of Chemicals
chemical compound used to oxidize another substance in a chemical reaction D27.720.642
D27.888.569.540
Oxytocics Reproductive Control Agents Drugs that stimulate contraction of the myometrium. They are used to induce labor, obstetric at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or wi D27.505.696.875.737
D27.505.954.705.737
ozone depletion physical process
hole
stratospheric phenomena of Earth G16.500.785
N06.230.300.100.700.500
Ozone layer
ozone layer layer region of Earth's stratosphere that absorbs most of the Sun's UV radiation D01.362.670.600.500
G16.500.275.063.700
N06.230.300.100.700
Ozone layer
palatine bone bone facial bone A02.835.232.781.324.502.660 Palatine bones
 
pancreas gland
organ
glandular organ in the digestive system and endocrine system of vertebrates A03.734 Pancreas
pancreatic duct duct joining the pancreas to the common bile duct A03.734.667 Pancreatic duct
paralysis health problem loss of muscle function for one or more muscles C10.597.622
C23.888.592.636
Paralysis
Paramesonephric duct Primordium A16.623 Müllerian duct
Paraproteinemia Immunoproliferative disorder Human disease C15.378.147.780
C20.683.780
parasitic worms C03.335 Helminths
parasomnia sleep disorder category of sleep disorders C10.886.659
Parasympatholytic Autonomic Agents Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists D27.505.696.663.050.650
Parasympathomimetic drug Autonomic Agents Drugs which mimic the action of stimulation of cholinergic receptors. D27.505.696.663.050.675 Parasympathomimetics
parathyroid endocrine gland endocrine gland A06.407.560 Parathyroid gland
Paratuberculosishvjcb mycobacterium infectious disease
animal disease
cattle disease C01.252.410.040.552.588
C22.688
Parenteral Nutrition Solutions Pharmaceutical Solutions Specialized solutions for parenteral nutrition. They may contain a variety of micronutrients; vitamins; amino acids; carbohydrates; lipids; and salts D27.720.752.733
D27.505.954.578.733
paresis neurological disorder condition typified by a weakness of voluntary movement C10.597.636
C23.888.592.643
paresthesia somatosensory disorder C10.597.751.791.875
C23.888.592.763.770.875
Parotid duct A03.556.500.760.640
patella bone bone of the leg A02.835.232.043.650.624 Patella
patellar ligament A02.513.514.475
patient advocacy I01.880.604.631
N03.706.678
Patient portal secure website used by patients to access their medical records or communicate with health care providers E05.318.308.940.968.249.500.500
E05.318.308.940.968.249.750
Patient Protection and Affordable Care Act legislation
Act of Congress
United States federal statute N03.219.521.576.343.918
N03.706.615.806
Patient Protection and Affordable Care Act
Patient Self-Determination Act N03.706.615.808
patients' rights human rights I01.880.604.473.650
N03.706.437.650
pay for performance managed care movement in health insurance N03.219.521.710.305.380
PDE3 inhibitor Phosphodiesterase inhibitor Compounds that specifically inhibit phosphodiesterase 3 D27.505.519.389.735.249
pectus carinatum bone development disease
deformity of chest and rib
C05.116.099.739
C05.182.525
C05.660.745
C16.131.621.745
C17.300.182.525
Pectus carinatum
pectus excavatum bone development disease
deformity of chest and rib
genetic disease
congenital deformity of the chest C05.116.099.386
C05.660.386
C16.131.621.386
Pectus excavatum
peer group group of humans
social group
F01.829.316.483 Peer group
peer pressure social influence influence that a peer group, observers or individual exerts that encourages others to change their attitudes, values, or behaviors to conform the group norms. A group trying to convince a person to do something they don't wanna do. F01.829.316.483.750
Peptidomimetics mechanism of action Compounds that are designed to mimic the 3d structure of a natural peptide or protein D27.505.519.828
Performance-Enhancing Substances Physiological Effects of Drugs Agents that improve the ability to carry out activities such as athletics, mental endurance, work, and resistance to stress. The substances can include prescription drugs; dietary supplements; phytochemicals; and illicit drugs D27.505.696.620
perfume cosmetics
aroma compound
mixture used to produce a pleasant smell D27.720.269.700 Perfumes
 
Peri-implantitis periodontal disease C07.465.714.282
periaqueductal gray A08.186.211.132.659.822.595
pericardium anatomical region double-walled sac containing the heart and the roots of the great vessels A07.541.795 Hearts
 
perineurium A08.800.800
Peripheral Nervous System Agents Physiological Effects of Drugs Drugs that act principally at one or more sites within the peripheral neuroeffector systems, the autonomic system, and motor nerve-skeletal system. (from smith and reynard, textbook of pharmacology, 1991, p75) D27.505.696.663
peripheral neuropathy neurological disorder
peripheral nervous system disease
disease C10.668.829
peritoneum serous membrane
mesothelium
serous membrane that forms the lining of the abdominal cavity or the coelom—it covers most of the intra-abdominal (or coelomic) organs—in amniotes and some invertebrates A01.047.025.600 Peritoneum
Peroxisome Proliferators carcinogen A class of nongenotoxic carcinogens that induce the production of hepatic peroxisomes and induce hepatic neoplasms after long-term administration D27.888.569.100.675
persistent vegetative state disorder of consciousness disorder of consciousness caused by severe brain damage C10.228.140.140.627
C10.597.606.358.800.400
C23.888.592.604.359.800.400
person descriptive item used as unit subject
individual
agent
item with given name property
being that has certain capacities or attributes constituting personhood (avoid use with P31; use Q5 for humans) M01 Person
personality test psychological test psychological or character questionnaire F04.711.647
pes cavus foot deformity C05.330.488.655.500
C05.330.495.681.500
C05.660.585.512.380.813.500
C16.131.621.585.512.500.681.500
pesticide biocide
Modes of Toxic Action
agrochemical
substance used to destroy pests D27.888.723
D27.720.031.700
Pesticides
Pesticide Residues pesticide Pesticides or their breakdown products remaining in the environment following their normal use or accidental contamination D27.888.723.697
D27.720.031.700.672
Pesticide Synergists pesticide Chemicals that, while not possessing inherent pesticidal activity, nonetheless promote or enhance the effectiveness of other pesticides when combined D27.720.031.700.748
D27.888.723.748
Phantom limb perceptual disorder C10.597.606.762.700
C10.597.617.841.500
C23.550.767.700.500
C23.888.592.604.764.700
C23.888.592.612.832.500
Phantom limb
Pharmaceutic Aids Specialty Uses of Chemicals Substances which are of little or no therapeutic value, but are necessary in the manufacture, compounding, storage, etc., of pharmaceutical preparations or drug dosage forms. They include solvents, diluting agents, and suspending agents, and emulsif D27.720.744
Pharmaceutical Solutions Specialty Uses of Chemicals
Therapeutic Uses
Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, the D27.505.954.578
D27.720.752
Pharmaceutical Vehicles Pharmaceutic Aids A carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (dictionary of pharmacy, 1986) D27.720.744.770
Pharmacologic Actions chemical Actions and Uses A broad category of chemical actions and uses that result in the prevention, treatment, cure or diagnosis of disease D27.505
Pharyngeal arch A16.142
phocomelia dysmelia
Ectromelia
congenital disorder C05.660.585.350
C16.131.621.585.350
Phocomelia
Phosphodiesterase 4 Inhibitors Phosphodiesterase inhibitor Compounds that specifically inhibit phosphodiesterase 4 D27.505.519.389.735.374
Phosphodiesterase 5 Inhibitors Phosphodiesterase inhibitor Compounds that specifically inhibit phosphodiesterase 5 D27.505.519.389.735.500
Phosphodiesterase inhibitor enzyme inhibitor Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases D27.505.519.389.735 Phosphodiesterase inhibitors
Phospholipase A2 Inhibitors enzyme inhibitor Compounds that inhibit or block the activity of a phospholipase a2 enzyme D27.505.519.389.737
Photoaffinity labeling Affinity Labels Biologically active molecules which are covalently bound to the enzymes or binding proteins normally acting on them. Binding occurs due to activation of the label by ultraviolet light. These labels are used primarily to identify binding sites on pro D27.720.470.410.080.600
Photoinitiators, Dental Dental Materials Chemical compound used to initiate polymerization of dental resins by the use of dental curing lights. It absorbs uv light and undergoes decomposition into free radicals that initiate polymerization process of the resins in the mix. Each photoinitia D27.720.102.339.249
Photosensitizer dermatologic drug
Radiosensitizer
Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or D27.505.954.600.710
D27.505.954.444.600
physical science natural science the study of physics and chemistry in nature H Physical sciences
Physiological Effects of Drugs Pharmacologic Actions Activities which affect organs and systemic functions without regard to a particular disease. D27.505.696
Phytoestrogens chemical substance
Estrogens, Non-Steroidal
Compounds derived from plants, primarily isoflavones that mimic or modulate endogenous estrogens, usually by binding to estrogen receptors D27.505.696.399.472.277.540.500 Phytoestrogens
Pia mater leptomeninx delicate innermost layer of the meninges, the membranes surrounding the brain and spinal cord A08.186.566.731 Pia mater
picibanil D20.215.659
pisiform bone bone
carpal bone
bone of the wrist A02.835.232.087.319.150.600 Pisiform bone
pituitary gland endocrine gland endocrine gland A06.407.747 Pituitary gland
Pityriasis papulosquamous disorder disease C17.800.859.600
Plant Growth Regulators Growth Substances Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins D27.505.696.377.760
plasma cell dyscrasia blood protein disease C04.557.595
Plasma Substitutes blood substitute Any liquid used to replace blood plasma, usually a saline solution, often with serum albumins, dextrans or other preparations. These substances do not enhance the oxygen- carrying capacity of blood, but merely replace the volume. They are also used D27.505.954.502.140.500
plasticizer chemical substance
film former
emulsifier
Specialty Uses of Chemicals
additives that increase the plasticity or decrease the viscosity of a material D27.720.760
platelet aggregation inhibitor drug
Hematologic Agents
member of a class of pharmaceuticals that decrease platelet aggregation and inhibit thrombus formation. D27.505.954.502.780 Antiplatelet drugs
platelet-rich plasma blood plasma A12.207.152.693.600
A12.207.270.695.600
A15.145.693.600
pleomorphic undifferentiated sarcoma sarcoma C04.557.450.565.590.425.360
C04.557.450.795.400
pleural cavity anatomical cavity thin fluid-filled space between the two pulmonary pleurae (visceral and parietal) of each lung A01.911.800.650
pleural effusion pleural disease
effusion
accumulation of excess fluid in the pleural cavity C08.528.652 Pleural effusion
poison chemical substance
Noxae
Specialty Uses of Chemicals
substance that causes disturbances to organisms D27.720.777
D27.888.569.612
Poisons
 
Poly(ADP-ribose) Polymerase Inhibitors antineoplastic
enzyme inhibitor
Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES. D27.505.519.389.739
D27.505.954.248.692
polymerase chain reaction chemical process nucleic acid methods E05.393.620.500 Polymerase chain reaction
polyneuritis polyneuropathy Human disease C10.668.829.650
polyphagia eating disorder excessive hunger or increased appetite C23.888.821.645
pons brain region part of the brainstem A08.186.211.132.810.428.600 Pons
Positional plagiocephaly Plagiocephaly C05.660.207.707.624
C16.131.621.207.707.624
posterior cruciate ligament cruciate ligament A02.513.514.600
Posterior root of spinal nerve nerve one of two "roots" which emerge from the spinal cord A08.800.800.720.725
Potassium channel blocker Cardiovascular Agents
Membrane Transport Modulators
A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of action potentials. They are used as anti-arrhythmia agents and vasodilator agents D27.505.519.562.500
D27.505.954.411.645
Potassium channel blockers
Potassium Ionophores Ionophore Chemical agents that increase the permeability of cell membranes to potassium ions D27.505.519.562.374.400
D27.720.395.400
Potassium-sparing diuretic diuretic A subclass of diuretics that limits the secretion of potassium into the urine D27.505.696.560.500.726 Potassium-sparing diuretics
preferred provider organization organization
managed care
a type of health insurance plan where a group of health care providers agree to provide services for reduced fees N03.219.521.576.343.800.750
N04.590.374.410.750
premolar molar A14.549.167.860.150
preoptic area A08.186.211.730.385.357.342.450
Preservatives, Pharmaceutical Pharmaceutic Aids Substances added to pharmaceutical preparations to protect them from chemical change or microbial action. They include anti-bacterial agents and antioxidants D27.720.744.771
Primitive streak A16.254.412
Principal sensory nucleus of trigeminal nerve nerve A08.186.211.132.810.428.600.650.718
prisoner's dilemma dilemma canonical example of a game analyzed in game theory E05.385.500 Prisoner's dilemma
Proctoscopy E01.370.372.250.250.600 Proctoscopy
 
Progestins hormone Compounds that interact with progesterone receptors in target tissues to bring about the effects similar to those of progesterone. Primary actions of progestins, including natural and synthetic steroids, are on the uterus and the mammary gland in pr D27.505.696.399.472.858
projective test psychological test F04.711.647.622
Prolyl-Hydroxylase Inhibitors enzyme inhibitor Compounds that inhibit the action of hydroxylases that act on proline to form hydroxyproline D27.505.519.389.740
prostate material anatomical entity
anatomical structure
gland of the male reproductive system in most mammals A05.360.444.575 Prostate
 
Protease inhibitor protein
enzyme inhibitor
molecule that prevents proteases from acting as such D27.505.519.389.745 Protease inhibitors
Protective Agents Specialty Uses of Chemicals
Physiological Effects of Drugs
Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. D27.720.799
D27.505.696.706
Protein kinase inhibitor enzyme inhibitor Agents that inhibit Protein kinases D27.505.519.389.755 Protein kinase inhibitors
Protein synthesis inhibitor reaction inhibitor
enzyme inhibitor
Compounds which inhibit the synthesis of proteins. They are usually anti-bacterial agents or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the a site of ribosomes, the misreading of D27.505.519.389.760
Proton Ionophores Ionophore
Uncoupling Agents
Chemical agents that increase the permeability of cell membranes to protons D27.505.519.562.374.500
D27.720.395.500
D27.505.519.389.936.500
Proton-pump inhibitor drugs for acid-related disorders
enzyme inhibitor
group of drugs whose main action is a pronounced and long-lasting reduction of gastric acid production D27.505.519.389.848 Proton pump inhibitors
Provitamin vitamin Precursor forms of vitamins D27.505.696.377.605.600.354
pseudorabies swine disease Herpesviridae infectious disease Human disease C02.182.710
C02.256.466.793
C10.228.228.245.710
C22.742
Pseudorabies
psychological test test F04.711 Psychological tests
psychology social science
academic discipline
social science study of mental functions and behaviours F04.096.628 Psychology
 
Psychotropic Drugs Central Nervous System Agents A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents) D27.505.954.427.700
pubic symphysis symphysis A02.835.583.656 Pubic symphysis
publication creative work
mass media
distribution
written work
output of the act of publishing, and also refers to any printed copies V Publications
Puerperal fever puerperal disorder Human disease C01.539.674.715
C13.703.700.715
C13.703.844.757
Pulmonary sequestration respiratory system disease congenital disorder of respiratory system C08.695.214
C16.131.740.214
Pulmonary Surfactants Respiratory System Agents Substances and drugs that lower the surface tension of the mucoid layer lining the pulmonary alveoli D27.505.954.796.600
Pulp Capping and Pulpectomy Agents Dental Materials Materials used in dental pulp capping or pulpectomy D27.720.102.339.500
Pure autonomic failure orthostatic hypotension
Dysautonomia
C10.177.575.650
Purinergic Agents neurotransmitter Compounds that act on purinergic receptors or influence the synthesis, storage, uptake, metabolism, or release of purinergic transmitters D27.505.696.577.725
D27.505.519.625.725
Purinergic Agonists Purinergic Agents Compounds that bind to and activate purinergic receptors D27.505.696.577.725.200
D27.505.519.625.725.200
Purinergic Antagonists Purinergic Agents Drugs that bind to and block the activation of purinergic receptors D27.505.519.625.725.400
D27.505.696.577.725.400
Purinergic P1 Receptor Agonists Purinergic Agonists Compounds that bind to and stimulate purinergic p1 receptors D27.505.696.577.725.200.100
D27.505.519.625.725.200.100
Purinergic P1 Receptor Antagonists Purinergic Antagonists Compounds that bind to and block the stimulation of purinergic p1 receptors D27.505.696.577.725.400.100
D27.505.519.625.725.400.100
Purinergic P2 Receptor Agonists Purinergic Agonists Compounds that bind to and stimulate purinergic p2 receptors D27.505.519.625.725.200.200
D27.505.696.577.725.200.200
Purinergic P2 Receptor Antagonists Purinergic Antagonists Compounds that bind to and block the stimulation of purinergic p2 receptors D27.505.696.577.725.400.200
D27.505.519.625.725.400.200
Purinergic P2X Receptor Agonists Purinergic P2 Receptor Agonists Compounds that bind to and stimulate purinergic p2x receptors. Included under this heading are agonists for specific p2x receptor subtypes D27.505.696.577.725.200.200.100
D27.505.519.625.725.200.200.100
Purinergic P2X Receptor Antagonists Purinergic P2 Receptor Antagonists Compounds that bind to and block the stimulation of purinergic p2x receptors. Included under this heading are antagonists for specific p2x receptor subtypes D27.505.519.625.725.400.200.100
D27.505.696.577.725.400.200.100
Purinergic P2Y Receptor Agonists Purinergic P2 Receptor Agonists Compounds that bind to and stimulate purinergic p2y receptors. Included under this heading are agonists for specific p2y receptor subtypes D27.505.519.625.725.200.200.200
D27.505.696.577.725.200.200.200
Purinergic P2Y Receptor Antagonists Purinergic P2 Receptor Antagonists Compounds that bind to and block the stimulation of purinergic p2y receptors. Included under this heading are antagonists for specific p2y receptor subtypes D27.505.519.625.725.400.200.200
D27.505.696.577.725.400.200.200
pyonephrosis renal infectious disease infection of the renal collecting system C12.777.419.307.500
C13.351.968.419.307.500
pyramidal tracts nerve tract A08.186.854.633
 
Pyrogens Noxae Substances capable of increasing body temperature and cause fever and may be used for fever therapy. They may be of microbial origin, often polysaccharides, and may contaminate distilled water D27.888.569.673
Quadrantanopia Anopsia C10.597.751.941.512
C11.966.075.500
C23.888.592.763.941.512
Quadrantanopia
radial nerve nerve nerve in the human body that supplies the posterior portion of the upper limb A08.800.800.720.050.700
 
Radiation-Protective Agents Protective Agents Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other, e.g. Military, purposes D27.720.799.763
D27.505.696.706.776
radioactive waste environmental issue waste
by-product
Hazardous waste
wastes that contain radioactive material D27.888.426.500.638 Nuclear waste
Radiopharmaceutical Indicators and Reagents
mechanism of action
Diagnostic Uses of Chemicals
Medicinal radiocompound D27.720.470.410.650
D27.505.259.843
D27.505.519.871
Radiopharmaceuticals
 
Radiosensitizer Therapeutic Uses Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells D27.505.954.600
Raphe nuclei A08.186.211.132.659.632
rare disease disease disease that affects a small percentage of the population C23.550.291.906 Rare diseases
Reagent Kits, Diagnostic Indicators and Reagents
Diagnostic Uses of Chemicals
Commercially prepared reagent sets, with accessory devices, containing all of the major components and literature necessary to perform one or more designated diagnostic tests or procedures. They may be for laboratory or personal use D27.505.259.875
D27.720.470.410.680
Reagent Strips Reagent Kits, Diagnostic Narrow pieces of material impregnated or covered with a substance used to produce a chemical reaction. The strips are used in detecting, measuring, producing, etc., other substances. (from dorland, 28th ed) D27.505.259.875.680
D27.720.470.410.680.680
real-time polymerase chain reaction polymerase chain reaction
Quantitative polymerase chain reaction
Method in molecular biology; laboratory technique of molecular biology based on the polymerase chain reaction (PCR) E05.393.620.500.706 Quantitative polymerase chain reaction
recto-uterine pouch A01.923.047.025.600.225
red nucleus A08.186.211.132.659.822.642 Red nucleus
Reducing Agents Indicators and Reagents Materials that add an electron to an element or compound, that is, decrease the positiveness of its valence. (from mcgraw-hill dictionary of scientific and technical terms, 5th ed) D27.720.470.410.690
Refeeding syndrome malnutrition C18.654.521.687
Renal Agents Therapeutic Uses Drugs used for their effects on the kidneys' regulation of body fluid composition and volume. The most commonly used are the diuretics. Also included are drugs used for their antidiuretic and uricosuric actions, for their effects on the kidneys' cle D27.505.954.613
Renal stem cell A05.810.453.736.560.610
Reperfusion injury vascular disease the tissue damage caused when blood supply returns to the tissue after a period of ischemia or lack of oxygen (anoxia, hypoxia) C14.907.725
C23.550.767.877
repetitive strain injury occupational disease
musculoskeletal disorder
injury to the musculoskeletal and nervous systems that may be caused by repetitive tasks, forceful exertions, vibrations, mechanical compression, or sustained or awkward positions C26.844.150
Reproductive Control Agents Physiological Effects of Drugs
Therapeutic Uses
Substances used either in the prevention or facilitation of pregnancy D27.505.954.705
D27.505.696.875
Respiratory System Agents Therapeutic Uses Drugs used for their effects on the respiratory system D27.505.954.796
respiratory tract infection infectious disease
respiratory system disease
any number of infectious diseases involving the respiratory tract C01.539.739
C08.730
Respiratory infections
rete testis A05.360.444.849.600
reticular formation spinal trigeminal nucleus A08.186.211.132.772 Reticular formation
Retroperitoneal fibrosis IgG4-related disease
immune system disease
rare abdominal surgical disease
Related to igG4-related disease C23.550.355.700
retroperitoneal space anatomical space in the abdominal cavity behind the peritoneum A01.047.025.750 Retroperitoneal space
reverse transcription and polymerase chain reaction polymerase chain reaction method in molecular biology; variant of polymerase chain reaction (PCR), is a technique commonly used in molecular biology to detect RNA expression E05.393.620.500.725
reverse-transcriptase inhibitor nucleic acid inhibitor
Anti-Retroviral Agents
Inhibitors of reverse transcriptase (rna-directed dna polymerase), an enzyme that synthesizes dna on an rna template D27.505.954.122.388.077.750
D27.505.519.389.675.850
Non-nucleoside reverse transcriptase inhibitors
Rhabdomyoma tumor C04.557.450.590.540.700 Rhabdomyoma
Rhinencephalon A08.186.211.577.699
rhytidectomy medical procedure E02.218.765 Rhytidectomy
 
ribosomal RNA non-coding RNA
chemical compound
RNA component of the ribosome, and is essential for protein synthesis in all living organisms D13.444.735.686 Ribosomal RNA
Rigor mortis decomposition sign of death C23.550.260.224.617.839 Rigor mortis
Riot Control Agents, Chemical Noxae
Specialty Uses of Chemicals
Chemical substances which are employed during a riot in order to control or disperse the rioting parties D27.888.569.734
D27.720.821
RNA Probes Nucleic Acid Probes Rna, usually prepared by transcription from cloned dna, which complements a specific mrna or dna and is generally used for studies of virus genes, distribution of specific rna in tissues and cells, integration of viral dna into genomes, transcriptio D27.720.470.530.600.825
D27.505.259.750.600.825
RNA, Complementary RNA Probes Synthetic transcripts of a specific dna molecule or fragment, made by an in vitro transcription system. This crna can be labeled with radioactive uracil and then used as a probe. (king & stansfield, a dictionary of genetics, 4th ed) D27.720.470.530.600.825.840
rodenticide zoocide
pesticide
Substances used to destroy or inhibit the action of rats, mice, or other rodents D27.888.723.853
D27.720.031.700.853
Rodenticides
Root Canal Irrigants Dental Disinfectants Chemicals used mainly to disinfect root canals after pulpectomy and before obturation. The major ones are camphorated monochlorophenol, edta, formocresol, hydrogen peroxide, metacresylacetate, and sodium hypochlorite. Root canal irrigants include al D27.505.954.122.425.300.500
D27.720.274.300.500
Rosai–Dorfman disease non-Langerhans-cell histiocytosis C15.604.250.410.450 Rosai–Dorfman disease
round ligament of uterus A05.360.319.114.803
round window A09.246.631.246.814
Ruptured spleen Blunt splenic trauma C15.604.744.742
C26.017.680
C26.761.555
Splenic injury
 
sarcopenia muscle atrophy
aging-associated diseases
muscle weakness
Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles C10.597.613.612.500
C23.300.070.500.500
C23.888.592.608.612.500
Sarcopenia
scaphoid bone bone
carpal bone
bone of the carpus A02.835.232.087.319.150.750 Scaphoid bone
Schistosomicides Antiplatyhelmintic Agents Agents that act systemically to kill adult schistosomes D27.505.954.122.250.075.100.750
Sclerosing Solutions Cardiovascular Agents
Pharmaceutical Solutions
Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized thrombosis; fibrosis, and obliteration of the vessels. This treatment is applied in a number of conditions such as varicose veins; hemorrhoids; gastric va D27.505.954.578.822
D27.505.954.411.700
D27.720.752.822
sebaceous gland holocrine microscopic exocrine glands in the skin that secrete an oily or waxy matter, called sebum, to lubricate and waterproof the skin and hair of mammals A10.336.827 Sebaceous gland
Selective estrogen-receptor modulator Estrogen Receptor Modulators A structurally diverse group of compounds distinguished from estrogens by their ability to bind and activate estrogen receptors but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as eithe D27.505.696.399.450.360.827 Selective estrogen receptor modulators
selective serotonin reuptake inhibitor antidepressant
Neurotransmitter Uptake Inhibitors
Serotonin Agents
a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder and anxiety disorders. D27.505.519.625.850.900
D27.505.696.577.600.850
D27.505.519.625.600.850
D27.505.696.577.850.900
D27.505.519.562.437.850
Selective serotonin reuptake inhibitors
semantic differential rating scale
personality test
F02.694.663
F04.711.647.745
seminal vesicle pair of simple tubular glands posteroinferior to the urinary bladder of male mammals A05.360.444.713
seminiferous tubule A05.360.444.849.700 Seminiferous tubule
Sensory System Agents Peripheral Nervous System Agents Drugs that act on neuronal sensory receptors resulting in an increase, decrease, or modification of afferent nerve activity. (from smith and reynard, textbook of pharmacology, 1991, p367) D27.505.696.663.850
sepsis general infection life-threatening organ dysfunction triggered by infection C01.539.757
C23.550.470.790.500
Sepsis
septum pellucidum A08.186.211.276.814 Septum pellucidum
Sequestering Agents Specialty Uses of Chemicals
mechanism of action
Compounds that bind to and reduce the biological availability of a chemical or pharmaceutical agent. D27.505.519.914
D27.720.832
Serine Peptidase Inhibitors, Kazal Type Serine Proteinase Inhibitors A family of serine peptidase inhibitors that occur in animals, some single-cell eukaryotes, and higher plants. They contain variable numbers of kazal motifs and inhibit serine endopeptidases such as acrosin and trypsin D27.505.519.389.745.800.562
Serine Proteinase Inhibitors Protease inhibitor Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. D27.505.519.389.745.800
Serotonin 5-HT1 Receptor Agonists serotonin receptor agonist Endogenous compounds and drugs that specifically stimulate serotonin 5-ht1 receptors. Included under this heading are agonists for one or more of the specific 5-ht1 receptor subtypes D27.505.696.577.850.800.100
D27.505.519.625.850.800.100
Serotonin 5-HT1 Receptor Antagonists serotonin antagonist Drugs that bind to but do not activate serotonin 5-ht1 receptors, thereby blocking the actions of serotonin 5-ht1 receptor agonists. Included under this heading are antagonists for one or more of the specific 5-ht1 receptor subtypes D27.505.519.625.850.850.100
D27.505.696.577.850.850.100
Serotonin 5-HT2 Receptor Antagonists serotonin antagonist Drugs that bind to but do not activate serotonin 5-ht2 receptors, thereby blocking the actions of serotonin or serotonin 5-ht2 receptor agonists. Included under this heading are antagonists for one or more specific 5-ht2 receptor subtypes D27.505.696.577.850.850.200
D27.505.519.625.850.850.200
Serotonin 5-HT3 Receptor Agonists serotonin receptor agonist Endogenous compounds and drugs that specifically stimulate serotonin 5-ht3 receptors D27.505.519.625.850.800.300
D27.505.696.577.850.800.300
Serotonin 5-HT3 Receptor Antagonists serotonin antagonist Drugs that bind to but do not activate serotonin 5-ht3 receptors, thereby blocking the actions of serotonin or serotonin 5-ht3 receptor agonists D27.505.519.625.850.850.300
D27.505.696.577.850.850.300
Serotonin 5-HT4 Receptor Agonists serotonin receptor agonist Endogenous compounds and drugs that specifically stimulate serotonin 5-ht4 receptors D27.505.696.577.850.800.400
D27.505.519.625.850.800.400
Serotonin 5-HT4 Receptor Antagonists serotonin antagonist Drugs that bind to but do not activate serotonin 5-ht4 receptors, thereby blocking the actions of serotonin or serotonin receptor agonists D27.505.696.577.850.850.400
D27.505.519.625.850.850.400
Serotonin Agents neurotransmitter Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons D27.505.519.625.850
D27.505.696.577.850
Serotonin and Noradrenaline Reuptake Inhibitors Neurotransmitter Uptake Inhibitors Drugs that selectively block or suppress the plasma membrane transport of serotonin and noradrenaline into axon terminals and are used as antidepressive agents D27.505.519.625.600.693
D27.505.696.577.600.693
D27.505.519.562.437.693
serotonin antagonist Serotonin Agents Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or serotonin receptor agonists D27.505.696.577.850.850
D27.505.519.625.850.850
Serotonin receptor antagonists
serotonin receptor agonist Serotonin Agents Endogenous compounds and drugs that bind to and activate serotonin receptors. Many serotonin receptor agonists are used as antidepressants; anxiolytics; and in the treatment of migraine disorders D27.505.696.577.850.800
D27.505.519.625.850.800
Serotonin receptor agonists
serotonin syndrome adverse drug reaction
rare disease with malignant hyperthermia
Serotoninergic syndrome is characterised by an excess of serotonin in the central nervous system, associated with the use of various agents, including selective serotonin reuptake inhibitors (SSRIs) C25.100.875
serous membrane mesothelium A10.615.789
Serpins Serine Proteinase Inhibitors A family of serine proteinase inhibitors which are similar in amino acid sequence and mechanism of inhibition, but differ in their specificity toward proteolytic enzymes. Some members of the serpin family may be substrates rather than inhibitors of D27.505.519.389.745.800.675
Sertoli cell Sustentacular cell A05.360.444.849.789
 
set of intercostal nerves set of ventral rami of spinal nerve A08.800.800.720.800.350
sexually transmitted infection infectious disease infection transmitted through human sexual behavior C01.539.778 Sexually transmitted diseases and disorders
shamanism alternative medical treatment E02.190.488.830
E02.190.901.788
I01.076.201.450.654.830
Shamanism
shellfish poisoning poisoning
food poisoning
C25.723.415.792
shin splints occupational disease
periostitis
C05.651.426
C10.668.491.087
C26.558.705
Shin splints
shoulder anatomical region part of the body A01.378.800.750 Shoulders
 
Siderophore Iron Chelating Agents Low-molecular-weight compounds produced by microorganisms that aid in the transport and sequestration of ferric iron. (the encyclopedia of molecular biology, 1994) D27.720.832.500.410.750
D27.505.519.914.500.410.750
Siderophores
single-payer health care health insurance
publicly funded health care
N03.219.521.576.343.962
N03.219.521.855
N03.349.550.805
Sinus tachycardia tachycardia heart rate greater than 100 beats/min (bpm) C14.280.067.845.880.845
C23.550.073.845.880.845
Sinus tachycardia
skin animal organ
material
soft outer covering organ of vertebrates A17.815.180 Skin
 
Skin Lightening Preparations cosmetics Substances used to obtain a lighter skin complexion or to treat hyperpigmentation disorders D27.720.269.750
Sleep Aids, Pharmaceutical Therapeutic Uses Drugs used to induce sleep, prevent sleeplessness, or treat sleep initiation and maintenance disorders D27.505.954.842
Small Molecule Libraries Laboratory Chemicals Large collections of small molecules (molecular weight about 600 or less), of similar or diverse nature which are used for high-throughput screening analysis of the gene function, protein interaction, cellular processing, biochemical pathways, or ot D27.720.470.765
smoke inhalation Q3153683
Acute inhalation injury
upper respiratory burn
inhalation
C26.200.322.800
snack food food portion of food often smaller than a regular meal G07.203.300.590.780
J02.500.590.780
Snack food
soap salt
detergent
sodium salt of fatty acids ( long chain carboxylic acids ), used for washing and cleaning D27.720.877.265.861 Soap
Social mobility I01.880.853.996.755.673
N01.824.782.673
Social mobility
Sodium Channel Agonists Membrane Transport Modulators A class of drugs that stimulate sodium influx through cell membrane channels D27.505.519.562.625
Sodium channel blocker Cardiovascular Agents
Membrane Transport Modulators
A class of drugs that act by inhibition of sodium influx through cell membranes. Blockade of sodium channels slows the rate and amplitude of initial rapid depolarization, reduces cell excitability, and reduces conduction velocity D27.505.519.562.750
D27.505.954.411.720
Sodium channel blockers
Sodium Chloride Symporter Inhibitors diuretic
Membrane Transport Modulators
Agents that inhibit sodium chloride symporters. They act as diuretics. Excess use is associated with hypokalemia D27.505.519.562.812
D27.505.696.560.500.863
Sodium Ionophores Ionophore Chemical agents that increase the permeability of cell membranes to sodium ions D27.505.519.562.374.750
D27.720.395.750
Sodium Potassium Chloride Symporter Inhibitors diuretic
Membrane Transport Modulators
Agents that inhibit sodium-potassium-chloride symporters which are concentrated in the thick ascending limb at the junction of the loop of henle and kidney tubules, distal. They act as diuretics. Excess use is associated with hypokalemia and hypergl D27.505.696.560.500.931
D27.505.519.562.906
Soil Pollutants Environmental Pollutants Substances which pollute the soil. Use for soil pollutants in general or for which there is no specific heading D27.888.284.756
Soil Pollutants, Radioactive Soil Pollutants Pollutants, present in soil, which exhibit radioactivity D27.888.284.756.674
Solitary nucleus A08.186.211.132.810.406.750
solvent chemical substance
Specialty Uses of Chemicals
substance that dissolves a solute (a chemically different liquid, solid or gas), resulting in a solution D27.720.844 Solvents
somatosensory disorder sensation disorder human disease C10.597.751.791
C23.888.592.763.770
somite division of the body of an animal or embryo A16.254.425.660.750 Somites
 
Specialty Uses of Chemicals chemical Actions and Uses Uses of chemicals in a research, industrial, or household setting. This does not include PHARMACOLOGIC ACTIONS D27.720
Sperm Immobilizing Agents Antispermatogenic Agents
Contraceptive Agents, Female
Chemical substances with sperm immobilizing activity used as topically administered vaginal contraceptives D27.505.954.705.360.276.727
D27.888.569.071.379
D27.505.696.875.360.276.727
D27.505.696.138.379
Spermatid Gametid A05.360.490.890.860
Spermatogenesis-Blocking Agents Antispermatogenic Agents Chemical substances which inhibit the process of spermatozoa formation at either the first stage, in which spermatogonia develop into spermatocytes and then into spermatids, or the second stage, in which spermatids transform into spermatozoa D27.888.569.071.760
D27.505.954.705.360.443.068.760
D27.505.696.138.760
D27.505.696.875.360.443.068.760
Spermatogonium A05.360.490.890.900
spermatozoon gamete male reproductive cell A05.360.490.890 Spermatozoa
Spermicide birth control Antispermatogenic Agents
Contraceptive Agents, Female
birth control D27.888.569.071.569
D27.505.696.138.569
D27.505.696.875.360.276.827
D27.505.954.705.360.276.827
sphenoid bone bone unpaired bone situated at the front middle of the skull in front of the temporal bone and basilar part of the occipital bone A02.835.232.781.802 Sphenoid bones
Sphincter of ampulla A03.159.183.079.300.950.600
spider bite Arthropod bites and stings bite caused by a spider C25.723.127.723
C26.176.790
 
spinal cord injury spinal cord disease
central nervous system trauma
C10.228.854.770
C10.900.850
C26.819
C26.117.500
Spinal cord injuries
spinal dysraphism Congenital vertebral anomaly D016135
spinal nerve peripheral nerve nerve that carries signals between the spinal chord and the body A08.800.800.720 Spinal nerves
Spinal trigeminal nucleus A08.186.211.132.931.920
Spiral ganglion A08.340.390.800
spirit possession paranormal belief that animas, demons, extraterrestrials, gods, or spirits can take control of a human body K01.844.619.500
Stanford–Binet Intelligence Scales IQ test संतोष माली उज्जैन F04.711.141.493.225
starvation undernutrition hunger severe deficiency in caloric energy, nutrient, and vitamin intake C18.654.521.750 Starvation
 
statin drug
Anticholesteremic Agents
enzyme inhibitor
a class of drugs used to lower cholesterol levels D27.505.519.389.370
D27.505.954.557.500.202.370
D27.505.519.186.071.202.370
Statins
Stellate ganglion A08.340.315.350.800
Steroid Synthesis Inhibitors enzyme inhibitor
Hormone Antagonists
Compounds that bind to and inhibit enzymes involved in the synthesis of steroids D27.505.696.399.450.855
D27.505.519.389.870
stimulant psychoactive drug
Central Nervous System Agents
Physiological Effects of Drugs
type of psychoactive drug D27.505.954.427.220
D27.505.696.282
Stimulants
Stimulants, Historical Therapeutic Uses Agents or remedies that historically have produced stimulation or excited functional activity D27.505.954.888
Straight sinus A07.231.908.224
street child child
the poor
homeless child living on the street M01.325.400 Street children
 
subcutaneous tissue connective tissue lowermost layer of the integumentary system in vertebrates A10.165.887
subfornical organ A08.713.840
submandibular duct A03.556.500.760.640
Substantia gelatinosa of Rolando A08.186.854.697.500.500
Substantia innominata A08.186.211.577.820 Substantia innominata
substantia nigra A08.186.211.132.659.687 Substantia nigra
Subtalar joint Joints of foot A02.835.583.378.831.780
Sudden unexpected nocturnal death syndrome sudden cardiac death C14.280.067.322
sugar substitute food additive
sweetener
sweetener that contains significantly less food energy than sugar D27.720.372.300.353.609.500 Sweeteners
suicide killing intentional act of causing one's own death F01.145.126.980.875 Suicide
 
Sulfhydryl Reagents Indicators and Reagents Chemical agents that react with sh groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling D27.720.470.410.700
sunscreen cosmetics
dermatologic drug
Radiation-Protective Agents
topical skin product that helps protect against sunburn D27.505.954.444.695
D27.720.799.763.764
D27.720.269.800
D27.505.696.706.776.800
Sunscreening agents
Superior cervical ganglion A08.340.315.350.850 Superior cervical ganglion
superior colliculus structure in the mammalian midbrain A08.186.211.132.659.237.816 Superior colliculus
Superior hypogastric plexus A08.800.050.050.400
suprachiasmatic nucleus A08.186.211.730.385.357.342.625 Suprachiasmatic nucleus
Supraoptic nucleus A08.186.211.730.385.357.342.650
supraventricular tachycardia tachycardia
supraventricular arrhythmia
paroxysmal tachycardia
abnormally fast heart rhythm arising from improper electrical activity in the upper part of the heart C14.280.067.845.880
C23.550.073.845.880
Sural nerve nerve A08.800.800.720.450.760.820.820
Surface plasmon resonance microscopy E05.196.890
E05.601.043.700
surfactant chemical substance
emulsifier
Specialty Uses of Chemicals
group of chemical substances D27.720.877 Surfactants
Susac's syndrome microangiopathy
immune system disease
Autoimmune connective tissue disorder
autoimmune disease of the nervous system
rare central nervous system and retinal vascular disease
C09.218.855
C10.228.140.300.787
C10.597.825
C11.768.400.500
C11.966.858
C14.907.137.780.500
C23.888.307.750
C23.888.592.848
Susac's syndrome
sweat gland exocrine gland small tubular structures of the skin that produce sweat; a type of exocrine gland, which are glands that produce and secrete substances onto an epithelial surface by way of a duct A10.336.899
 
sweetener food additive
flavoring agent
substance added to food to give it the basic taste of sweetness D27.720.372.300.353.609
Sydenham's chorea choreatic disease
postinfectious autoimmune disease with chorea
Human disease C10.228.662.262.249
C10.597.350.250
C23.888.592.350.250
Sympatholytic Autonomic Agents medication that opposes the downstream effects of postganglionic nerve firing in effector organs innervated by the sympathetic nervous system D27.505.696.663.050.850
Sympathomimetic drug Autonomic Agents stimulant compounds D27.505.696.663.050.870 Sympathomimetics
Syncytiotrophoblast A16.254.085.162
systemic inflammatory response syndrome inflammation Human disease C23.550.470.790
C23.550.835.900
Tactile corpuscle Q1648747 A08.675.650.915.750 Meissner's corpuscle
Takotsubo cardiomyopathy cardiomyopathy
Ventricular Dysfunction, Left
unclassified cardiomyopathy
Sudden temporary weakening of the heart muscle C14.280.945.900.500 Takotsubo cardiomyopathy
talus bone bone of the ankle A02.835.232.043.300.710.780 Talus
 
tear gas non-lethal weapon
chemical weapon
gas
Riot Control Agents, Chemical
non-lethal chemical weapon D27.720.821.500
D27.888.569.734.500
Lachrymatory agents
 
technology applied science making, modification, usage, and knowledge of tools, machines, techniques, crafts, systems, and methods of organization J01.897 Technology
 
temporal bone bone bones situated at the sides and base of the skull, and lateral to the temporal lobes of the cerebrum A02.835.232.781.885 Temporal bone
 
temporomandibular joint disorder Internal Derangement
Internal Displacement
ankylosis
joint dislocation
Temporomandibular joint pathology
Human disease C05.500.607.221.897.897
C05.550.905.905
C05.651.243.897.897
C05.651.550.905
C07.320.610.291.897.897
C07.678.949
Temporomandibular joint dysfunction
 
tendinopathy musculoskeletal disorder
soft tissue disorder
synovial, tendon or bursa disorder
Bruised tendon C05.651.869
C26.874.800
Tendinopathy
Teratogen Noxae An agent that causes the production of physical defects in the developing embryo D27.888.569.864 Teratogens
Teratospermia male infertility C12.294.365.700.877
Thematic Apperception Test projective test projective psychological test F04.711.647.622.851
Therapeutic Uses Pharmacologic Actions Uses of chemicals which affect the course of conditions, diseases, syndromes or pathology to benefit the health of an individual. D27.505.954
Thiobarbituric Acid Reactive Substances Indicators and Reagents Low-molecular-weight end products, probably malondialdehyde, that are formed during the decomposition of lipid peroxidation products. These compounds react with thiobarbituric acid to form a fluorescent red adduct D27.720.470.410.750
Third metacarpal bone metacarpal bone A02.835.232.087.319.550 Third metacarpal bone
Thoracic duct Lymph trunk A15.382.520.301.750 Thoracic duct
Thoracic splanchnic nerves A08.800.050.050.800
thumb finger first digit of the hand A01.378.800.667.430.705 Thumbs
 
thyroid cartilage cartilage A02.165.257.625.870 Thyroid cartilage
thyroid gloubu endocrine gland
lobular organ
endocrine glandi A06.407.900 Thyroid
tibia bone larger of the two bones of the leg below the knee for vertebrates A02.835.232.043.650.883 Tibia
 
tibial nerve nerve A08.800.800.720.450.760.820
 
tick-borne disease zoonosis disease caused by infectious agents transmitted by tick bites C01.252.400.825
C02.081.885
C03.752.875
Tick-borne diseases
Tietze syndrome Tietze's syndrome C05.182.790
C17.300.182.790
 
tissue multicellular structure
biological component
organism substance
group of cells
cellular organizational level intermediate between cells and a complete organism; cells that are grouped together with a common function A10 Biological tissue
Tissue Adhesives Biomedical and Dental Materials Substances used to cause adherence of tissue to tissue or tissue to non-tissue surfaces, as for prostheses D27.720.102.919
Tocolytic Agents Reproductive Control Agents Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (tocolysis). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adre D27.505.954.705.825
D27.505.696.875.825
tonsillectomy lymphatic ectomy surgical removal of the tonsils E04.580.848 Tonsillectomy
 
Tooth Bleaching Agents Bleaching Agents Chemicals that are used to oxidize pigments in teeth and thus effect whitening D27.720.642.315.500
tooth discoloration change
concept
medical finding
tooth disease abnormal tooth color, hue or translucency C07.793.735
Tooth impaction failure of eruption of teeth C07.793.846
Topoisomerase I Inhibitors Topoisomerase Inhibitor Compounds that inhibit the activity of DNA TOPOISOMERASE I. D27.505.954.248.794.500
D27.505.519.389.892.500
Topoisomerase II Inhibitors Topoisomerase Inhibitor Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of D27.505.954.248.794.750
D27.505.519.389.892.750
Topoisomerase Inhibitor antineoplastic
enzyme inhibitor
Topoisomerase inhibitors D27.505.954.248.794
D27.505.519.389.892
Topoisomerase inhibitors
Torsades de pointes heart arrhythmia
ventricular tachycardia
specific type of abnormal heart rhythm that can lead to sudden cardiac death. It is a polymorphic ventricular tachycardia that exhibits distinct characteristics on the electrocardiogram C14.280.067.845.940.700
C23.550.073.845.940.700
Torsades de pointes
Torsion dystonia generalized dystonia C10.228.140.079.357
C10.228.662.300.200
C10.574.500.393
C16.320.400.330
Total body irradiation E02.815.814
Trace Elements Micronutrients A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (from mcgraw-hill dictionary of scientific and technical terms, 4th ed) D27.505.696.377.605.555
traditional medicine alternative medicine medicine based on traditional beliefs E02.190.488
I01.076.201.450.654
Traditional medicine
transfer RNA non-coding RNA D13.444.735.757 TRNA
transient tachypnea of the newborn Respiratory Distress Syndrome, Newborn Human disease C08.381.842.737
C08.618.842.737
C08.618.961.500
C16.614.521.563.737
C23.888.852.944.500
trapezium bone bone of the wrist A02.835.232.087.319.150.800 Trapezium (bone)
trapezoid bone bone A02.835.232.087.319.150.805 Trapezoid bone
treponematosis spirochetal diseases Human disease C01.252.400.840
C01.252.847.840
Triangular fibrocartilage A02.835.583.405.930.800
Trichiasis eyelid disease C11.338.912 Trichiasis
tricyclic antidepressant antidepressant chemical compounds used primarily as antidepressants. D27.505.954.427.700.122.055 Tricyclic antidepressants
Trigeminal ganglion sensory ganglion of the trigeminal nerve A08.340.390.850 Trigeminal ganglion
Trigeminal motor nucleus A08.186.211.132.931
 
Trigeminal nerve nuclei nerve A08.186.211.132.931
triquetral bone bone
carpal bone
bone in the wrist A02.835.232.087.319.150.831 Triquetral bone
trophoblast cells forming the outer layer of a blastocyst A11.382.992
truncus arteriosus anatomical structure
embryonic structure
arterial trunk that is arising from fetal heart A07.541.278.930
Trypanocidal Agents antiprotozoal Agents destructive to the protozoal organisms belonging to the suborder trypanosomatina D27.505.954.122.250.100.875
Trypsin inhibitor Serine Proteinase Inhibitors Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds D27.505.519.389.745.800.900
Tubulin Modulators Antimitotic Agents Agents that interact with tubulin to inhibit or promote polymerization of microtubules D27.505.519.593.249.500
ulnar nerve nerve nerve which runs near the ulna bone A08.800.800.720.050.850
Ulnar nerve entrapment occupational disease
ulnar nerve lesion
nerve compression syndrome
C10.668.829.500.850.600
C10.668.829.550.925
C26.844.150.957
Ultimopharyngeal body A13.939
Uncoupling Agents enzyme inhibitor Chemical agents that uncouple oxidation from phosphorylation in the metabolic cycle so that atp synthesis does not occur. Included here are those ionophores that disrupt electron transfer by short-circuiting the proton gradient across mitochondrial D27.505.519.389.936
upper limb anatomical structure arm (hand + forearm + upper arm + shoulder) A01.378.800 Human upper extremities
Urachus A16.254.835 Urachus
Uricosuric Agents Gout Suppressants
Renal Agents
Gout suppressants that act directly on the renal tubule to increase the excretion of uric acid, thus reducing its concentrations in plasma D27.505.954.613.860
D27.505.954.329.337.900
Urological Agents Therapeutic Uses Drugs used in the treatment of urogenital conditions and diseases such as urinary incontinence; prostatic hyperplasia; and erectile dysfunction D27.505.954.944
Uterine atony abnormality of forces of labor C13.703.420.288.728
uterine prolapse prolapse of female genital organ C13.351.500.852.833
C23.300.842.624.750
Uterine prolapse
uterus sex organ major female hormone-responsive reproductive sex organ of most mammals including humans A05.360.319.679 Uterus
vaginismus vaginal disease C13.351.500.665.656
C13.351.500.894.870
Value-Based Insurance Design health insurance N03.219.521.576.343.972
N04.761.744.750
vas deferens part of the male reproductive system of many vertebrates A05.360.444.930 Vas deferens
Vasoconstrictor Agents Cardiovascular Agents Drugs used to cause constriction of the blood vessels D27.505.954.411.793
Vasopeptidase Inhibitors ACE inhibitor A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both neutral endopeptidase and angiotensin converting enzyme. They increase the availability of natriuretic peptides and bradykinin a D27.505.519.389.745.085.500
vein blood vessel blood vessels that carry blood towards the heart A07.231.908 Veins
vertebra bone bone in the spinal column A02.835.232.834 Vertebrae
vestibular nerve nerve A08.800.800.120.910.900
 
Viral Fusion Protein Inhibitors mechanism of action
antiviral agent
Drugs that are designed to block the action of viral fusion proteins and prevent viruses from entering the cell D27.505.954.122.388.538
D27.505.519.957
viral hemorrhagic fever viral infectious disease C02.782.417 Viral hemorrhagic fevers
Viremia hematopoietic system diseases
viral infectious disease
C02.937
C23.550.470.790.500.900
Viscoelastic Substances Specialty Uses of Chemicals Substances that display the physical properties of ELASTICITY and VISCOSITY. The dual-nature of these substances causes them to resist applied forces in a time-dependent manner. D27.720.944
Viscosupplements Protective Agents
lubricant
Viscoelastic Substances
Viscoelastic solutions that are injected into joints in order to alleviate symptoms of joint-related disorders such as osteoarthritis D27.720.944.500
D27.505.696.706.888
D27.720.556.500
vision disorder sensation disorder human disease C10.597.751.941
C11.966
C23.888.592.763.941
visual impairment eye disease
vision disorder
sensory loss
decreased ability to see C10.597.751.941.905
C11.966.905
C23.888.592.763.941.848
Visual impairment
 
vitamin B vitamin vitamin D27.505.696.377.605.600.708 B vitamins
 
vitamin E vitamin
group of chemical substances
generic descriptor for all tocopherols and tocotrienols that exhibit alpha-tocopherol activity D03.438.150.909 Vitamin E
Vitelline duct A16.254.891
vitelline membrane structure directly adjacent to the outer surface of the plasma membrane of an ovum A16.631.886
vocal cord dysfunction speech disorder
upper respiratory tract disease
C08.360.895
C08.618.980
C09.400.895
vocal folds anatomical structure composed of twin infoldings of mucous membrane stretched horizontally, from back to front, across the larynx. They vibrate, modulating the flow of air being expelled from the lungs during phonation A04.329.364.737 Vocal folds
 
Voltage-Gated Sodium Channel Agonists Sodium Channel Agonists Compounds that either stimulate the opening or prevent closure of voltage-gated sodium channels D27.505.519.562.625.500
Voltage-Gated Sodium Channel Blockers Sodium channel blocker A class of drugs that inhibit the activation of voltage-gated sodium channels D27.505.519.562.750.500
D27.505.954.411.720.500
vulva anatomical structure external genital organs of the female mammal A05.360.319.887 Vulvas
 
vulvodynia vulvar disease
dysesthesia
C13.351.500.944.951 Vulvodynia
Wakefulness-Promoting Agents stimulant A specific category of drugs that prevent sleepiness by specifically targeting sleep-mechanisms in the brain. They are used to treat disorders of excessive somnolence such as narcolepsy. Note that this drug category does not include broadly-acting c D27.505.954.427.220.612
Waldenström hyperglobulinemic purpura hyperglobulinemic purpura C14.907.454.550
C15.378.100.802.250
C15.378.463.515.550
C23.550.414.950.250
C23.888.885.687.250
Wallerian degeneration neurological disorder C23.550.737.750
Water Pollutants Environmental Pollutants Substances or organisms which pollute the water or bodies of water. Use for water pollutants in general or those for which there is no specific heading D27.888.284.903
Water Pollutants, Chemical Water Pollutants Chemical compounds which pollute the water of rivers, streams, lakes, the sea, reservoirs, or other bodies of water D27.888.284.903.655
Water Pollutants, Radioactive Water Pollutants Pollutants, present in water or bodies of water, which exhibit radioactivity D27.888.284.903.821
waterborne disease infectious disease disease caused by pathogenic microorganisms that most commonly are transmitted in contaminated fresh water C01.539.221.750
Wernicke encephalopathy trifunctional transcriptional regulator/proline dehydrogenase/pyrroline-5-carboxylate dehydrogenase NRG857 04915
disease
brain disease
long-term effects of alcohol
Human disease C10.228.140.163.960
C18.452.132.960
C18.654.521.500.133.699.827.822
C25.775.100.625
 
Wetting Agents surfactant A surfactant that renders a surface wettable by water or enhances the spreading of water over the surface D27.720.877.974
Whiplash trauma
Cervical fracture
range of injuries to the neck related to a sudden distortion of the neck C26.700.500 Whiplash (medicine)
 
Word association test personality test F04.711.647.905
work accident accident occurrence during work that leads to physical or mental harm N06.850.135.240 Work accidents
xiphoid process small cartilaginous process (extension) of the lower part of the sternum which is usually ossified in the adult human A02.835.232.904.766.825 Xiphoid processes
yolk sac a membranous sac attached to an embryo, formed by cells of the hypoblast adjacent to the embryonic disk A10.615.284.981
Zona pellucida A05.360.490.690.950 Zona pellucida
End of auto-generated list.